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Routinely collected outcomes (case fatality by 30 days and discharge home by 56
days) have been used to indicate the quality of hospital stroke services in Scotland
since 1994. However, the validity of these data is in doubt. In particular, it is
difficult to know whether differences in outcome are due to differences in the quality
of care or to inadequate adjustment for casemix, biased measurement or the play of
chance. Also, because the majority of patients survive their stroke, the relevance and
sensitivity of the indicators is limited by the failure to report functional outcome.
It would be useful, therefore, to investigate whether a substantially improved system
(one which adjusts comparisons of outcome for important differences in casemix and
which measures functional outcome at a defined time after admission) would be
routinely feasible and provide valid measurements of the quality of stroke care.
We attempted to address these questions in the context of a study of 2724 patients
with an acute stroke admitted to five Scottish hospitals between 1995 and 1997. We
identified patients using routine hospital discharge information and then identified
cases of acute stroke and data describing casemix and the process of care from the
medical record. We collected case fatality by linkage to death certificate data and
functional outcome and institutionalisation by postal survey at six months. We
adjusted comparisons of outcome for casemix using a set of simple, externally
validated logistic regression models.
Abstract
The study shows that a considerably improved routine system for measuring outcome
after stroke is a realistic possibility. Specifically, it suggests that the proposed
system for identifying hospital cohorts and collecting casemix data would be
reasonably accurate and that the proposed system for measuring functional outcome,
although compromised by non-response, would not be seriously biased.
Nonetheless, whether these improvements would result in valid measurements of the
quality of stroke care remains uncertain. At best, it appears that a system reporting
case fatality and death or dependency at six months might be sensitive to moderately
large differences in the quality of care. However, there may be alternative
explanations for this finding and the system would certainly fail to identify
opportunities to improve care at the majority of hospitals. The collection of data
describing simple but important aspects of the process of care in addition to outcome




" People measure what is measurable and collect the results like jackdaws,
regardless ofvalue or usefulness "
Maxwell, 1992
Until not so very long ago, questions regarding the quality of clinical services were
rarely raised in the UK. By and large, physicians were presumed to work to the best
of their abilities to deliver high quality medical care, trust being placed in their
training and professionalism to ensure that this was the case. Recently, however, the
medical and social climate has changed and, for better or for worse, the trust of
patients, public and government in the medical profession has been eroded. As a
result, and combined with recent reforms of the NHS, physicians in the UK now find
themselves subject to considerable pressures to demonstrate the quality of their work
and, where necessary, show that they are making efforts to bring about
improvements. The medical profession has itself contributed to this state of affairs,
and, armed with its evidence-based methods, systematic reviews and clinical
guidelines, it too has become interested in checking the quality of its own practice
and in identifying opportunities to enhance and expand services.
Unfortunately, the simple convergence of opinion that the quality of care should be
measured has not detracted from the fundamental complexities of the task. Whether
the aim is to establish the quality of the environment of care (structure) or of the
actions of clinicians and other staff (process), or to measure the net result of care
(outcome) methodological pitfalls abound, especially when the system of measuring
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the quality of care is to be applied routinely. The tendency to compromise
measurement - for reasons of cost - by relying on sub-optimal data collection
systems that already happen to be in place is a particular source of difficulty.
Problems also arise from the purpose and context of the system of measurement.
Systems which aim to ensure accountability can seem remote and carry notions of
public scrutiny and punishment and so may not foster much in the way of quality
improvement, whilst internal systems which aim to improve quality of care, although
'user friendly', run the risk of being quietly ignored. Thus, there has been and
remains much debate as to the correct approach to measuring the quality of care and
uncertainty as to the value of the mechanisms that are in place.
The Stroke Outcomes Project (SOP), the study upon which this thesis is based, was
conceived in response to the establishment of an external system for measuring the
quality of hospital stroke services in Scotland in 1994. Drawing on its legacy of
(relatively) high quality routine hospital discharge information and its ability to link
these data with centrally held death certification data, the Clinical Resource and
Audit Group (CRAG) of the NHS in Scotland determined that these data should be
used to measure and compare the outcomes of patients admitted to Scottish hospitals
with an acute stroke. Specifically, the system compared 30 day case fatality and the
proportion discharged home within 56 days of admission from there, adjusted for
age, sex and socio-economic status, and its findings were made public. Despite their
relative sophistication, the CRAG Stroke Outcome Indicators were received with
scepticism by the medical profession. In particular, reservations remained about the
accuracy with which the routine hospital discharge data were able to identity cases of
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stroke, the failure to adjust the comparisons of outcome for clinically important
differences in casemix (i.e. the failure to compare like with like), the failure to
measure functional status (the outcome of most relevance to survivors) and the
continuing impact of the play of chance. As a result, the system generated much
debate about the pros and cons of quality measurement but little actual improvement
in the quality of stroke care.
As a response to the publication of the CRAG Stroke Outcome Indicators, the
purpose of the SOP was two-fold. First, the SOP aimed to determine whether the
key shortcomings of the CRAG data could be addressed and hence whether a
considerably improved system for measuring outcome after stroke could be made to
work in the real world; and second, the SOP aimed to explore whether such an
improved system might then act as a valid method for identifying hospitals with
different standards of stroke care. The specific improvements to be tested were the
routine collection of simple but important baseline data (to more adequately adjust
the comparisons of outcome for differences in casemix) and the routine collection of
functional status in survivors at a defined time after admission.
This thesis describes the SOP and attempts to place its findings into context. Chapter
One describes the underlying concepts and approaches to measuring the quality of
care in general, its historical background, the forces that drive the 'quality agenda'
and its current focus on outcomes, and the considerable methodological hurdles
faced by anyone wishing to use comparative outcomes data to indicate the quality of
care. Chapter Two concentrates on the factors that have influenced the current drive
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to measure the quality of care for patients with stroke and (non-systematically)
reviews the literature describing the validity of using casemix-adjusted, observational
outcomes data for this purpose. Chapter Three describes the methods of the SOP in
detail.
The next three chapters address specific aspects of routine outcome measurement.
Chapter Four explores the accuracy with which routine hospital discharge data are
able to identify cases of acute stroke and estimates the impact of any inaccuracy on
the comparison of outcomes; Chapter Five investigates the reliability and validity
with which key baseline characteristics (used to adjust for casemix) can be collected;
and Chapter Six tests simple strategies to improve response to follow up and
estimates the impact of any non-response bias on comparisons of functional
outcome.
The last three chapters relate to the SOP proper. Chapter Seven describes our
success in identifying cases of acute stroke and in collecting casemix and outcomes
data, and then compares the outcomes of the study hospitals before and after
adjusting for casemix. Chapter Eight describes the findings of our survey of
structure and process of care and relates them to the outcomes, adjusted for casemix.
The final chapter, Chapter Nine, summarises the main findings of the SOP, suggests
possible improvements to our proposed system and explores alternative approaches
to the measurement of the quality of stroke care.
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GCS Glasgow Coma Scale
GP General Practitioner
GRO General Register Office
ICD International Classification of Diseases
ISD Information & Statistics Department
(of the Common Services Agency of the NHS in Scotland)
MRC Medical Research Council
MDT Multi-Disciplinary Team
OR Odds Ratio
RCPSAP Royal College ofPhysicians Stroke Audit Package
RR Relative Risk
SAH Subarachnoid Haemorrhage
SMR1 Scottish Morbidity Record (Type 1)
SRU Stroke Rehabilitation Unit
TIA Transient Ischaemic Attack
Chapter One
Chapter One: Quality of care and its measurement using
outcomes
1.1 An approach to measuring the quality of health care
Defined by the Oxford English Dictionary, the term 'quality' refers to the degree of
excellence of a thing. Given its many facets and complexities, modern health care
may be considered to be excellent (or otherwise) in a number of different ways. The
Institute of Medicine distilled the concerns of most observers into its single
definition of the quality of care, namely 'the degree to which health services for
individuals and populations increase the likelihood of desired health outcomes and
are consistent with current professional knowledge' (Blumenthal 1996a). This
definition is useful in that it emphases the need to consider different perspectives, the
need for quantification, the probabilistic relationship between care and its outcome
and the importance of scientific knowledge (Miles et al. 1995). However, it remains
a theoretical construct and, in order to make it operational, one must return to a
multidimensional view. Maxwell suggested that the quality of care could be judged
using a framework of six dimensions (Maxwell 1984):
Effectiveness. Is the best technical care being provided as judged by those with the
requisite knowledge and experience?
Acceptability. Is the health care provided in a socially acceptable manner taking into
account the views of patients and interested third parties?
Efficiency. Is the provision of care value for money?
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Access. Are there barriers between patients and services, such as distance, ability to
pay, waiting lists, waiting times or poor supply?
Equity. Are patients treated fairly in relation to others?
Relevance. Is the overall provision of services in line with the health care needs and
desires of the population as a whole?
The framework can be used to guide the measurement of quality at all levels of care
from the individual clinician through to the national level (Maxwell 1992). Different
observers tend to be specifically interested in different dimensions: health
professionals tend to be most interested in the effectiveness of care; funding bodies
in efficiency; patients and families in acceptability and accessibility; and government
in equity and relevance.
Performance within each dimension can be measured according to Donabedian's
triad of structure, process and outcome (Donabedian 1988). Structure refers to the
setting of care and encompasses its physical and human resources (e.g. equipment
and services, the qualifications and numbers of staff) and its methods of organisation
(e.g. of its clinical teams, volume of patients, training, quality control, funding, etc.).
Process refers to what is actually done during the patients journey through the health
care system and encompasses assessment, investigation, diagnosis and the provision
of treatment. Outcome refers to the change in the health status of the patient that
results. A vital point regarding any 'structure, process, outcome' triad is that its
individual elements should be inter-linked. For questions of effectiveness and
relevance, the evidence of these linkages should come from the medical sciences or,
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failing that, from rigorously derived consensus statements of best practice. Thus, a
process based measurement of the effectiveness of care is only valid if it is known
(or strongly believed) that variation in the measured process leads to variation in
outcome; similarly, an outcome based measurement of the effectiveness of care is
only valid if it is known (or strongly believed) that variation in the measured
outcome can be attributed to variation in the process of care (Brook et al. 1996;
Donabedian 1988).
The relative merits of the structure, process and outcome triad are often debated.
Structure is generally regarded as the least important, necessary but not sufficient to
ensure the provision of high quality care, and as such viewed as a blunt tool more
important to system design than the routine measurement of quality (Donabedian
1988). Evidence that associates potentially measurable structural elements such as
numbers of nursing staff, organisational culture and patient volumes with health care
outcomes has lead some to question this assumption (Knaus et al. 1986; McKee et al.
1997; Rudd et al. 2001a; Stroke Unit Trialists' Collaboration. 1997a). Nonetheless,
the emphasis has remained on measurements of process and outcome, with each
falling in and out of favour. In truth, the two approaches have different measurement
properties and the decision as to which is the better to use depends very much on the
nature of the care that is under investigation and the level at which the measurement
is being made (Donabedian 1988; Mant 2001; Mant and Hicks 1996). Arguably, a
more rounded view would result in any situation if both were measured (Donabedian
1988). However, for practical reasons this is not always possible. On the whole,
where there is sound evidence that well-defined treatments are effective and
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generalisable, it makes most sense to measure quality simply by measuring the
process of care directly (Long 1997a; Mant and Hicks 1996). Here, rigorously
derived evidence and consensus based clinical guidelines can be used to derive
credible review criteria (Baker and Fraser 1995a; Grimshaw and Russell 1993). This
is not to say that the approach is easy or unbiased (Gompertz et al. 1994a; Hulka and
Romm 1979; Mannion and Davies 2002; Ryan and Dodd 1993), but it is the most
direct, and hence it is the most sensitive and specific to variations in quality of care
and its findings are the most simple to interpret (Crombie and Davies 1998; Mant
and Hicks 1996; Palmer 1997). In many other situations where knowledge about the
processes of care and/or their generalisability is less secure it may be more sensible
to monitor patient outcomes (Long 1997a). This approach is, however, considerably
less direct. Basic observational epidemiology reminds us that many factors other
than the quality of the process of care, namely measurement error (bias), the impact
of patient characteristics (casemix) and the play of chance also have an important
impact on patient outcomes and must be taken into account before any conclusions
regarding quality of care can be made. Given the often modest efficacy of medical
interventions, the impact of these other factors is usually considerably greater than
the impact of the processes of care, let alone the impact of variations in the quality of
the processes of care. Thus, using outcomes data to obtain credible evidence with
which to measure and so influence the provision of medical care is challenging.
Nevertheless, as will be seen, we currently find ourselves in an era in which
outcomes data are highly regarded and in which there is considerable pressure to use
them in this way.
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1.2 A brief history & experience of the USA in measuring quality of care
Interest in the quality of health care is not new. The Code of Hammurabi (1795 -
1750 BC) shows that the ancient Babylonians were interested in the quality of
medical care, also principally in terms of its outcome. Thus, law 218 states that 'if a
physician make a large incision with the operating knife, and kill him, or open a
tumour with the operating knife, and cut out the eye, his hands shall be cut off,
suggesting a somewhat uncompromising approach. An interest in the skill and
effectiveness of physicians can also be found in other ancient cultures (Schwartz and
Lurie 1990). However, the seeds of the modem era of quality assessment date back
to the mid 19th century. By this time hospitals in Britain had collected patient
statistics, chiefly case fatality data, for over 200 years but had made little proper use
of them (Iezzoni 1996). Nonetheless, they were keenly sensitive to their
unsophisticated comparison, as for example, the Glasgow Royal Infirmary whose
report from 1846 stated that 'the reception of moribund cases greatly swells the
number of deaths recorded in the Hospital, and very materially increases the
proportionate mortality thereby producing misconceptions in the public mind...'
(quoted in (Iezzoni 1996)). Florence Nightingale changed all this. She returned
from the Crimean War in 1856 having used systematic record-keeping and statistical
methods to show that improvements in sanitation could dramatically reduce mortality
at military hospitals and determined to continue these efforts in the hospitals at
home. Allied with William Farr, she set about publishing a series of influential
reports, her Notes on Hospitals, that were packed full with comparative statistics,
including observed and expected mortality rates, and ingenious statistical diagrams
of her own invention, with which she helped to revolutionise attitudes to hospital
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design, administration and care (Spiegelhalter 1999). She believed passionately in
statistics and campaigned for all hospitals to publish a uniform set. However, she
was also acutely aware of the difficulties in gathering and making sense of these
data, in particular the potential for manipulation, stating 'We have known incurable
cases discharged from one hospital, to which the deaths ought to have been
accounted and received into another hospital, to die there in a day or two after
admission, thereby lowering the mortality rate of the first at the expense of the
second' (quoted in (Spiegelhalter 1999)). Sadly, her systems of publishing uniform
hospital statistics were ultimately abandoned and the next major step in the
measurement of quality of care was not to occur for another 50 years.
This occurred in early 20th century Boston, USA. Here, a remarkable young
surgeon, Ernest Amory Codman, worked in the Massachusetts General Hospital
which, like many others, reported patient outcomes at the time of discharge but made
little use of the data (Neuhauser 1990). Guided by his lifelong interest, even
obsession, with precision and record keeping (a keen hunter, he kept a record of
every bird shot and calculated the ratio of birds shot per cartridge fired for every year
of his life until 1910) Codman set about designing a better system. In 1900 he came
up with the End Results System, a method by which he systematically located
patients one year after discharge and brought them back for examination in order to
define their disease and establish their outcome. In 1911 he set up his own hospital
to implement his ideas more fully. Each patient was supplied with an end result card
on which were recorded their presentation, initial diagnosis, treatments,
complications, diagnosis at discharge, and outcome at one year. These cards were
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summarised and an annual statement of the end results of the hospital published and
specifically provided to prospective patients. Errors and adverse events were openly
acknowledged and studied. By today's standards, his honesty was incredible, for
example, the classification of errors included those due to lack of technical
knowledge or skill, lack of surgical judgement and lack of care or equipment. His
ideas proved briefly popular and even influenced the American College of Surgeons
who based their initial system of hospital accreditation upon them. However, when
only 89 of the 692 relevant hospitals could meet the required standards, the method
was quickly abandoned. Codman himself fell out of favour and his End Results
Hospital closed in 1918. The End Results System gradually fell away, no doubt
because of the great efforts and honesty required by it, and with it systematic efforts
to measure the quality of care again came to a halt.
Nonetheless, many of the major developments that have since occurred in the field of
quality assessment have derived from the USA and an understanding of this history
is useful, not least for showing how, over time, the individual elements of structure,
process and outcome triad have fallen in and out of favour. Whilst interest in quality
assessment in the USA no doubt reflected concern for quality of care per se, it is
clear that the main reason for this concern derived from its free-market and
somewhat unregulated medical culture. In this climate there was considerable
disquiet that a significant proportion of surgical procedures were being performed
without good reason (Neuhauser 1990). From 1918 onwards, the fledgling American
College of Surgeons chose to use structural measures to tackle the problem. Thus, it
set up a programme that specified minimum standards in terms of hospital and staff
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organisation, services and training, presuming that adequate environments would
spawn adequate care (Wilkin and McColl 1987). Whilst this approach undoubtedly
helped to drive up the quality of hospital care in general, the method was criticised
for not actually measuring the quality of care directly. As a result, in the 1940s, the
focus shifted away from structural elements to attempts to measure the quality of the
process of care itself (Wilkin and McColl 1987). This era was dominated by the
ideas of Lembcke who promoted a 'scientific' approach in which uniform methods
were used to abstract data from medical records which were then judged by explicit
performance review criteria (Lembcke 1967). In line with an era where empirical
proof of effective medical care was very limited, the standards used to judge quality
were those that might be achieved in teaching hospitals, a rather fuzzy concept
(Lembcke 1967).
Through the 1950s and 1960s, medical knowledge and resources expanded greatly
and access to health care improved through the state subsidisation of medical
insurance for the poor and elderly (Relman 1988). As a result, the costs of health
care escalated wildly (Relman 1988). Desperate to contain the spiralling costs, the
federal government intervened in the early 1970's with new methods to inspect and
limit the provision of health care. Measurements of structure and process remained
the tools of choice and the most important of these were the Professional Standards
Review Organisations (PRSOs) whose brief was to regulate the process of care by
inspecting medical records and by sanctioning certain proposed treatments prior to
their use (Wilkin and McColl 1987). Whilst quality of care was an ostensible
interest, everyone recognised that the main task was to limit activity (Sprague 2002).
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Not surprisingly, clinicians disliked and distrusted the system. Furthermore, the
system was methodologically poor and, as before, tended to measure processes of
care without a valid link to patient outcomes (Sprague 2002; Wilkin and McColl
1987). The shortcomings of the approach were reinforced by an influential series of
studies which failed to find any correlation between better performance, as measured
by commonly used process-based tools, and better patient outcomes (McAuliffe
1978). With time, the concept of using measurements of the structure and process of
care to indicate the quality of care fell out of favour (McAuliffe 1978; Sprague 2002;
Wilkin and McColl 1987).
The early 1980's saw a new approach to cost containment with the introduction of
flat rate payments for packages of care ('prospective payment'), passing the
incentive to cut costs from government and insurers onto hospitals and physicians.
Together with other forces at work in medicine and society (see section 1.4) a further
round of interest in performance assessment followed, this time with outcomes very
firmly regarded as the most important tool ofmeasurement (Ellwood 1988). Starting
in 1986, the Health Care Financing Administration (HCFA), the government body
responsible for funding Medicare, published annual reports that compared mortality
between hospitals across the entire nation. Others agencies joined in and eventually
accreditation bodies, state governments, cities, insurers, employers, hospitals and
even the media started to release information, so-called 'report cards', much of it
focused on outcomes and some of it even reporting on individual practitioners
(Campion and Rosenblatt 1996; Epstein 1998; Green et al. 1997; Iezzoni 1997a).
The most well known of these is perhaps New York State's annual publication of
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outcome data pertaining to individual surgeons performing coronary artery bypass
graft surgery (Green and Wintfeld 1995). The quality of the data and the methods
used to produce these publications varied and some of it was suspect. Process
measurement continued with the PRSOs replaced by Peer Review Organisations
(PROs) although their remit was little different (Dans et al. 1985). Thus, a
confusing, disjointed and expensive morass of performance data emerged, once again
much of it distrusted by the medical profession (Berwick and Wald 1990; Bindman
1999; Dans et al. 1985).
With time, some order has begun to appear. The HCFA terminated its publication of
hospital mortality data in 1993 citing serious difficulties in their interpretation. More
uniform and less adversarial approaches often emphasising evidence based process
measures in addition to or in place of outcome measures have started to appear. In
particular, PROs (renamed Quality Improvement Organisations) and the national
agencies charged with accrediting hospitals have stopped trying to identify failing
hospitals and instead now work with hospitals in an attempt to facilitate improvement
in the quality of care at all (Campion and Rosenblatt 1996; Jencks et al. 2000; Jencks
et al. 2003; Sprague 2002); and the majority of health plans in the USA now
compare their performance according to the Health Plan Employer Data and
Information Set (HEDIS), a uniform system which reports compliance with a number
of measures of the process of care (albeit mainly in the field of prevention) and
information about access and patient satisfaction (Epstein 1998). Nonetheless, a
confusing proliferation of agencies and methods for measuring the quality of care
persists, many continue to feel uneasy with the current measurement tools, methods
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of data collection and results reporting, and consequently many remain uncertain
whether the current 'quality systems' provide valid information about truly important
aspects of health care and whether those measurements result in any real
improvements (Bobrow 2000; Mannion and Davies 2002).
1.3 The UK perspective
Until recently, the UK has seen little of the systematic methods used in the USA to
measure the quality of care. In the main, the medical profession has been left to its
own devices, trust being placed in its professionalism and institutions to ensure that
high quality medical care was provided. As Aneurin Bevan said 'My job is to give
you all the facilities, resources, apparatus and help I can, and then to leave you alone
as professional men and women to use your skill and judgement without
hindrance'(quoted in (Anonymous 1998a)). An important reason for this is the
different culture of health care in the UK where under rather than over provision has
been the main concern (Wilkin and McColl 1987). This is not to say that medical
care has not been subject to external quality reviews. Up to the 1980s there were
several: for example, inspection of medical training posts by the Royal Colleges, the
national confidential inquiries into maternal and peri-operative deaths, the national
quality control scheme for clinical chemistry, the UK Cardiac Surgical Register, and
analyses of routine data to identify mental hospitals at risk of providing poor care
(English et al. 1984; Maxwell 1984; Yates and Davidge 1984). However, these
efforts were piecemeal and voluntary rather than part of a systematic attempt to
measure the quality of care across the entire NHS. Similarly, the NHS has for many
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years reported a great number of process-related statistics, but primarily in terms of
managerial efficiency and costs without any regard to questions of quality of care.
Things have changed very considerably over the last 15 years. In 1989, the
Conservative government reformed the NHS, creating an 'internal market' in which
purchasers (Health Authorities and fund-holding general practitioners) were expected
to procure health care for their clients (patients and public) from providers (NHS
Hospital Trusts) who in turn would compete for 'business' (Secretary of State for
Health 1989). High quality information describing the provision of care was to be
the 'fuel' that would power the purchasing 'engines', allowing purchasers to
comprehend and influence the care they procured. Regrettably, the official
information generated over this period did not match this aim but focused instead on
demonstrating that 'activity' and efficiency had increased (through the flawed tools
of the finished consultant episode (Clarke and McKee 1992) and the efficiency
index), that waiting times or lists had reduced and that certain very simple aspects of
care (such as food quality or access to single sex wards) were acceptable (Radical
Statistics Health Group 1995). Questions regarding the effectiveness,
appropriateness or outcome of care were simply not tackled (Radical Statistics
Health Group 1995). The same period also saw the introduction of compulsory
clinical audit. Although well intended, audit was bolted on to medical practice
without any connection to the levers for change and became viewed as an extra chore
of little benefit to be squeezed in to an already full timetable (Hopkins 1996).
Consequently, whilst this period heard much talk about the need to systematically
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measure and describe the quality of care, little useful data emerged and physicians
became disillusioned with the entire process.
A notable exception occurred in Scotland. Since the 1960's, all hospital discharge
data, cancer registrations and records of death in Scotland have been held centrally in
machine readable form and capable of automatic linkage. In 1989, the Clinical
Resource and Audit Group (CRAG) of the Scottish Office decided that these data
should be put to use in order to help inform purchasing decisions. The pilot set of
data, released in 1993, compared outcomes between Health Boards (Clinical
Outcome Working Group 1993) and an expanded set, released in 1994, compared
outcomes between individual Hospital Trusts (Clinical Outcomes Working Group
1994a). Annual reports followed and in many respects these data were indeed a real
step forward. In particular, efforts were made to account for differences in patients'
baseline characteristics and to make clear the potential impact of the play of chance.
Also, clear explanatory notes were given to aid their proper interpretation.
Nonetheless, partly because of the mistrustful environment into which they were
released and partly because of their remaining methodological shortcomings, the
CRAG outcomes data were originally received with some uncertainty (Anonymous
1993). With time, however, their publication has become less controversial and the
accompanying media furore has died away (although not necessarily in the local
press). No contracts have been shifted and soft evidence suggesting that the data
may have helped to drive forward serivce improvements has emerged (Clinical
Outcome Working Group 1998). However, until very recently, little or no rigorous
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investigation of the true impact of the CRAG outcomes data has been performed
(Mannion and Goddard 2003).
In 1997 a Labour government was elected and with it came further reorganisation of
the NHS (Secretary of State for Scotland 1997; The Secretary of State for Health
1997). A major element was the establishment of statutory bodies to advise on best
practice and to set and police minimum standards of care, including National Service
Frameworks; the National Institute for Clinical Excellence and the Commission for
Health Improvement in England & Wales; and the Health Technology and the
Clinical Standards Boards for Scotland, more recently merged, along with CRAG, to
form NHS Quality Improvement Scotland . The concept of clinical governance was
introduced by which providers were expected to account for their clinical activities
by publishing a broad range of clinical indicators. The principal measurement tool
was to be clinical outcomes. In England & Wales the set of indicators, the
Performance Assessment Framework, is based on Maxwell's six dimensions of the
quality of care; in Scotland the CRAG indicators continue and are expanded upon.
The presentation of the data in England & Wales is very similar to that in Scotland.
Most recently, an incentive scheme has been added in England & Wales whereby
hospitals are assigned zero to three stars according to their Performance Assessment
Framework results; three star Trusts are to receive financial and administrative
rewards whilst zero star Trusts are to face reorganisation and potentially external
control. Thus, in contrast to the situation only a few years ago, the NHS (and
especially that in England & Wales) now finds itself with a broad, complex and
expanding range of instruments which purport to measure the quality of care.
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Furthermore, potentially serious consequences are set to flow from their findings.
The validity of these systems and their impact on the delivery of care in the NHS
very much remains to be seen.
1.4 The reasons for measuring quality of care
Having established the context for the current interest in measuring quality of care, it
is perhaps appropriate to ask why there should be any interest in its measurement at
all. The simple answer is that measurement is needed to ensure that the standards of
care are acceptable and to identify opportunities for their improvement. However,
the more interesting question is why is it felt that care is not already of a uniformly
high standard and that clinicians cannot simply be trusted to provide best care. There
is no simple answer to this. Rather, various strands of evidence and societal shifts
have joined to raise doubts about the quality ofmedical care in observers minds.
The first consideration is the phenomenon of unexplained variation. No matter
which field of medicine is considered, studies show that patients with similar
conditions treated by ostensibly similar health care providers experience different
outcomes (McKee and Hunter 1995). Whilst there may sometimes be good
methodological reasons for this (see section 1.6), not all the variation can be
explained, and the suspicion remains that some of the differences must result from
differences in care, and hence that some patients are receiving worse care than
others. This is especially true when the variations in outcome are reported in
sensational terms in the lay press (Anonymous 1993). However, suspicions of
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variations in the processes of care are well founded. Numerous studies have shown
large variations in the processes of care between health care providers between and
within countries, for example, in the use of simple surgical procedures (McPherson
et al. 1982; Wennberg et al. 1987), the treatment of myocardial infarction (O'Connor
et al. 1999), the provision of cancer services (Department of Health Expert Advisory
Group on Cancer 1995) and in the treatment of emergency cases (Clinical Standards
Advisory Group 1995). Analyses frequently cannot account for these variations in
terms of patient differences alone, in turn suggesting that they must represent either
mis-use of proven interventions, variation in choice between acceptable interventions
(which is to say a choice based on opinion rather than empirical fact) or variation in
provision due to supply side factors (differential use of facilities simply because they
exist in different amounts in different places) (Wennberg 2002). The key issue is
that these differences may either have important implications for patient outcomes
or, if they do not, suggest that clinicians may be providing illogical and/or
unnecessary interventions. These conclusions have helped to rob physicians of some
of their scientific legitimacy and encouraged purchasers and public to challenge their
authority on clinical matters (Blumenthal 1994).
The second consideration is the growing realisation that medical care is potentially
dangerous and that a large proportion of adverse events may be preventable. Thus, it
is estimated that 3.7% of patients admitted to hospital in New York in 1984 suffered
an adverse event as a result of medical care (Brennan et al. 1991). Of these, 13.7%
suffered moderate disability with recovery within six months, 2.6% permanent total
disability and a staggering 13.6% died (Brennan et al. 1991). In the NHS, it is
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estimated that every year about 850,000 patients admitted to hospital experience an
adverse event which results in harm (Department of Health 2000). These adverse
events are costly, resulting in £2 billion of expenditure for the additional hospital
stays (Department of Health 2000). Similarly, hospital acquired infections are
estimated to cost the NHS £1 billion and yet 15% may be avoidable (Department of
Health 2000). Annual NHS expenditure on settling cases of clinical negligence is
£400 million (Department of Health 2000). Thus, it has become very clear to public
and purchasers alike that doctors are fallible and that this fallibility is expensive.
This impression has only been compounded by a series of unprecedented medical
scandals, including those involving the removal and retention of human tissue at the
Royal Liverpool Children's Hospital (Alder Hey), paediatric cardiac surgery at
Bristol Royal Infirmary and even the mass murder of patients in Hyde, Manchester
by their general practitioner (Walshe and Higgins 2002). These revelations have
severely shaken the trust of the public in the medical profession and in its methods of
self-regulation.
The third consideration is allied with the first and second. Recent years have
witnessed great changes in the society of the UK. The public are less subservient to
and less trusting of authority and at the same time more consumer orientated,
demanding clear and simple information about the value of services. The public are
also better informed about health care in general and about the failings of the health
service in particular (Davies and Shields 1999). As such, they are empowered to ask
searching questions. These societal shifts have led to a desire by the public to re¬
negotiate their 'contract' with the medical profession and fostered the view that the
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new contract should include the establishment of systems providing evidence of good
practice (Smith 1998).
The fourth consideration relates to the ever increasing cost ofmedical care. Over the
last 30 years, this phenomenon has led virtually all modern systems of health care to
limit expenditure. As noted, the main focus in the USA has been to limit medical
intervention. Physicians have responded by citing fears of reduced quality to which
purchasers have responded by demanding evidence of the benefits of care
(Blumenthal 1996b). In the UK, with the introduction of an internal market,
purchasers also became concerned to "buy right", although with our traditional lack
of resources the focus of the exercise has been subtly different (Frater and Costain
1992). Nonetheless, on both sides of the Atlantic the looming question of efficiency
has generated a need for data describing the quality of care in order to demonstrate
value for money. Closely allied with consideration of costs, since the early 1980's
the UK has also witnessed a movement to ensure accountability in all areas of public
service through the use of performance indicators (Smith 1990).
The final consideration is that a climate of systematic evaluation now permeates the
practice of medicine. Thus, the last decades have witnessed the rise of an empirical
approach to defining medical facts (evidence based medicine) and, in particular,
efforts have been made to define the efficacy of medical interventions using the
randomised controlled trial (RCT) and to guide best practice through the production
of systematic reviews of RCT data and clinical guidelines. By helping to identify
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that which constitutes effective care this work has allowed interested parties to
question more clearly than ever before whether the right thing is being done.
Furthermore, coupled with modern epidemiology, the evidence based medicine
movement has provided the previously missing tools with which to make valid
measurements of the processes and outcome of care (Blumenthal 1996b).
1.5 The reasons for focusing on measuring outcomes
Thus, issues of unexplained variation, potential danger, lack of trust, cost-
effectiveness and evidence-based medicine underpin the current powerful drive to
measure the quality of care. However, a theme common to recent attempts to
measure quality of care both in the USA and the UK - especially in the 1980s and
1990s - has been a profound emphasis on the importance of measuring patient
outcomes and an apparent downgrading of the importance of measuring the process
of care. A number of other reasons are likely to account for this, some more
understandable than others.
First, there is no doubt that outcomes have a number of desirable measurement
properties (Mannion and Davies 2002):
Given that the very purpose of health care is to effect an advantageous change in
a patient's health status, outcomes are rightly of prime concern to patients and
public i.e. they have considerable face validity as an indicator of quality of care.
• Outcomes data are generally easy to understand.
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. Outcomes are non-prescriptive, which is to say that (in theory at least) physicians
may maintain the freedom to provide care as they see fit so long as the outcomes
of their patients remain acceptable.
Outcomes provide a useful summary function, acting as a clinical 'bottom line' to
the often various items that make up modern packages of care, their measurement
preventing the need for the collection of data on multiple, perhaps poorly
understood, processes of care.
Outcomes are useful when the question is how skilfully a procedure is performed,
a question of particular relevance to surgeons (Mant and Hicks 1996).
. Outcomes are vital when the complication rate of a procedure dictates whether or
not the procedure should be performed, the classic example being carotid
endarterectomy where a three year risk of disabling stroke or death of much over
6% may make the operation pointless (European Carotid Surgery Trialists'
Collaborative Group 1991).
To summarise the latter three points, outcomes are useful where it is uncertain that an
efficacious treatment (one proven to work under experimental conditions) is also an
effective treatment (one which works in the real world) (Long 1997a).
The second major reason to focus on outcomes is to do with expediency. Hospitals
already collect a certain amount of data regarding patients' admissions, diagnoses,
characteristics and outcome, principally in terms of case fatality. In the UK these
data are relatively brief whilst in the USA they tend to be more detailed. Although
the accuracy, completeness and depth of these data have been questioned (Demlo and
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Campbell 1981a; McKee and James 1997a), the fundamental issue is that an
unobtrusive routine system of collecting outcomes data already exists. Therefore, a
routine system that attempts to measure quality of care using outcomes is currently
practical and affordable in a manner that a system based on process measurement
simply is not. Furthermore, it is only in the last couple of decades that we have
developed both the computing power necessary to handle very large databases
simply and cheaply and a wide range of validated survey instruments with which to
measure important health outcomes (McDowell and Newell 1996). Thus, a further
reason to focus on outcomes data is that it is only in recent times that we have really
been able to do so.
The third major reason to focus on outcomes relates to our relative ignorance about
the value of many of the processes of medical care. Thus, our library of RCT data
remains relatively small in comparison to the immense number of health care
interventions that are in use (Naylor 1995) and even where we have RCT data, it is
not always clear that the findings are applicable to routine practice because the
setting of the trial and participating clinicians may have been atypical, because the
trial participants may have received atypical care (even placebo allocated trial
participants tend to do better than non-participants) or because the patients in the trial
may have been atypical (because of the use of restricted entry criteria or a low
recruitment rate) (Black 1996). There are also situations in which RCT data may
never be available (Black 1996). In all these situations, therefore, it can be argued
that it is better to monitor patient outcomes, albeit tentatively and ideally in
conjunction with some process data, rather than do nothing at all (Long 1997a).
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Here, however, logic becomes fuzzy since we do not know what is or is not useful
care, which brings us back to where we started from, and the object of the exercise
drifts from audit to research (Davies and Crombie 1997). This is not to say such
research might not be useful, but whether it should form part of a routine system to
improve the quality of care, where the time and resources available for such
analytical work are limited, is open to debate.
The final reason to focus on outcomes is that in recent times the alternative, the
collection of process data, has fallen out of favour. With hindsight, however, some
of the criticisms of process data, especially those made prior to the 1980s, now seem
rather harsh. In particular, many of the U.S. studies that influenced the turn against
process measurements have subsequently been shown to have been heavily biased
against finding any association between process and outcome because of basic flaws
in their measurement techniques, study designs and statistical methods (McAuliffe
1978). Furthermore, the limited state of knowledge about the value of medical
interventions in the 1970s and early 1980s necessarily limited the extent to which
process measures could be linked to outcomes; with more sophisticated process-
based tools and better study design, process-based measures have since (Kahn et al.
1990) and even then (Greenfield et al. 1981) been shown to correlate with outcome.
Lastly, dissatisfaction with the flawed PRSO and PRO systems in the USA and the
domination of UK routine hospital data by the "..dreary emphasis on managerial




1.6 The methodology of using outcomes to indicate quality of care
As already noted, when used to indicate the quality of care, the principles underlying
the measurement of patient outcomes are those of analytical observational
epidemiology. The various factors involved can helpfully be considered in the form
of an equation, where V indicates variation in outcome:
V OVERALL = V QUALITY OF CARE + V Blas + V CASEMIX + V CHANCE
This formula makes it clear that outcomes can only properly be used to indicate the
quality of care if it is possible to sufficiently 'cancel out' the impact of the other
factors on the right hand side of the equation so that the remaining variation in
outcome (or at least the greater part of it) can confidently be attributed to variation in
the quality of care. The key difference from analytic epidemiology, however, is that
for the purpose ofmeasuring quality of care, measurements of patient outcomes must
take place alongside routine clinical practice and should not intrude upon it. Thus
many of the careful techniques of an epidemiological study cannot be used and the
methods must compromise between the ideals of an academic study and that which is
routinely practicable. These difficulties are outlined below.
1.6.1 Measuring an outcome
What to measure
The principal requirement of the chosen outcome is that it should be relevant i.e.
important to patients and clinicians and plainly attributable to the processes of care
under investigation (Giuffrida et al. 1999; Long 1997a). The instrument used to
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measure the outcome should be valid (measure what it purports to measure), reliable
(give the same outcome on repeat measurement when all other factors are held
constant), responsive (show a change when there is a clinically significant change in
the quality of care), acceptable (to patients in terms of language, layout and length)
and practical (in terms of proven suitability to administration, analysis and
communication of results) (Streiner and Norman 1989). Ideally, all these
requirements should be satisfied. In practice, this is not always possible. For routine
systems, where time and resources are limited, relevance, acceptability and
practicality are particularly important (Long 1997b).
Over the years, the outcome most commonly used to measure quality of care has
been case fatality. The advantages are clear: death is unambiguous and so relatively
free from measurement bias; it is easy to collect from centrally held death
certification or hospital discharge data; and, for serious disorders where death is a
distinct but preventable possibility, it is undeniably important. However, most
patients with potentially life-threatening disorders do not die, although their recovery
may be incomplete, and many other patients have conditions with a major impact on
their health but which are unlikely to cause death. An important disadvantage of
case fatality data, therefore, is that they often do not provide information pertinent to
the majority of patients whose care is under investigation.
To collect data pertinent to survivors, it is necessary to collect data describing the
quality of survival. The World Health Organisation International Classification of
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Impairments, Disabilities and Handicaps (ICDIH) provides a useful framework for
this task (World Health Organisation 1980). The ICDIH describes the consequences
of disease at four levels, namely: pathology, the damage or abnormal processes that
affect an organ or system of the body; impairment-, the loss of psychological,
physiological or anatomical structure or function; disability, the restriction in
performance of activities that results from impairment; and handicap-, the social
disadvantage that results from the interaction of impairment or disability with the
individuals physical and social environment. Recently, disability has been replaced
with the term 'activity limitation' and handicap with 'participation restriction' but the
concepts remain the same (World Health Organisation 2001). Although not part of
the ICIDH, quality oflife is often viewed as a summary step in this hierarchy and, in
terms of health, is usually taken to mean a multidimensional set of measurements
reflecting the patient's physical, psychological and social functioning. Also not part
of the ICIDH, dependency describes a state in which an individual is reliant upon
others for assistance in meeting recognised needs (Wilkin 1987). It reflects the
interplay between limitations in activity and the social environment and sits astride
the concepts of activity and participation (Wilkin 1987).
On the whole, the outcomes of greatest importance to survivors lie in the middle
(activity and dependency) and, even more so, at the higher end (participation and
quality of life) of this spectrum (Roberts and Counsell 1998a). Whilst undeniably
important to survivors, the problem with all these outcomes is that their great
strength, their qualitative nature, means that unlike case fatality they are considerably
more prone to measurement error and, because they are not routinely reported, they
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are more difficult and costly to collect. With greater subjectivity and greater scope
for confounding, these difficulties increase as the outcome spectrum is ascended
(Duncan et al. 2000; Roberts and Counsell 1998a). For the same reasons, the very
highest levels of outcome are also more difficult to relate to the underlying
pathologies and impairments and hence to the processes of care (De Haan et al.
1993; Duncan et al. 2000), many of which primarily act at these levels. There is also
a relative paucity of empirical (RCT) data linking better processes of care to better
quality of life (Treurniet et al. 1997). For these reasons, when attempting to measure
quality of care, it may be most sensible to concentrate on the collection of outcomes
in the middle range of the outcome spectrum, supplemented perhaps by
measurements of participation or quality of life where appropriate.
Whilst the foregoing should be the language of routine outcome surveys, their
requirement for special methods of data collection means that this is often not the
case. More often, routine systems must make use of those outcomes that can already
be derived from routine hospital discharge data, such as readmission after discharge,
complications (listed as secondary diagnoses) and place of discharge. A reasonable
case can be made for each: the first two may represent failures of best care and
discharge home is generally desirable. However, the convenience of these outcomes
comes at the price of measurement error and difficulty in interpretation, stemming
from the fact routine hospital discharge data systems were not specifically designed
for their collection. Thus, readmission is sometimes a planned or a simply
unavoidable event which also depends on local hospital capacity, admission
thresholds and referral patterns. Readmission data are therefore only interpretable if
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the proportion of readmissions that are avoidable and the proportion of patients with
adverse outcomes who are readmitted are also known, which of course is not
routinely the case (Gautam et al. 1996; Milne and Clarke 1990; Smith 1994; Thomas
and Holloway 1991). Complication rates may vary between hospitals because of
differences between clinicians in their vigilance and diagnostic criteria for
complications, in the recording of those complications in the medical record and in
the completeness of their reporting on discharge summaries; furthermore, better units
may in fact have higher complication rates because they manage to keep severely ill,
and hence more susceptible, patients alive (Davenport et al. 1996a; Silber et al.
1995). Discharge home is a straightforward concept and, by distinguishing those
requiring some form of institutionalised care, is potentially more useful. However, it
depends partly on the pre-admission home circumstances, local availability of
support services and the desires and expectations of the patient and their family.
Local social and cultural factors, over which a hospital has little or no control, may
therefore influence return home just as much as the impact of care; measurement at
the time of discharge is also problematic (see below). Thus, all of these 'convenient'
outcome measures should be interpreted with caution.
Whose outcome should be measured
The sample of patients whose outcomes are measured should be truly representative
of the population of patients in question. Ideally, a complete sample, derived
prospectively according to rigorous and standardised methods, should be used. In
the real world, routine efforts to identify patient samples are likely to have to rely on
hospital data systems which are retrospective and only partially standardised. As
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such, hospital samples are prone to selection biases, in particular diagnostic bias
(systematic variation between hospitals in the criteria used to make a diagnosis) and
coding bias (systematic variation between hospitals in the accuracy and refinement
with which that diagnosis is converted into a discharge diagnostic code). If it is also
necessary to obtain patients' medical records the sample may be further biased by the
tendency for the medical records of deceased or complex patients to be less likely to
be found (case-note retrieval bias) (Gulliford et al. 1991; Westgren et al. 1986).
When to measure
The optimum time to measure outcome represents a compromise between the
provision of sufficient time for treatment effects and natural recovery to occur and a
realisation that inter-current events increasingly influence the outcome as the follow
up interval extends. Regardless of the interval chosen, a basic requirement is that
that it should be uniform across health care providers. In many cases, this implies
measurement of outcome after discharge and again argues for a special method of
data collection. However, for reasons of cost, routine systems often make do with
measurement of outcome at the time of discharge. Unfortunately, because length of
stay varies, sometimes considerably, between hospitals, this convenient practice can
result in misleading comparisons of outcomes (Jencks et al. 1988a). It also opens up




A fundamental principle of medical science is that un-blinded observers make
erroneous judgements about the effectiveness of interventions i.e. they systematically
over or under estimate treatment effects (Noseworthy et al. 1994). As far from
impartial observers, clinicians are unlikely to make unbiased judgements about the
outcomes of patients they have treated themselves (Bilsker and Goldner 2002;
Rothwell and Warlow 1995), especially if sanctions or rewards are to be applied.
Ideally, therefore, clinicians should not be involved in gathering outcomes data used
to measure the quality of care that they have provided. To avoid this bias, functional
outcome data should be collected directly from the patients themselves and by an
outside agency, implying a centralised system of follow up.
For reasons of cost, it is most likely that any such central system would have to rely
on postal follow up rather than telephone or personal interview. Postal follow up has
other advantages, namely, it is standardised, unobtrusive and relaxed (affording
plenty of time for the respondent to consider their answers or, where necessary, for a
proxy to become available) and it may also be especially suited to asking sensitive or
embarrassing questions (Siemiatycki 1979). The key issue is that the response rate
should be high in order to minimise the potential for non-response bias (systematic
differences in outcome between responders and non-responders). The literature on
the response rate to postal surveys is ambiguous, with studies reporting response
rates higher (Doll et al. 1991; Smeeth et al. 2001), equal (Siemiatycki 1979) or lower
(Mallinson 1998; Picavet 2001) than to personal or telephone surveys. Postal
surveys are, however, prone items being left blank or being incorrectly filled,
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especially amongst the elderly, reducing the effective response (Mallinson 1998;
O'Mahoney et al. 1998; Smeeth et al. 2001) Simple survey instruments may reduce
this bias (Brazier et al. 1996; Dorman et al. 1997a). However, the chief method to
maximise response is to persistently follow non-responders. Long experience shows
that this is often necessary (Dillman 1978a). A routine system which does not have
this facility runs the risk of reaching invalid conclusions about patient outcomes.
1.6.2 Adjustingfor casemix
Outcomes data can only be interpreted through comparison. Occasionally this may
be against an absolute standard, as for example with carotid endarterectomy (see
section 1.5). More often, it is against a relative standard, sense being made of an
outcome by comparing it either with outcomes previously achieved at the same
institution or with outcomes achieved at other institutions. In either case, for the
comparison to be fair it is essential that like is compared with like, which is to say
that the many patient characteristics which have an impact on outcome and which
can vary over time and between settings must be taken into account. Failure to do so
can result in very misleading conclusions (Aron et al. 1998; Green et al. 1990; Green
et al. 1991; McKee and Hunter 1995; Rockall et al. 1995; Wen et al. 1995). In an
experimental setting, such as a trial, variation in casemix can relatively easily be
taken into account through the random allocation of patients to different treatment
groups, the play of chance and other techniques ensuring a similar distribution of
prognostic factors (known and unknown) in each. Randomisation has even been
used to routinely allocate patients to different treatment groups within a single
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institution for the purposes of research (Cargill et al. 1986). However, the routine
randomisation of patients between institutions for the purpose of measuring quality
of care would be neither sensible nor practicable. Here instead one must rely on
statistical modelling techniques to control (hold constant mathematically) for
differences in casemix.
The problem here is that although the statistical techniques are potentially powerful,
they have their limitations. In particular, it is rarely possible to adjust fully for
differences in casemix. A statistical model is an artificial construct whose power to
control for casemix depends on our knowledge of the factors that influence outcome.
Commonly identified prognostic variables for acute conditions include age, disease
severity, the presence of comorbid disease (and its severity), physiological findings,
previous medical events and 'frailty' (Orchard 1994). Often, however, many other
risk factors such as gender, socio-economic status, dietary and other habits, family
and social supports, psychological and cultural factors, physiological reserve, genetic
predisposition and patient preferences may also be relevant. In addition to their
multitude, many risk factors are difficult to define and measure and, often, their
precise identity remains simply unknown. Even when identified, little may be
known about the relative weights of risk factors nor the reasons they affect some
patients more than others (Orchard 1994). Thus, even when excellent methods and
large and detailed databases are used, statistical models based on commonly
available prognostic factors may explain only a proportion of the total variation in
outcome (Normand et al. 1996). All too frequent shortcomings in the construction
and testing of statistical models may also contribute to error in their ability to adjust
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for casemix (Harrell, Jr. et al. 1996a; Laupacis et al. 1997a; Wyatt and Altman
1995a). Moreover, where no single and accepted model exists, conclusions
regarding hospital performance by adjusted outcome can vary quite considerably
depending on the statistical model used (Iezzoni 1997b).
However, quite apart from these methodological shortcomings, in the setting of the
routine measurement of quality of care, the major limitation in using statistical
models to adjust outcomes for casemix is the simple difficulty in obtaining sufficient
and valid data describing casemix. As noted, for reasons of cost and uniformity,
routine systems often rely on the descriptive data that already happen to be available
in hospital discharge returns, such as simple demographics, urgency and source of
admission, principal and secondary diagnoses, and procedures performed. Whilst
these data offer the possibility of making some adjustments for casemix, the method
is fraught with difficulties. Most obviously, the range of data is limited and not
tailored to the disorder in question, a problem of particular relevance to the
description of disease severity which essentially requires clinical information. Thus,
in comparison with the use ofmore relevant data, the ability to account for variation
in outcomes using routinely coded data is considerably reduced (Green et al. 1990;
Green et al. 1991; Hannan et al. 1997; Hartz.A.J. and Kuhn 1994). Similarly, the
ICD coding system with which primary and secondary diagnoses are reported fails to
distinguish between mild and severe cases and, because the system lacks clear
clinical definitions, it allows for the differential assignment of risk factors between
hospitals in otherwise identical patients (Iezzoni 1990). The standard of clinical
information supplied to coding clerks and the guidelines used to derive coded data
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may also lead to incompleteness and inaccuracy in routinely reported risk factor
information (Iezzoni 1990). Variation between hospitals in the degree of error in
these data can significantly bias the comparison of adjusted outcomes, the impact
potentially rivalling that of variation in quality of care (Green and Wintfeld 1993).
Particular biases relate to secondary diagnosis data. Secondary diagnoses are those
conditions other than the primary condition which were also present on admission
(comorbidities) or which developed during the admission (complications) and which
affected the management of the patient (Anonymous 1990). Comorbidities and
complications are reported together and yet when adjusting for casemix it is only
legitimate to adjust for comorbidities since the development of complications may, in
part, reflect the quality of care provided. Failure to exclude complications from
adjustments for casemix may therefore lead to 'over-adjustment', falsely
compensating and hence obscuring poorly performing hospitals (where
complications are presumably more likely to have occurred) (Blumberg 1991;
Hannan et al. 1997; Shapiro et al. 1994). The problem is that it is often not easy to
distinguish comorbid conditions from complications, even on detailed review (Jencks
et al. 1988a). Furthermore, to ignore all complications may be simplistic and lead to
under-adjustment given that some do indeed occur simply because of the severity of
the patient's condition (Shapiro et al. 1994). Thus, it is very difficult to define which
secondary diagnoses should be selected to make adjustments for casemix. Added to
this difficulty is the fact that physicians and coding clerks tend to report
complications in preference to comorbid conditions when a patient dies (Green and
Wintfeld 1993; Iezzoni et al. 1992; Jencks et al. 1988a; Romano and Mark 1994).
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This sometimes leads to a paradoxical association of comorbidities with survival and
hence biased adjustment for casemix (Iezzoni et al. 1992; Jencks et al. 1988a). The
use of risk factor data derived from clinical investigations (e.g. CT head imaging
after stroke) may also be problematic when there is appreciable variation in the use
of that investigation between centres. Here, variation in the presence of the risk
factor (e.g. haemorrhagic stroke) may then simply reflect variation in the use of the
test. Lastly, if reimbursement for hospital care depends on routinely reported patient
characteristics (e.g. if greater payments are made for treating sicker patients) there
may be a tendency for hospitals to over-report the presence of certain comorbidities
(Hsia et al. 1988).
A number of strategies might be employed to reduce these shortcomings, for
example, altering discharge returns to allow the reporting of a greater number of
secondary diagnoses, allowing comorbidities to be reported separately from
complications, and improving and monitoring the quality of routine discharge
information. Nonetheless, it is clear that credible adjustments for casemix are only
likely to result if specific and detailed clinical data are collected for the task.
Particularly in the USA, efforts to obtain such data have focused on the clinical data
contained within the medical record. However, this approach also has its important
shortcomings. First, the completeness and accuracy of information may vary
between hospitals; second, the collection of data is prone to inter-observer error, an
important consideration since a large number of non-medical staff are usually
required for the task (Iezzoni 1994); and third, the approach is extremely expensive.
For example, in the early 1990s, the total annual cost for a system in California was
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estimated to be $61.2 million (Iezzoni 1997b). For this reason alone, few of the
states which originally collected or even considered collecting casemix data from the
medical record have continued with it (Iezzoni 1997b).
A prospective approach would clearly be the best way to gather clinically relevant
casemix information but a routine system would require the widespread co-operation
of physicians and also new and perhaps costly methods of data collection. The
method is sometimes used in specific circumstances, as for example, in the reporting
of outcomes after cardiac surgery in New York State (Green and Wintfeld 1995) and
in the United Kingdom (Fine et al. 2003). However, even here data collection
problems may occur either in the terms of incompleteness and reduced reliability
(Fine et al. 2003) or bias resulting from physicians reporting information that is then
used to judge their own performance (Green and Wintfeld 1995).
1.6.3 Theplay ofchance
In some ways it can be argued that one need not account for the play of chance when
comparing hospital outcomes data. After all, the sample of patients for whom the
outcome is being reported is usually the entire population of patients at each hospital
and hence the question of random error in the estimate of outcome should not arise.
However, this policy ignores the fact that the play of chance is a very important
arbiter of the outcome of medical care, a phenomenon well illustrated by a
comparison of risk adjusted case fatality between UK neonatal intensive care units in
which, without any feedback of data, hospital rankings fluctuated very widely from
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one year to the next (Parry et al. 1998a). Therefore, in order to take account of the
impact of the play of chance, it is widely agreed that, for the purposes of measuring
quality of care, each hospital population should be viewed as a sample drawn from
an underlying population of potential patients (Thomas and Hofer 1999). Thus,
statistical tools can and should be used to quantify the play of chance (Goldstein and
Spiegelhalter 1996). In keeping with most medical research, a p value of 0.05 is
widely used, although stricter p values are sometimes used to account for multiple
comparisons. For graphical comparisons of unadjusted data, the point estimates of
outcome are usually accompanied by confidence limits that indicate hospitals with
outcomes significantly different to the mean; for risk adjusted data, confidence limits
are used to indicate whether the point estimates of the observed outcomes are
significantly different to the expected outcomes. Hospitals with outcomes that are
significantly different to the average or expected value are termed 'outliers'. By
definition, outliers are unlikely to have experienced their outcomes because of
chance and, hence (so the theory goes) provided proper account has been taken of
bias and casemix, have a high probability of having provided exceptionally good or
exceptionally bad care.
Regrettably, there are two problems with this approach. The first is the simple
question of numbers. Even for important medical conditions such as stroke or
myocardial infarction, in statistical terms most hospitals admit relatively few patients
per condition per year (usually a few hundred) amongst whom fewer still experience
an outcome event. Thus, the degree of uncertainty in any estimate of outcome over
one year is high and so the ability to confidently differentiate between hospitals with
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different outcomes is limited and the rankings of hospitals by adjusted outcomes are
frequently unstable, changes over time being more likely to reflect regression to the
mean rather than to changes in the quality of care (Goldstein and Spiegelhalter 1996;
Jencks et al. 1988b; Luft and Hunt 1986; Marshall and Spiegelhalter 1998; Parry et
al. 1998a; Rothwell 2000).
The second problem, intimately connected to the first, relates to the need to stipulate
a cut-off within the outcome distribution above which one may assume that a poor
outcome is unlikely to be due to chance. To properly understand this problem, it is
helpful to view the overall outcome distribution as being made up of two over¬
lapping bell curves: a large curve derived from hospitals with acceptable quality of
care and a smaller curve, shifted toward the right-hand tail of the large curve, derived
from hospitals with poor quality of care. The 'quality cut-off (usually the upper
97.5th percentile) within the overall distribution bisects the two constituent bell
curves, leaving, in terms of poor quality of care, true and false positives on one side
and true and false negatives on the other. The key questions, therefore, are what
proportion of hospitals beyond the 'quality cut-off truly provide poor quality of care
(i.e. what is the positive predictive value of outlier status) and what proportion of
poor quality hospitals remain hidden within the body of the overall outcome




Somewhat disappointingly, rigorous statistical simulation studies suggest that even
under ideal conditions (total adjustment for casemix and large differences in
potentially avoidable mortality between average and poor quality hospitals) for
common medical conditions the impact of random variation is such that the positive
predictive value and sensitivity of outcomes data is surprisingly low (Hartz.A.J. et al.
1997; Hofer and Hayward 1996; Thomas and Hofer 1999; Zalkind and Eastaugh
1997). For example, in a comparison of hospitals each with a sample size of 200
patients, for common medical conditions outlier status was estimated to have only a
38% positive predictive value and a 12% sensitivity for poor quality of care (Thomas
and Hofer 1999). Greater precision in the estimates of outcome and hence more
accurate predictions of quality of care result if sample sizes are increased. However,
even with hospital sample sizes of 900, simulation studies suggest that for common
medical conditions the positive predictive value of outlier status may only reach 32%
and sensitivity only 68% (Thomas and Hofer 1999). Furthermore, for many
hospitals, reaching these sample sizes is difficult and requires the summation of
outcomes over time or across diagnoses. Summation over time is the most sensible
approach but if data must be aggregated over several years the resulting outcomes
data may be of little relevance to the current situation (Jencks et al. 1988b). The
alternative, summation over diagnoses, allows the data to be more timely but, given
the poor correlation of the outcomes of patients with common medical disorders
admitted to the same institution, the method would very likely simply trade random
error for systematic error and so obscure any problems in individual conditions
(Jencks et al. 1988b; Rosenthal et al. 1998).
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1.6.4 Interpretation, publication & unintended consequences
The foregoing makes it abundantly clear that, especially when current data collection
systems are used, the collection of patient outcomes entails considerable deviations
from the best practices of analytical epidemiology. As a result, our ability to 'cancel
out' the impact ofmeasurement error, variation in casemix and the play of chance is
limited. Hence, even at their best, comparisons of outcomes result only in
hypotheses about relative performance which then require further investigation by
direct measurements of the process of care. The rationale for using outcomes data
therefore is one of efficiency, the method in theory limiting the need for more
complex investigation. The successful application of this strategy depends very
much on the outcomes data having a high positive predictive value and a high
sensitivity for poor quality of care, which as noted, may be a problem. Unless the
positive predictive value is high, considerable resource will be expended on
unnecessary investigations of the process of care and the morale of staff and the
confidence of the public in their local hospital (to which, in the UK, there is usually
no alternative) will in many cases be needlessly damaged. Unless sensitivity is high,
the ability of the entire exercise to influence and improve the overall quality of care
will be low. A further and related difficulty of using outcomes as a screening tool is
the simplistic dichotomisation that results, hospitals and physicians being divided
into groups either likely or unlikely to have deficiencies in care; the so-called hunt
for "bad apples". The problem with the bad apples approach is that it ignores the
reality that the process of care is unlikely to be perfect at any provider and hence that
all have the scope to improve their services in one way or another. A danger in using
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outcomes data, therefore, is that by allowing the majority of hospitals to 'shelter' in
the body of the outcomes distribution, this important fact may become obscured.
These issues are brought sharply into focus by the decision whether or not to publish
comparisons of outcome data. Those against publication suggest that the limitations
of comparative outcomes data will not be understood outside of scientific circles and
hence that erroneous conclusions about quality of care will be drawn (Goldstein and
Myers 1996; Marshall et al. 2000) and that those with poor outcomes will be more
likely to try to explain away their results (e.g. 'our patients are sicker', 'poor quality
data', etc.) rather than to explore the data in an attempt to improve quality, as would
occur if the data were quietly fed back to providers (Anderson 1999; Thomson et al.
1997). Proponents, on the other hand, suggest that publication of outcomes data may
help the public and purchasers to make rational health care choices and, for fear of
coming bottom in any league table, may spur all providers into improving services,
something which would not occur if poor results could be quietly ignored
(Leatherman and McCarthy 1999; Marshall et al. 2000). Empirical studies
conducted in the USA suggest that, in fact, consumers, clinicians and purchasers are
little interested in and/or do not understand published performance data but that
hospitals and health care provider organisations are interested in them, are able to
respond, and that in some cases health improvements have resulted (Leatherman and
McCarthy 1999; Marshall et al. 2000). That said, recent work (related to the CRAG
outcomes data) suggests that even hospitals take little note of official, published
performance data in the UK (Mannion and Goddard 2003). In truth, however, too
little time has elapsed and too few studies have been performed to draw definitive
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conclusions (Leatherman and McCarthy 1999; Marshall et al. 2000). In the
meantime, given the current demand for public disclosure of information in nearly all
walks of life, it is likely that the public disclosure of comparative outcomes data will
continue.
An important consideration in the use of performance indicators is that, in addition to
any planned benefits, their use may have a number of unintended consequences,
especially if the indicator data are made public (Smith 1995; Tymms and Wiggins
2000). Reflecting the understandable desire of clinicians to avoid coming last in any
league table, the unintended consequences most relevant to the publication of
outcomes are the deliberate manipulation of data in order to appear to have better
outcomes than is truly the case (a practice known as 'gaming') and the deliberate
limitation of clinical practice to cases where a good outcome is likely. Examples of
both have been mooted in relation to the publication of mortality rates after cardiac
surgery in New York State, USA (Green and Wintfeld 1995). Thus, between 1989
and 1991, the reporting system went from being a non-controversial internal activity
to a league table of individual surgeons outcomes published in the lay media. Over
the same period, the reported incidence of patient risk factors jumped considerably.
For instance, the average incidence of chronic obstructive pulmonary disease
(COPD) jumped from 7% in 1989 to 12% in 1990 and then to 17% in 1991; at some
hospitals the increase in the incidence of COPD over this period was almost
unbelievable, up from 2% to 53%. Whilst some of this increase may have resulted
from a change in risk factor definition, there is a strong suspicion that some may
have resulted from a deliberate attempt by some clinicians to portray their patients as
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'sicker' than was truly the case and hence to spuriously lower their adjusted case
fatality rates (Green and Wintfeld 1995). At the same time, lay and medical journals
suggested that, as result of the publication of outcomes data, high risk patients were
more likely to be refused cardiac surgery in New York State or were being referred
for cardiac surgery in another state (Green and Wintfeld 1995; Omoigui et al. 1996).
Interestingly, however, neither of these suspicions were confirmed by later more
rigorous investigation (Peterson et al. 1998), and with stability in their definition and
the introduction of a system to inspect their accuracy, the large fluctuations in the
prevalence of risk factors has much reduced (Chassin et al. 1996).
1.6.5 Summary
This review makes plain the considerable methodological hurdles and limitations
inherent in using outcomes to indicate the quality of health care. On an optimistic
note, it is clear that many of the methodological barriers might be overcome with
better system design, in particular the establishment of a dedicated system to identify
patients and their baseline characteristics, to inspect the validity of that data, to
collect important outcome data in a valid manner, and to adjust for casemix using
powerful and externally validated statistical models. Of course, each of these
'simple' steps is challenging and the establishment of such a system would
undoubtedly be expensive. Unfortunately, the question of low numbers and hence of
uncertainty in those comparisons is less easily solved and, when used as the sole
indicator of quality, the focus of outcomes on "bad apples" is likely to remain.
Summarised in a recent non-systematic review (Thomas and Hofer 1998), studies
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that have directly addressed the question ofwhether adjusted outcome data do indeed
indicate quality of care have given mixed results (Thomas and Hofer 1998). Thus,
uncertainty, tinged with quite some doubt, continues to reign over the use of
outcomes to indicate the quality of care provided by hospitals, even more so that
provided by individual clinicians. Despite this, the pressure to routinely measure and
compare patient outcomes continues and, as noted, such data are currently routinely
published for hospitals in the UK. Prominent among these, both in Scotland and in
England & Wales, are data describing outcome after stroke. A consideration of the
reasons for this state of affairs and of the literature relating to the use of outcomes to
measure the quality of stroke care forms the subject of the chapter that follows.
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Chapter Two: Stroke and the quality of stroke care
2.1 The importance of stroke
Stroke is of considerable importance. It is estimated that it is the second commonest
cause of death and the sixth commonest cause of premature disability (including
mortality) in the world (Murray and Lopez 1997a; Murray and Lopez 1997b). In the
UK, it is estimated that there are 125,000 new strokes every year and that ofmen and
women aged 45 years, nearly 25% and 20%, respectively, can expect to suffer a
stroke if they live to be 85 (Bonita 2002). The majority of patients survive their
stroke (Thorvaldsen et al. 1995) and hence the major impact of stroke is felt in terms
of chronic disability and impairment (Wolfe 2000). At one year after stroke about
one third of survivors remain dependent on other people in order to perform simple
activities of daily life (Bamford et al. 1990a). Stroke is the second commonest cause
of severe disability amongst adults living in private households in the UK (Martin et
al. 1988) and is a leading cause of dementia, depression, epilepsy and falls. The
most common stroke related residual impairments are in the areas of cognition,
speech and use of the lower limbs (Wolfe 2000). The economic burden of stroke is
also large and accounts for nearly 6% of total annual NHS and Social Services
expenditure (about £2.3 billion) (Anonymous 1998b). The indirect costs of stroke
(loss to the workforce, sickness benefits, early retirement) are also substantial.
However, the great burden of stroke falls mainly on the elderly with about three
quarters of all strokes occurring in those over 65 years of age and about half in those
over 75 years of age (Bamford et al. 1988). Given that the current rapid increase in
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the elderly population, and hence the incidence of stroke, these burdens are only set
to increase, especially in the area of acute care (Malmgren et al. 1989).
2.2 The provision of stroke care
Despite its clear importance, stroke has only recently been viewed as a significant
priority by most policy makers and health service professionals (King's Fund
Consensus Conference 1988). According to the report of a consensus conference
held in 1988, services for stroke patients were "...haphazard, fragmented and poorly
tailored to patients' needs.." and treatment was hampered by "...a striking lack of
convincing data on the effectiveness of widely used medical, psychological, and
specific rehabilitative treatments." (King's Fund Consensus Conference 1988). Since
then, however, interest in stroke has grown considerably, beginning with the
publication of a series of studies which detailed its epidemiology (Bamford et al.
1988) and which showed the effectiveness of strategies of primary (Atrial Fibrillation
Investigators 1994; Collins et al. 1990) and secondary prevention (North American
Symptomatic Carotid Endarterectomy Trial Collaborators 1991; European Carotid
Surgery Trialists' Collaborative Group 1991; Antiplatelet Trialists' Collaboration
1988; Collins et al. 1990). By far the most important advance came in the early
1990s when evidence of an effective treatment emerged, a systematic review
showing that when compared to conventional ward care, organised stroke unit care
resulted in a 21% reduction in the odds of death at one year (Langhorne et al. 1993).
An expanded review subsequently confirmed this benefit and showed that it was not
simply at the expense of an increased proportion of disabled survivors, stroke unit
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care resulting also in a 31% reduction in the odds of death or dependency and a 25%
reduction in the odds of death or institutionalisation (Stroke Unit Trialists'
Collaboration 1997a). This period also witnessed considerable interest in the use of
thrombolysis to treat acute ischaemic stroke, although only one trial (The National
Institute for Neurological Disorders and Stroke rt-PA Stroke Study Group 1995) of
several reported any significant benefit. By the mid 1990s - the period of the SOP -
trials investigating the use of anti-thrombotic drugs in acute ischaemic stroke were
actively recruiting (International Stroke Trial Collaborative Group. 1997) and data
suggesting the potential value of specific interventions such as physiotherapy
(Langhorne et al. 1996) and the prevention of dysphagia (Barer 1989; Smithard et al.
1996) were beginning to emerge.
In the last few years further progress has been made. In particular, studies have
started to un-pick the 'black-box' of stroke unit care and plausible reasons for its
efficacy have started to emerge (including preservation of physiological homeostasis
and early mobilisation in the acute phase; aggressive prevention and intervention for
complications; specialisation and education of staff; the formal co-ordination of
activities toward common goals; and the education and involvement of carers)
although the precise impact of individual aspects of organised stroke care remain to
be formally tested or reported (Evans et al. 2001; Hoening et al. 2001; Indredavik et
al. 1999; Langhorne et al. 1999; Langhorne and Dennis 1998; Langhorne and
Pollock 2002; Pound et al. 1999; Stroke Unit Trialists' Collaboration 1997b).
Aspirin has been shown to have a small but real impact on acute ischaemic stroke,
resulting in nine fewer serious vascular events (non-fatal myocardial infarction, non-
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fatal stroke or death from vascular cause) per 1000 treated (Antithrombotic Trialists'
Collaboration 2002); the limited role of acute anticoagulation has become clear
(International Stroke Trial Collaborative Group 1997); the potentially large impact of
thrombolysis on ischaemic stroke has emerged with an estimated 44 extra patients
alive and independent per 1000 treated when used within six hours of onset and 126
extra patients alive and independent per 1000 treated when used within three hours of
onset (Wardlaw et al. 2003); and there has been considerable expansion in the field
of secondary prevention, particularly in relation to antiplatelet drugs (Antithrombotic
Trialists' Collaboration 2002), blood pressure and cholesterol reduction (Heart
Protection Study Collaborative Group 2002; PROGRESS Collaborative Group 2001;
The Heart Outcome Prevention Evaluation Study Investigators 2000) and strategies
for dealing with carotid stenosis (Brown 2003; Rothwell et al. 2003). Throughout
this period, current best practice has been periodically distilled into authoritative
clinical guidelines both within the UK and at a European level (King's Fund
Consensus Conference 1988; Royal College of Physicians 1989; Scottish
Intercollegiate Guidelines Network (SIGN) 1997a; Scottish Intercollegiate
Guidelines Network (SIGN) 1997b; Scottish Intercollegiate Guidelines Network
(SIGN) 1997c; Scottish Intercollegiate Guidelines Network (SIGN) 1998; The
Intercollegiate Working Party for Stroke 2002; Aboderin and Venables 1996).
Thus, in the space of about 15 years, our understanding of and ability to intervene in
stroke has undoubtedly improved. However, the implementation of this new
knowledge throughout the UK has been patchy, a situation highlighted in 1995 by a
survey of consultant physicians (who routinely treated patients with stroke) which
61
Chapter Two
showed that only 44% had access to a specialised stroke rehabilitation unit, that only
17% worked in a hospital where they could identify a physician with a special
interest in stroke, that 20% had no access to non-invasive carotid imaging and that
about one third of patients were admitted to hospitals without on-site CT scanning
facilities (Lindley et al. 1995). Whilst a number of surveys have subsequently
documented improvements in these areas, particularly in the provision of specialised
rehabilitation, the fact remains that there are unacceptably large variations between
hospitals and regions in the UK in access to and use of stroke services (Ebrahim and
Redfern 1999; Rudd et al. 1999; Rudd et al. 2001a; Rudd et al. 2001b). Thus, for
example, in the period 2001-2, only 27% of patients admitted to hospital with stroke
spent more than half of their hospital stay on a stroke unit (an improvement from
18% in 1998) and the documentation of care remained poor with only about two
thirds having a record of a swallowing assessment or a visual field examination
recorded in the medical record (Rudd and Pearson 2002). Disturbingly, there are
also data to suggest that the outcomes of patients admitted to hospital with a stroke in
the UK, both in terms ofmortality and morbidity, may be worse than that of patients
in continental Europe (Wolfe et al. 1999) and elsewhere in the world (Weir et al.




2.3 Measuring the quality of stroke care
2.3.1 The situation in the UK
Thus, classic pressures (disease importance, high costs, availability of effective
interventions, and known variation in processes and outcome) have focused attention
on the need to measure the quality of stroke care in the UK. To this can be added the
governments decision to make stroke a priority for disease prevention and treatment
under its Health of the Nation programme (Dennis and Warlow 1991) and the
introduction of the purchaser-provider split to the NHS in the 1990s, with the
implication that purchasing decisions would be guided by (and hence the need for)
data describing clinical activities (Miles et al. 1995). A number of attempts to
measure the quality of stroke care have followed.
Clinicians have been primarily interested in structure and process data and focused
initially on the development of a credible and reliable measurement instrument, the
Royal College of Physicians Stroke Audit Package (RCPSAP). The RCPSAP is an
audit form comprising 60 evidence and consensus based criteria and is used to assess
the completeness of the medical record (and hence, in theory, the quality of care) in
relation to key items of stroke assessment and intervention (Anonymous 1994;
Gompertz et al. 1994). Initially the RCPSAP was designed for ad hoc use. More
recently, an up-dated and expanded version (the Intercollegiate Stroke Audit
Package) that also incorporates criteria relating to the organisation of care has been
used in three national audits of stroke care in England, Wales and Northern Ireland
(Rudd et al. 1999; Rudd et al. 2001b; Rudd and Pearson 2002). The national clinical
63
Chapter Two
guidelines for stroke in England & Wales and in Scotland recommend the periodic
collection of data describing the process of care for the purpose of quality
improvement (Scottish Intercollegiate Guidelines Network (SIGN) 1997a; The
Intercollegiate Working Party for Stroke 2000). In Scotland, a systematic survey of
the structure and some elements of the process of stroke care has been performed in
order to identify any deficiencies in relation to clinical guideline statements of best
practice (Anonymous 2003a); and surveys of structure and process have also been
carried out in the remainder of the UK under the auspices of the Stroke Association
(Ebrahim and Redfern 1999; Lindley et al. 1995) and more recently by the British
Association of Stroke Physicians (Rodgers et al. 2003).
However, over the last 10 years government and purchasers have been primarily
interested in measuring the quality of stroke care using comparisons of outcome, in
particular using outcomes derived from hospital discharge returns. As noted, this
may simply reflect the desire to make best use of data collection systems that already
happen to be in place. However, it is also arguable that outcomes might actually be
peculiarly suited to measuring the quality of stroke care because of the great number
of small and repeated processes of care that are involved (that might otherwise have
to be measured individually) and because the key element of stroke care, its formal
organisation on a stroke unit, is still only partially understood and hence difficult to
define for the purposes ofmeasurement (Langhorne and Dennis 1998).
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Scotland was the first country within the UK to publish comparisons of routinely
collected stroke outcomes between hospitals in 1994 with the release of data
describing 30 day mortality and the proportion of patients discharged to their home
address within 56 days of admission from there (Clinical Outcomes Working Group
1994a). Similar data followed in England & Wales in 1999 (NHS Executive 1999).
Regular reports have followed with outcomes aggregated over three year periods in
Scotland and annually in England & Wales; in each case 95% confidence intervals
are given. However, very limited attempts have been made to control for variation in
casemix. For hospital level comparisons adjustment is made only for age, sex and
socio-economic status; in England & Wales comparisons are then also stratified by
hospital type. Thus, a major shortcoming of the published data is that the
comparisons of outcome are not adjusted for more important prognostic variables
such as pre-stroke functional status and living arrangements nor for the severity of
the stroke, factors which can vary between hospitals, even those of similar type,
(Rudd et al. 2001a) presumably because of differences in the characteristics of the
populations served and because of differences in local referral patterns and admission
thresholds. Furthermore, neither system directly reports disability or dependency,
the outcomes of greatest importance to survivors of stroke. Thus, coupled to
anxieties regarding the quality of routine hospital discharge data and the difficulties
in allowing for chance, the value of the stroke outcomes data published in the UK
remains in some doubt.
65
Chapter Two
2.3.2 Brief review ofprevious work
The literature describing the use of observational, risk-adjusted outcomes data to
indicate the quality of stroke care gives only limited guidance. On balance, it seems
that a relationship between better adjusted outcome and better stroke care can be
discerned at a population level. The first large study in this field was carried out by
the RAND corporation in the USA which, in a sample of 2824 stroke patients,
showed a significant association between 30 day mortality, adjusted for casemix, and
the quality of the process of care as judged by explicit review of the medical record
(Kahn et al. 1990). More recently a study of 6,666 patients from 149 Veterans
Affairs hospitals in the USA showed that, after adjusting for casemix, populations
treated in better staffed, co-ordinated and resourced rehabilitation units, which
provided better staff education and which dealt with higher volumes of patients had
better outcomes in terms of discharge to community accommodation (Hoening et al.
2001). Two large studies from Sweden have shown that patients who were
independent prior to their stroke, conscious on admission and treated on a stroke unit
were significantly less likely to be dead or institutionalised at three months, and more
likely to be independent in activities of daily living at two and a half years, than
similar patients treated on the general wards (Glader et al. 2001; Stegmayr et al.
1999). Two smaller but more detailed studies of 128 highly selected stroke patients
from 11 Veterans Affairs hospitals in the USA showed a positive relationship
between improved structure and process of care (using systematically developed and
tested measurement instruments) and better adjusted functional outcome at six
months (Duncan et al. 2002a; Hoening et al. 2002). Studies investigating the
provision of stroke care by physician type (neurologist vs. others) (Mitchell et al.
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1996) and by method of reimbursement (Kramer et al. 2000) have also shown that
patients with greater access to specialist investigations and/or rehabilitation facilities
had better adjusted outcomes in terms of case fatality and long term
institutionalisation, respectively, and a study comparing American academic centres
found that units with vascular neurologists, with guidelines limiting the use of
thrombolysis and (just not significantly) with a mobile stroke team had lower
adjusted in-hospital case fatality (Gillum and Johnston 2001).
However, not all studies have been supportive. The same study of American
academic centres failed to find any relationship between lower adjusted case fatality
and greater access to stroke unit care (Gillum and Johnston 2001); a large American
study of 3,611 patients (based on routinely collected data) failed to find higher case
fatality, after adjusting for casemix, in those judged to have poor quality of care (as
defined by Peer Review Organisation review criteria) (Thomas et al. 1993); and a
small study found no relationship between adjusted case fatality and greater access to
specialist rehabilitation (Retchin et al. 1997). On the whole, however, the negative
or ambiguous studies are less credible than the positive ones because they generally
make less detailed or relevant adjustment for casemix (Gillum and Johnston 2001;
Retchin et al. 1997; Thomas et al. 1993) (only one positive study does the same
(Mitchell et al. 1996)); because of a reliance on limited and potentially dubious
measurements of the process of care (Thomas et al. 1993); and because of the use of
an insensitive outcome measure (case fatality rather than disability when the
difference in care was access to specialised rehabilitation) (Retchin et al. 1997).
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Studies in which the hospital is the unit of analysis represent a much sterner and
more realistic test of the validity of using outcomes to indicate the quality of stroke
care. Thus, whilst population level analyses ask the question of whether in general,
or (more often) in selected groups, better outcomes are associated with better care,
hospital level analyses ask the more difficult question of whether this relationship
can be discerned when relatively small and heterogeneous populations (a substantial
proportion of whom may derive little benefit from the measured treatments) are
compared. At this level, the literature relating to the use of observational, risk-
adjusted outcomes to indicate the quality of stroke care is much less encouraging.
Of three studies which have made a comparison between hospitals with and without
a stroke unit and which have accounted for clinically important casemix, only one (a
before and after study' by Duncan et al. (1995)) showed that stroke unit care resulted
in a substantial reduction in mortality. Oddly, however, it did not show any benefit
in terms of improved functional status. The two other studies (one a 'before and
after' study (Davenport et al. 1996b), the other a comparison between two districts
(Gompertz et al. 1995)) failed to find a significant relationship between stroke unit
care and better outcome in terms of case fatality, functional status or discharge home.
The same is also true of a more recent study which measured the process of care at
three hospitals using the RCPSAP and adjusted for clinically important casemix
(McNaughton et al. 2003). However, all these studies can be criticised because of
their small size, both in terms of the numbers of hospitals studied and numbers of
patients at each, a failing especially pertinent to the studies conducted by Duncan et
al. (1995) and by McNaughton et al. (2003) in which the hospital samples included
Chapter Two
fewer than 100 patients. Nonetheless, studies involving larger numbers of hospitals
and patients have reached similarly negative conclusions. Thus, an American study
failed to find any difference in a hospital-wide measure of the structure of care
between 62 hospitals classified as either high or low outliers in terms of adjusted 30
day stroke mortality (Jessee and Schranz 1990); another study of 21 American
hospitals failed to find any correlation between adjusted case fatality and the
proportion of cases judged to have poor stroke care (as defined by Peer Review
Organisation review criteria) (Thomas et al. 1993); a study of 12 European hospitals
could not explain the residual differences in survival and dependency, after adjusting
for important differences in casemix, by further adjustment for measured differences
in the process of care (length of stay, type of bed used, access to brain imaging)
(Wolfe et al. 1999); and another study of 12 American hospitals (six high and six
low quality 'outliers') could not find any relationship between in-hospital adjusted
mortality and the quality of the process of stroke care when measured by explicit
process review criteria (although it did find some some rather soft evidence
suggesting fewer potentially preventable deaths at low mortality outlying hospitals)
(Dubois et al. 1987). Although not strictly a hospital level analysis, a recent study
which amalgamated consecutive series of about 40 patients admitted to hospitals
within the same region within the UK also failed to find any relationship between the
regional mean scores for the structure and process of care (measured using the
Intercollegiate Stroke Audit Package (ISAP)) and outcome (in terms of 30 day
mortality, length of stay, disability or institutionalisation) after adjusting for
important differences in casemix (Rudd et al. 2001a). However, the interpretation of
these larger studies is also difficult for various reasons, including: failure to make
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stroke specific measurements of the structure of care (Jessee and Schranz 1990);
limited measurements of the process of stroke care (Thomas et al. 1993); unreliable
collection of the process data (Thomas et al. 1993); limited adjustment for casemix
(Jessee and Schranz 1990; Thomas et al. 1993) or, where more detailed data were
potentially available, failure to properly adjust for stroke severity (Rudd et al.
2001a); failure to relate adjusted outcomes to a hospital level measure of the quality
of stroke care (Wolfe et al. 1999); by the use of small numbers (the study by Dubois
et al. (1987) involved only 106 patients); by the use of amalgamated rather than true
hospital samples (Dubois et al. 1987; Rudd et al. 2001a); and by a general reliance
on retrospectively collected data (Jessee and Schranz 1990; Thomas et al. 1993;
Dubois et al. 1987; Rudd et al. 2001a).
In summary, the literature appears to show that, provided they are appropriate and
adjusted for clinically important casemix, outcomes data show a generally positive
relationship with the quality of the structure and process of stroke care, especially if
patients unlikely to benefit from care are excluded from the analysis. Importantly,
however, it also appears that there is no body of evidence to show that this positive
relationship can be reliably discerned when the outcomes of hospitals are compared.
That said, because of the real and potential shortcomings of the hospital level studies
performed to date, methodological reasons may account for this fact. In particular, it
is clear that the literature continues to lack a study that tests the strategy of using
outcomes to indicate the quality of stroke care in a large numbers of hospitals, in
which adjustments are made for important differences in casemix and in which
important aspects of the structure and process of stroke care are measured.
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2.4 The Stroke Outcomes Project
The Stroke Outcomes Project (SOP), the study upon which this thesis is based, was
designed in the early 1990s in response to the decision by the Scottish Office to
commence publication of routinely collected stroke outcomes data and the concern
that, because of their crudeness, these data might mislead rather than inform. Extra
impetus for the study derived from the medical and media attention that greeted the
first set of outcomes data (Anonymous 1993; News at Ten, Independent Television
News 1994) and the suggestion that, in the internal market then in operation in the
NHS, purchasing decisions might be based upon them. More generally, the limited
state of the literature (especially in the mid 1990s) relating to the use of outcomes to
indicate the quality of hospital stroke services demanded that higher quality hospital
level studies be performed.
The fundamental premise of the SOP was that if routinely collected outcomes data
were indeed to be the sole official measure of the quality of stroke care in Scotland,
then it was imperative that an improved method of measuring and comparing stroke
outcomes be developed and tested. In particular, the SOP wished to explore two key
improvements: the possibility of routinely measuring functional status in addition to
case fatality (in order to report an outcome of direct relevance to survivors) and the
possibility of routinely adjusting outcomes for clinically important prognostic
variables. The methods used to determine the feasibility and validity of this 'ideal'
yet routine system are detailed in the chapter that follows.
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Chapter Three. The Stroke Outcomes Project
3.1 Introduction
As noted, the purpose of the Stroke Outcomes Project (SOP) was to investigate an
improved yet still routinely applicable system of measuring outcome after stroke.
Specifically, the SOP aimed to investigate:
1. Whether it is feasible to collect valid measures of functional status in addition to
case fatality and to adjust these outcomes for important differences in casemix.
2. Whether these outcomes can then be used to indicate the quality of the structure
and process of stroke care.
Of course, in order to truly define the value the proposed system (i.e. to define the
sensitivity and positive predictive value with which it might identify hospitals with
poor quality of care) we would have had to study tens of hospitals. Regrettably, the
limited resources available meant that, in fact, we could study only five. Right from
the outset, therefore, it is important to appreciate that the SOP is akin to a pilot study,
capable of exploring the validity of our proposed system but unable to provide a
definitive answer.
The SOP involved the collection of data using both retrospective and prospective
means. The methods were complex and can be divided into five inter-related steps:
1. the identification of patients admitted to hospital with an acute stroke;
2. the collection of data describing casemix;
Chapter Three
3. the collection of data describing the structure and process of stroke care.
4. the collection of data describing important outcomes after stroke;
5. adjustment of the outcomes for important differences in casemix.
This chapter describes the methods underlying each step.
3.2 Study setting
Hospital characteristics
The five participating hospitals were all acute NHS Hospital Trusts in the central belt
of Scotland. They took part on the understanding that they would remain anonymous
and therefore I will refer to them as Hospitals A, B, C, D and E. We deliberately
selected these hospitals to represent a range of settings, the different hospitals
varying in terms of urban or rural catchment area, admission threshold, teaching or
district general hospital status and in the degree of organisation of stroke care. The
broad differences between the Trusts at the start of the study are summarised in
Table 3.1. The hospitals differed in the number and location of their constituent
parts. A summary of the make up of each hospital is given in Table 3.2.
Outcome after stroke 1990-1993
We selected the hospitals such that their 30 day case fatalities spanned the range of
the 1994 publication of stroke outcome indicators (Clinical Outcomes Working
Group 1994b) (Figure 3.1) in which adjustment was made for age, sex and ICD
cerebrovascular disease code. Hospital D had the lowest adjusted 30 day case
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fatality (21%) in Scotland while Hospitals A and E had the highest (38%) and second
highest (37%), respectively. The case fatalities of Hospital B and C were
intermediate to these cases (30% and 31%, respectively) and were not significantly
different to the Scottish average.
Studyperiod
We identified patients admitted between 1 August 1995 and 31 July 1997. The study
therefore reports comparisons of stroke outcomes collected over two rather than three
years, the period used in the publication of stroke outcome data in Scotland. The
study period represents a compromise between the need to collect sufficient numbers
to minimise the impact of chance and the resources available for the project.
3.3 Identifying potential cases of stroke using routine methods
Currently, the only method that allows the routine identification of patients admitted
to hospital with a stroke in Scotland is the inspection of hospital discharge data. The
study method of identifying stroke patients is therefore based on these data.
3.3.1 Routinely collected hospital discharge data in Scotland
Consultant episodes and the SMR.1
Scottish hospital discharge data are reported as 'consultant episodes', a term used to
describe an occasion on which an in-patient is under the care of a individual
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consultant. In theory, after every consultant episode, a Scottish Morbidity Record
(SMR) is submitted to the Information and Statistics Division (ISD) of the Scottish
National Health Service. In practice, SMRs are generally only produced when
patients are discharged from hospital or transferred to another department within the
same hospital. The production of SMRs when patients are transferred between
consultants within the same department is unusual. There are several different types
of SMR form; that relevant to stroke is the SMR1. The SMR system was upgraded
during the study and hospitals switched to the new version at different times between
April 1996 to April 1997 i.e. starting eight months into our study period (Anonymous
1995).
Cerebrovascular Disease Codes
The principal diagnosis given on an SMR1 is defined as the main condition managed
or investigated during that episode of care. Diagnoses are coded according to the
International Classification of Disease (ICD). The ninth revision (ICD 9) was
replaced with the updated version, ICD 10, on the 1 April 1996. The codes used to
describe the different categories of cerebrovascular disease are given in Table 3.3.
Many, but not all, of the ICD 9 codes map to those of ICD 10.
Diagnostic codes on the SMR1 were assigned by trained coding staff in each
hospital. Codes were assigned on the basis of clinical information provided by
clinicians on hand-written or typed discharge summaries or, in some cases, using
data recorded in the medical record itself. The limited amount of data pertinent to
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stroke patients that are collected on the SMR1 in addition to the primary diagnosis
are shown in Table 3.4.
Hospital stays
The term 'hospital stay' is used to refer to a continuous period of in-patient
treatment. Patients are frequently transferred from the care of one consultant to
another during their hospital stay and, as noted, in these situations, two or more
SMRls may be generated. In particular, for stroke, one SMR1 may be generated
when a patient is transferred from the admitting to the rehabilitation team and a
second when the patient is discharged from rehabilitation. More complicated
admissions may result in a number of SMR1 forms. Difficulties with SMR1 data are
that those pertaining to the same hospital stay do not always give the same principal
diagnosis and the delay between admission and the generation of an SMR1, and
between a first and any subsequent SMR1, may sometimes be considerable. Also,
ISD link SMR1 returns to provide a record of completed hospital stays only
periodically.
3.4.2 Identifyingpatientsfor the SOP
Our choice of method for identifying patients for the SOP was principally driven by
our aim of identifying functional outcome in survivors at six months after admission.
This requirement meant that our system of identifying patients had to be fast and on¬




We based our system of patient identification on the assumption that the great
majority of patients admitted with an acute stroke would have a cerebrovascular
disease code listed as the primary diagnosis on at least one SMR1. We therefore set
up a link with ISD such that each month we were sent an electronic file of every
SMR1 generated by the study hospitals that had any cerebrovascular disease code
listed as the primary discharge diagnosis. We modified our collection of SMR1 data
after the first six months in light of an analysis of the accuracy these data (see section
4.3.2). We continued to collect monthly SMR1 data until March 1998 in order not to
miss patients admitted towards the end of the recruitment period.
Study database
We entered the SMR1 data onto a computerised database (Microsoft FoxPro 2.6).
Since it was necessary that we receive SMRls with the minimum of delay, it was
impossible for ISD to link them to identify hospital stays when those stays consisted
of two or more consultant episodes. We therefore established our own system of
identifying hospital stays, automatically linking SMRls if the patient identification
data matched (surname and initial, sex and post code all the same) and if the dates of
admission and discharge overlapped or were immediately adjacent. This system also
identified duplicate SMRls (SMRls referring to the same consultant episode for the
same patient) and kept only one on the study database.
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Where there was a gap of more than one day between SMR1 dates belonging to the
same patient, our system could not identify whether the SMRls referred to one stay
(reported as separate consultant episodes) or to two separate stays. Similarly, our
system could not identify instances where patient identification data varied, in error,
between SMR1 returns e.g. a single hospital stay reported by two SMRls, each with
a slightly different date of birth. During data collection, therefore, our database
listed a mixture of full stays (all SMRls correctly linked, copies deleted), partial
stays (unlinked SMRls) or duplicate stays (SMRls we could not identify as a copy).
The practical result of this was that some patients on the database appeared to have
been admitted more times than was the case. We therefore put systems in place to
prevent multiple audits and follow up of the same hospital stay (see below). Once
data collection was complete and prior to analysis, we linked or deleted these 'extra'
stays as appropriate to create a final database that described only full hospital stays.
Thus, using routine methods, we established a cohort of patients at each hospital who
might have had an acute stroke. The next task was to identify which of these cases
had truly had an acute stroke and to collect data describing their casemix and the
quality of the care provided.
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3.4 Baseline data collection: background
3.4.1 Research Assistant
We employed a single research assistant to collect data describing diagnosis, baseline
characteristics and the process of care from the medical record. Previously, she had
worked as registered hospital nurse for ten years and, in the four years immediately
before the study, she was employed as a senior audit assistant and coding clerk. She
therefore had considerable clinical experience and a good understanding of the
requirements and difficulties of retrospective review. She was given detailed
instructions in the study methods of data abstraction and, before starting, audited 30
medical records as a test exercise. Her interpretation of the recorded data and the
accuracy with which she collected the study variables were checked and any errors in
her technique corrected.
3.4.2 Data abstraction
Casemix and process of care data extracted from the medical record refer to complete
hospital stays. For the purpose of baseline data collection, we defined a complete
hospital stay as the interval between admission and death in hospital or discharge
from in-patient rehabilitation. Patients transferred to long term care facilities within
hospital were treated as if discharged. Where patients were clearly undergoing
rehabilitation whilst housed in a ward designated for long term care, we defined the
end of a hospital stay as the date after which active rehabilitation ceased.
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We inspected all entries to the medical record (medical, nursing and, if available,
therapist) pertaining to the stay in question and recorded abstracted data on a
standard proforma (Appendix 1). Our research assistant resolved any difficulties
through discussion with medically qualified staff. We checked the repeatability of
some of our data collection by means of an inter-rater study (see chapter 5).
3.4.3 Assignment ofpatients to hospitals
We assigned patients and their outcomes to the hospital (identified by audit the
medical record) to which they were first admitted. This rule allowed us to deal with
patients transferred between hospitals. For example, for a patient transferred from
Hospital A to Hospital D, we assigned the measurements of the process and outcome
of care to Hospital A alone. If patients were first admitted to a non-study hospital
and then transferred to a study hospital, we excluded them from the study altogether.
It is recognised that patients transferred between study hospitals are difficult to
classify (Jollis and Romano 1998). Fortunately, other than for patients with SAH
(who are excluded from analysis, see below) transfer between hospitals for stroke is
unusual. Any bias resulting from our method of assigning patients to hospitals
should therefore be small.
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3.5 Baseline data collection: diagnosis and casemix
3.5.1 Diagnosis ofacute stroke
Acute stroke
We decided not to use the formal WHO criteria to define cases of acute stroke
(Asplund et al. 1988a). We reasoned that its use would have entailed our non
medically qualified research assistant using the limited data available in the medical
record to second guess the diagnosis assigned by the clinicians who cared for the
patient, a difficult and potentially inaccurate task (Asplund et al. 1988a). Instead, we
used a pragmatic definition, namely whether a diagnosis of acute stroke was noted in
the medical record. In the great majority of cases, a final diagnosis of an acute stroke
assigned by a hospital physician, especially if supported by a CT head scan, is likely
to be correct (Ferro et al. 1998a; Kothari et al. 1995; von Arbin et al. 1981a). We
accepted the diagnosis of acute stroke only if it was the diagnosis assigned by the
most senior physician whose opinion was recorded and if the delay between the onset
of the stroke and admission to hospital was 30 days or less. We included patients
admitted to hospital with stroke and those whose stroke occurred after admission for
another disorder. If a patient suffered a second stroke after admission, this was
ignored. We used a 30 day period to define acute stroke because the prognostic
models we intended to use to adjust for casemix were developed and validated using
a very similar definition (see section 3.9.1). Furthermore, patients presenting after
this period represent a cohort of survivors whose outcome may be little influenced by
the measured items of stroke care.
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We assigned each hospital stay to one of four diagnostic categories:
1. Acute Stroke Stroke verified by audit
2. Ineligible stroke Stroke verified by audit BUT over 30 days between onset and
admission and/or transferred from a non-study hospital
3. Not stroke Non stroke disorder defined by audit
4. Unknown Insufficient data in the medical record to establish a diagnosis
'Not stroke' included re-admissions (after an admission for acute stroke) if the
patient was discharged for longer than 24 hours. We recorded the principal reason
for admission in all cases of 'not stroke' based on the most senior recorded opinion.
Pathological subtype ofacute stroke
We identified the pathological subtype of an acute stroke if the result of a CT head
scan, lumbar puncture or autopsy was recorded in the medical record. We assigned
acute strokes to one of four pathological categories: ischaemic stroke; haemorrhagic
stroke; subarachnoid haemorrhage (SAH); not known. If the CT head scan was
reported as normal, or if no bleed was reported, we assumed that the patient had had
an ischaemic stroke regardless of the interval between the onset of the stroke and the




Study patients: acute, non-SAH stroke
We restricted the principal analyses in the SOP to patients with an acute, non-SAH
stroke. Patients with SAH are excluded because the presentation, treatment and
outcome of this condition is distinct to that of other pathological subtypes of stroke.
Moreover, our methods of adjusting outcome for casemix are not applicable to
patients with SAH.
3.5.2 Collection ofcasemix data
All hospital stays
We collected limited identification and demographic data for all hospital stays (Table
3.5). We calculated age as the number of decimalised years from birth until
admission to hospital (i.e. 70 years 6 months = 70.5 years).
Social deprivation
We derived the socio-economic status from the Carstairs deprivation score which, in
turn, is derived from the postcode of the patient's usual place of residence
(McCloone 1994). The Carstairs score is based on four markers of social deprivation
(overcrowding, male unemployment, low social class for the economically active
head of the household and car ownership) and is calculated for each postcode sector
(the area described by the first four digits of the code) in Scotland using small area
census data. On the basis of the Carstairs score, each postcode sector is assigned a
deprivation category ranging from one (most affluent) to seven (most deprived).
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Acute stroke
In cases of acute stroke, we also obtained data describing patients' characteristics
prior to admission and the severity of their condition at presentation. The variables
selected for this purpose were all recognised or potentially important predictors of
outcome after stroke (Counsell and Dennis 2001) and which, when the SOP was
designed, were undergoing investigation by our department (see Table 3.6).
We abstracted data describing severity at presentation from entries relating to the
first 24 hours of admission. If a patient's condition varied during this 24 hour period,
we used the worst scenario except for the measurement of systolic blood pressure,
where we used the most representative reading for that day. The only exception to
the 24 hour time interval for data describing baseline severity was for urinary
incontinence which was noted over the first seven days of admission. If the medical
and nursing notes disagreed with regard to data describing severity at presentation,
we collected the data in the medical notes (except for urinary incontinence, in which
case we preferred the nursing notes).
3.6 Baseline data collection: the structure and process of stroke care
We wished to base our audit of the structure and process of stroke care primarily
upon items that had been shown to improve outcome after stroke in large randomised
controlled trials (RCTs) and systematic reviews or items whose importance was
derived from authoritative statements of best practice that were in existence or in
preparation at the time of the study i.e. the mid 1990s (Aboderin and Venables
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1996b; King's Fund Consensus Conference 1988b; Royal College of Physicians
1989b; Scottish Intercollegiate Guidelines Network (SIGN) 1997c).
Regrettably, our use of review criteria based on unequivocal evidence was limited.
In the mid 1990s only four interventions were supported by evidence from large
RCTs or systematic reviews: organised stroke care (Langhorne et al. 1993b),
secondary prevention with aspirin and anticoagulation after ischaemic stroke
(Antiplatelet Trialists' Collaboration 1994; Atrial Fibrillation Investigators 1994),
and carotid endarterectomy in patients with a recent, non-disabling ischaemic stroke
and a critical stenosis of the ipsilateral carotid artery (North American Symptomatic
Carotid Endarterectomy Trial Collaborators 1991; European Carotid Surgery
Trialists' Collaborative Group 1991). Anticoagulation and carotid endarterectomy
are applicable to only a small proportion of patients and hence are only likely to have
a small impact on hospital outcome (Warlow et al. 1996). We therefore elected not
to collect information about carotid endarterectomy at all. We did collect
information about the use of anticoagulation but with the intention of reporting it in
conjunction with the use of aspirin i.e. the overall use of anti-thrombotic medication.
The value of CT brain imaging in acute stroke is supported only by opinion and
observational data (Donnan 1992; Wardlaw 1994). However, it is an important
diagnostic tool and a pre-requisite to rational secondary prevention using anti¬
thrombotic drugs and carotid endarterectomy, and is best performed within a few
days of stroke onset (Bogousslavsky et al. 1991; Dennis et al. 1987). We therefore
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included measures of the access to and speed of CT brain imaging amongst our
principal measures of the structure and process of care.
A further problem was the difficulty of defining organised stroke care. We wished to
define organised care by its supposed fundamental characteristics: the provision of
care in a geographically defined unit; the co-ordination of care by regular and formal
multidisciplinary team (MDT) meetings; the specialisation and expertise of staff in
stroke; and the provision of education and training for staff and carers in stroke
(Langhorne et al. 1993b; Langhorne 1995; Stroke Unit Trialists' Collaboration
1997c). However, auditing even these limited parameters was difficult. In
particular, there is no accepted definition of a SRU or expertise in stroke care and
potentially important aspects of care such as the proper co-ordination of
rehabilitation, staff education and carer involvement in rehabilitation cannot be
measured by auditing the medical record. The criteria we used to assess the
organisation of care are therefore somewhat simplistic.
3.6.1 The structure ofstroke care
We collected data to describe the organisation of care, the wards and the availability
of key non-medical staff involved in providing stroke care, access to diagnostic
facilities, outpatient facilities and other miscellaneous items (Table 3.7). We
performed two surveys of the structure of stroke care, the first in December 1995 and
the second in April 1997. The first survey was performed by the research assistant
only; the second by both myself and the research assistant. At each hospital, we
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collected data by interviewing the study liaison physician, the therapists involved in
providing stroke care and qualified nursing staff on the wards that usually cared for
patients with stroke. Our audit assistant identified the wards to which stroke patients
were usually admitted and we ascertained the number of beds per ward from
information held by the medical records departments of each hospital. In addition,
because our research assistant visited most hospitals each month, we were able to
keep abreast of important changes in the structure of care at other times during the
study period by informal contacts with hospital staff.
3.6.2 Theprocess ofstroke care
Data collected in all cases ofacute stroke
Table 3.8 shows the data describing the process of care collected for each patient.
Our principal measures of the process of care were: the provision of organised stroke
care; access to CT brain imaging; and the prescription of an anti-thrombotic drug on
discharge. We also measured the use of certain other items of acute stroke care
whose value was less certain or unknown (at the time of the SOP): use of
subcutaneous heparin, administration of parenteral fluids and insertion of a urinary
catheter.
For all items, we collected the date on which their provision/use was first recorded.
When there was no record of an item of care in the medical record, our audit of the
process of care did not differentiate between circumstances where this appeared
appropriate (e.g. in the presence of a recognised contraindication) and where it
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appeared to represent a failure of care. The methods employed in an attempt to take
account of patients' characteristics are detailed in chapter eight.
In each case, we defined the provision of organised stroke care by three criteria:
1. Whether there was a record that a MDT meeting had been held at any time. We
accepted that a MDT meeting had been held if the notes clearly stated that this
was so, or, where this was not explicit, if the opinions/management decisions of
members of three or more therapeutic disciplines (e.g. physician, speech therapist
and physiotherapist) were recorded at the same note entry.
2. Whether the patient was admitted to a geographically defined stroke unit, and, if
so, the dates of admission and discharge.
3. Whether the patient was discharged from the care of a physician with a special
interest in stroke. A physician with a special interest in stroke was defined as one
with specific responsibility for providing the stroke service in that hospital.
Where there was a geographically defined stroke unit we also collected further
information about selected aspects of their usual practice by discussion with
members of staff on that unit (Table 3.8).
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The Royal College ofPhysicians Stroke Audit Package (RCPSAP)
We audited the completeness of the physicians entries to the medical record (i.e.
ignoring any nursing or therapists sections of the medical record) in relation to the 60
key items of history, examination, investigation and management described in the
original version of the Royal College of Physicians Stroke Audit Package (RCPSAP;
see Appendix 2) (Gompertz et al. 1994b; Hancock et al. 1997; McNaughton 1996).
In addition, we gave two RCPSAP criteria individual consideration. First, the
swallowing question, which enquires whether attention to the ability to swallow
safely has been documented within 24 hours of admission. Observational data and
expert opinion hold that this is an important part of the initial assessment because it
appears to reduce the incidence of aspiration pneumonia and hence improves
outcome after stroke (Barer 1989; Smithard et al. 1996). Second, the 'clinical
diagnosis' question, which enquires whether the initial clerking finishes with a
summary detailing the patient's neurological deficit, the likely site of their cerebral
lesion and the relevant risk factors. Such a summary demonstrates stroke specific
thinking on the part of the admitting physician and is held by the developers of the
RCPSAP to be the most important step in developing a management plan
(Anonymous 1994).
Unlike our main process of care audit criteria, the RCPSAP audit criteria allow for
the omission of items of care in the presence of certain common contraindications
e.g. failing to record an assessment of the ability to swallow is disregarded if the
patient is documented as being unconscious. Such appropriate omissions of items of
care are recorded as 'no, but...' whereas inappropriate omissions are recorded as
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'no'. Thus, compliance with each item of care is calculated as the proportion of
patients in whom the item of care was relevant (those with yes or no responses) in
whom the standard was achieved (compliance = number of yes responses/ number of
yes and no responses). A similar method can be used to calculate a compliance score
for the RCPSAP as a whole. We collected RCPSAP data in a representative sample
of about 100 patients with acute stroke at each hospital. We derived this sample by
selecting every nth case on the audit list at each hospital, n varying to ensure a
similar number of cases audited across hospitals. Where a case was selected to have
RCPSAP data collected but did not have an acute stroke, the case immediately below
on the audit list was audited.
Patients transferred between hospitals
For patients transferred between study hospitals, we audited the process of care at
both hospitals and assigned all process data to the first hospital. However, if a
patient was transferred from a study hospital to a non-study hospital (as was possible
at Hospitals B and C) we were unable to audit the medical records at the transfer
hospital. Our measurements of the process of care at the transfer hospital were
therefore limited to the information contained in any discharge letter resulting from
that care. Again, however, other than for patients with SAH (who are excluded from
analysis) transfer between hospitals for stroke is unusual.
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3.7 Outcome: definitions and timing
3.7.1 Outcome measures
In addition to case fatality, we measured functional outcome in survivors in terms of
the need for help from others in activities of daily living (dependency) and in terms
of place of residence. We reported dependency and residence in conjunction with
case fatality, giving the combined outcomes of 'death or dependency' and being
'alive and at home'. These measures are important, relevant to patients, easy to
interpret, influenced by intervention and are recommended for and widely used in
trials of acute treatment and secondary prevention after stroke (Duncan et al. 2000;
Roberts and Counsell 1998b; van Gijn 1992). They are also capable of being
adjusted for important differences in casemix by our prognostic models (see below).
Case fatality and 'alive and at home' also approximate the two measurements of
outcome after stroke that are currently published in Scotland.
Although collected, I have not reported data describing quality of life collected using
the Euroquol, a measure of health related quality of life after stroke (Dorman et al.
1997b). This instrument measures physical function, depression and anxiety and the
presence of pain. In the absence of a validated method of adjusting the Euroquol
data for casemix, their comparison between hospitals is unlikely to be useful for
measuring the quality of care. However, the data are useful descriptors of patients
per se and I have therefore used them to compare the casemix of responders and non-
responders to our outcome questionnaire (see chapter six).
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3.7.2 Definition ofoutcome states
We defined case fatality as death from any cause.
We measured dependency using the dependency question of the 'simple questions'
originally used in the International Stroke Trial (International Stroke Trial
Collaborative Group 1997b; Lindley et al. 1994a). This question asks: do you need
help from anybody with everyday activities? Our main reason for using it in the SOP
was the assumption that, in a routine system where repeated follow up of non-
responders might not be possible, a simple and brief outcome measure would be
most likely to encourage a high level of response. The absence of any clinically
important bias when the question is answered by proxy is a further practical
advantage (Lindley et al. 1994a).
A potential drawback to using the simple dependency question is that it has only
been demonstrated to have reasonable validity and reliability (Dennis et al. 1997b;
Dennis et al. 1997a; Kay et al. 1997; Lindley et al. 1994a). Although perfectly
adequate for comparisons of outcome between very large groups of patients
(thousands in each), its use may reduce our ability to identify differences in outcome
between smaller groups, such as between the hospitals in this study. In the last eight
months, we also collected functional status using the Modified Rankin Scale (MRS)
(Bamford et al. 1989) in order to compare its findings with those of the simple
dependency question. This scale is widely used as a measure of functional status
after stroke and allows a finer classification than the simple dependency question:
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scores 0, 1 and 2 indicate functional independence at increasing levels of difficulty
while scores 3, 4 and 5 indicate increasing levels of functional dependency (see
Appendix 3).
We determined place of residence by means of a specific question. This question
asked: 'where are you staying now?' and gave five alternatives: same place as before
illness; in hospital; with family; in a nursing or residential home; other (asked to
specify). For the purpose of the SOP, we defined 'at home' to mean living
somewhere other than a hospital or a residential/nursing home. Thus, we considered
patients living at the same place as before their illness or with family to be 'at home'.
For those living in an 'other' place, we inspected the accompanying details and
assigned their place of residence accordingly. Where patients indicated that they
lived in sheltered accommodation we defined them to be 'at home'.
3.7.2 Timing ofoutcome assessment
We measured outcome six months after admission, a period widely regarded as
sufficient to allow for natural recovery and the impact of treatment to become
apparent and that is recommended for use in trials of treatments of stroke (Dombovy
et al. 1987; Duncan et al. 2000; Jorgensen et al. 1995; Stroke Unit Trialists'
Collaboration. 1997b; Wade and Hewer 1987). Equally important in choosing a six
month follow up were the practicalities of our system of identifying patients. SMRls
are frequently only completed after the patient is discharged, and in all cases up to
four weeks could elapse before ISD passed the SMR1 on to us. ISD estimate that six
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months need to elapse after the end of a given period in order for 99% of SMRls to
be completed and returned (Clinical Outcomes Working Group 1999a). Thus, using
our system of identifying cases, the first point at which it is actually possible to send
a follow up after a fixed interval to the majority of cases is approximately six months
after admission. Lastly, we followed patients at six months because our prognostic
models are able to make predictions of outcome at this time.
3.7.3 Definition ofoutcomes measures (as used in main analyses)
Case fatality: all analyses of case fatality are based on linked survival data (see
section 3.8.1), with six month case fatality (from any cause) calculated at 183 days
after the first day of the complete hospital stay, taking the admission date obtained by
auditing the medical record as baseline.
Death and dependency: we identified case fatality at six months as above. In cases
alive at six months, we preferentially used the simple question to identify
dependency; if the dependency question was left blank but the MRS was filled, we
defined patients with a score of 3, 4 or 5 as dependent.
Alive and at home: we identified case fatality at six months as above. In cases alive
at six months, we used the response to the question 'where are you staying now' (see
3.7.1) to define place of residence.
94
Chapter Three
All survey data pertaining to patients alive at six months, regardless of when the
questionnaire was actually filled, were defined as 'six month outcome data'. This
rule allowed us to include returns that were late either because there was delay in
identifying their stay (late SMR1 data) or because of delay in mailing, filling or
returning the questionnaire.
3.8 Outcome: methods of follow up
We used separate methods to identify those patients who had died and to collect data
describing the quality of survival in patients alive at six months. The fundamental
principle underlying each was that the method had to be feasible on a routine basis
i.e. capable of being used on a large scale (national) and on-going basis.
3.8.1 Casefatality
Unlike other parts of the UK in the 1990s, Scotland was fortunate in that it already
possessed an accurate and simple system for routinely identifying survival at a fixed
time after admission to hospital. This was possible because ISD were able to link
SMR1 data to the Registrar General's death certificate records and do so with a
minimum of 99% accuracy (Clinical Outcomes Working Group 1999a). Given that a
practical and reliable routine system of identifying death was already in place, there
seemed little point in developing an alternative. The draw back to the method is that
linkage to death certification data is currently performed only periodically. We
obtained linked fatality data from ISD and therefore had to wait until ISD had
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identified six month survival status for all patients in the study. These data were not
available till 1999, nearly two years after the last patient was recruited. Therefore,
although the linked data provided a definitive and routine measurement of survival at
this time, we could not use them to guide our system of following up survivors. In
the future much more rapid linkage may be possible (Clinical Outcomes Working
Group 1999a).
3.8.2 Following up survivors
We set out to test a centralised and semi-automated system to follow survivors using
a postal questionnaire. Our outcome questionnaire is shown in Appendix 4.
We designed our system to overcome two practical difficulties to routine postal
follow up in Scotland. First, SMR1 data do not give the address the patient was
discharged to or even the address from which they were admitted; instead, they
simply give the post code of the patient's residence before they were admitted.
Second, we had no way of knowing if patients had died after discharge and wished to
avoid mailing questionnaires to recently bereaved relatives. However, SMR1 data do
give the address and sometimes the name of the patient's general practitioner (GP)
(the latter is an optional field) prior to admission to hospital and, we reasoned, the
GP was highly likely to know whether the patient was alive and if so, to know their
current address. We therefore designed a two stage system of follow up that relied
on the GP to act as our 'middle-man'.
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First, we checked all hospital stays listed on our database to determine whether the
patient had died in hospital. Then, in all patients where the SMR1 discharge code
showed that the patient was discharged alive, we sent a follow up pack to the pre¬
admission GP surgery, naming the relevant GP whenever possible. The follow up
pack consisted of two parts, one for the GP and one for the patient.
The 'GPpack'
This included an explanatory letter, a single sided response form and a reply paid
envelope (Appendix 5). We requested that the GP tell us if and when the patient had
died or, if the patient was still alive, to forward our 'patient pack' to them. We also
requested that the GP let us know if the patient was no longer on their list. The
explanatory letter made it clear that the patient's consultant had let us know about the
hospital stay, that the purpose of the survey was to collect data to measure the quality
of hospital care and that any data collected would be confidential.
The 'patient pack'
This was provided as an envelope (left unsealed so the GP could inspect the
contents) with the patient's name and a postage stamp already attached; the surgery
simply had to add the patient's address and post the envelope on. The pack included
a brief explanatory letter (Appendix 6), a questionnaire and a reply paid return
envelope. To encourage response, we tried to make the explanatory letter personal
by using the patient's name and by mentioning that the consultant in charge of their
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care. The letter also made it clear that the information requested would be kept
confidential and would help in trying to improve care at their local hospital.
Postingfollow up packs
We posted the follow up pack to the GP three weeks before the six month follow up
date to allow sufficient time for the questionnaire to reach the patient. Follow ups
were generated and sent on a weekly basis. In cases where we first received SMR1
data more than six months after the patient was admitted to hospital, follow up was
sent in the next weekly batch .
Minimising the number offollow ups sent
Because our database sometimes listed erroneous extra hospital stays (see section
3.4.2), there was the potential for some patients to be sent more than one
questionnaire. The same applied to patients who genuinely had two or more hospital
stays for acute stroke in quick succession. In both cases, to reduce workload and
avoid antagonising GPs, we established systems to minimise the number of follow
ups. Thus, only one follow up was sent and the same outcome data used if the ISD
admission dates of two stays were within 30 days of one another or if the follow up
form for the first stay was completed within the 30 day period before the follow up
form for the second stay was due to be sent. To further reduce follow up, when we
became aware that a hospital stay was due to an 'ineligible stroke' or a 'not stroke'




Soon after starting follow up, it became apparent that GPs were making two common
mistakes. First, instead of forwarding the patient pack, some would reply that it was
'fine for us to contact' the patient or simply confirm that the patient was alive.
Second, some GPs would reply telling us the patient's current address. We reasoned
that these same mistakes would likely occur in a real system and altered our follow
up system accordingly: where GPs gave their permission for us to mail a
questionnaire or confirmed the patient was alive, we sent back another follow up
pack with a letter reiterating that we could not follow the patient ourselves; where we
were provided with the current address, we forwarded a patient follow up pack
ourselves.
Returned questionnaires
We defined the date on which follow up actually occurred as the date the
questionnaire was completed. We did not attempt to contact GPs or patients in cases
of non-response for the first 14 months of the study. For the final 10 months we
modified our methods of follow up in an attempt to improve response (see chapter 6)
3.9 Outcome: adjusting for casemix
3.9.1 The study prognostic models
We adjusted the comparisons of outcome between hospitals for variation in casemix
using multiple logistic regression. To do so, we applied three simple prognostic
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models (the 'study models') recently developed within our own department (Table
3.10). The development of these models and their predictive properties are described
in detail elsewhere (Counsell et al. 2002; Counsell 1998). Briefly, the models were
rigorously derived according to established guidelines (Laupacis et al. 1997b;
Wasson et al. 1985; Wyatt and Altman 1995b) using a training data set taken from
the Oxfordshire Community Stroke Project (OCSP), an unselected cohort of patients
with first ever stroke (Bamford et al. 1988). Each model uses the same six simple
clinical variables, each of which can be collected during a single visit to the patient's
bedside. The external validity of the models was tested in two independent cohorts:
a community-based cohort of 538 patients with first ever stroke (Anderson et al.
1993; Ricci et al. 1991) and a hospital-based cohort of 1330 patients with first and
recurrent stroke (derived from the prospective stroke register of the Western General
Hospital, Edinburgh). These data sets provided a stern test of the external validity of
the models by assessing their accuracy across time, place and patient type (Braitman
and Davidoff 1996; Harrell, Jr. et al. 1996b; Justice et al. 1999; Laupacis et al.
1997b; Wyatt and Altman 1995b). The models describing survival and independent
survival were found to have good external validity and the model for 'alive and at
home' reasonable external validity (Counsell et al. 2002; Counsell 1998).
3.9.2 Applying the study models to the SOP data set
Two terms, discrimination and calibration, are used to describe the accuracy of the
predictions of a logistic regression model (Harrell, Jr. et al. 1996a; Justice et al.
1999). Discrimination refers to the ability of a model to differentiate between
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individuals who do and do not experience an outcome whilst calibration refers to the
accuracy with which a model predicts outcomes for groups of patients. In the
comparison of adjusted outcome between hospitals, it is most important that a model
is well calibrated.
The calibration of an externally derived prognostic model can be improved by
customising the coefficients of its predictive variables to the dataset under
investigation i.e. by building a new model in the study data set, forcing in exactly the
same predictive variables as used in the original model (Moreno and Apolone 1997;
Shu et al. 1996). Ideally, I wished to use customised models to adjust the
comparisons of all three outcomes in the SOP. Unfortunately, a customised model is
only likely to be valid if there is complete ascertainment of outcome, which, in the
SOP, was only likely to be the case for death. For the outcomes collected by postal
survey (dependency and residence) it was inevitable that there would be losses to
follow up. I therefore used a customised version of the study model only for the
outcome of case fatality. For the outcomes of 'death or dependency' and 'alive & at
home' I used the models in their original format.
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3.9.3 Measures ofadjusted outcome
I used two complimentary measures of adjusted outcome.
1. p values and odds ratios
I used logistic regression analysis to estimate the statistical significance of any
overall variation in outcome between hospitals and to describe the outcomes of the
hospitals relative to one another. To do so, I entered a hospital term as a categorical
variable, with Hospital A as the reference category, into each regression analysis. I
took the significance of the hospital term overall (not of the individual comparisons
A vs. B, A vs. C, etc.) to indicate the significance of any variation in outcome
between hospitals. I calculated odds ratios to describe the outcomes of the hospitals
relative to Hospital A. I derived the odds ratios and their 95% confidence intervals
using the formula
2 (Logistic Coefficient ofeach hospital + /- 1.96 x StandardError)
For unadjusted outcomes, I performed a logistic regression analysis with the hospital
term as the only covariate. For adjusted case fatality, I performed a logistic
regression analysis with the hospital term entered in addition to the covariates of the
customised study model. For adjusted 'death or dependency' and 'alive and at
home' I first calculated a linear predictor value for each patient in order to preserve
the predictive properties of the study model (the method is given in appendix 7)
(Moreno and Apolone 1997; Shu et al. 1996). I then performed a logistic regression
analysis with the linear predictor and the hospital term as the only covariates. All
logistic regression analyses were performed using SPSS version 9.0
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2. The Wscore method
The W score method provides a measure of adjusted outcome in absolute terms. W
scores are easy to interpret and have been used in previous studies investigating
variations in mortality between centres and over time (Parry et al. 1998b; Smith et
al. 1990; Yates et al. 1992). The W score measures the difference between the
observed and the predicted number of outcome events per 100 patients treated within
a hospital. The W score is calculated using the formula
w = (o -p) / (n/100)
where o is the observed number of events, p the predicted number of events and n the
total number of patients per hospital. For example, if 500 patients are treated, 150
deaths observed and 100 deaths are predicted, then the W score is
(150-100)/(500/100) = +10
that is, 10 more deaths than predicted per 100 patients treated.
The overall predicted number of events at each hospital p is calculated by summing
the individual predicted probabilities of an event /?, generated for each patient by the
prognostic model {p = Ip,). The method for calculating p, is shown in Appendix 7
and that for calculating the standard error and 95% confidence interval for a W score
are shown in appendix 8.
In order to directly compare hospital outcomes before and after adjusting for
casemix, the unadjusted outcome must also be expressed as a W score. An
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unadjusted W score is calculated by defining the predicted number of events p at
each hospital as npQ, where n is the number of patients at the hospital and p0 is the
proportion of patients observed to have experienced the outcome in the SOP overall.
(Parry et al. 1998b)
The comparison ofW scores between hospitals
In the SOP, I was chiefly interested in the comparison of W scores between the
hospitals rather than the value of the W score at each hospital in isolation. The
validity of a comparison ofW scores depends on the uniformity of the calibration of
the prognostic model, that is, the accuracy of the model predictions for groups of
patients across the entire range of predicted risks e.g. low risk, medium risk, high
risk groups, etc. This is usually assessed graphically (Harrell, Jr. et al. 1996a; Justice
et al. 1999). In the SOP, I derived calibration plots by stratifying the data set into
deciles according to predicted risk (0 to 9.9%, 10 to 19.9%, ...90 to 100%) and then
plotting the mean predicted risk against the mean observed risk for each decile. For
a well calibrated model, a calibration plot should follow a 45° line.
If a model is properly calibrated, model predictions for groups of patients are free
from bias and the absolute difference in adjusted outcome between hospitals can be
calculated simply by subtracting W scores. For example, if the W score at Hospital
X is +3 and that at Hospital Y is -3, then one may infer that there are 6 more events
per 100 patients treated at Hospital X than at Hospital Y. However, if the calibration
plot deviates substantially from the 45° line, then simple comparisons ofW scores
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are not valid. To illustrate, consider a prognostic model predicting death that
systematically under-estimates risk in groups of patients at high actual risk of death.
The greater the proportion of patients at high risk of death admitted, the greater the
under-estimate in the overall number of predicted deaths. Any difference of W
scores between hospitals will therefore reflect differences in casemix, in this
instance, favouring hospitals admitting a smaller proportion of patients at high risk of
death. I drew calibration plots for each model to guard against this bias. If the plot
largely followed the 45° line, then I calculated the absolute difference in outcome
between hospitals simply by subtracting W scores; if the plot deviated markedly
from the 45° line, I used the strategy described below.
The Standardised W score
The Standardised W score (Ws score) is a modification of the W score that reduces
the bias that results when comparisons in adjusted outcome are made between
populations with differing casemix structures when a model used to adjust for
casemix fails to calibrate uniformly (Glance et al. 2000; Hollis et al. 1995; Younge
et al. 1997). The modification involves standardising the W scores with respect to
baseline predicted risk against a reference population; that is to say, the method
artificially assigns a similar casemix structure to all hospitals. To do so, the data set
at each hospital is first divided into strata according to baseline predicted risk (0 to
9.9%, 10 to 19.9%, etc.) and a W score, termed Wj, calculated for each stratum using
the formula:
wj = (Oj-pj) /(nj/100)
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where oj is the observed number of events in stratum j, pj is the predicted number of
events in stratumj (calculated as E p, within stratum j) and rij the number of cases in
stratum j. The standardised W score (Ws score) is then calculated as the product of
Wj and fj (the fraction of the reference population in interval j) summed over all
strata:
Ws — Z*over strata (W/ fj)
For relevance, I have used the entire SOP data set as the reference population. Thus,
in the SOP, the Ws score is the W score that would result if the casemix structure of
each hospital were the same as that of the SOP overall. Since all hospitals are
assigned a similar casemix structure, the extent to which their adjusted outcomes are
in error because of non-uniform model calibration is also similar, and hence a
comparison of adjusted outcomes between hospitals is valid.
The methods used to calculate the standard error and 95% confidence limits for Ws
scores are shown in appendix 8.
3.10 Other statistical methods
I have shown proportions as percentages and, where appropriate, given 95%
confidence intervals (calculated using Confidence Interval Analysis, version 1.0) and
tested for the significance of any differences using the Chi square test or Fisher's
exact test. I have presented odds ratios and relative risk ratios with 95% confidence
intervals (calculated using either SPSS for Windows, version 9.0 or Epi Info, version
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6.04b). For continuous variables, histogram plots showed that most data were not
normally distributed. In the main, therefore, I have presented these data using
median and percentile values and used non-parametric methods (either the Mann-
Whitney or Kruskall-Wallis tests) to test for the significance of any differences
between cohorts (using SPSS for Windows, version 9.0). For data that were
normally distributed, I have presented mean values with 95% confidence intervals
and tested for the significance of any differences using the independent t-test (SPSS
for Windows, version 9.0). Any other calculations were performed using an Excel
97 spreadsheet. All figures were produced either from this spreadsheet or directly
from SPSS, version 9.0.
3.11 Data quality
All data were entered into the study database by double punching and verification. I
investigated the accuracy of the database prior to analysis using recognised checking
procedures (Altman 1999a). Anomalous and missing entries were cross checked
against the original audit form and corrected. As a final check on the accuracy of the
database, we randomly selected the records of 300 acute stroke hospital stays (-10%
sample) and checked all entries abstracted from the medical record against the
original audit forms. Only seven omissions or mis-punched items were found out of
an estimated 20 000 items of data (two describing stroke pathological type, one
describing severity and four describing the process of care).
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Table 3.1 Characteristics of the five participating hospitals at the start of the SOP
Trust Characteristics




DGH Yes No Conventional
B Urban Teaching Yes No Organised
C Rural DGH Yes No Conventional
D Urban Teaching No Yes Organised
E Urban DGH Yes No Conventional
DGH District General Hospital
Neuro Neurology and neurosurgery
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Main hospital GP and A&E Dept. Acute care & some rehabilitation
♦Subsidiary 1 Main hospital Acute care and rehabilitation (geriatrics)
♦Subsidiary 2 Main hospital Rehabilitation & long stay beds
♦Subsidiary 3 Main hospital Rehabilitation & long stay beds
♦Subsidiary 4 Main hospital Temporary admission while awaiting a
place at a rehabilitation facility; also
some long stay beds
Hospital B
Main hospital GP and A&E Dept. Acute care & some rehabilitation
Subsidiary Main hospital only Rehabilitation
Hospital C
Single hospital GP and A&E Dept. Acute care & rehabilitation; also some
long stay beds
Hospital D
Main hospital GP only
Surrounding hospitals
Acute care & rehabilitation
Neurology & neurosurgery
Subsidiary GP & Main hospital Acute care & rehabilitation (geriatrics)
Hospital E
Single hospital GP and A&E Dept. Acute care & rehabilitation; also some
long stay beds<t>
* These hospitals officially belonged to another NHS Trust. However, patients
admitted to Hospital A with stroke are routinely transferred to these hospitals for
rehabilitation and sometimes acute care. Patients that were directly admitted to
these hospitals with stroke are not included in this study.
<|> The long stay wards at Hospital E belong to another NHS Trust.
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Table 3.3 ICD Cerebrovascular Disease Codes, ninth and tenth revisions
ICD 9 codes Definition
430* Subarachnoid haemorrhage
431* Intracerebral haemorrhage
432.0/1 Non-traumatic extradural/subdural haemorrhage
432.9 Unspecified non-traumatic intracranial haemorrhage
433* Occlusion and stenosis of precerebral arteries
434* Occlusion of cerebral arteries
435* Transient cerebral ischaemia
436* Acute but ill-defined cerebrovascular disease
437* Other and ill-defined cerebrovascular disease




162.0/1 Non-traumatic extradural/subdural haemorrhage
I62.9 Unspecified non-traumatic intracranial haemorrhage
I63* Cerebral infarction
I64* Stroke, not specified as haemorrhage or infarction
I65 /166* Occlusion and stenosis of precerebral/cerebral arteries,
not resulting in cerebral infarction
I67* Other cerebrovascular diseases
I68* Cerebrovascular disorders in diseases classified elsewhere
I69* Sequelae of cerebrovascular disease




Table 3.4 The information routinely reported for stroke patients on the SMR1
(Scottish Morbidity Record Type 1)
About the patient:
Hospital case reference number




Post code only of their home address prior to admission
About their illness:
Principal diagnosis (the main condition managed or investigated during the patient's stay)
Up to five subsidiary diagnoses (complications and co-morbid conditions)
About their General Practioner:
A unique code number identifying the address of the GP practice
The GP's General Medical Council registration number (optional)
About their consultant:
A unique code identifying the consultant responsible for the patient whilst in hospital
The medical specialty of the consultant.
About their admission:
Where they were admitted from e.g. home, other hospital etc.
Type of admission e.g. emergency, transfer, waiting list, etc.
Dates of admission and discharge
Discharge code e.g. to home, to other hospital, died in hospital, etc.
Type of hospital facility e.g. in-patient, day case, etc.
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Table 3.5 Information abstracted from the medical record and entered onto the study




Postcode of usual place of residence (used to derive socio-economic status)
Marital state (by SMR1 definitions f)
About the admission
Date of first admission
Date of first clerking in the medical record
Diagnostic category (stroke, ineligible stroke, not stroke, not known)
Diagnosis if not a stroke







Table 3.6 Definition of variables used to describe casemix in patients with an audited
diagnosis of acute stroke







Past history of diabetes mellitus
Past history of angina, myocardial infarction or
coronary artery bypass graft surgery
Past history of a myocardial infarction
Patient regularly lived alone
Able to perform everyday activities without
assistance e.g. walking, bathing, feeding, dressing
In regular part or full time employment
Within first 24 hours of admission
Orientated & able to speak
Normal GCS Eye score
Normal GCS Motor score
Able to lift both arms
Able to walk without help
High systolic blood pressure
Urinary incontinence *
Speech understandable and orientated in time and
place (i.e. normal verbal component of the GCS)
Eyes open spontaneously
Able to move unaffected/ least affected limb
purposefully
MRC motor score grade 3 or more in both arms
Able to walk without human assistance i.e. the use
of walking aids was acceptable
Systolic blood pressure over 160 mmHg
Two or more episodes of urinary incontinence or
any use of an indwelling catheter *
* within the first seven days of admission
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Table 3.7 Data collected by the survey of the structure of stroke care
Organisation & specialisation of care
Geographically defined stroke unit
If present: Type of unit: acute and/or rehabilitation
On/ off main hospital site
Number of beds/ ability to expand
Date opened
Physician specifically responsible for patients with stroke
If yes: membership of stroke related interest groups
Provision and use of a stroke specific clerking proforma
Wards & staff usually involved in providing stroke care
Number of beds per ward
Nurses: number and grade per ward
Therapists: number and grade assigned to medical wards/stroke unit
Stroke liaison nurse
Social services
Access to diagnostic facilities
CT and MRI head scan




Access to a day hospital and therapists
Provision of specialist neurovascular clinic for patients with TIA and minor stroke
Other
Written protocol for the treatment of stroke patients within the hospital
Maintenance of a hospital stroke register
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Table 3.8 Data describing the process of care collected in cases of acute stroke
Principal measures (from the medical record)
Organisation of care
multidisciplinary team (MDT) meeting held; date of first
• admitted to a geographically defined stroke unit; date first admitted
. discharged from the care of a physician with a special interest in stroke
Discharge on an antithrombotic medication (aspirin or anticoagulant)
CT Head scan; date of first scan
Supplementary measures (from the medical record)
Use of subcutaneous heparin; date started
Use of parenteral fluids; date started
Insertion of a urinary catheter; date inserted
Stroke units only (by hospital survey/ auditors experience only)
Age related admission policy
Provision of education and training for staff
Provision of education and support for patients and carers
Setting and documenting of rehabilitation goals
Formal assessment/ re-assessment of progress of rehabilitation




Table 3.9 The predictive variables of the models used to predict outcome after stroke
1. Age on admission
Prior to the stroke
2. Was the patient independent in activities of daily living?
3. Did the patient live alone?
On admission
4. Was the patient orientated and able to speak?
5. Was the patient able to lift both arms?
6. Was the patient able to walk without help?
116
Chapter Three
Table 3.10 Details of the logistic regression models used to predict outcome at six
months after stroke.
Model covariate





Orientated and able to speak
Able to lift both arms
Able to walk without help





Orientated and able to speak
Able to lift both arms
Able to walk without help





Orientated and able to speak
Able to lift both arms
























Outcomes: alive, 'alive and independent', 'alive and at home' = 1;
dead, 'dead or dependent', 'dead or not at home' = 0.
i.e. the models predict the probability of good outcomes.
Covariates: presence of the attribute = 1, absence of the attribute = 2.
The predicted probability of death or of 'death or dependency'
= (1 - the predicted probability of being alive or 'alive and independent', respectively).
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Figure 3.1 Deaths within 30 days of emergency admission for stroke for each Scottish
hospital for the period July 1990 to June 1993 as published by the Clinical Outcomes
Working Group of the Scottish Office in December 1994 (corrected in February 1995)
The proportion dead (with 95% condifence interval) for each hospital is shown by a
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Chapter Four. How accurately do routine hospital discharge
data identify patients with acute stroke?
4.1 introduction
Hospital discharge data currently provide the only practical means of identifying
patients with a given disorder routinely and across an entire country. These data are
easily available and are generated unobtrusively and automatically, nearly all being
derived from the clinical summaries that are sent to the GP shortly after a patient's
discharge. Unfortunately, these practical advantages are offset by the well
recognised potential for inaccuracy (Demlo and Campbell 1981b; Harley and Jones
1996; McKee and James 1997b; Williams and Mann 2002). First, only some of the
patients labelled as having the disorder in question may in fact do so (i.e. there may
be false positive error) and second, the data may identify only a proportion of the
total number of the patients admitted with the disorder (i.e. there may be false
negative error). Both errors reduce the credibility of the data and, more importantly,
may lead to bias and reduced power in any comparison of outcome between
hospitals. If the intention is to follow patients to determine their functional status
after discharge, false positive error also increases the number of patients to be
followed.
This chapter describes an attempt to determine the accuracy with which routine
discharge data identified patients with acute stroke. This investigation is primarily
related to false positive error. The identification of error requires a gold standard
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against which the study data can be compared: to identify false positive error, I have
used the diagnosis data collected by our research assistant as the final arbiter of
whether or not a patient had an acute stroke; to identify false negative error
(sensitivity), we would have had to identify all patients with stroke at each hospital
independently of their discharge data i.e. we would have had to set up five
prospective stroke registers. This was beyond our resources. Nonetheless, false
negative error resulting from the selection of subsets of CVD codes can be studied
and the potential impact of any reduced sensitivity in CVD discharge data as a whole
can be estimated.
I have investigated false positive error in CVD discharge data per hospital and per
ICD code. For the per hospital analyses, I have concentrated on the accuracy of the
subsets ofCVD codes used by ISD and by the Department ofHealth (DoH) to derive
the stroke outcomes data currently published in Scotland and in England & Wales,
respectively, and attempted to quantify the impact of such error on comparisons of
case fatality between hospitals. I have also summarised the reasons for admission in
patients with a CVD code as the primary diagnosis but who did not have an acute
stroke and briefly considered various other aspects of SMR1 data that pertain to case




CVD codes and SMR1 data
All analyses are based on SMRls that had a CVD code in the primary diagnostic
position (see Table 3.3). When the same hospital stay was reported using SMRls
with differing CVD codes I categorised the stay by the CVD code given on the final
SMR1. I categorised hospital stays as emergency or non-emergency admissions
according to the type of admission code given on the first SMR1. We collected all
CVD discharge diagnosis codes only for the first six months of the study (during
which time the majority of SMRls used ICD9 codes). All analyses refer to data
collected over this period except for that describing the accuracy of the individual
ICD codes which is based upon the entire period the codes were collected (which
ranged from six months to two years). ISD collects all emergency admissions with
any CVD code except TIA listed as the primary SMR1 diagnosis whilst the
Department of Health collects all emergency admissions with ICD 10 codes 161 to
164 listed as the primary diagnosis (analogous to ICD 9 codes 431, 432, 434 & 436).
False positive and negative error
I quantified the false positive error in terms of positive predictive value (PPV),
calculated as the proportion of all hospital stays that were verified as having been for
acute stroke. I quantified false negative error in terms of the proportion of hospital




All analyses in this chapter refer only to hospital stays for acute stroke, ineligible
stroke and not stroke. For the purpose of calculating PPV, I have classified patients
with ineligible stroke (see section 3.5.1 for definition) as having a non-stroke
disorder. Thus, the estimates of PPV indicate the proportion of hospital stays for
patients who presented within four weeks of stroke onset and who were not treated
elsewhere first i.e. patients by whom a hospital's 'performance' with regard to the
treatment of acute stroke care might fairly be judged.
4.3 Results
In the first six months, we inspected the medical record and identified a diagnosis in
97% (1255) of the 1291 hospital stays with a CVD code listed as the primary SMR1
diagnosis: 713 acute strokes; 64 ineligible strokes; 478 not strokes. Using the ISD
method of identification there were 638 acute strokes, 24 ineligible strokes and 177
not strokes; using the DoH method there were 578 acute strokes, 11 ineligible strokes
and 118 not strokes.
4.3.1 Positivepredictive valueper hospital
The results of the per hospital analyses are shown in Table 4.1. When all CVD codes
were used to identify acute stroke, PPV was poor and varied significantly between
hospitals (range 51 to 69%, p 0.0007). When the ISD method of case identification
was used, PPV improved (overall PPV 76%; range 70 to 82%, p 0.146). The DoH
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method of identification was somewhat better (overall PPV 82%) and the variation
between hospitals smaller (78 to 85%, p 0.596). The ISD method of identification
resulted in a loss of 11% of audit verified acute strokes (range 2% to 17%). The
DoH method of identification resulted in an overall loss of 19% of audit verified
acute strokes (range 10% to 32%).
4.3.2 Thepositivepredictive value of individual CVD codes
The PPV of individual CVD codes are shown in Table 4.2. The great majority of
hospital stays relating to acute stroke were assigned one of four codes: intra-cerebral
haemorrhage (431/161); 'ischaemic stroke' (434/163); acute unspecified stroke
(436/164); and non-specific cerebrovascular disease (437/167). The PPV of the first
three codes were relatively high (range 80 to 87%) but that for 437/167, the third
most commonly used CVD code, was only 26%.
The code for SAH (430/160) had a moderate PPV for acute stroke (69%). However,
of the 125 hospital stays for an acute stroke that were assigned this code, 86% had in
fact had a SAH i.e. the code had a very low PPV for non-SAH acute stroke.
The code for non-traumatic intracranial haemorrhage (432/162) appeared to have
only a moderate PPV for acute stroke (50%). However, the PPV of the sub-code
referring to non-specific intracranial haemorrhage (432.9/162.9) was high
(93%; 14/15 cases). The low PPV for the code overall related to the inclusion of sub-
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codes for non-traumatic subdural/extradural haemorrhage (162.0/162.1) which had a
PPV for acute stroke of only 7% (1/15 cases).
Three CVD codes had very low PPV for acute stroke: transient ischaemic attack
(code 435; PPV 5%); stenosis or occlusion of precerebral arteries (code 433; PPV
1%) and late effects of cerebrovascular disease (code 438; PPV 0%). In order to
increase the efficiency of our audit of the medical records, we stopped collecting
these codes after the first six months of the study. Similarly, we stopped collecting
hospital stays with a SAH code listed as the primary SMR.1 diagnosis after the first
year.
The overall PPV of the 980 hospital stays coded as an emergency admission was
66% while that for the 275 hospital stays coded as a non-emergency admission was
24%.
4.3.3 Modifying the ISD method of identifying acute stroke
With the knowledge that certain CVD codes had a low PPV for acute stroke, I
explored the possibility of improving the PPV of the ISD method by omitting cases
with the ICD9 codes 430, 433 & 438 (a method which equates to the DoH method
plus code 437). The benefit of this modification was minimal (overall PPV 77%)
and was essentially limited to Hospital D. Here, the PPV of its cohort improved
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from 73 to 79% but also resulted in the loss of 19% of the acute strokes identified
using the standard ISD method.
4.3.4 Impact of the measured coding errors on comparisons ofcasefatality
When any CVD code was used to identify patients with acute stroke, the absolute
estimates of six month case fatality were uniformly and substantially low (refer
forward to Table 7.19, page 276). The absolute estimates of six month case fatality
improved at all hospitals when the standard ISD and the DoH methods of patient
identification were used. The estimates of case fatality at Hospitals B & D were
essentially correct using each method and those at Hospitals A,C & E were moderate
under-estimates (up to 4% in absolute terms) except at Hospital A where the ISD
method led to an absolute under-estimate of 7%. The modified ISD method gave
very similar estimates of case fatality as the standard ISD method.
The comparisons of case fatality between hospitals were in reasonable agreement
with the truth except for the comparisons between Hospitals A & B (for both the ISD
and DoH methods) and between Hospitals A & D (for the ISD method only). Thus,
the ISD method suggested that case fatality at Hospital B was 12% lower than at
Hospital A and the DoH method suggested that the difference in case fatality was
17%. In fact, the gold standard suggested that case fatality at Hospital B was 26%
lower than at Hospital A. Similarly, the ISD method suggested that case fatality at
Hospital D was 40% lower than that at Hospital A when in fact it was 47% lower.
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4.3.5 Actual diagnosis in non-stroke cases assigned a CVD code
The actual reason for admission in 478 patients assigned a CVD code as their
primary SMR1 diagnosis but who did not have an acute or ineligible stroke is shown
in Table 4.3. The reason for admission fell into the following categories: other
cerebrovascular disease (almost exclusively TIA) (29%); an investigation or
procedure (nearly all relating to a prior stroke or TIA) (16%); a specific neurological
symptom or condition (25%); a non specific and/or non neurological condition
(25%); and unknown disorder/missed stroke (5%). The notes made by our audit
assistant showed that the specific neurological symptoms or conditions and the non¬
specific and/or non neurological conditions often either presented in a manner that
resembled stroke or occurred on a background of established cerebrovascular
disease. The ISD method reduced the identification of non-stroke patients across all
categories but especially those with TIA and those who had been admitted for an
investigation or procedure.
4.3.6 Otherfindings
Less than one percent of the post codes referring to the patient's pre-admission
address differed from that extracted from the medical record. These few errors were
in the last three symbols of the code, not the area codes. 77% (550) hospital stays
consisted of only one finished consultant episode (FCE), 17% (119) consisted of two
FCEs and only 6% (44) consisted of three or more FCEs. The median delay between
admission to hospital and ISD providing us with the SMR1 was 137 days; we were
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informed of 95% of relevant SMRls by 177 days (i.e. within six months.) and 98%
by 270 days (i.e. within nine months).
4.4 Discussion
These analyses suggest that if all SMRls with any CVD code listed as the primary
diagnosis are used to identify acute stroke, the resulting hospital samples are very
impure with between one half and one third of hospital stays referring to another
disorder. This finding is not really a surprise. It is, after all, the purpose of CVD
codes to describe cerebrovascular diseases other than acute stroke. It was therefore
to be expected that our samples would also contain patients with TIA, SAH, less
common cerebrovascular pathologies and, given the coding convention of diagnosis
first and procedure second, some with carotid artery stenosis admitted for
angiography, angioplasty or endarterectomy. Also, mis-coding of non-
cerebrovascular disorders using CVD codes is well recognised. As in other studies,
these disorders generally presented in a manner that resembled or might commonly
be misdiagnosed as stroke or occurred on the background of established
cerebrovascular disease (Davenport et al. 1996c; Goldstein 1998; Mant et al. 1997;
Stegmayr and Asplund 1992). The prognosis of all these conditions is generally
better than that of acute stroke and hence it was also not a surprise that the estimates
of case fatality based on these hospital cohorts were uniformly and substantially low.
The ISD and the DoH methods of selecting subsets of CVD codes are designed to
increase the proportion of acute strokes in each hospital cohort and to improve the
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accuracy of their estimates of outcome. Our findings confirm the rationale of each
method in that the excluded codes all had a low PPV for acute stroke. As a result of
their exclusion, the PPV of the hospital cohorts improved substantially, more so with
the DoH method than with the ISD method. The lower PPV of the ISD method
primarily relates to its inclusion of code 437/167, which, although often used to code
acute stroke, appears to be even more often used to code for a 'rag-bag' of non-
stroke disorders. These findings are in keeping with other studies that have
investigated the PPV of subsets of CVD codes (Goldstein 1998; Harley and Jones
1996; Liu et al. 1999; Mant et al. 1997).
However, neither the DoH nor the ISD methods were especially powerful and about
a fifth to a quarter of cases identified by them still referred to patients without an
acute stroke. The practical consequence of this is that any system of routine follow
up based upon them would be inefficient and would run the risk of alienating
patients, public and GPs who might not understand why they, their relatives or
patients were being needlessly questioned. From a measurement perspective, the
PPV of the hospital cohorts continued to vary appreciably using the ISD method of
patient identification and both, but especially the DoH method, led to non-uniform
and in some cases large losses of patients with acute stroke. Despite this, most
estimates and comparisons of case fatality were only minimally in error. However,
at some hospitals, and especially using the ISD method, the degree of error was more
substantial. In particular, the ISD method underestimated the relative difference in
case fatality between Hospitals A & B by 14%. This degree of error is equivalent to
about two-thirds of the treatment effect that might be expected if one hospital were to
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admit all its patients to a stroke unit and the other none at all (Langhome et al.
1993a), which is to say a degree of error that might mis-lead a study that aimed to
measure quality of stroke care using case fatality data. The slightly more accurate
estimates and comparisons of case fatality obtained using the DoH method of
identification suggest that it should be used in preference to the ISD method,
although, by also giving smaller sample sizes and hence wider confidence intervals,
it may be less able to differentiate between hospitals with truly different outcomes.
An important caveat to all these conclusions is that this study is small, both in terms
of the number of hospitals studied and, because we collected all CVD codes only for
six months, in terms of the numbers of patients in each cohort. As a result, it is
possible that my estimates of the degree of bias in measurements of case fatality and
of the number of hospitals where this bias is large may themselves be influenced by
the play of chance. Hence, my findings should be viewed cautiously and, ideally, a
larger study should be performed to confirm or refute them. Also, my findings only
describe accuracy in relation to the population of strokes that had a CVD code
assigned as the primary SMR1 diagnosis i.e. they ignore the other major potential
source of bias, namely false negative coding error.
The impact of false negative coding error can be estimated from the literature and by
inference. Mant (1997) summarised a number of single hospital studies which
investigated the accuracy of routine data systems for acute stroke in the UK and
found that their sensitivity varied from as low as 66% to as high as 97% (although
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some of this apparent variation may have related to differences in the number of
diagnoses and subsets ofCVD codes that were collected). Acute strokes appeared to
be 'missed' by routine systems for a number of reasons, including (Barer et al. 1996;
Davenport et al. 1996c; Leibson et al. 1994; Mant et al. 1997; Panayiotou et al.
1993; Stegmayr and Asplund 1992):
. coding the stroke as a symptom or sign e.g. hemiplegia;
coding the stroke as 'unknown cause of morbidity/mortality' because a clinical
diagnosis was unavailable to the coding staff;
coding the stroke as a secondary diagnosis with a complication or risk factor
given as the primary diagnosis;
coding the stroke as a secondary diagnosis because it occurred during an
admission for another disorder;
. coding a risk factor or complication whilst failing to code the stroke at all;
. misdiagnosing and hence mis-coding minor stroke as TIA (where TIA codes are
excluded from the subset under collection);
and in cases of rapidly fatal stroke, those who die in the accident & emergency
department and hence have not been formally admitted to the hospital.
In some cases, therefore, false negative coding may relate to stroke severity and/or
treatment failure and hence to outcome. On this basis, variation between hospitals in
the sensitivity of their routine CVD discharge data may indeed bias the comparison
of outcomes. A rough approximation of the potential impact of this bias can be
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made by taking, as an example, a hospital with 1000 admissions for acute stroke, a
true observed and predicted case fatality of 30% (i.e. a ratio of observed (O) to
predicted (P) deaths of 1.0) and, amongst the false negative cases, a clinically
plausible range of baseline severity and quality of care (see appendix 9 for methods).
The findings are shown in Table 4.4.
At 90% sensitivity, the error in overall case fatality appears to be minimal. At 80%
sensitivity, the error is only appreciable when the unreported strokes are substantially
more severe and/or receive substantially lower quality of care than the reported
cases. However, at 70% sensitivity, the error is appreciable even when unreported
strokes are only moderately more severe and/or receive only moderately lower
quality of care than reported cases. On balance, it seems that most hospitals in the
UK (and elsewhere) produce routine CVD discharge data with a sensitivity of greater
than 80% (Mant et al. 1997) and therefore, in most cases, the impact of reduced
sensitivity is unlikely to be large. However, should sensitivity be closer to 70%, as it
appears may sometimes be the case (Mant et al. 1997), then estimates and
comparisons of outcome after stroke may be appreciably in error.
The bias resulting from reduced sensitivity may be partly overcome by adjusting
comparisons of outcome for casemix. Here, the predictive model provides a standard
(the predicted outcome) against which the outcome of each patient may be compared
(e.g. observed/predicted) to produce an index of performance that is independent of
the proportion of patients whose outcome is reported. This ability to 'correct' for
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reduced sensitivity appears to hold true regardless of how insensitive the CVD
discharge data are and regardless of how different the prognosis of the unreported
cohort is from that of the reported cohort (Table 4.4). However, it clearly does not
hold true if the quality of care provided to the unreported cohort is different to that of
the reported cohort (Table 4.4). Furthermore, the process of adjusting for casemix
may itself be a source of bias given the inevitable presence of false positive coding
error and the fact that the predictive models developed for patients with stroke are
unlikely to be applicable to those with non-stroke disorders.
Thus, no simple statement can be made about the accuracy with which routine CVD
discharge data identify patients with acute stroke. Using the DoH or ISD methods,
the bias due to false positive coding error seems likely to be modest at many
hospitals but at some, perhaps the minority, it may be sufficiently large to mislead
studies which aim to measure quality of care. The potential for false negative coding
bias is less certain but it appears that it may be significant at some hospitals and it is
difficult to tell how far adjustment for casemix can compensate for it. A further
problem, thus far un-remarked, is that the coding of stroke is unrefined. The great
majority of acute strokes are assigned the code 436/164.9 (acute strokes not defined
as a haemorrhage or infarct) preventing the proper identification of their pathological
sub-type, a problem well recognised by others (Ellekjaer et al. 1999; Leibson et al.
1994; Liu et al. 1999; Mant et al. 1997) and which may hamper attempts to use
outcomes data to explore the quality of care in more detail e.g. what proportion of
patients with ischaemic stroke were discharged on an antithrombotic drug. No
amount of shuffling of the remaining CVD codes can overcome any of these
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difficulties which can only be addressed, and hence truly confident comparisons of
outcome between hospitals only be made, if the quality of routine coding of acute
stroke is improved.
Several factors contribute to the current poor quality of routine CVD data. By far the
most important is the poor quality of the information supplied by physicians to
coding clerks, usually on a hand-written discharge letter or a typed discharge
summary (Davenport et al. 1996c; Harley and Jones 1996; Hasan et al. 1995; Mant
et al. 1997; Panayiotou et al. 1993; Patel et al. 1976a). The job of providing these
data frequently falls to junior doctors almost none of whom have received any formal
training, who often have no idea that their statements form the basis of important
official statistics, who view the task as a chore that often has to be completed outside
of working hours and who get little or no feedback on the quality of their efforts
(Frain et al. 1996). As a result, it is not a surprise that the required information may
sometimes fail to materialise or is greatly delayed, contains mis-diagnoses or mis-
ordered diagnoses, or is incomplete, vague or illegible.
Other less important factors also play their part in the poor quality of routine
discharge diagnosis data. Although trained, lack of medical knowledge may lead
coding staff to mis-interpret the diagnosis or the order of diagnoses (if they are
forced to do so) (Panayiotou et al. 1993; Yao et al. 1999) and lack of time may lead
coding staff to use less refined codes or to make simple errors; subtle differences in
coding policy may also exist between hospitals (Harley and Jones 1996). The ICD
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CVD codes themselves are also problematic (McKee and James 1997a), in particular
437/167 (other/ill-defined cerebrovascular disease) some of whose sub-categoreis
have pathological definitions that have no clear clinical counterpart and which can
also be 'unspecified' (167.9) providing a pigeon-hole for vague diagnostic terms.
Thus there are a number ofways by which the quality of routine discharge diagnostic
data might be improved. Coding staff clearly require training, support, up-dates and
quality control both within and between departments, items which in fact are already
in place in Scotland (Harley and Jones 1996). Clinically based coding systems, such
as Read codes, may make the translation of the physicians terms into a pathologically
based ICD code easier, although Read codes themselves are not necessarily
straightforward to use and their implementation is patchy. However, the key to
improving the quality of discharge data would be to improve the quality of the data
provided by physicians. Unfortunately, issuing guidelines on best practice
(Anonymous 1990) and exhorting physicians to do better is unlikely to bring this
about. Rather, it will require their education and commitment and also the
commitment of hospital management (Davenport et al. 1996c; Frain et al. 1996;
Panayiotou et al. 1993; Patel et al. 1976b; Williams and Mann 2002; Yao et al.
1999).
Physicians should be educated, perhaps starting at medical school, about routine data
systems and their importance, and trained in approved methods of recording clinical
information both in the medical record and in discharge documentation (in particular,
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the importance of assigning a clear primary diagnosis and the use of symptoms/signs
rather than vague terms when the primary diagnosis is not clear). Physicians should
also be prepared to discuss cases, resolve difficulties with coding staff and respond to
feedback on the quality of their work. More accurate diagnostic coding would also
result if physicians became involved in their assignment themselves (Yeoh and
Davies 1993), especially if senior doctors were involved (Leibson et al. 1994). This
extra commitment would clearly be time consuming. It should therefore be matched
by the provision of protected time within the working day and, where relevant,
electronic look-up systems should be provided. Unfortunately, none of these
suggestions are new, indeed some are over 25 years old (Patel et al. 1976b). The
failure to instigate them probably reflects the real world of the NHS where there are
many more immediate priorities, the failure (until recently) of analyses based upon
routine data to impact on clinicians, and the fact that the implementation of these
recommendations would require culture change on the part of physicians (Williams
and Mann 2002; Wyatt 1995). Maybe now, with a the imminent introduction of new
electronic data systems within the NHS, some progress may be made.
Finally, it is necessary to consider the other aspects of SMR1 that are important in
identifying cases and which allow a routine system of follow up to contact survivors
at six months after admission. As noted, currently the only address data on the
SMR1 is the post code of the patients address prior to admission and, fortunately, it
appears this is very accurate. Although not directly studied, other demographic data
and admission and discharge dates on the SMR1 are also likely to be correct in 97 to
99% of cases (Harley and Jones 1996; Kohli and Knill-Jones 1992). SMRls are
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clearly returned by hospitals sufficiently quickly that a follow up questionnaire can
be mailed before six months in the great majority of cases and in virtually all by nine
months (when measured in large groups, functional outcome changes little between
six and nine months after stroke (Skilbeck et al. 1983)). Lastly, about a quarter
admissions are reported using more than one SMR1, confirming the need to link
SMRls to prevent the despatch of multiple follow ups. ISD report a high degree of
accuracy in their ability to link SMRls to make hospital stays (Kendrick and Clarke
1993) but their linkage is periodic and has never been tested in an on-going basis.
Nonetheless, our experience suggests that it is possible. An alternative solution
might be to respond only to the first SMR1 received on any patient and to ignore any
others received later. However, arrangements would have to be made to deal with
SMRls arriving in the wrong order and to halt follow up when subsequent SMRls
indicate that the patient is dead. In the long run, better still might be to abandon the
concept of consultant episodes and to return to a simpler and more logical system of
simply reporting finished episodes of care, which for stroke, would be a single




1. Only about half to two-thirds of patients in Scotland with any CVD code listed
as the primary diagnosis have had an acute stroke.
2. The positive predictive value for acute stroke of the methods of identification
used by ISD and the DoH is 75 to 80%. The use of either method leads to a
substantial loss of patients with acute stroke.
3. Most estimates of case fatality derived using the ISD and DoH methods of case
identification are only modestly biased (in terms of false positive coding error).
However, in some cases, and especially using the ISD method, the error may be
large enough to mislead efforts to measure the quality of care using outcomes
data. These conclusions require confirmation by a larger study.
4. This study had not addressed the question of variation in sensitivity (false
negative coding error) of routine CVD discharge data. The literature suggests
that sensitivity is usually greater than 80%, a level where bias seems likely to be
low. If the sensitivity falls to 70% then only moderate differences between
reported and unreported cases in stroke severity or quality of care may lead to
important bias in estimates and comparisons of outcome.
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5. Adjustment for casemix reduces bias due to reduced sensitivity provided the
unreported and reported cases have received care of the same quality. However,
by the very nature of false negative reporting in stroke, it is dangerous to assume
that this is the case.
6. Truly confident comparison of outcome after stroke requires improvement in the
accuracy of CVD discharge data. This is only likely to occur if clinicians
improve the quality of clinical data reported in routine discharge data and/or take



























































































































































































































































































































































































































































Table 4.3 The diagnoses of cases assigned a CVD code as the primary SMR1
diagnosis but which were not found to have had an acute stroke.
Audited diagnosis All cases Emergency, non-
TIA cases only
% n % n
1. Other cerebrovascular diagnoses 29 138 15 27
TIA 136 27
Other 2 0
2. Investigation or procedure 25 120 2 3
Angiography / endovascular intervention/other
investigation for stroke, TIA or SAH 79 1
Pre-operative assessment 4 0
CEA/other vascular procedure 17 0
PEG tube insertion/management 7 2
Other 13 0
3. Neurological symptom or disorder 16 84 30 54
Headache (including 'exclude SAH') 7 7
Cerebral tumour 4 3





Collapse/loss of consciousness 7 4
Miscellaneous 19 13
4. Non-specific or non-neurological disorder 25 118 49 86
(intercurrent or non-specific illness, confusion, poor
mobility, inability to cope, falls, fractures, etc.)
5. Probably was acute or ineligible stroke * 1 3 1 2
6. Unclassifiable 1 3 1 2
7. No details recorded 3 12 2 3
TOTAL 478 177
VBI Vertebrobasilar artery ischaemia
CEA Carotid endarterectomy
PEG Percutaneous endoscopic gastrotomy
* In these cases our research assistant recorded erroneously classified venous sinus
thrombosis and stroke admissions over 4 weeks after symptom onset as a non-
































































































































































































































































































































Chapter Five. How reliably can the variables of our predictive
models be collected?
5.1 Introduction
Accurate adjustment for casemix using a statistical model can only be made if the
predictive variables included in the model are valid (measure what they purport to
measure) and reliable (consistent on repeated measurement) (Laupacis et al. 1997c;
Wyatt and Altman 1995c). Should detailed adjustment of stroke outcomes ever
become routine, the necessary predictive variables will have to be collected by a
clinician at the time of the patient's admission (prospectively) or by an auditor
inspecting the information that was laid down in the medical record (retrospectively).
The predictive variables included in our prognostic models (see Table 3.9) are, by
design, simple and purely clinical and so ought to lend themselves to routine
collection. The aim of this chapter is to determine whether or not this is the case by
estimating the reliability of our predictive variables when prospectively collected and
their reliability and validity when retrospectively collected. Urinary incontinence
and conscious level are other simple and important predictors of outcome after stroke
(Gladman et al. 1992a; Henon et al. 1995; Irwin and Rudd 1998; Ween et al. 1996)
which might also be used to adjust stroke outcomes for casemix on a routine basis;
indeed, both are currently included in the Royal College of Physicians minimum data
set for stroke (Irwin and Rudd 1998). Urinary incontinence is particularly important,
being able to predict death, disability and residence after stroke more accurately than
conscious level alone (Wade and Hewer 1985) and at least as well as some published
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multivariate prognostic models (Barer and Mitchell 1989; Gladman et al. 1992b;
Taub et al. 1994). A further aim of this chapter, therefore, is to assess the reliability
and validity of data describing urinary incontinence and conscious level (the latter in
terms of GCS eye score, normal vs. abnormal, a rough approximation for normal or
reduced level of consciousness).
Reliability can be assessed either by comparing the values assigned on more than one
occasion by the same observer (intra-rater reliability) or by comparing the values
assigned by two or more different observers (inter-rater reliability). I chose to
measure inter-rater reliability because, in a routine setting, our prognostic data would
necessarily be collected by many different observers. This chapter therefore
describes two straightforward inter-rater studies, one prospective (clinician vs.
clinician) and the other retrospective (auditor vs. auditor). To determine the validity
of the retrospectively collected predictive data, it was necessary to compare them
against a gold standard. I defined the gold standard to be the same data collected
prospectively by an independent and expert observer, close to the time the
retrospective data were collected. Thus, I determined the validity of our
retrospectively collected data by means of a third inter-rater study (clinician vs.
abstractor). Similar methods have been used to validate the retrospective collection
of the variables of the Canadian Neurological Scale (Bushnell et al. 2001; Goldstein
and Chilukuri 1997) and the National Institutes of Health Stroke Scale (Baird et al.
2000; Bushnell et al. 2001; Kasner et al. 1999; Williams et al. 2000).
145
Chapter Five
There were two main reasons to doubt the validity of our retrospectively collected
predictive data. First, from an audit and research perspective, the quality of the data
ordinarily laid down in the medical record may be poor. Thus, the recording of
baseline characteristics may be incomplete, inaccurate, and lacking in detail; the
entries may be contradictory, illegible or in code; and the records themselves may be
disordered or partly or wholly missing. As a result, the collection of predictive data
often involves a process of decipherment and inference and hence the potential for
error. Second, inspection of the medical record often identifies the hospital to which
the patient was admitted and/or the patient's outcome and this knowledge may
consciously or unconsciously bias the collection of data (Caplan et al. 1991a). It is
of course possible that data collected prospectively may also be invalid since
clinicians may make incorrect assessments. However, in view of the simplicity of
the predictive variables studied, I suspected that any such bias would be small.
Moreover, the potential for systematic disagreement between prospective observers
(i.e. biased measurement by one) can be estimated from a study of reliability (see
below).
5.2 Methods
5.2.1 Study 1. Prospective inter-rater reliability (clinician vs. clinician)
This study was limited to Hospital D. Here, two neurology registrars with an interest
in stroke (NUW and CEC) assessed a consecutive series of patients admitted with an
acute stroke between March and September 1997. We identified patients by daily
contact with the admitting physicians and by monitoring cases referred for CT head
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scan. We tried to assess the patient as soon as possible after each other and always
did so on the same day, which, in nearly all cases, was the day after admission. We
gathered data by interviewing and examining patients directly; where this was not
possible (e.g. due to dysphasia or reduced conscious level) we collected the missing
variables from the medical record or by interviewing nursing staff and relatives. All
data were collected using a standardised form and blind to the findings of each other.
5.2.2 Study 2. Retrospective inter-rater reliability (auditor vs. auditor)
This study was performed at all five hospitals in the SOP. Two observers (NUW and
the study research assistant, AG) assessed the medical records, including the nursing
entries, of a sample of patients eligible for the study. We derived our sample by
selecting every nA patient on the SOP database with n varying per hospital in order to
provide 60 patients at each. Each observer first determined whether or not the
patient had been diagnosed to have an acute stroke (see section 3.6.1) and then
collected the predictive variables, plus data describing stroke pathological sub-type
(see section 3.6.2). This study therefore also allowed me to estimate how reliably we
identified cases of acute stroke and their pathological sub-type in the SOP. All data
were collected blind to the findings of the other auditor and using forms with the
same wording and prompts.
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5.2.3 Study 3. Prospective vs. retrospective reliability (retrospective validity)
This study was also limited to Hospital D. Here, I extracted prospectively collected
predictive data from the hospital stroke register, these data having been originally
collected by one of five research registrars with a special interest in stroke using the
same methods as described under Study 1 (see section 5.2.1). The retrospectively
collected data were extracted from the medical record, including nursing entries, by
our research assistant and pertained to the day of admission. Ideally, both
prospective and retrospective examinations should relate to the same day. However,
the majority of patients on the stroke register were not examined till the day after
admission or even later still. As a compromise, therefore, I restricted this analysis to
patients in whom prospective data were collected within 48 hours of admission.
5.2.4 Definitions and data entry
For prospective assessments, we defined acute stroke by the WHO criteria (Asplund
et al. 1988b) and included cases within 30 days of stroke onset. For the retrospective
assessments, we defined acute stroke using the SOP criteria (see section 3.5.1). The
definitions of the predictive variables have already been given (see Table 3.6). All
data were entered onto the study database by means of double punching and
verification except, because of limited resources, the data collected by NUW in the
retrospective reliability study (see section 5.2.2). These data were entered using only





The only continuous prognostic variable that we collected was age. I used the
method proposed by Altman to quantity the inter-observer agreement (Altman
1999b). To do so , I first calculated the difference in the age assigned by each
observer to the same patient and then calculated the median value of such differences
over all patients, the 'median difference'. The median difference along with the 5th
to 95th percentiles summarise the range ofdisagreement between the two observers.
Categorical data
For categorical data, I have expressed inter-rater reliability using the proportion of
agreement between observers and using the kappa statistic (k) which expresses the
degree of agreement achieved beyond that attributable to chance. The concept of
agreement beyond that attributable to chance is best understood graphically (see
Figure 5.1). Kappa is calculated using the formula
k = {p0-pe)l{l -Pe)
where pQ is the observed proportion of agreement and pe is the proportion of
agreement attributable to chance (Altman 1999b). The standard error (and hence
confidence interval) for kappa can be derived using a standard formula (Fleiss et al.
1969). Kappa is constrained to vary from —1, which indicates perfect disagreement,
to +1, which indicates perfect agreement. By convention, k values between 0 and
0.20 indicate slight agreement, between 0.21 and 0.40 fair agreement, 0.41 and 0.60
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moderate agreement, 0.61 and 0.80 good agreement, and 0.81 to 1.00 excellent
agreement (Altman 1999b; Brennan and Silman 1992).
Whilst this hierarchy provides a useful rule of thumb, it is important to realise that
very different contingency tables can result in similar k values; k values should
therefore always be interpreted in the context of the raw data from which they were
derived (Brennan and Silman 1992). Two points should be borne in mind. First,
kappa values are dependent on the prevalence of the attribute in question: a high
prevalence necessarily results in high chance agreement. Here, high observed levels
of agreement may be accompanied by surprisingly low kappa values. The
dependence of kappa on the prevalence of the attribute also means that simple
comparisons between populations where the prevalence varies may not be valid.
Second, the observed level of agreement reflects both random variation and any
systematic differences between observers i.e. chance and bias. As a summary
statistic, kappa is unable to separately identify the influence of bias. Bias may,
however, be identified by the presence of imbalance in the 'off diagonal' cells in the
contingency table. The significance of any suspected bias can be estimated using
McNemar's test (Brennan and Silman 1992). This test computes a z statistic of the
null hypothesis that there is no bias; the p value of the null hypothesis may then be




5.3.1 Study 1. Prospective inter-rater reliability (clinician vs. clinician)
Both observers examined 93 patients at a median of two days after stroke onset
(inter-quartile range 1 to 4 days; range 1 to 17 days). The mean time between
examination by NUW and by CEC was 3.5 hours (range 0.3 to 7 hours). One patient
had a further stroke in the interval between examinations and hence has been
excluded from analysis. Also, we did not collect data on urinary incontinence in the
first six patients. Therefore, all analyses refer to our findings in 92 patients except
for urinary incontinence which is based on our findings in 86. The median predicted
risk of death by six months (by NUW ratings) in the study cohort was 15% (IQR: 4
to 40%) i.e. the majority had mild to moderate stroke.
The median difference in the assessment of age was zero years (5th to 95th
percentiles: 0 to 0 years) (see Table 5.1). The minor disagreements were the result of
small differences in our assessment of the day of stroke onset; the two larger
discrepancies (1.18 and 1.99 years) were the result of difference in our assessment of
date of birth. In both these cases, the patients were confused. We collected the
categorical variables of our study models with good to excellent reliability (Table
5.2). Agreement was lowest on pre-stroke independence in the activities of daily
living (ADLs) (k 0.67). Some of the disagreement on this variable was systematic (z
2.41, p 0.016); NUW was less likely to find that the patient had been independent
than CEC. Agreement on urinary incontinence and on GCS eye score was excellent.
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5.3.2 Study 2. Retrospective inter-rater reliability (auditor vs. auditor)
The identification of cases for this study is shown in Figure 5.2. Of the 298 cases
originally identified, both auditors inspected the medical records of 274 (92%). Of
these, nine had been included in error (they were admitted directly to one of the
affiliated units at Hospital A, see section 3.3) and so were excluded from analysis.
The reliability of the diagnosis of stroke is therefore based on a sample of 265 cases;
the reliability of the collection of predictive variables and of the diagnosis of stroke
pathological subtype is based on the 200 cases where both NUW and AG agreed on
the diagnosis of acute stroke. The median delay between stroke onset and the first
recording of predictive data in the medical record was zero days (inter-quartile range
0 to 1 days; range 0 to 20 days); ten patients had a stroke whilst already admitted for
another condition. The median predicted risk of death by six months (by NUW
ratings) in the cohort of 200 cases was 48% (IQR: 16 to 77%) i.e. the study included
patients with a broad range of stroke severity.
The median difference in the assessment of age was zero years (5th to 95th
percentiles: 0 to 0 years). Disagreement was generally only a matter of one to two
years but in one instance it was marked (10 years) (see Table 5.1). Discrepancies
were due to transcription error by the observers and to differences in dates in
different parts of the medical record. We collected the categorical variables of the
study models with moderate to excellent reliability (Table 5.2) although the level of
agreement was less than that achieved by the two prospective observers (except for
the variable 'living alone'). Agreement was lowest on the ability to walk without
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assistance (k 0.55) and second lowest on independence in ADLs (k 0.61).
Disagreement on independence in ADLs and on orientation and ability to speak was
systematic (z 2.01, p 0.044 and z 2.89, p 0.004, respectively); in both cases, NUW
was less likely to find the patient to have been independent or orientated and able to
speak than AG. Agreement on urinary incontinence was excellent and that on the
GCS eye score was good . Agreement on the diagnosis of acute stroke was good (k
0.76) and almost perfect on the diagnosis of stroke pathological sub-type (k 0.95)
(Table 5.3).
5.3.3 Study 3. Prospective vs. retrospective reliability ( retrospective validity)
We collected predictive data both retrospectively (relating to the day of admission)
and prospectively (within 48 hours of admission) in 195 patients (see Figure 5.3);
only 35 patients had both sets of data collected on the day of admission. Excluding
six cases without a date of stroke onset and six cases where stroke occurred whilst
already in hospital, the median delay from stroke onset to admission was zero days
(IQR: 0 to 1 day, range 0 to 21 days). The median predicted risk of death by six
months (by NUW ratings) in the cohort of 195 cases was 11% (IQR: 5 to 43%) i.e.
the majority had mild to moderate stroke.
The median difference in the assessment of age between retrospective and
prospective observers was zero years (5th to 95th percentiles: 0 to 0 years). Any*
disagreements on age were minor (see Table 5.1). Agreement on the categorical
variables included in our models ranged from moderate to good (Table 5.2).
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Agreement was least for independence in ADLs (k 0.49) with disagreement being
partly systematic (z 4.23, p < 0.0001); the prospective observer was less likely to
find that a patient had been independent than the retrospective observer. Agreement
on urinary incontinence and on GCS eye score was good. Some of the disagreement
on urinary incontinence was systematic (z 4.63, p < 0.0001); the retrospective
observer was more likely to judge the patient to be incontinent than the prospective
observer.
5.4 Discussion
This study shows that the six variables included in our prognostic models and data
describing urinary incontinence and conscious level (in terms of the normality or
otherwise of the GCS eye score) can be collected very reliably by clinicians at the
patient's bedside. It also suggests that the same data remain reliable and reasonably
valid when retrospectively collected from the medical record. Thus, the variables
included in our prognostic models, urinary incontinence and GCS eye score (normal
vs. otherwise) may indeed be suitable for routine collection, whether by prospective
or retrospective means, and hence to the routine adjustment of stroke outcomes for
casemix. The study also shows that we were able to identify acute stroke and its
pathological sub-types very reliably in the SOP as a whole.
The satisfactory reliability of the variables included in our prognostic models is
likely to reflect the decision to exclude, as far as was possible, variables with known
or presumed low reliability (e.g. sensory impairments) and variables which are
Chapter Five
informative in only a small proportion of patients (e.g. bilateral extensor plantar
reflexes) during model development (Counsell et al. 2002). We achieved the lowest
level of inter-rater agreement over the three assessments for the variable describing
pre-stroke independence in ADL (k 0.49 - 0.67). In each assessment, disagreement
between observers was partly systematic. Discussion revealed that this was because
of variation between observers in the definitions of ADL and dependency. More
reliable assessments might have been possible if we had used a checklist to specify
which ADL to consider and defined the threshold at which the patient should be
considered dependent. While ADL are often taken to include washing, dressing,
feeding, toileting and mobilising (Wade 1995), it is less clear, for instance, whether
bathing or shopping should be included since these are not necessarily daily
activities. Indeed, a definition of functional independence which excludes bathing
and shopping would probably be sensible given the importance of environmental
factors in determining abilities in these areas (i.e. bath or shower; distance from
shops). Similarly, there should be clear agreement between observers on how to
assess dependency in the presence of alterations to the patient's environment (Burn
1992).
As noted, comparisons of inter-rater data derived from different populations should
be performed cautiously. Nonetheless, as one might expect, we found generally
better agreement between observers when data were collected prospectively than
when they were collected retrospectively. In particular, the ability to walk unaided
was extremely reliable when assessed prospectively but only moderately reliable
when assessed retrospectively. Reviewing the medical records showed that this
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discrepancy was probably due to the inffequency with which physicians specifically
record the ability to walk soon after admission. Often, the ability to walk unaided
had to be inferred from other information that was recorded by the physicians (e.g.
leg strength) and/or by the nursing staff. Although the nursing records usually
contained information about mobility, it was frequently in terms of the need for
supervision and thus was difficult to interpret. For example, it was difficult to tell
whether the patient needed 'one to help with walking' because they could not walk
alone or because the nurse felt they were potentially unsafe if left to their own
devices; moreover, whether the nurse provided physical support or simply walked
alongside was often unclear.
These observations support the contention that if clinical predictive data are ever to
be routinely collected, it would be preferable for clinicians to explicitly record them
in the medical record at the time of admission using standard set of definitions. This
would be greatly facilitated if the predictive variables were included on a stroke
clerking proforma (Davenport et al. 1995a). Not only would such prospective
collection be more accurate than retrospective collection, it would also be much
cheaper (see section 1.5.2). Certainly, a pilot study that investigated the ability of
coding clerks (in Scotland) to collect our six casemix variables showed that it would
require a great deal of training and supervision to avoid error (Dr Jill Peel, personal
communication). However collected, a very important secondary benefit of the
routine collection of clinical predictive data is that it would improve the accuracy
with which routine hospital discharge data are able to identify cases of acute stroke:
those cases with predictive data appended would, by definition, be highly likely to
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have been admitted with an acute stroke and therefore to receive an appropriate
diagnostic code. As such, the creation of a system to collect predictive data would
reduce the need to educate and persuade clinicians to provide higher quality clinical
information in discharge summaries, a task that has proved rather thankless over
many years (see section 4.4)
Routine transfer of predictive data from the hospital to the centre would require that
hospital discharge data be capable of reporting descriptive clinical variables.
Although not currently possible in England and Wales, Scotland is fortunate that
those responsible for designing the up-dated version of the SMR1 (introduced in the
mid 1990s) had the foresight to include the capacity to report up to six condition
specific casemix or outcome variables (Anonymous 1995), which is to say, a system
that would allow routine transfer of our predictive variables already exists. Even so,
this system would rely on a chain of doctors and coding clerks and would be both
inefficient and open to error. In the longer term, the introduction of an electronic
patient record (Burns 1998) has the potential to transform the collection of predictive
data by forcing clinicians to enter the variables on the day of admission and then by
automatically appending the data to the SMR1.
Given their importance as predictors of outcome after stroke, it is reassuring that data
describing urinary incontinence and conscious level are reliable and reasonably valid
when collected retrospectively. Indeed, our data probably under-estimate the validity
of retrospectively collected incontinence data: our prospective data relate only to the
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first two days of admission while the retrospective data relate to the first seven days,
hence the systematic tendency for the retrospective observer to find incontinence
when the prospective observer did not. Previous studies suggest that the reliability of
the assessment of level of consciousness varies from fair to excellent
(D'Olhaberriague et al. 1996; Dewey et al. 1999). Higher levels of agreement appear
to result when observers have been given special training. Inexperienced observers
have little difficulty identifying patients at the extremes of consciousness (i.e. normal
or very low) but are unreliable and inaccurate in the middle range (Rowley and
Fielding 1991a). The Royal College of Physicians stroke minimum data set (Irwin
and Rudd 1998) currently proposes the worst level of consciousness in the first 24
hours as a marker of stroke severity, measured using a loosely defined four point
scale (fully conscious, drowsy, semi-conscious, unconscious). Given that these data
would likely be recorded by junior physicians without special training, it is arguable
that the use of a simple and reliable dichotomous variable, such as whether or not the
GCS eye score was normal, might be preferable.
The principal shortcoming of all three studies is the extent to which their findings
can be confidently generalised to other settings. Doubts in this regard refer to the
observers, hospitals, types of patient and timing of assessment that were used. Thus,
the variables were collected either by trainee neurologists with an interest in stroke or
by an experienced audit assistant with a nursing background; two studies were
performed at a single hospital and, because this hospital lacked an Accident &
Emergency department, included very few patients with severe stroke; the same
studies also made the majority of their observations on the day after admission.
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Hence, it cannot be assumed that less experienced observers (whether junior hospital
doctors or coding clerks) dealing with less alert and less co-operative patients during
the 'hurley-burley' of admission would make equally accurate assessments (Rowley
and Fielding 1991b; Shinar et al. 1985). In other words, our findings cannot
confidently be generalised to the settings that would apply if the predictive variables
were routinely collected for the purposes of routinely adjusting stroke outcomes for
casemix. Nonetheless, our findings are an important step in this direction and
suggest that accurate data collection might at least be possible. Ideally, the next step
would be to repeat the studies described here, heeding the need for more explicit
definitions and methods of recording, using a less selected group of patients,
clinicians, auditors and hospitals. A useful addition to these studies would be the
inclusion of experienced clinicians whose assessments might act as a 'gold standard'
against which the accuracy of the assessments of the less experienced observers
might be measured (Rowley and Fielding 1991a). That said, given the relative
simplicity of our six casemix variables and the encouraging findings of the studies
that were performed, it seems unlikely that their collection by junior doctors would




1. The variables included in our prognostic models and data describing urinary
incontinence and GCS eye score (normal vs. otherwise) appear to be very reliable
when prospectively collected and reasonably reliable and valid when
retrospectively collected under the conditions of the study. The validity of
retrospectively collected urinary incontinence data may be even higher than that
shown.
2. It is likely that the reliability of data collection would be improved if our
variables were more explicitly defined and if they were clearly recorded in the
medical record at the time of admission. For the purpose of routine data
collection this might best be achieved if the predictive variables were included in
a stroke clerking proforma.
3. Although encouraging, the estimates of the reliability and validity of the
predictive variables cannot be confidently generalised to the routine setting.
Further study using less specialised observers and a wider range of patients and
hospitals is indicated.
4. The routine collection of predictive data would, by default, also improve the
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Table 5.3 Agreement between auditors on the diagnosis of acute stroke and its
pathological subtype in the retrospective inter-rater study





















2. Diagnosis of stroke pathological sub-type
n 200
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Kappa = actual agreement beyond chance
potential agreement beyond chance
Figure adapted from Clinical Epidemiology: A basic science for medicine, D Sackett, RB
Haynes, P Tugwell, Little, Brown and Company, Boston/Toronto, 1985
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Figure 5.2 Deriving the sample for the retrospective reliability study
* Sample used to estimate reliability of the diagnosis of stroke
<j> Sample used to estimate reliability of collection of the prognostic variables
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Figure 5.3 Deriving the sample for the prospective vs. retrospective reliability study
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Chapter 6. Can the response to our outcome questionnaire
be improved and what is the impact of non-response?
6.1 Introduction
A high follow up rate is important to any study which aims to measure patient
outcomes for two reasons. First, as Sackett et al (1985) put it, "..patients do not
disappear from a study for trivial reasons", which is to say, patients often fail to
respond to follow up for reasons that are associated with the outcome under
investigation. Non-response is therefore a potential source of bias. Consider, for
example, the measurement of disability after stroke. Disabled survivors are more
likely to move to a nursing home than able bodied survivors and so may also be more
difficult to find and survey. A measurement of the prevalence of disability based
only upon the responders might therefore be an underestimate. Worse, if the causes
of non-response are associated with the outcome and the hospital which treated the
patient, the comparison of outcome between hospitals - as, for example, in the
measurement of quality of care - might also be biased (Hennekens and Buring 1987).
Thus, for example, a comparison of disability after stroke might be biased if the
hospitals differ substantially in the proportion of disabled patients discharged to a
nursing home. Unfortunately, it is difficult to know exactly which factors are
associated with non-response and even more difficult to know whether they are
associated with the outcomes and hospitals under investigation. From a practical
perspective, therefore, the only sure way to prevent non-response bias is to keep non-
response to a minimum. The second reason to avoid non-response is statistical. As
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noted (see section 1.5.3), a major problem in using outcomes to measure the quality
of care is that, at most hospitals, the numbers of patients admitted with stroke over
one year is relatively small. Comparisons of outcome between hospitals are
therefore often imprecise. If non-response further reduces the effective size of
hospital samples, the probability of identifying real differences in outcomes is also
reduced. High response rates therefore also improve the confidence in comparisons
of outcome.
After the first ten months of collecting outcome data in the SOP, it was clear that
about a third of patients discharged from hospital had not responded to our outcome
questionnaire. At this level of non-response, the possibility of bias in our estimates
of functional outcome appeared strong and reduced power in their comparison a fact.
The purpose of the studies described in this chapter were two-fold. First, I wished to
investigate methods to improve the response to our outcome questionnaire, keeping
in mind that the methods should be applicable to a routine system of follow up i.e.
that they should be practical and simple; and second, I wished to determine how non-
response affected our estimates and comparisons of outcome.
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6.2 improving response to the outcome questionnaire
6.2.1 Study rationale
I tested two methods designed to improve response.
1. Mailing the outcome questionnaire directly to the patient
Our original system of follow up (described in section 3.8.2) used the GP as a
middle-man to circumvent the lack of detailed patient address data on the SMR1 and
to prevent follow up in recently deceased cases. However, using this approach, a
potentially important reason for non-response might be failure of GPs to send on our
outcome questionnaire either because inadequacies in our SMR1 GP address data or
because of simple lack of co-operation. Directly mailing follow up to the patient
after obtaining their survival status and full address data from an alternative source
might avoid these difficulties. A direct system like this is in fact a realistic
possibility: the updated version of the SMR1 has the capability of reporting the
patient's entire address rather than simply their post code while the General Register
Office (GRO) maintains a computerised record of all deaths with new cases entered
within three weeks. The aim of this sub-study was to test this more direct system.
2. Sending a second outcome questionnaire to non-responders
It is well known that response to mailed follow up can be improved by sending
further follow ups to non-responders (Scott 1961; Yammarino et al. 1991a). Surveys
that use three or four waves of follow up have been shown to achieve response rates
of over 90% (Dillman 1978b). However, such intensive methods are unlikely to be
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applicable in a routine system. It may also be counter productive to antagonise GPs
by sending them a stream of reminders when the reason for non-response may lie
with the patient. Similarly, some patients may not respond because they do not wish
to dwell on their problems. Repeated requests to these patients might be viewed as
unethical. In a routine setting, therefore, it seems unlikely that more than one
reminder would be feasible or acceptable. Hence, the aim of this sub-study was to
test the impact of a single reminder questionnaire.
6.2.2 Methods
Study design
I compared the response to the original, 'indirect' method of follow up with that to
the new, 'direct' method of follow up by means of a randomised, controlled trial
(RCT). I investigated the impact of sending a reminder by comparing the response
rate before and after mailing the second follow up. All patients listed for follow up
in the SOP were eligible for the study. Because of the nature of SMR1 data, at the
time of randomisation we could not definitively identify completed hospital stays, a
patient with stroke or a patient alive at the time of follow up. This caused some
difficulty with randomisation and the selection of the outcome measures (see below).
Follow up procedure
The direct and indirect systems used very similar covering letters for both the GP and
patient (see Appendix 10) and our standard (identical) outcome questionnaires
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(Appendix 4). Patients were randomised six weeks before follow up was due and
follow up sent three weeks later.
Directfollow up
I obtained the following data for each patient between randomisation and mailing:
survival status by weekly link to GRO death certificate data
. pre-admission address from the hospital medical records office (to mimic a more
detailed SMR1)
passive consent from the patient's GP by sending a letter explaining our intent to
contact the patient and asking the GP to inform us only if we should not do so
(the letter included a pre-printed form and a freepost envelope for this purpose;
see Appendix 10).
We mailed the follow up pack to the patient if, according to GRO, they were still
alive and if the GP did not withhold their consent.
Indirectfollow up
I used the standard follow up described in section 3.8.2 except for one modification.
While checking the survival status of the patients in the direct group with GRO, I
took the opportunity to do the same with the patients in the indirect group. Since
survival at six months is in any case measured by linkage to death certification data
(see section 3.8.1), the check with GRO served simply to reduce the number of
171
Chapter Six
follow ups mailed. The 'middle-man' function of the GP for surviving patients was
unaltered.
Non-response and sending a secondfollow up
I defined initial non-response as the failure to return a questionnaire to the trial office
in time to stop a second follow up being sent at 28 days after the first mailing. For
the direct method, I sent the reminder without rechecking with GRO and the GP.
The covering letters to the GP and patient emphasised the importance of the study
and of identifying the outcome of non-responders. I defined final non-response as
the failure to return an outcome questionnaire by 63 days after initial mailing (35
days after sending the reminder).
Incorrect GP or patient address
Prior to the trial, I noted that GPs sometimes replied that the patient was not known
to their surgery or had now changed to a different surgery. I reasoned that a routine
system might have the facility to link with the database of the relevant Health Board,
identify the correct or new GP, and re-direct the follow up. Similarly, where a letter
sent directly to the patient's home was returned by the Post Office as 'not known at
this address', a link with the Health Board might allow the new GP and patient's
address to be identified, and the follow up to be re-directed. I investigated the




The primary outcome measures were
. the proportion of cases either dead at follow up or who responded within 63 days.
# the difference in the proportion of cases 'dead at follow up or who responded' at
28 days (before sending a reminder) and at 63 days (after sending a reminder).
The primary outcome measures allow an 'intention to treat' analysis (a comparison
of all patients entered into the trial) and so include some patients who, after auditing
the medical record, were found not to have had an acute stroke. To account for the
fact that some patients had died by the time of follow up, the primary outcomes also
had to include death. However, my key interest was in patients with acute stroke
and, in particular, patients with acute stroke alive at the time of follow up. I
therefore examined the response from these groups as secondary outcomes.
Unfortunately, these comparisons are not between truly randomly allocated groups.
Randomisation
I used a computer generated minimisation technique to allocate patients to follow up.
I used sex and age (under 65, 65 to 74, 75 years and above) as stratification factors.
Ideally, I would like to have randomised patients once only per hospital stay.
However, as described in section 3.4.2, because our database sometimes listed the
same hospital stay using more than one SMR1, a small proportion of patients were
allocated to receive more than one follow up. In some of these cases, both methods




I estimated that the indirect method, without the addition of a reminder, would result
in a similar level of response from patients discharged alive as the method employed
before the trial i.e. about 65%. I estimated that the addition of a reminder would
increase response by about 10% i.e. from 65 to 75%. I assumed that it would be
worthwhile looking for an improvement above this level of response of about 10%
e.g. 75% response in the indirect method and about 85% (or more) in the direct
method. I designed the trial to have 90% power to reliably detect at least an 10%
absolute difference in response above a baseline of 75% when the null hypothesis is
rejected at p values of 0.05 and below. This required a total of 708 patients divided
equally between the two groups. I calculated the sample size requirements using Epi
Info (version 6.04b).
Ethical approval




846 cases on the study database were entered into the trial. Of these, 829 referred to
a single hospital stay (416 direct and 413 indirect). Seven cases in the direct arm and
eight in the indirect arm of the trial were listed more than once for the same hospital
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stay (Table 6.1). Four were allocated to both methods of follow up on the same day;
to retain these cases, I randomly assigned two to each arm of the trial.
Baseline characteristics
Of the 829 cases, 71% (588) had an acute stroke, 3% (25) had an ineligible or SAH
stroke, 20% (166) had not had a stroke; and 6% (52) had no diagnosis because of
failure to find the medical records or because of lack of diagnostic data therein.
There were only minimal differences in the age, sex, socio-economic status, hospital
of admission and proportion with an acute stroke between the two groups (Table
6.2). The subgroups of patients with acute stroke were also similar in terms of stroke
pathological subtype, prevalence of ischaemic heart disease and diabetes mellitus,
the proportion discharged to their pre-admission address and the proportion still in
hospital five months after admission (Table 6.3). However, in terms of our key
predictive variables (lived alone pre-stroke, functional independence pre-stroke and
stroke severity) patients with acute stroke in the indirect group had a worse profile
than those in the direct group (Table 6.3). As a result, more patients died by six
months in the indirect arm (17% overall, 15% of acute strokes) than in the direct arm
(12% overall, 10% of acute strokes).
Comparison of the indirect and direct methods offollow up
The results of the trial are shown in Table 6.4. There was no significant difference
between the two methods of follow up in terms of the primary outcome nor in terms
of the secondary outcomes i.e. both the indirect and direct methods of follow up
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appeared equally effective at eliciting a response from patients who, by routine
discharge data, might have had an acute stroke and from patients who, after audit of
the medical record, were known to have an acute stroke and who were alive at the
time of follow up.
The impact ofsending a secondfollow up to non-responders at 28 days
The addition of a second follow up considerably increased the response in both arms
of the trial (Table 6.4). The proportion with a measured primary outcome (the
proportion dead or who responded by day 63) improved from 65-67% to 83-84%, an
absolute increase of 16-19% and a relative increase of 24-29%. Similar sized
improvements occurred in the secondary outcomes.
Response after a single follow up was non-significantly lower using the indirect
system. This difference reflected the definition of response as the return of the
questionnaire and the inherent delay in contacting patients in the indirect system.
When response was defined as the date the patient completed the questionnaire, it
was clear that (for patients with an acute stroke alive at six months) response by day
28 was the same using either system (67% direct; 64% indirect; see Figure 6.1).
The benefit oflinking with the Health Board
Overall, we obtained new address details from the Health Board in 24 (3%) of the
829 patients, 12 in each arm. As a result of mailing to the new address, we obtained
six questionnaire returns in the direct arm and eight in the indirect arm. Linking with
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the Health Board therefore increased overall response in terms of the primary
outcome by 2% (14 of the 691 cases dead or responders by day 63).
6.3 Investigating the potential for non-response bias
6.3.1 Background
To determine whether non-response is a source of bias, it is first necessary to
determine whether the outcomes of the non-responders and responders are
systematically different. Indirect means are often used for this purpose: either the
baseline characteristics of responders and non-responders are compared or the
outcome of early and late responders are compared (Scott 1961; Sheikh and
Mattingly 1981). Ideally, however, the outcome of the non-responders should be
surveyed directly. I used this method to determine the outcome of the final non-
responders within the follow up trial. To determine whether any differences between
responders and non-responders were sufficient to substantially bias the estimates and
comparisons of outcome, I compared the outcomes of responders (to one or to two
postal follow ups) with the outcomes of the entire cohort. I limited this analysis to
the sample of 512 patients with an acute stroke alive at the time of follow up. The




I defined return of the outcome questionnaire by day 28 'early response'; by day 63
'late response' and failure to return any questionnaire as 'non-response'. I attempted
to contact non-responders first by contacting their GP to ascertain survival status,
permission to make contact and current address. If the patient was no longer
registered with the GP, I identified the new GP from the Health Board; if the Health
Board did not know the patient's current GP or address, I attempted to identify the
data from the hospital's information system.
I attempted to contact non-responders by telephone. When a patient could not come
to the phone, or if proper communication was not possible, I interviewed a proxy. I
sent a further postal questionnaire if the patient could not be contacted by phone or if
it was requested. I interviewed the patient in person only if it was necessary and
feasible.
I took a standard approach to each telephone interview. I prefaced each with an
explanation of the study and the importance of identifying the outcome of non-
responders. I reassured the patient or proxy that they were not obligated to
participate and that they did not have to answer every question. I read the questions
out exactly as they were written on the outcome questionnaire and always in the
same order. As far as possible, I used standardised prompts and explanations.
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For the purpose of this sub-study, I have reported the following outcomes: functional
status (by simple questions and MRS), current place of residence (by the SOP
residence question) and response to the Euroquol quality of life questions (the
walking, self care, usual activities, pain/discomfort and anxiety/depression domains).
I have also reported the reasons for non-response.
6.3.3 Results
Identifying non-responders
Of the 512 stroke patients alive at six months, 320 were early responders, 104 were
late responders and 88 were non-responders (Figure 6.2). I was able to obtain
outcome data in 75% (66) of the non-responders.
Of the 22 un-traced non-responders, contact with the GP revealed that six had died
after six month follow up was due. In a further case, the GP revealed that the patient
had died shortly after hospital admission i.e. both our SMR1 and our 'gold standard'
survival data - record linkage performed in 1999 - were wrong. The remaining 15
un-traced non-responders were alive. In six, the GP said it was inappropriate to
make contact (two of these patients died shortly after); in two cases, I could not
locate the correct GP; one patient did not wish to participate; one failed to reply
despite making contact; and five were not followed in error. The predicted risk of
'death or dependency' (by our study predictive models) of the traced non-responders




The methods used to contact the 66 non-responders are shown in Table 6.5. Overall,
I obtained outcome data by telephone in 86% and collected data directly from
patients in 41% and from proxies in 59%. In five cases the only proxy I could find
was a GP. In two patients response was limited to identifying their current residence.
•
Comparison ofoutcomes between early, late and non-responders
The outcomes of the early, late and non-responders are compared in Table 6.6. A
greater proportion of late and non-responders were dependent when measured using
the simple questions than early responders (70-72% vs. 66%) but this difference was
not significant. However, there were significant trends for later responders to live
somewhere other than in their own home (in a residential or nursing home, hospital
or some other place); to not live with their family; to be less likely to be able to walk
and to perform their usual activities. There was also a trend for later responders to be
less likely to be able to wash and dress themselves which just failed to reach
significance (p 0.08). There was no significant association between time of response
and reports of pain & discomfort or of anxiety & depression.
It was surprising that later response was significantly associated with greater
difficulty in walking, usual activities, washing and dressing (probably) and the need
to live away from home and yet not with greater dependency. I hypothesised that
this might relate to the measurement properties of the simple dependency question.
To investigate, I compared the dependency data obtained using the simple question
with that derived using the MRS (a 'gold standard'; analysis restricted to 389 patients
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with both types of dependency data) and also tabulated dependency data defined by
the MRS against time of response (analysis includes all 399 patients with MRS data).
The simple dependency question and the MRS disagreed on dependency in 11% of
cases (Table 6.8a). The principal reason for disagreement was that, in about a fifth
of cases, the simple dependency question was 'over sensitive' and tended to label a
proportion of functionally impaired but independent patients as dependent (the
simple question was 96% sensitive but only 78% specific). Using the MRS to define
dependence, the expected trend for a greater prevalence of dependency in late and
non-responders was found (p 0.012; Table 6.8b). The proportion of blank or mis-
filled responses was not significantly different between the two methods (MRS: 18
cases (5.1%); simple dependency question: 12 cases (3.4%) p 0.54 (analysis
restricted to the 352 patients with both sets of dependency data and who responded
prior to the telephone survey).
Comparison ofoutcomes between early responders and the whole cohort
The outcomes of the early responders (i.e. estimates of outcome based on about a
65% response rate) and of the whole cohort are compared in Table 6.7 and in Table
6.8b. These analyses show that the estimates of outcome based upon the findings of
the early responders were generally over-optimistic. In absolute terms, the errors
were modest (4% or less) and none were statistically significant. The only exception
was dependency as measured by the MRS where the finding in the early responders
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was, in absolute terms, a 6% under-estimate (57% vs. 63% dependent), but this too
was not significant.
Comparison ofoutcome between hospitals stratified by response status
Tables 6.9a and 6.9b show comparisons between hospitals of the proportion of
patients dependent in ADL and the proportion living at home, stratified by the
number of follow ups sent. For these analyses, I defined dependency using the MRS
(dependency defined as a MRS score of 3-5) and residence 'at home' using the SOP
method (institutional care vs. other; see section 3.7.3)
Taking the outcomes of the entire cohort as the gold standard, the comparison based
upon early response alone overestimated the differences in dependency between
hospitals by 3 to 22%; this error was smaller when early and late responses were
combined (2 to 11%). For the proportion living at home, the comparisons based
upon early response and on early and late response combined were only minimally in
error (0 to 5% and 2 to 7%), respectively. In all analyses, the point estimates of the
relative risk ratios based upon early response alone fell within the 95% confidence
interval of the true relative risk ratios i.e. the comparisons based upon early response
alone were not significantly biased.
Reasonsfor non-response
I identified a reason for non-response in 47 of the 66 final non-responders (in the
remaining 19 cases the patient could not give a clear reason or, because postal follow
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up was used, no reason was requested) (see Table 6.10). Two reasons accounted for
83% of non-response: either the respondent could not remember ever having
received the questionnaire or they had received it but, for various reasons, had failed
to fill or return it. Nearly twice as many in the direct arm could not remember
receiving the questionnaire as in the indirect arm (36 vs. 20%).
6.4 Discussion
This study confirms our previous observation that only about two-thirds of patients
with a cerebrovascular disease code listed as the primary SMR1 diagnosis - the type
of patients likely to be included in a routine system for measuring the quality of
stroke care - are likely to respond to a single postal follow up. The same finding
applies to the sub-group of patients with acute stoke alive at the time of follow up.
At this level of response, it is unlikely that a routine system of measurement would
be credible because of reduced power and the potential for bias in the comparisons of
outcome.
This study helps to quantify the potential for bias. Although non-responders to a
single follow up were significantly more likely than responders to be restricted in
ADL and to require institutional care, these differences were small in absolute terms
and hence, as a group, the outcomes of the initial responders were not significantly
different to the outcomes of the entire cohort. Even after a single follow up,
therefore, error in estimates of dependency in ADL and in the need for institutional
care seem likely to be modest at the majority of hospitals. However, the potential for
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biased comparison of outcome, in this case dependency in ADL, appears to remain
between some hospitals. Thus, after a single follow up, the estimate of the difference
in dependency between Hospital A and Hospital B was substantially wrong (22%
overestimate; true relative risk ratio 1.19; estimated relative risk ratio 1.41), a level
of error that, if real, would certainly mislead a study which aimed to use dependency
data to indicate differences in the quality of care. The use of a second follow up led
to a substantial increase in response (up to 83-84%). At this level of response, the
potential for error in the comparisons of dependency halved but continued to vary
between hospitals (from 2 to 11%). Although undoubtedly an improvement, the
potential for moderately biased comparison of dependency between some hospitals
would appear to remain - after all, an 11% difference in dependency approximates to
about a third of the treatment effect of one hospital admitting all its patients to a
stroke unit and the other hospital admitting none (Stroke Unit Trialists' Collaboration
1997a). That said, the precise interpretation of all these errors is difficult because the
small size of the hospital samples means that none were significant i.e. they may
quite plausibly be due to chance rather than bias. Clearly, however, the potential for
important bias cannot be excluded.
My findings relating to response rate and bias are likely to be generalisable given
that they derive from a consecutive series of patients discharged from five, typical
Scottish hospitals; that the levels of response are in good agreement with other
studies that have reported response to two waves of postal follow up after stroke
(Dorman et al. 1997a; Parker et al. 2000); that others have found response to postal
follow up after stroke to vary substantially between hospitals (Parker et al. 2000);
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and that some (Hoeymans et al. 1998), although not all (Parker et al. 2000), have
also shown that the prevalence of disability is higher in non-responders than in
responders to a single postal contact. Taken together, they strongly suggest that a
routine system aiming to follow stroke patients several months after discharge
should, as a minimum, have the facility to send a second follow up to initial non-
responders. However, as noted, even with such a system, misleading comparisons of
dependency might still result. Fortunately, as will be shown, other routinely practical
strategies might also be used to improve response and reduce non-response bias to an
acceptable level.
Contrary to expectations, response was not improved by excluding the GP from the
system of follow up. There may even have been a small disadvantage in doing so
since response by the indirect method was marginally greater than by the direct
method and because this difference may have been a slight under-estimate (the
indirect arm of the trial included more patients with baseline characteristics
indicative of severe stroke i.e. those less likely to respond). Any benefit from
retaining the GP most likely relates to their knowledge of their patient's current
whereabouts since nearly twice as many final non-responders in the direct arm could
not remember receiving our questionnaire. In the absence of a major difference in
response, the choice of method of follow up for a routine system should be guided by
considerations of cost and acceptability. The indirect method is simple, cheap and
immediately feasible. However, whether GPs would find it acceptable to act as a
middle-man to a real system is unknown, especially as such a system would need to
accommodate reminders and perhaps also patients with a number of disorders other
185
Chapter Six
than stroke. Moreover, there is evidence that GPs are already reluctant to participate
in postal questionnaire surveys (Barclay et al. 2002). Although more complicated
and expensive to establish, the direct system might also prove cheap to run and, by
minimising work for GPs and their staff, might be more acceptable in the longer
term. Regardless of the method chosen, it is clear that contact with the Health Board
only marginally improves overall response and hence would be worthwhile only if a
routine link were simple and inexpensive.
Follow up of survivors of stroke is challenging given that, as group, they are likely to
experience the problems of communication associated with older age (cognitive
impairment, poor vision, deafness) and those associated with stroke (dysphasia,
dysarthria, disability and depression). Furthermore, a substantial proportion move or
to remain in hospital by six months after admission and hence are more difficult to
find. In this context, a five-sixths response to an unheralded postal follow up (plus
one reminder) is actually very good. Nonetheless, our experience suggests that other
simple strategies might improve response further.
First, it might be possible to improve the delivery of the outcome questionnaire.
Both systems of follow up had to deal with the fact that the name of the patient's GP
is an optional field on the SMR1 and hence is often not reported. In these cases, we
had to mail follow up to the address of the surgery alone. This was problematic
when several surgeries shared the same building (as occurred in some urban areas,
especially at Hospital B) or where a surgery had two or more sites. Staff had
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difficulty in identifying the relevant GP and we received a number of letters
complaining about the work generated in doing so. Mandatory reporting of the GP's
name on the SMR1 would have prevented this problem. The systems of follow up
also had to deal with the fact that the SMR1 reports the patient's address prior to
admission. It is common-sense to suggest that improved response from patients who
change their place of residence after a stroke might follow if the SMR1 were to
report the address to which the patient was discharged. In this regard, it is worth
recalling that the Health Board maintains a central database listing the patient's
current GP and address and it is conceivable that, if ever set up, an official system of
follow up might be able to automatically link with these data. Co-operation from
GPs and response from patients might also be higher if a national system of follow
up were known to be in operation (Sloan et al. 1997). For an indirect system, a
covering letter making clear that the follow up had come via their GP might also help
(Smith et al. 1985).
Second, it might be possible to improve response by improving the format of our
questionnaire. Thus, our questionnaire was rather plain, printed on white paper and,
including the MRS, was four (single-sided) pages long (see Appendix 4). A more
professional, shorter and possibly larger print version (perhaps asking the key
questions of dependency and residence only) might be more appealing and so
increase response (Yammarino et al. 1991b). Further attempts at follow up, perhaps
by telephone, would also be likely to improve response. Telephone follow up
appears to be less problematic in the elderly than was formerly the case (Wilson and
Roe 1998) and the simple questions and MRS are valid when administered in this
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way (Candelise et al. 1990a; Lindley et al. 1994b). However, it should be stressed
that telephone follow up can involve a number of calls simply to establish contact
and then sometimes a further call or postal follow up to obtain the outcome data i.e.
it is labour intensive. It may not, therefore, be cost-effective.
Lastly, and importantly, the impact of variation in response to follow up between
hospitals may be less serious when comparisons of outcome are adjusted for
important differences in casemix. Thus, outcomes that have been adjusted for
important casemix have, by definition, already been internally standardised i.e.
judged to be better, worse or in-line with the predicted outcome derived from a
prognostic model. As a result, comparisons of the adjusted outcomes are, to some
extent, unaffected by the exclusion of a proportion of cases from the analysis. To
illustrate, consider if only half the patients dependent at six months reply to follow
up. Provided the quality of care afforded to the responding and non-responding
dependent patients was the same (see section 4.4), the ratio of observed and predicted
outcome in each group will be the same, which is to say, the adjusted outcome
derived from the responding patients will not be biased. The problem with this
assumption, however, is that worse adjusted outcome may be associated both with
worse care and with non-response (e.g. the less severely dependent patients may be
more likely to respond while the more severely dependent patients may not and they
may have had worse care). Thus, the extent to which adjustment 'protects' against
differential non-response depends on the extent to which non-responders received the
same quality of care as the responders, and clearly this may vary between hospitals.
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The failure of the simple dependency question to recognise a proportion of impaired
but functionally independent patients, as defined by the MRS, is perhaps not a
surprise. This finding reflects the trade off between simplicity (and hence ease of
completion) and detail (and hence fine discrimination) accepted in its development
(Lindley et al. 1994b). The simple dependency question was originally developed
for use in treatment trials with many thousands of patients in each arm where less
refined measurement of outcome is not essential (Lindley et al. 1994b). However, its
lack of refinement may be a problem in studies with only a few hundred patients in
each group (i.e. in studies of quality of care) where it appears to obscure real
differences in functional outcome (and so, apriori, reduces the ability to differentiate
between hospitals with different standards of care). Moreover, the proportion of
blank or mis-filled responses was small and not significantly different with the
simple dependency question and with the MRS. Given its greater refinement, it is
arguable, that the MRS should be the preferred measure of dependency for the
purpose of routinely measuring the quality of stroke care.
Indeed, given the small sample sizes and potential for dilution of treatment effects
(by the inclusion of patients too well or unwell to show appreciable benefit), the case
for a more discriminating measure of functional outcome in studies of the quality of
stroke care can be extended. The dichotomisation of the MRS into groups with
'good' or 'bad' functional outcome (e.g. MRS 0-2 vs. 3-5) inevitably leads to a loss
of information and hence to less powerful comparisons. A more discriminating
strategy might be to abandon the concept of dependency and instead to compare
responses across the entire six point scale of the MRS using non-parametric
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statistical methods (Duncan et al. 2000). Re-analysis of the Second European-
Australasian Acute Stroke Study (ECASS 2) of thrombolysis after ischaemic stroke
illustrates this point (Stingele et al. 2001). Using the prespecified primary endpoint
of the percentage of patients with favourable outcome (MRS scores zero and one) the
trial was inconclusive, the 3.7% absolute improvement with thrombolysis over
placebo failing to reach statistical significance (p 0.277). However, using non-
parametric methods to compare the entire MRS outcome distributions between the
two groups, it is clear that the outcomes of patients treated with thrombolysis were
just significantly better (p 0.047).
A better approach still might be to use more finely scaled but still relatively simple
instruments that measure ability in terms of basic and extended ADL (Duncan et al.
2000), for example, the combination of the Barthel Index and the Nottingham
extended ADL index (Wade 1995b), or the recently (and rigorously) developed
Stroke Impact Scale 16 (SIS-16) which incorporates both aspects of ADL, hand
function and mobility in a 16 point measurement tool (Duncan et al. 2003).
Importantly, the Stroke Impact Scale (from which the SIS-16 is derived) has been
shown to be valid when administered by postal survey (Duncan et al. 2002b) and by
proxy (Duncan et al. 2002c). Of course, the argument for more discriminating
measures can be extended even further to include measures of cognition,
communication, and higher social function. However, longer measures may be
counter-productive in terms of greater non- and incomplete response, especially in an
elderly and brain damaged population and in a routine setting where the ability to
make repeated contact and to query incomplete or mis-filled responses is limited
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(Parker et al. 2000). For routine systems which aim to measure the quality of stroke
care a compromise between the detail and the practicality of the outcome measure is
clearly needed. While the suggested alternatives to the MRS may be theoretically
attractive, their practical suitability should be tested before any superiority in a
routine postal setting is automatically assumed.
The studies described in this chapter have a number of methodological shortcomings.
Fortunately, these are unlikely to be a major source of bias or were largely
unavoidable. First, the unit of randomisation in the trial was not the unit of analysis
in all cases. However, this problem affected only a small and equal proportion (2%)
of cases in each arm of the trial. Second, the trial did not primarily study patients
with acute stroke and, because of limited information on the SMR1, could not stratify
by the clinical baseline characteristics which influence response. The practical result
is that I may have modestly under-estimated the response to the indirect system of
follow up. A benefit, however, is that the findings are generalisable to the population
of patients likely to be included in any real system of follow up. Third, I failed to
contact 22 (25%) patients in the survey of non-responders. However, this was
unavoidable in seven cases (because the patient had died) and the traced and un-
traced non-responders had similar predicted risks of being dead or dependent at six
months. Fourth, the method used to survey responders (postal questionnaire in
100%) differed from that used to survey non-responders (telephone in 86%). In
mitigation, the simple dependency question has been shown to be equally accurate
when administered by telephone or by post (Lindley et al. 1994a); and Rankin scores
obtained by face-to-face interview agree with those obtained by telephone (Candelise
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et al. 1990b). Fifth, I accepted the GP as a proxy in the survey of non-responders. A
GP's estimate of functional status might not be as valid as that given by a partner or
regular carer. However, this potential bias occurred only in five of the 66 cases
surveyed and I used the GP as a proxy only if they had seen the patient recently.
Lastly, the study involved too few hospitals and too few patients to definitively
determine whether non-response leads to bias in the comparison of dependency
between some hospitals. Ideally, a much larger study involving more hospitals and





1. Response to a single, unheralded postal follow up six months after admission for
acute stroke was in the region of 60-65%. The addition of a second follow up
increased response to 83-84%.
2. Later response to follow up was associated with a significant trend toward greater
restriction or dependency in ADL and greater likelihood of institutional care.
However, in absolute terms, the differences in outcome between early and later
responders were small.
3. Even after a single follow up, estimates and comparisons of dependency and
institutionalisation were reasonably accurate at many hospitals. However, at
some hospitals, comparisons of these outcomes may be unacceptably biased even
after a second follow up.
4. As a minimum, a routine system of follow up should have the facility to send a
second follow up to initial non-responders. However, to reduce non-response
bias to an acceptable level, other strategies should be employed.
5. Response is not increased by posting follow up directly to the patient's pre¬
admission address. The choice between a direct or indirect system of follow up
should be made on grounds of cost and acceptability.
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6. Improved delivery of the outcome questionnaire, and hence improved response,
might result if the SMR1 routinely listed the name of the patient's GP and the
address to which the patient was discharged. A simpler and more authoritative
questionnaire might also improve response. Further attempts at follow up, in
particular by telephone, would also improve response but might not be cost-
effective.
7. Adjustment for casemix reduces bias due to non-response provided the
responders and non-responders have received care of the same quality. However,
by the very nature of non-response, this may not always be the case and hence
the degree of 'protection' afforded by adjustment may vary between hospitals.
8. The MRS may be better suited to the measurement of dependency than the
simple dependency question for the purpose of measuring the quality of stroke
care. Comparison of functional outcome across the entire range of the MRS
rather than its simple dichotomisation is likely to be more sensitive to differences
in quality of care. The suitability of more detailed measures of functional
outcome to a routine setting merits investigation.
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Table 6.1 Number of times a single hospital stay was allocated to follow up







Table 6.2 Baseline characteristics of the patients in the follow up trial
Direct follow up I Indirect follow up p (x2)
n % n %
Patients 416 413
Median age (in years) 74 73 0.97*
Male 196 48 197 48 0.91
DepCat* 1 to 2 46 11 49 12 0.74
3 to 5 262 64 250 61
6 to 7 103 25 110 27
Hospital A 84 20 101 25 0.53
B 94 23 97 23
C 70 17 68 17
D 106 26 90 22
E 62 15 57 14
Audited diagnosis *
Acute stroke 287 69 298 72 0.85
Other diagnoses 129 31 115 28 0.75
Ineligible or SAH stroke 11 3 14 3
Not stroke 88 21 78 19
Not known 30 8 23 5
Mann Whitney U test
t Missing values for 9 cases (5 Direct, 4 Indirect)
t Identified by inspection of the medical record
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Table 6.3 Baseline characteristics of acute stroke patients in the follow up trial
Direct Indirect p(x2)
follow up follow up
% n % n
Patients 49 287 51 298
Demographics
Median age (years) 73 72 0.57 *
Male 49 140 48 143 0.91
Deprivation Categories
1 to 2 11 32* 13 37* 0.49
3 to 5 64 183t 60 176*
6 to 7 24 69+ 28 82*
Hospital
A 16 45 22 64 0.27
B 22 62 23 69
C 19 53 19 57
D 29 83 23 69
E 15 44 13 39
Stroke pathological subtype
Ischaemic stroke 79 227 82 244 0.68
Haemorrhagic stroke 11 32 10 30
Type unknown 10 28 8 24
Pre-stroke
Lived alone 36 101* 43 127 0.10
Independent in ADL 88 251* 90 267 0.74
Diabetes mellitus 13 37§ 15 tt:COTj- 0.72
Ischaemic Heart Disease 33 92s 31 92* 0.74
On admission
Orientated & able to speak 72 204* 68 202 0.33
Able to lift both arms 74 210* 70 209 0.35
Able to walk without help 41 117* 36 108 0.25
Incontinent of urine 42 117§ 42 125* 0.90
At discharge
In hospital > 5 months 2 5 2 6 0.95
Returned to pre-admission address 78 220* 75 222 0.46
Mann Whitney U test
Denominator d varies in some cases due to missing data
(t d = 284, t d = 295, § d = 282, # d = 297)
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Table 6.4 Response to the Direct and Indirect methods of follow up before and after
sending a reminder to initial non-responders
Outcomes identified Follow up method Relative risk
ratio (95% CI)
Direct Indirect
% n % n
Primary outcomes (n 829) 416 413
Dead or responded within 28days 67 280 65 270 1.04 (0.90, 1.21)
Dead or responded within 63 days 83 344 84 347 0.95 (0.80, 1.14)
Secondary outcomes
Acute strokes (n 585) 287 298
Dead or responded within 28 days 68 195 66 198 1.04 (0.87, 1.23)
Dead or responded within 63 days 83 239 87 258 0.88 (0.71, 1.09)
Acute strokes alive at 6 months (n 512) 260 252
Responded within 28 days 65 168 60 152 1.10 (0.91, 1.31)
Responded within 63 days 82 212 84 212 0.92 (0.74, 1.13)
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Table 6.5 The methods used to elicit a response in the survey of patients with a
stroke and alive at six months who did not return an outcome questionnaire i.e. in








Patient 23 3 1 27 (41%)
Relative 16 0 0 16 (24%)
Carer 12 4 0 16 (24%)
Friend 1 1 0 2 (3%)
GP 5 0 0 5 (8%)



































































































































































































































































































































































































































































































































































































































































































































































Table 6.8a Accuracy of dependency data obtained using the simple dependency













Agreement with MRS 346/ 389 89% (95% CI: 86 - 92)
Sensitivity 235/ 246 96% (92 - 98)
Specificity 111 / 143 78% (71 - 85)
204
Chapter Six
Table 6.8b Comparison of Modified Rankin Scale scores by response status
Response status
MRS score Early Late Non All cases
n %* n %* n %* n %*
Independent
Scores 0-2 104 43 27 30 18 28 149 37
Dependent
Scores 3-5 141 57 63 70 46 72 250 63
Confused/blank 15 3 2 20
MRS not measured 60 11 0 71
Total 320 104 66 490
* confused/blank/unmeasured values excluded from calculation of percentages
and x2
Comparisons of proportions with MRS 0-2 vs. 3-5
between early, late and non-responders: p 0.012 (%2 trend)













































































































































































































































































































































































Table 6.10 The reasons given by non-respondents for not having replied to our earlier
attempts to obtain outcome data
Reason Direct follow up Indirect follow up Total
n =36 n = 30 n = 66
% n % n % n
GP initially did not want us to
contact the patient no
questionnaire received
2 1 7 2 4 3
Thinks that they did return the
questionnaire
6 2 10 3 8 5
Received the questionnaire
but did not fill it in
28 10 33 10 30 20
Cannot remember ever having
received the questionnaire
36 13 20 6 29 19























































Figure 6.2 Follow up of the 512 patients with an acute stroke who were alive six
months after admission to hospital
* Survival status by record linkage performed in 1999
i.e. 12 months after the end of the follow up study
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Chapter Seven. SOP results (1): Outcome
7.1 Introduction
Having pondered the practicalities of routinely measuring outcome after stroke, it is
now time to consider the other question addressed by the SOP, namely, whether
routinely collected stroke outcomes, once adjusted for casemix (using our methods),
are likely to be useful indicators of the quality of stroke care. An attempt to answer
this question is laid out in this chapter and the next. This chapter describes the
ascertainment of the hospital cohorts, their baseline characteristics and their
outcomes before and after adjusting for casemix. Alternative methods of adjusting
for casemix and explorations of the main findings are also presented. The quality of
the structure and processes of stroke care at each hospital and their relationship to the
adjusted outcomes are described in the chapter that follows.
7.2 Additional analyses
7.2.1 Alternative methods ofadjusting outcomefor casemix
In addition to our principal method of adjusting outcomes for casemix (described in
section 3.9) I have also presented analyses of outcomes adjusted for:
1. Age, sex and social deprivation: to mimic the method used to adjust the stroke
outcome data currently published in Scotland.
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2. Urinary incontinence: to estimate whether this simple variable provides
adjustment equal to that of our study models.
3. The study models plus urinary incontinence or social deprivation: to determine
whether the adjustment achieved by our study models can be improved by the
addition of a further simple variable. I tested the addition of urinary incontinence
because it is an established predictor of outcome after stroke and social
deprivation because it is routinely available in Scotland and associated with
outcome after stroke (Anonymous 1997; Kunst et al. 1998; Modan and Wagener
1992).
4. All measured casemix variables (see Table 7.6): to determine whether any
residual variation in outcome, after adjusting for the variables in our study
models, might be explicable by any remaining differences in measured casemix.
For the first two analyses, I built logistic regression models within the SOP data set
and forced in the relevant predictive variables; for the latter two, I forced in the
additional predictive variables along with either the variables of the study model (for
case fatality) or with the linear predictor of the study models (for 'death or
dependency' and 'alive & at home'). I entered two categorical variables: social
deprivation using Carstairs scores (with the least deprived social stratum as the
reference category; see section 3.5.2); and the interval between stroke onset and
admission to hospital (11-30 days prior (reference category), 1-10 days prior, zero
days, 1-10 days after, 11-20 days after and over 21 days after admission).
212
Chapter Seven
7.2.2 Exploring outcomes adjusted using the study models
I performed two analyses in an attempt to understand the reasons for any residual
differences in adjusted outcome between hospitals.
1. I determined how any overall differences in adjusted outcome between hospitals
reflected the outcome of patients with mild, moderate and severe stroke
(approximated by low, medium and high predicted risk of the outcome in
question) by ordering the entire SOP cohort by the predicted risk, dividing it into
three equal sized parts (tertiles), and then comparing the adjusted outcomes
between hospitals for each tertile.
2. I determined when any differences in adjusted case fatality occurred by
constructing a Cox proportional hazards regression model within the SOP data
set (using the same predictive variables as in our study models) and then plotting
adjusted survival curves for each hospital cohort. I checked the proportionality
assumption for each variable by means of log minus log survival plots before
using the model (data not shown).
7.2 Case ascertainment
The SOP identified a total of 4223 hospital admissions in which a SMR1 listed a
cerebrovascular disease code as the principal diagnosis (Table 7.1). Of these, we
audited the medical records of 4017 (95% overall; ranging from 93% at Hospital A
to 98% at Hospital C). The main reason for not auditing admissions was inability to
obtain the relevant medical records. In 10 cases the medical record did not allow us
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to identify the hospital to which the patient was first admitted; I assigned these
patients to hospitals using SMR1 data alone.
I compared the characteristics and outcomes of the audited and unaudited cases in
Table 7.2 (using a significance level of 0.01 given the multiple comparisons). There
were no significant differences in terms of age, sex, the proportion dead or the
proportion dead or dependent at six months either overall or within any hospital. Un¬
audited cases were significantly more likely to have been coded as non-emergency
admissions (p 0.01) i.e. they were less likely to have had an acute stroke than the
audited cases (see section 4.3.2).
Of the 4017 audited admissions, 2845 (71%) had had an acute stroke, 160 (4%) had
had an ineligible stroke (see section 3.5.1) and 1012 (25%) had not had a stroke
(Table 7.3). The hospital with the highest proportion of ineligible stroke admissions
(whose definition includes cases transferred from non-study hospitals) was inevitably
Hospital D, the only hospital to house a regional neurology and neurosurgery centre.
The SMR1 and our audit data disagreed on the hospital to which the patient was first
admitted in 17 cases of acute stroke (Table 7.4). Our audit revealed that 15 of these
were actually first admitted to Hospital A or E and then later transferred to Hospital
D (14 had either a SAH or haemorrhagic stroke). In these cases I assumed that our
audit data were correct and altered the hospital assignment accordingly.
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Of the 2845 admissions with an acute stroke, 121 (4%) were for SAH. The
proportion with SAH was similar (2%) at all hospitals except Hospital D (12%). The
remaining 2724 (96%) acute stroke admissions had had non-SAH strokes. The
derivation of this cohort, on whom all the following analyses are based, is illustrated
in Figure 7.1. The final cohort comprises 2574 patients with a single admission for
acute non-SAH stroke and 73 patients with two or more admissions, each for a
separate non-SAH stroke (70 had two admissions, two had three admissions and one
had four admissions).
7.3 Baseline characteristics of patients with acute stroke
We extracted data describing each baseline characteristic in over 99% of admissions
except for two variables (Table 7.5). These variables were whether the systolic BP
was greater than 160 mmHg (data missing in 37 cases) and the interval between
stroke onset and admission to hospital (exact date of onset missing in 158 cases).
Our audit assistant noted particular difficulty in extracting data from the medical
record in a significantly greater proportion of cases at Hospital A than at any other
hospital (13% vs. 5 - 9%). A greater proportion of these cases were dead at six
months at Hospital A than elsewhere (54% vs. 30 - 40%). Discussion revealed that
this related, in part, to the practice of storing the medical records of deceased patients
on microfiche at a much shorter interval after death at Hospital A than elsewhere.
Our audit assistant commented that the medical records of these cases were often
jumbled and sometimes incomplete.
215
Chapter Seven
We failed to collect all six study model variables in 19 cases; urinary incontinence in
14 cases; and social deprivation in 19 cases (Table 7.5). I replaced these missing
values in order to retain all 2724 cases in each analysis of adjusted outcome. For the
study model variables and for urinary incontinence, I replaced the missing values
using the most pessimistic option e.g. for the ability to walk unaided I marked all
missing values as 'unable'. For social deprivation the missing information was the
post code of the patient's pre-admission address (see section 3.5.2). I first replaced
any missing values using SMR1 post code data (4 cases). In the remaining cases, the
post codes obtained by our audit were not listed in the Carstairs database (McCloone
1994). Here, I identified the deprivation category of any listed post codes which had
the same first three symbols as the audited post code (e.g. EH1) and assigned the
median value (six cases). In the remainder, I simply inserted the lowest deprivation
category (nine cases). To determine whether the pessimistic replacement of missing
variables was a source of bias I repeated all comparisons of adjusted outcomes with
the missing values replaced using the most optimistic option.
The baseline characteristics of the patients with acute stroke (prior to the replacement
ofmissing values) are shown in Tables 7.6a and 7.6b. Setting p to 0.01 to allow for
multiple comparisons, there were highly significant differences between hospital
cohorts in terms of age, social deprivation, pre-stroke employment status, interval
between stroke onset and admission, proportion of strokes which occurred after
admission for another disorder, and on admission: the proportion with normal GCS
verbal, motor and eye sub-scale scores, the ability to lift both arms against gravity,
the ability to walk without the help of another person and urinary incontinence. The
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proportion of patients with different pathological types of stroke also varied highly
significantly between hospitals. However, these differences should be interpreted
cautiously as they are likely to be biased by the large differences in the use of CT
scanning between hospitals (refer forward to Table 8.9).
There were no significant differences between cohorts in terms of sex, prior history
of diabetes mellitus, ischaemic heart disease or myocardial infarction, independence
in activities of daily living prior to the stroke, whether the patient lived alone prior to
the stroke or the proportion with a systolic BP of greater than 160 mmHg on
admission (although the differences in the latter three variables approached statistical
significance: p = 0.07, 0.02 and 0.02 respectively).
The prevalence of adverse prognostic variables was highest at Hospital A, lowest at
Hospital D and intermediate and similar at Hospitals B, C and E. In particular, of the
variables included in the study models, Hospital A had the highest or equal highest
proportion of patients with adverse findings (except for whether the patient lived
alone prior to the stroke) while Hospital D had the lowest or equal lowest proportion
of patients with adverse findings. A substantially greater proportion of patients at
Hospital B came from the two most deprived social strata than at any other hospital
(73% versus 1 - 29%).
The differences between hospitals in terms of the variables included in the study
models is summarised in the different proportions predicted to be dead, dead or
dependent or alive & at home at six months (Table 7.7). In each case, the predicted
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prognosis of the cohort at Hospital D was considerably better than that at any other
hospital. The differences in predicted prognosis between the remaining hospitals
were less marked. The cohort at Hospital E had the next best predicted prognosis,
followed by that at Hospital B, then Hospital C and, worst of all, Hospital A. The
absolute differences in the proportion predicted dead, dead or dependent and alive &
at home between Hospitals A & D were very large: 16%, 20% and 19%,
respectively.
7.4 Response to follow up at six months
7.4.3 Casefatality
Measured by linkage to death certification data (provided by ISD 20 months after the
last patient entered the study) there were a total of 1007 deaths by six months
amongst the 2724 patients with acute stroke (37% case fatality).
During the data collection phase of the SOP we used a 'hot-pursuit' method to
identify deaths to guide our system of follow up (see section 3.8.2). The success of
this method (using the linked survival data as a gold standard) is shown in Figure 7.2.
The majority of deaths within six months (77%; 777 deaths) occurred in hospital and
were identified using SMR1 data. We attempted to identify the 230 out of hospital
deaths using our standard method of follow up in 154 cases (see section 3.8) and an
enhanced method in 73 cases (see section 6.2); we identified three deaths after
discharge using miscellaneous methods. The two methods of follow up identified
80% and 99% of out of hospital deaths, respectively. Of the 1717 cases alive at six
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months according to the linked survival data (Figure 7.3), our hot pursuit methods
disagreed in only 19 cases (10 reported dead by SMR1, 9 reported dead by GP).
7.4.4 Functional status andplace of residence
The methods used to follow up the 1717 patients alive at six months are shown in
Table 7.8. The great majority (95%) were contacted using either our standard
method (1120 cases) or our enhanced method (508 cases in the follow up trial). The
remainder were contacted using one of two other methods: firstly, after the follow up
trial had finished, we continued to send a reminder to non-responders (57 cases); and
secondly, some patients were simultaneously entered into the SOP and the Feed or
Ordinary Diet (FOOD) trial, a randomised trial investigating feeding strategies after
acute stroke administered by our department (14 cases) (Dennis 2001). We followed
these patients using the FOOD trial methods. We failed to send any follow up in 19
cases (10 because the SMR1 indicated that they had died in hospital, 8 because of
administrative error and one because of no GP data).
In total, we collected follow up data from 1257 (73%) of the patients alive at six
months (Table 7.8). The overall response to a single follow up was 63% (1075
responses). Examining only the two phases of follow up in which a reminder was
sent (the follow up trial and the post follow up trial period) the combined cumulative
response after a second follow up was 82% (464 responses from 565 mailings).
Response after a single follow up, after a second follow up and after special follow
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up is summarised in Figure 7.4. These levels of response are in keeping with those
described in chapter six.
Of the 1257 completed outcome questionnaires, 1216 (97%) provided interpretable
responses to the questions about dependency in ADL and 1222 (97%) to the
questions about place of residence (see Tables 7.9a and 7.9b). The total useable
response to follow up from patients alive at six months was therefore 71%. Table
7.9a shows that, in returned questionnaires, the principal reason that we failed to
collect dependency data was that the simple dependency question was not answered.
This contrasts with the residence question (Table 7.9b) in which only eight responses
were left blank or were uninterpretable. However, 150 patients had difficulty in
selecting a single response to the residency question, although only eight of these
multiple responses were uninterpretable.
The median interval between admission to hospital and the completion of an
outcome questionnaire for all 1257 responders was 179 days (range between 5th and
95th percentile = 167 to 251 days) and did not vary significantly between hospitals
(Table 7.10). The median interval between admission to hospital and the completion
of an outcome questionnaire was 202 days and 237 days in the patients in the follow
up trial who replied after our second and special contacts, respectively. Only eight
questionnaires were completed and returned over one year after the patient had been
admitted to hospital. In the 1191 patients in whom we collected follow up data
without the use of special methods, 44% of questionnaires were filled by the patient,
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52% by a proxy (Table 7.11). As expected, the patient rather than a proxy was more
likely to complete the questionnaire if the patient was independent (OR 7.9; 95% CI
5.8 to 10.8) or lived at home (OR 11.6; 95% CI 6.3 to 21.8).
The proportion of patients who were alive at six months and responded to follow up
varied highly significantly between hospitals (Table 7.12). Response was greatest at
Hospitals A, D and E (79 to 80%), intermediate at Hospital C (71%) and least at
Hospital B (63%). Non-responders (n = 460) were significantly more likely than
responders (n = 1257) to come from the two most deprived social strata, to be
unemployed, and on admission, to have characteristics indicative of severe stroke
(Table 7.13).
Table 7.14 shows the comparison of the proportions predicted to experience each
outcome between responders, non-responders and all patients (i.e. the responders +
the non-responders) alive at six months. For each outcome, the proportion predicted
to experience a poor outcome was always higher amongst the non-responders than
amongst the responders. However, in absolute terms, the predicted risk of the
responders only moderately and non-significantly underestimated the predicted risk
of each hospital cohort (by up to 5% at Hospital A, up to 4% at Hospital B and up to




Case fatality is reported for all 2724 patients with acute stroke. However, because of
losses to follow up, the total number of patients in whom 'death or dependency' can
be reported is 2223 (82%: 1007 deaths + 1216 with useable dependency data) and in
whom 'alive & at home' can be reported is 2229 (82%: 1007 deaths + 1222 with
useable residency data).
There were large and highly significant differences between hospitals in each
outcome (shown as proportions in Tables 7.15 (a. to c.) and as unadjusted W scores
and odds ratios in Tables 7.16 (a. to c.). Hospital D had, by far, the 'best' set of
unadjusted outcomes: the lowest proportions dead and dead or dependent and the
highest proportion alive & at home at six months. Hospital A had the 'worst' set of
unadjusted outcomes: the highest proportion dead, the second (almost equal) highest
proportion dead or dependent and the lowest proportion alive & at home at six
months. In absolute terms, the differences in unadjusted outcomes between
Hospitals A & D were large: per 100 admissions, 21 more patients were dead, 23
more were dead or dependent and 18 fewer were alive and at home at six months at
Hospital A than at Hospital D.
The unadjusted outcomes at Hospitals B,C & E were less consistent. Case fatality
was similar at all three hospitals and mid-way between that at Hospitals A & D:
about 11 more patients were dead per 100 admitted to Hospital A than to Hospitals
B,C & E; and about 10 more patients were dead per 100 admitted to Hospitals B,C &
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E than to Hospital D. The proportions dead or dependent at Hospitals A,B & C were
almost identical while that at Hospital E was moderately lower (between 4 to 6 fewer
patients were dead or dependent per 100 admitted than at Hospitals A,B & C); all
were very much higher than at Hospital D. The pattern of outcome for the
proportion alive & at home followed that for death or dependency: about 9 more
patients per 100 admitted were alive & at home at Hospital D than at Hospital E; and
between 4 and 8 more patients per 100 admitted were alive & at home at Hospital E
than at Hospitals A,B & C.
7.6 Outcomes adjusted for casemix
7.6.3 The calibration of the study models and the use of Wor Ws score methods
The calibration plots of the three study models set are shown in Figure 7.5. The
calibration plots of the customised model of case fatality at six months and of the
original model for alive & at home at six months follow the 45° line closely,
indicating that they are well calibrated. I have therefore reported these outcomes,
after adjustment, using ordinary W scores (see section 3.9.3).
The calibration plot of the model of death or dependency at six months diverges
markedly from the 45° line, particularly in the categories with medium and low
predicted risks (the model considerably under-predicts the number of patients dead or
dependent in patients with a lower than 70% predicted risk). I have therefore
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reported adjusted death or dependency using standardised W scores (Ws scores; see
section 3.9.3).
7.6.4 Adjustmentfor casemix using the study models
Each adjusted outcome is given in Tables 7.16 (a. to c.). The comparisons ofW or
Ws scores between hospitals are illustrated in Figures 7.6 (a. to c.). To facilitate
these comparisons I have artificially set the W (Ws) score of Hospital A to zero and
subtracted the score of Hospital A from the score of each of the other hospitals in
each figure. Thus, Figures 7.6 (a. to c.) illustrate the difference in W (Ws) score
between each hospital and Hospital A. Note, the comparison ofW scores indicates
the true differences between hospitals while the comparison of Ws scores indicates
the differences between hospitals that would be seen if each had the same casemix
structure as the SOP overall.
For case fatality, after adjustment, the variation between hospitals remained just
significant (p 0.047). In absolute terms, the differences in case fatality between
Hospital D and Hospitals B,C & E were virtually abolished and the differences in
case fatality between Hospital A and the other four hospitals reduced from 21 to
between 5 and 7 more deaths per 100 patients admitted.
For death or dependency, after adjustment, the variation between hospitals remained
highly significant (p < 0.0005) and the ranking of hospitals was unchanged i.e.
adjusted death or dependency was significantly lower at Hospital D than at any other
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hospital; adjusted death or dependency at Hospital E was significantly lower than
that at Hospital B (OR 0.54 (95% CI 0.35-0.85)) but only slightly and non-
significantly lower than that at Hospitals A & C. However, in absolute terms, the
variation in death and dependency between Hospital D and the other four hospitals
was halved: the difference between Hospital D and A reduced from 23 to 11 fewer
cases dead or dependent per 100 admitted and the difference between Hospital D and
E reduced from 18 to 8 fewer cases dead or dependent per 100 admitted.
For alive & at home, after adjustment, the large differences between hospitals
reduced very considerably (down to between 2 and 4 more cases alive & at home per
100 admitted) and were no longer statistically significant (p 0.574).
Analyses in which missing predictor variables were replaced using optimistic values;
in which cases where stroke occurred after admission were excluded; and in which
cases with conflicting survival data (record linkage vs. hot pursuit) were re-coded
gave almost identical results as our primary analyses (Table 7.17). The exclusion of
cases in which our audit assistant had noted particular difficulty in extracting data
from the medical record (Table 7.17) did not alter our findings in terms of death or
dependency and alive & at home. It did lead the variation in adjusted case fatality
between hospitals to become non significant (from p 0.047 to 0.075) but the point
estimates of the adjusted odds ratios were almost unaltered.
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7.6.5 A Iternative adjustmentsfor casemix
The results of the alternative adjustments for casemix are also given in Tables 7.16
(a. to c.). Their comparison with adjustment using the study models is shown in
Figures 7.6 (a. to c.) and in Figures 7.7 (a. to c.). Again, the figures illustrate the
difference in W score or Ws score between each hospital and Hospital A.
These data show that, after adjusting for age, sex and social deprivation, the
differences in each outcome between hospitals remained substantial and highly
significant (p < 0.0001 in each case). Similarly, adjustment for urinary incontinence
alone explained a much smaller proportion of the variation in each outcome between
hospitals than adjustment using the study models. When added to the study models
urinary incontinence remained an independent predictor of each outcome (p <
0.00005 for its Wald statistic) but did not alter the residual variation in outcome
between hospitals.
When added to the study models social deprivation was not an independent predictor
of case fatality or being alive & at home (p for its Wald statistic 0.68 and 0.52,
respectively). The slight reduction in variation in adjusted case fatality between
hospitals that resulted is therefore of dubious significance. However, when added to
the study model for death or dependency social deprivation was an independent
predictor with greater social deprivation being clearly associated with a greater risk
of being dead or dependent (this relationship appeared linear (Figure 7.8) and, for
this analysis, I entered social deprivation as a continuous variable; p <0.0001 for its
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Wald statistic). The additional adjustment for social deprivation led to a modest
absolute reduction in the variation in death or dependency between hospitals. As a
result, the difference in death or dependency between Hospitals E & B became non¬
significant (OR 0.74 (0.47 - 1.15).
The adjustment for all measured casemix took account of all the characteristics listed
in Table 7.6 except stroke pathological subtype (because of missing values for
certain casemix variables this analysis was restricted to 2543 patients for case
fatality, 2073 for death or dependency and 2076 for alive & at home). Compared
with adjustment using the study models, this adjustment did not alter the absolute
differences between hospitals in terms of case fatality or being alive & at home. For
death or dependency, it led to a similar reduction in variation as did the addition of
social deprivation to the study model i.e. other than social deprivation, none of the
remaining casemix variables explained the residual variation in death or dependency.
I omitted stroke pathological subtype (haemorrhagic stroke vs. not) from the 'all
casemix' model because of the potential for biased measurement (see Table 8.9).
Tested separately, however, the addition of stroke pathological subtype did not
account for the residual variation in any outcome (Table 7.18). Its addition did (non-
significantly) reduce the variation in death or dependency between Hospital A and
Hospitals B & C, but haemorrhage actually appeared to reduce the risk of a poor
outcome, almost certainly a spurious finding (Table 7.18).
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7.6.6 Exploring the differences in adjusted outcome between hospitals
Bypredicted stroke severity
For case fatality, after adjusting for casemix, there was a suggestion that the worse
overall outcome at Hospital A was due to the outcome of patients with severe and,
less so, moderate stroke (Figure 7.9a).
For death or dependency, after adjusting for casemix, it was clear that the overall
better outcome at Hospital D was due to the outcome of patients with mild and, much
less so, moderate stroke (Figure 7.9b).
By the timing ofdifferences in adjusted case fatality
The adjusted survival curves of the five hospitals started to diverge within 5 to 10
days of admission and continued to diverge until about 30 days (Figure 7.10). The
curves then ran parallel till about 130 days. At six months, the adjusted survival
curves of Hospitals B to E were almost superimposed and clearly separate from the




Prior to adjusting for casemix, there were very large differences between hospitals in
the proportion of patients dead, dead or dependent and alive & at home at six
months. For each outcome, the results at Hospital D appeared to be considerably
'better' than the results at the other four hospitals. The differences in outcome
between Hospitals A,B,C & E were generally less marked, followed a less clear cut
pattern and not all were statistically significant. Overall, however, Hospital A tended
to have the 'worst' set of outcomes and Hospital E the second 'best'; the results at
Hospitals B and C were intermediate to those of Hospitals A and E.
Perhaps not unexpectedly, the large differences in outcome between hospitals were
associated with large differences in the baseline characteristics of the patients
admitted. The cohort at Hospital D had, by far, the most advantageous set of
baseline characteristics while the cohort at Hospital A had the least; the baseline
characteristics of the cohorts at Hospitals B, C and E were generally similar and
intermediate. Once these differences in casemix were taken into account (using the
study models) the overall variation in outcome between hospitals was considerably
reduced and, between certain pairs of hospitals, virtually abolished. Much of the
variation that remained could be attributed to the play of chance. Indeed, after
adjusting for casemix, there were no significant differences in the proportion of
patients alive & at home at six months between any of the hospitals.
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These findings indicate that most of the variation between hospitals in each outcome
was due to factors outside of their control rather than to any differences in the quality
of the care they provided. Importantly, adjustment only for age, sex and social
deprivation, the method currently used to adjust stroke outcomes data published in
Scotland, accounted for substantially less of the variation in outcome between
hospitals than did our study models; indeed, adjustment for age, sex and social
deprivation appeared to be only modestly better than no adjustment at all. These
findings strongly suggest that stroke outcomes data as currently published in
Scotland - and by extrapolation that in England & Wales - are inadequately adjusted
for casemix and hence are unlikely to be accurate indicators of the quality of stroke
care.
Nonetheless, despite adjustment using the study models, case fatality and death or
dependency at six months continued to vary significantly between hospitals. This
residual variation was principally due to Hospitals A and D: case fatality remained
significantly higher at Hospital A than at any other hospital (whose case fatalities
were almost identical); and death or dependency remained significantly and
substantially lower at Hospital D than at any other hospital (whose proportions dead
or dependent were similar, except between Hospitals B & E). Given that we used
robust prognostic models to adjust for casemix, it is tempting to infer that these
residual differences in outcome must be the result of differences in the quality of
care. However, as with all observational studies, but especially those based upon
routinely and retrospectively derived data, it is likely that other factors may have
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been at work. Before drawing any conclusions, therefore, I will first reconsider the
quality of our data.
Hospital samples
The first consideration is the validity of our hospital samples. Although case-note
retrieval bias seems very unlikely, the possibility that diagnosis and coding bias (see
section 1.6.1) may have prevented comparisons of outcome between truly
representative samples of patients merits exploration.
Diagnosis bias is possible because we identified cases of stroke simply by accepting
the diagnosis recorded in the medical record (see section 3.5.1). False positive
diagnosis is more likely if the patient has altered consciousness and false negative
diagnosis if the stroke is minor (Ferro et al. 1996; Ferro et al. 1998b; Libman et al.
1995). Such errors may be more likely if the assessing physician is inexperienced
(Ferro et al. 1998b; Norris and Hachinski 1982) and, to a lesser extent, when there is
limited access to CT imaging (Britton et al. 1984). These factors may have been
more prominent at Hospital A (see chapter 8) and it is possible that its higher case
fatality might reflect a greater tendency for its physicians to diagnose moribund non-
stroke patients as stroke, and to label patients with minor stroke as a TIA, errors
which would spuriously worsen the prognosis of the cohort entered into the SOP.
However, even if present, it is unlikely that this bias was large because a bedside
diagnosis of stroke is correct in the great majority of cases (Ferro et al. 1998b; von
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Arbin et al. 1981b) and most patients at Hospital A would have had their diagnosis
considered by a senior physician shortly after admission.
False positive coding bias cannot influence our findings because we excluded cases
who had not in fact had an acute stroke (who we identified reliably - see section
5.3.2). In doing so, it is important to note that we have tested the validity of a system
that identifies cohorts of patients with acute stroke more accurately than is currently
possible using subsets of routine CVD discharge codes; which is to say, we have
tested a system that approximates an improvement in identification of acute stroke
likely to result from the routine collection of our casemix variables (see section 5.4).
However, our data may still be biased by false negative coding error. Thus, it is
arguable that the smaller proportion of patients dead or dependent at Hospital D may
have resulted from a greater tendency to assign co-morbid conditions and
complications as the primary SMR1 diagnosis in patients with severe stroke
(spuriously improving the prognosis of the cohort entered into the SOP) and,
similarly, that the higher proportion of patients dead at Hospital A may have resulted
from the coding of minor stroke as TLA (spuriously worsening the prognosis of the
cohort). Again, however, even if present, it seems unlikely that this bias can explain
much of the residual variation in outcome: a previous study suggests that false
negative coding affects only about 14% of acute strokes at Hospital D, that only a
third of these have a stroke code listed as a secondary diagnosis and that their
exclusion does not bias the estimates of case fatality or discharge home (Davenport
et al. 1996c); and our own audit revealed that a primary SMR1 diagnosis of TLA had
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a very low positive predictive value for stroke i.e. strokes were not being 'hidden'
within that code at any hospital.
Casemix data
The second consideration is the possibility that the validity of our data describing
casemix, and hence of our adjustments for casemix, may have varied between
hospitals. In many respects, the quality of our casemix data was good: we were able
to abstract a complete set in virtually all cases; the replacement of the small number
of missing values was not a source of bias; the data pooled from all five hospitals
were reliable (see section 5.3.2); and the data abstracted at Hospital D were valid
(see section 5.3.3). However, I did not directly address the question of variation in
the validity of the data between hospitals and across patient types. The possibility
remains, therefore, that variation in the methods used by clinicians to collect and
record baseline characteristics and by our research assistant to extract those data may
have been a source of bias. Furthermore, there is reason to suspect that any such
error may have been most marked at Hospital A, and hence that its higher adjusted
case fatality may in fact reflect our failure to properly adjust for its 'sicker' patients.
First, Hospital A admitted the greatest proportion of patients with severe stroke,
many of whom died within a few days of admission. Clinical data collection has
been shown to be less accurate in such patients (Shinar et al. 1985) and it may also
be less comprehensive. Second, the accuracy and completeness of data recorded in
the medical record is influenced by the training and knowledge of the clinician
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(Rowley and Fielding 1991b; Schmulling et al. 1998) and by the use of specific
prompts (such as those found on a stroke clerking proforma) (Davenport et al.
1995b). Hospital A differed from the other hospitals in both these regards (refer
forward to Table 8.1). Third, our audit assistant may have been influenced by the
knowledge of in-hospital death when abstracting data from the medical record; a bias
which, if present, would be most marked at Hospital A; and lastly, our audit assistant
noted greater difficulty in extracting data from the medical record (and so perhaps
needed to make more inferences and extrapolations in order to extract predictive
data) at Hospital A than at any other hospital. Indeed, after the exclusion of the cases
which were difficult to audit, the residual differences in case fatality between
hospitals were no longer significant.
Two points can be made against this argument. First, the exclusion of cases which
were difficult to audit did not alter the point estimates of the odds ratios of adjusted
case fatality, suggesting that their exclusion may only have reduced the certainty of
the original findings rather than demonstrated the presence of bias; and second,
where the medical record made it clear that the patient had had a severe stroke or had
died, one might imagine that our audit assistant would have been most likely to make
overly pessimistic assessments of casemix (Caplan et al. 1991b; Gjorup et al. 1986),
leading us to over rather than under adjust. Nonetheless, the possibility of bias in our




The next consideration is the validity of our measurements of outcome. Given its
unambiguous nature and collection by record linkage, our measurements of survival
are likely to be accurate. However, our measurements of place of residence and
functional status are open to bias because they depend on the measurement properties
of the measuring instruments and on the response to our outcome questionnaire.
We measured dependency in ADL using the simple dependency question. Although
a validated instrument it is only moderately precise (see section 3.7.2), and, as
already discussed, its use may have led us to miss moderate differences in death or
dependency (see section 6.4). The use of the simple dependency question may
therefore have contributed to the limited variation in adjusted death or dependency
between Hospitals A,B,C & E; however, the markedly lower adjusted death or
dependency at Hospital D cannot be explained by a second order bias such as this.
Our method ofmeasuring place of residence (a menu of possible responses) has not
been validated and led 12% of survivors to give multiple responses. Fortunately the
simple dichotomisation of place of residence into institutional care versus all other
forms of accommodation ('home') allowed sensible interpretation of virtually all
multiple responses. However, dichotomisation also reduced the degree to which
residence data were able to approximate level of disability. This may partly explain
the failure of the alive & at home data to mirror the death or dependency data, after
adjustment for casemix. In particular, it is possible that the dichotomisation may
235
Chapter Seven
have hidden a superior residential outcome at Hospital D, where significantly fewer
survivors were dependent at six months. Thus, institutionalised patients at Hospital
D may have primarily lived in residential homes whilst those elsewhere may have
made greater use of nursing homes or long term hospital care; and non-
institutionalised patients at Hospital D may have primarily lived in their original
home whilst those elsewhere may have been more likely to move, for example, to
live with family or in sheltered accommodation.
Given the high and variable level of non-response across hospitals to our survey of
outcome in survivors, the possibility of non-response bias is clear. Certainly, as a
group, non-responders had a higher prevalence of adverse prognostic variables (see
Table 7.13) and, in the follow up trial, had non-significantly worse outcomes than
responders (see section 6.3.3). More importantly, even after two follow ups, the
follow up trial also showed that there may be important bias in comparisons of
dependency between some hospitals (see section 6.3.3). As such, the potential for
non-response bias would seem to be greatest at Hospitals B & C, the two hospitals
with the lowest levels of response (63% and 71%, respectively).
Against this, however, the follow up study also showed that, even at low levels of
response, many estimates of dependency and all estimates of institutionalisation were
only modestly biased (see section 6.3.3). Also, in the analysis in Table 7.14, the
differences in the proportion predicted 'dead or dependent' and the proportion
predicted 'alive & at home' between the responders and the entire population at
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each hospital and overall were moderate (0 to 5% in absolute terms) and none were
significant. Our main analyses are also adjusted for casemix, further reducing the
impact of non-response (see section 6.4). Hence, whilst the possibility of substantial
non-response bias cannot be excluded, it seems most likely that it was moderate.
Specifically, whilst non-response may explain some of the variation, or lack of
variation, in adjusted death or dependency between Hospitals A,B,C & E it seems an
implausible explanation for the very much lower adjusted death or dependency at
Hospital D.
Adjustmentfor casemix
The final potential source of error is failure to properly adjust for differences in
casemix. Assuming that all the predictor variables are unbiased, the ability to adjust
for casemix depends on the statistical and clinical validity of the predictive model
(Altman and Royston 2000). A statistically validated model is 'one which passes all
appropriate statistical checks, including goodness of fit on the original data set and
unbiased prediction on a new data set' (Altman and Royston 2000). By this
definition, our models all showed good statistical validity prior to the start of the
study (see section 3.9.1). The models predicting case fatality and the proportion
alive & at home also calibrated very well within the SOP, providing further evidence
of their external validity and allowing unbiased comparisons of these outcomes using
ordinary W scores. The model predicting case fatality can be criticised because it
was customised within the SOP in which about 6% of patients had two or more
admissions i.e. the model transgressed the assumption that all predictor variables in a
237
Chapter Seven
logistic regression analysis are independent of each other. However, given the small
numbers involved it is likely that any resulting error is small.
The model predicting death or dependency calibrated poorly within the SOP, under¬
estimating the risk of death or dependency in all groups but especially in those with a
truly low or intermediate risk. The explanation for this is uncertain and may relate to
deficiencies in the validity, reliability and completeness of our data. However, it is
notable that the model also gave 'over-optimistic' predictions of death or dependency
in groups at low or intermediate risk in the community cohort first used to establish
its external validity (Counsell et al. 2002). Together, these observations suggest that
additional predictive data may be needed for the model to accurately predict death or
dependency in lower risk groups. From a practical perspective, ordinary W scores
calculated using the model would have provided a biased comparison of adjusted
death or dependency, particularly disfavouring Hospital D (the hospital which
admitted the greatest proportion of patients at low or intermediate baseline risk).
Fortunately, this was prevented by the use of the standardised W score and so the
comparison of adjusted death or dependency between hospitals is valid.
Clinical validation refers to whether or not a model 'performs satisfactorily on a new
data set according to context-dependent statistical criteria laid down for it' (Altman
and Royston 2000). In the SOP, the task was to provide sufficient adjustment such
that the majority of any residual variation in outcome might confidently be ascribed
to differences in the processes of stroke care. The problem, of course, is that in the
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absence of perfect models with which to compare the performance of our own, it is
impossible to know how close they come to fulfilling this aim. Three factors suggest
that our models may have good clinical validity. First, the models explained large
amounts of the variation in each outcome i.e. the predictive data intrinsic to each
model appears to be strong. Second, after adjustment, the residual differences in
outcome between hospitals were of the same order of magnitude as that found in a
systematic review of randomised trials comparing stroke unit care with care on
general wards i.e. it is plausible that differences in stroke care can produce
differences in outcome of roughly these sizes (Mant and Hicks 1996; Stroke Unit
Trialists' Collaboration 1997a). Third, only a small amount of the residual variation
in outcome could be explained by further adjustment for other measured and
potentially important markers of casemix. The failure of urinary incontinence to add
to the predictive power of our models and the clear inferiority of adjusting for
urinary incontinence alone is particularly interesting given its recognised importance
as a powerful predictor of outcome after stroke; it also provides somewhat indirect
evidence that our models may be superior to some previous models that predict
outcome after stroke (Barer and Mitchell 1989; Gladman et al. 1992a; Taub et al.
1994).
The only instance when the addition of another variable resulted in a material
(although still modest) improvement in adjustment was when social deprivation was
added to the model predicting death or dependency. Its addition suggested that the
apparently worse 'performance' of Hospital B as compared to Hospital E was an
artefact of the populations served. The improvement in the predictive power of the
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model is most likely to have resulted from an improvement in the prediction of
dependency since social deprivation was not an independent predictor of case
fatality. The improvement is credible if one considers that dependency reflects the
interplay of the patient's disability and their social environment (Wilkin 1987).
Other investigators (Jakovljevic et al. 2001; van den Bos et al. 2002) (but not all
(Fullerton et al. 1988)) have found a similar relationship and a previous study that
tested the addition of social deprivation to our model also found a non-significant
trend toward it being an independent predictor of death or dependency (Counsell
1998) (the failure to reach significance perhaps reflecting the small proportion (8%)
of patients in the two lowest socio-economic groups in this study). The addition of
social deprivation to our model therefore appears worthy of further investigation.
Clearly, our models fail to take account ofmany other factors relating to the patient's
social background, psychological status, past medical and stroke history, clinical
examination, laboratory investigations and brain imaging that have at one time or
another been put forward as independent predictors of outcome after stroke and
which were not measured in the SOP. The importance of these omissions is difficult
to gauge. Many were considered during the development of our models and were not
found to be independently associated with outcome, or, even if they were, they did
not add to the models' predictive power (Counsell et al. 2002; Counsell 1998). Also,
few were found to be consistent predictors of outcome in a recent systematic review
of multivariate prognostic models (Counsell and Dennis 2001). On the other hand,
the developers of our models were clearly unable to consider all known predictive
factors and the frequent poor methodological quality of the studies in the systematic
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review allowed for few definitive conclusions (Counsell and Dennis 2001). Hence,
whilst our models are undoubtedly very good, not to say state of the art, caution
remains sensible and one must be careful not to succumb to 'the fallacy of
omnimetrics', namely "the ill-conceived idea that if one just identifies the right
things to measure and develops the right scales of measurement, then one can
determine all that one needs to know about prognosis and can make valid treatment
comparisons" (Green and Byar 1984). It cannot be overemphasised that, in the
context of comparisons between non-randomly allocated groups, one can never
discount the possibility, indeed probability, that a proportion of the residual variation
in outcome may be due to variation in factors that have not been considered or which
remain to be understood. In support of this possibility, it is notable that our methods
did not pick out Hospitals A and D from the generality of hospitals. Rather, these
hospitals had the most extreme outcomes before adjustment for casemix. The
nagging doubt remains, therefore, that their continued status as the hospitals with the
most extreme outcomes after adjustment may simply reflect the difficulties of
adjusting for all variations in casemix when those variations are very large.
The play ofchance
The final consideration is that the residual differences in outcome may be due to the
play of chance. Clearly, given the p value of < 0.0005, this is an extremely unlikely
explanation for the residual differences in death or dependency. However, the
residual differences in case fatality were only just significant (p 0.047), a result so
close to the traditional cut-off of p < 0.05 that it must remain plausible that Hospital
A appeared to have the highest adjusted case fatality simply because of bad luck
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(Sterne and Davey Smith 2001). Indeed, the use of the traditional p < 0.05 level of
statistical significance might be criticised because the study measures three outcomes
and a shrunken p value (e.g. p < 0.017, generated using the Bonferroni correction)
should perhaps have been used to minimise the risk of a Type 1 error (Anonymous
1996;Anonymous 1999). Similarly, the use of binomial methods to calculate the
confidence intervals for our W scores fails to account for the uncertainty in the
adjusted outcome that results from the uncertainty in the estimated co-efficients of
our prognostic models (Hosmer and Lemeshow 1995; Signorini and Weir 1999) i.e.
it is arguable that the confidence intervals of our W scores should overlap somewhat
more than appears to be the case. If we had used these stricter methods, the residual
difference in case fatality between Hospital A and the other four hospitals would
certainly not have been significant. It is debatable, however, whether such strict
statistical methods are appropriate to the field of quality assessment where the aim is
to identify hospitals likely to have outcomes significantly different to the remainder,
not to prove it beyond all reasonable doubt. Also, we collected data only over a two
rather than three year period (as is the case for the stroke outcomes data published in
Scotland). It is possible that the finding of lower adjusted case fatality at Hospital A
would have been more certain ifwe had collected data for another year.
Conclusion
Having considered our methods in some detail, it is clear that no aspect of our
comparison of outcomes escapes criticism. This is, of course, not a surprise given
that the SOP is an observational study quite purposefully based on routinely and
retrospectively derived data and specifically limited in the detail and tenacity of its
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measurements of outcome. These factors have undoubtedly led to a considerable
number of potential biases which differ in their extent and direction across the study
hospitals. Although none are large in themselves, the impact of their accumulation is
difficult to predict and, in combination, it is quite possible that they may explain
much of the residual variation in outcome between hospitals. As is always the case,
variation in unmeasured baseline characteristics may also explain some of the
remaining variation in outcome and the play of chance is a plausible explanation of
the residual variation in case fatality. To return to the original question, therefore,
are these data sufficiently robust that one can conclude that the residual differences
in outcome between the study hospitals are the result of differences in the quality of
care? Clearly, the answer must be no. The fact that so many misgivings remain
despite our efforts to use an idealised system of measuring outcome underlines the
enormous difficulties inherent to this approach of measuring the quality of stroke
care.
Nonetheless, as previously noted, it is also true that the purpose of the measuring
outcomes is to indicate hospitals likely to have especially poor or excellent care, not
to prove that this is the case beyond all reasonable doubt. By demonstrating that
there are no biases that definitively explain our findings, this review leaves open the
possibility that much of the residual variation in outcome might be due to variation in
the quality of stroke care. The divergence of the adjusted hospital survival curves
over the period from 5 to 10 days until 30 days lends some weight to this possibility
- this is the period after a stroke when death is most likely to result from the
complications of immobility and cardiovascular disease, disorders potentially
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preventable by appropriate intervention (Bamford et al. 1990b; Davenport et al.
1996a; Stroke Unit Trialists' Collaboration 1997b). However, whether the residual
differences in adjusted outcome are truly associated with differences in the quality of
stroke care can only be determined by its direct inspection. If adjusted outcomes
really are indicators of the quality of stroke care, one would expect to find
deficiencies in aspects of care that promote survival at Hospital A; excellence in
aspects of care that promote independence in ADL at Hospital D; and broad






1. Prior to adjustment for casemix there were very large differences between
hospitals in the proportion dead, dead or dependent or alive & at home at six
months. These differences were associated with large differences between
hospitals in the measured baseline characteristics of the patients admitted.
2. Once these differences in casemix were taken into account, the variation in each
outcome reduced considerably and much that remained could be attributed to the
play of chance. After adjustment, there were no significant differences in the
proportion alive & at home between any hospitals. Variation in outcomes after
stroke appears to be mostly due to factors that are outside of hospital control.
3. After adjustment, compared with the other hospitals, case fatality remained
significantly higher at Hospital D and the proportion dead or dependent remained
significantly and substantially lower at Hospital A. These differences might
reflect differences in the quality of care but equally might simply reflect biased
measurements, inadequate adjustment for casemix and, for case fatality, the play
of chance.
4. If the residual differences in outcome are the result of differences in quality of
care, one would expect to find: deficiencies in aspects of care that promote
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survival at Hospital A; excellence in aspects of care that promote independent
survival at Hospital D; and broad similarities in care at Hospitals B, C & E.
Otherfindings
1. This study provides further evidence of the external validity of our models for the
prediction of case fatality and being alive & at home at six months. It also
confirms a previous observation that the model predicting death or dependency at
six months may be inaccurate ('over-optimistic') in patients at low and
intermediate risk.
2. The predictive power of the study models appears to be considerably greater than
that of urinary incontinence alone and is not improved by its addition. Social
deprivation appeared to be an independent predictor of death or dependency
when added to the study model and modestly improved its predictive power.
These findings require further study in a large, prospectively collected data set.
3. The methods used to adjust the stroke outcomes data currently published in
Scotland and in England & Wales are clearly inadequate. Any inferences relating
to the quality of stroke care based upon them are likely to be misleading.
246
Chapter Seven
4. Data describing the six predictive variables included in the study models, urinary
incontinence and social deprivation can be abstracted from the medical records of
virtually all patients with acute stroke.
5. In the absence of a link to central death certification data, a 'hot-pursuit' contact
with the GP is likely to identify about 80% of deaths that occur after discharge
from hospital. The addition of a rapid link to centrally held death certification
data is likely to increase this to about 99%.
6. The proportion of questionnaires in which the simple dependency question is left
blank or mis-filled is very low. However, 12% of respondents found the menu of
responses for the residence question confusing; a simple question asking whether





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 7.7 Predicted outcomes at six months after admission per hospital
Hospital Proportion predicted with each outcome at six months
Dead Dead or dependent Alive & at home
n % P % P % P
Hospital A 521 43 224.9 78 403.8 41 211.7
Hospital B 746 38 280.9 74 548.8 45 338.9
Hospital C 520 40 205.5 75 391.9 43 222.9
Hospital D 551 28 151.4 58 317.8 60 328.9
Hospital E 386 37 144.4 72 279.3 46 177.3
p = total number of cases predicted to have an outcome, calculated as the sum of the



























































































































































































































Table 7.9a The proportion of responses to the questions about dependency from
which useable outcome data could be obtained
1257 Patients with outcome data collected
To the question:" Do you need help from anybody with everyday activities?"
1201 Replied Yes or No
53 Left the question blank (one due to a printing error)
3 Gave an unintelligible response
56 Unusable responses
Of these 56 patients, 15 correctly completed the Modified Rankin Scale
Useable response to dependency questions
= 1201 +15 = 1216
= 97% of patients with outcome data collected (denominator = 1257)
= 71% of patients followed & who were alive at 6 months (d = 1717)
64 of the 66 patients who responded to special follow up gave dependency data
.-.response (as above) to mailed survey = 1152/1191 = 97%
= 1152/1717 = 67%
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Table 7.9b The proportion of responses to the questions about residence from which
useable outcome data could be obtained
1258 Patients with outcome data collected
17 No inquiry about residence made *
1240 Response to residence question as below
Response to multiple option residence question (Y = yes) Number Interpretation T
At Home With Other Hospital Residential care/
family place Nursing Home
Y - - - - 823 Home
Y Y - - - 135 Home
Y - Y - - 4 Home
Y - - Y - 1 ?
Y - - - Y 2 ?
Y Y - Y - 2 ?
Y Y - - Y 1 ?
Y - Y Y - 1 ?
_ Y _ _ _ 52 Home
- Y Y - - 1 Home
- Y Y Y Y 1 ?
_ _ Y* _ _ 25 Home
- - Y* - - 2 ?
- - Y* - - 2 Not home
- - Y Y Y 1 Not home
_ _ _ Y _ 70 Not home
- - - Y Y 1 Not home
- - - - Y 108 Not home
8 blank/ ?
confused
* Patients in both the SOP and the FOOD trial whose outcome questionnaire did not inquire about
residence. We used FOOD trial data to identify the outcome in these cases (13 followed up using
FOOD methods only; 4 both FOOD and SOP follow up sent but reply to FOOD questionnaire only).
t Home = 'at home' or "with family*; 'Not home' = 'hospital' or 'residential/nursing care'.
Interpretation of response required in cases of multiple response.
4: Where the only response was 'other place', I used the other details supplied to define home vs. not.
Useable response = 823 + 135 + 4 + 52 + 1 +25 + 2 + 1 +70 + 1 +108 = 1222
= 97% of patients with outcome data collected (denominator = 1257)
= 99% of patients in whom residence questioned (d = 1240)
= 71% of patients followed & who were alive at 6 months (d = 1717)
All 66 patients who responded special follow up gave residence data
.-. useable response by mailed survey =1156 (response 97%, 98%, 67% respectively)





























































































































































































































































































































































































































Table 7.13 Comparison of baseline characteristics between responders and non-
responders to follow up (for patients with acute stroke alive at six months)
Responder = a patient who responded to any method of follow up (n = 1257)
Characteristic Responder Non-responder Difference
% d % d PX2
Demographics
Age median (IQR) 72 (62-79) 71 (63-79) 0.762 MW
Male 51 1257 50 460 0.746
Social deprivation (by DepCat) 1247 459 <0.0005
1 to 2 11 7
3 to 5 63 54
6 to 7 26 39
Prior to stroke
Independent in ADLs 93 1252 91 460 0.093
Lived alone 36 1251 40 459 0.110
Employed 12 1252 7 460 0.005
Diabetes mellitus 13 1252 15 460 0.227
Ischaemic Heart Disease 34 1252 32 460 0.474
Previous myocardial infarction 17 1252 17 460 0.924
Admitted to 1257 460 <0.0005
Hosp. A 17 12
Hosp. B 24 38
Hosp. C 18 20
Hosp. D 25 19
Hosp. E 16 11
On admission
Normal GCS Verbal score 73 1251 60 458 <0.0005
Motor score 96 1250 91 458 <0.0005
Eye score 93 1250 88 458 0.001
Able to lift both arms against gravity 75 1250 62 459 <0.0005
Able to walk without assistance 35 1252 25 459 <0.0005
Systolic BP > 160 mmHg 40 1245 40 458 0.902
Urinary incontinence 38 1249 57 458 <0.0005
Stroke onset in hospital 2 1257 2 460 0.906




d = denominator (varies due to missing data) IQR = inter-quartile range; MW = Mann Whitney U test
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Table 7.14 The comparison of the baseline predicted risks of each outcome between
cohorts of responders, non-responders and all patients alive at six months
Proportion PREDICTED to experience Responders vs.





Dead 20 40 25 0.31
Dead or dependent 59 77 63 0.40
Alive & at home 62 44 58 0.44
n 215 56 271
Hospital B
Dead 22 30 25 0.35
Dead or dependent 59 70 63 0.24
Alive & at home 61 50 57 0.25
n 297 176 473
Hospital C
Dead 25 33 27 0.51
Dead or dependent 65 69 66 0.77
Alive & at home 55 50 54 0.70
n 232 93 325
Hospital D
Dead 17 21 17 0.73
Dead or dependent 46 50 47 0.82
Alive & at home 71 68 71 0.88
n 318 86 404
Hospital E
Dead 23 34 25 0.64
Dead or dependent 61 67 62 0.77
Alive & at home 60 51 58 0.70
n 195 49 244
OVERALL
Dead 21 31 24 0.10
Dead or dependent 57 67 60 0.16
Alive & at home 63 53 60 0.14
n 1257 460 1717
* Calculated as the sum of the individual predictions of outcome (generated for each patient
by the study models) divided by the number of patients.
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Table 7.15 Observed outcomes six months after admission per hospital
Hospital Proportion observed with each outcome at six months
Dead Dead or dependent Alive & at home
% n/d % n/d % n/d
Hospital A 48 251 / 521 89 406 / 457 40 184 / 461
Hospital B 37 273 / 746 90 504 / 560 45 253 / 564
Hospital C 38 195/520 87 367 / 420 43 183/425
Hospital D 27 147/551 66 303 / 460 58 257 / 446
Hospital E 37 142/386 84 273 / 326 49 163/333
Difference p (x2) <0.0005 <0.0005 <0.0005












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 7.18 The impact of adding stroke pathological sub-type (haemorrhage vs. not)
to the model that adjusts for all measured casemix
Outcome at six months Odds ratio of each outcome (95% CI)
Adjusted for all casemix Adjusted for all casemix
data excluding stroke data including stroke
pathological subtype pathological subtype
Death
Hosp B vs A
Hosp C vs A
Hosp D vs A















Hosp B vs A
Hosp C vs A
Hosp D vs A














Alive & at home
Hosp B vs A
Hosp C vs A
Hosp D vs A


















































































































































































































































































Figure 7.1 The identification of patients with acute non-SAH stroke
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Figure 7.2 The success of the SOP 'hot-pursuit' method of follow up in identifying
deaths at six months after admission (death certificate data used as gold standard)
* One via FOOD trial follow up, one via the Health Board & one via stroke
register at Hospital D
f After the follow up trial a reminder was sent to non-responding GPs/patients




Figure 7.3 The success of the SOP 'hot-pursuit' method of follow up in identifying
patients alive at six months after admission (death certificate data as gold standard)
10 + 1+ 8 = 19 cases (1%) of 1717 patients alive at six months by
linkage to death certificate data were dead at six months according
to SMR1/GP
Distribution: 7 cases at Hosp A, 5 cases at Hosp B, 2 cases at
Hosp C, 3 cases at Hosp D and 2 cases at Hosp E
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Figure 7.4 The success in collecting follow up data from patients who were alive at
six months after admission (according to death certificate data)
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Figure 7.5 Calibration of the prognostic models in the SOP data set
1. Case fatality at six months
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
Proportion PREDICTED dead
2. Dead or dependent at six months




3. Alive and at home at six months
1
0 ~r I 1 1 1 1 1 I 1 1 1
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
Proportion PREDICTED alive & at home
The dashed line represents the line of perfect calibration
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Figure 7.6a W scores for case fatality at six months: unadjusted; adjusted for age,
sex and social deprivation; and adjusted using the study model.
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Figure 7.6b Ws scores for death or dependency at six months: unadjusted; adjusted
for age, sex and social deprivation; and adjusted using the study model.
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Figure 7.6c W scores for alive & at home at six months: unadjusted; adjusted for age,
sex and social deprivation; and adjusted using the study model.
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Figure 7.7a Alternative methods of adjusting case fatality at six months.
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Figure 7.7b Alternative methods of adjusting death or dependency at six months.
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Figure 7.7c Alternative methods of adjusting alive & at home at six months.
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Figure 7.8 The logistic coefficients of the categories of social deprivation for death or
dependency at six months plotted against each category of social deprivation
Deprivation category
( 7 = most deprived)
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Figure 7.9a Comparison of W scores between hospitals for case fatality, adjusted
using the study model, with the cohort divided into tertiles of predicted risk.
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Figure 7.9b Comparison of Ws scores between hospitals for death or dependency,
adjusted using the study model, with the cohort divided into tertiles of predicted risk.
















-30 -25 -20 -15 -10 -5 0 5 10
Ws Score compared to Hospital A (set to zero)
291
Chapter Seven
Figure 7.9c Comparison of W scores between hospitals for alive & at home, adjusted
using the study model, with the cohort divided into tertiles of predicted risk.
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Chapter Eight. SOP results (2): Structure and process of
care and their link with outcomes after adjusting for casemix
8.1 Introduction
This chapter describes the results of the survey of the structure and process of stroke
care at each hospital and relates them to the comparisons of outcomes, adjusted for
casemix. The principal methods used to survey the structure and process of care
have already been described in section 3.6.
8.2 Allowing for legitimate variation in the process of care
Our measurements of the process of care record only whether or not an item was
provided. As such, they fail to take account of situations where the failure to provide
particular items is appropriate, for example, not holding a MDT meeting for a patient
discharged within a few days or not prescribing an anti-thrombotic drug after a
haemorrhagic stroke. Simple comparisons of these data are likely, therefore, to be
confounded by variation in casemix. I used two methods to minimise this bias.
First, I stratified the comparisons of the process of care by the predicted risk of death
at six months. Thus, I divided each hospital cohort into tertiles of predicted risk (see
section 7.2.2) approximating to mild, moderate and severe stroke in order to make
comparisons between groups with roughly similar treatment needs. I used box and
whisker plots to demonstrate the predicted 'risk profile' of the hospital cohorts in
order to gauge the success of this strategy. Second, where appropriate, I used other
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data to refine the comparisons, for example, rather than compare the proportion of
patients prescribed an anti-thrombotic drug I limited the comparison to those not
shown to have had a haemorrhagic stroke and who were discharged alive; on the
assumption that early hydration may reflect better quality of care (Indredavik et al.
1999), I limited the comparison of the use of parenteral fluids to the first 24 hours of
admission; etc.
8.3 Results
8.3.1 Thepredictedprognoses ofthe hospital cohorts within each stratum
The 'risk profiles' of the hospital cohorts within each tertile of predicted risk of death
at six months are shown in Figure 8.1. Within each box-plot the line bisecting the
box indicates the median predicted risk, the ends of the box indicate the 25th and 75th
percentile risks, and the whiskers indicate the 2.5th and 97.5th percentile risks.
Within the middle and upper tertiles the predicted prognoses of the hospital cohorts
were very similar. Within the lower tertile the predicted prognoses of the cohorts




8.3.2 Comparisons of the structure andprocess ofcare
The structures and processes of stroke care of each hospital are shown in Tables 8.1
to 8.4 and Tables 8.5 to 8.14, respectively. I have summarised the key findings
below.
Access to specialised and organised stroke care
The provision of specialised and organised stroke care varied considerably between
hospitals. The most important differences were between Hospital A and Hospitals B
to E. Hospital A did not have a physician specifically responsible for its stroke
services, did not provide any specialised rehabilitation for patients with stroke and
only 10% of its patients had the results of a MDT meeting noted in their medical
record, and only then after a median delay of 50 days. Hospitals B to E, on the other
hand, each provided organised and specialised stroke care at some point during the
study. However, access to organised services varied between these hospitals. Thus,
in comparison with Hospitals B & C, double the proportion of patients were admitted
to a SRU at Hospital E and two and a half fold more were discharged from the care
of a specialist stroke physician at Hospital D. Only Hospitals B & D provided
organised stroke care for patients not admitted to their SRU, the former by means of
a mobile stroke rehabilitation team, the latter by informal extension of the SRU care
to a nearby ward (as evidenced by the high proportion of patients who were under the
care of a specialist stroke physician and who had a MDT meeting documented
despite not being admitted to the SRU itself).
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Access to specialised care also varied in subtle ways. The SRUs at Hospitals B & C
and, for a few months, at Hospital E operated age related admission policies.
Hospital B delayed admission to its SRU for an average of two or more weeks while
the other hospitals admitted patients within a few days (hence the SRU at Hospital B
admitted proportionately fewer patients with mild stroke and its median length of
stay was longer). At Hospital C, patients deemed suitable for SRU care were
admitted very quickly but access for patients with severe stroke was relatively poor
(only a half to a third of that elsewhere). At Hospitals C & E, the SRUs opened half
and three quarters of the way through the study, respectively. Once open, access to a
SRU was in fact considerably greater than at Hospitals B & D.
Factors indicating the extent to which care truly was specialised and organised
The degree to which care was truly organised and specialised varied between
hospitals. At Hospitals B & D, organisation was well established. The specialist
stroke physicians were active members of the stroke interest and research community
and the hospitals had written protocols describing assessment and treatment
strategies, ran hospital stroke registers and provided specialist clinics for minor
stroke and TIA. At Hospital D, virtually all patients admitted to the SRU came under
the care of a specialist stroke physician and had a MDT meeting documented. The
interval between admission and the first recorded MDT meeting was shortest at
Hospital D and its SRU also stood out in terms of education of staff, for reporting the
longest MDT meetings in relation unit size, for the regular attendance of nurses at
therapy sessions and for running a carer support group throughout the study. At
Hospital B, on the other hand, only about 60% of patients admitted to the SRU came
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under the care of a specialist stroke physician or had a MDT meeting documented
and the mobile stroke rehabilitation team functioned without any regular medical
input.
At Hospitals C & E, organised stroke care developed during the study and it is likely
that staff will have taken time to become experienced in working as an effective
team. These hospitals did not have written protocols describing assessment and
treatment strategies, did not run specialist clinics for minor stroke and TLA, and both
appeared to allocate less time to their MDT meetings. At Hospital C the specialist
stroke physician was not a member of any stroke interest group and, although MDT
meetings were reported to be held regularly (according to our survey) the results
were infrequently noted in the medical record. The delay between admission and the
first recording of a MDT meeting was also much longer at Hospital C than
elsewhere. At Hospital E, only about 40% of patients admitted to the SRU came
under the care of the specialist stroke physician, the lowest proportion of any SRU,
despite the fact that Hospital E admitted the lowest number of stroke patients overall.
Also, the MDT at Hospital E did not appear to set formal rehabilitation goals and the
nursing staff appeared disengaged.
Access to diagnostic imaging
Access to CT head scanning varied considerably. Hospital A scanned by far the
smallest proportion of patients, particularly those with moderate and severe stroke,
reflecting the fact that it was the only hospital without a CT scanner. Surprisingly,
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Hospital B scanned the second lowest proportion and with the greatest delay.
Hospital D scanned the highest proportion and with the least delay. All hospitals had
access to carotid doppler ultrasound, echocardiography and video-fluoroscopy of the
ability to swallow, although at Hospital A the latter required a 30 mile transfer.
The use ofanti-thrombotic agents for secondaryprevention
The use of anti-thrombotic agents in patients discharged alive and in whom a
haemorrhage was not identified varied significantly. Their use was greatest at
Hospital D and lowest at Hospital A. The overall variation in the use of anti¬
thrombotic drugs was principally driven by different prescribing practices in patients
with severe stroke: these patients were much less likely to receive anti-thrombotic
drugs at Hospitals A,B & C than at Hospitals D & E. When patients with ischaemic
stroke only were considered the variation followed a similar but less marked pattern.
The Royal College ofPhysicians Stroke Audit Package
The median compliance with the RCPSAP criteria was highest at Hospital D,
intermediate and similar at Hospitals B, C & E and lowest at Hospital A. Hospital A
also had the lowest score and Hospital D the highest score for the individual criteria
which measured whether a swallow assessment and a clear diagnostic formulation
had been recorded within 24 hours of admission. Despite providing organised stroke
care, Hospital B also scored relatively poorly on these items.
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Non-evidence based medical interventions
The use of medical interventions without an accepted evidence base (at the time of
the SOP) varied significantly. Hospital E gave parenteral fluids on the day of
admission to the greatest proportion of patients while Hospital D gave the least.
Hospital A inserted the fewest urinary catheters into patients with moderate and
severe stroke (even in patients with severe stroke still alive after seven days i.e. those
most 'at risk'). Almost no patients were prescribed subcutaneous heparin within 48
hours of admission at Hospital A while nearly 7% were at Hospital D.
Nursing staffand the Professions Allied to Medicine
The number of nursing staff per 100 beds to which stroke patients were usually
admitted was similar across hospitals except Hospital D. Here the provision of
nurses on its SRU was considerably higher than that on SRUs elsewhere but,
surprisingly, the provision of nursing staff on its geriatric wards was considerably
lower than that on geriatric wards elsewhere.
The number of therapists per 100 beds to which stroke patients were usually admitted
varied between hospitals and especially between SRUs. The SRU at Hospital D had
a consistently high provision of physiotherapists and occupational therapists in
comparison with SRUs elsewhere while the provision of occupational therapists on
the SRUs at Hospitals B & E was comparatively low. The provision of occupational
therapists on the geriatric wards at Hospital A (where the majority of its
rehabilitation took place) was also low. It should be noted that the provision of
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therapists outside of the SRU at Hospital B is likely to have been higher than that
shown because the calculation of therapists per 100 beds included the members of its
mobile stroke team who, in reality, will have focused their activities on patients with
stroke alone.
8.3.3 Ranking ofhospitals by the overall quality ofstroke care
Hospital A
The overall quality of care appeared to be lowest at Hospital A. To summarise, it
was the only hospital which failed to provide any organised and specialised stroke
care, which had the lowest access to brain imaging, which was the least likely to
prescribe anti-thrombotic drugs for secondary prevention, which was the least likely
to record a swallow assessment or diagnostic formulation on admission and whose
medical records were, by some margin, the least complete in relation to the
RCPSAP.
Hospital D
The overall quality of care appeared to be highest at Hospital D. Specifically, it
provided the greatest access to specialist stroke physician care and recorded the
greatest proportion ofMDT meetings; it admitted the second greatest proportion of
patients to a SRU but this care was more likely to be genuinely organised and
specialised, and better staffed, than at Hospital E (which admitted the greatest
proportion to a SRU). Hospital D also provided the best access to brain imaging,
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was the most likely to prescribe anti-thrombotic drugs for secondary prevention, was
the most likely to record a swallow assessment and clear diagnostic formulation on
admission and had the most complete medical records in relation to the RCPSAP.
Hospitals B,C & E
The quality of care at Hospitals B,C & E was intermediate to that at Hospitals A & D
(although generally closer to that at Hospital D than at Hospital A) and there was no
consistent trend for one hospital to 'out perform' the others. In these respects, the
overall quality of care at Hospitals B,C & E might be considered similar. However,
there were a number of important differences. The organised service at Hospital B
was mature and catered for patients on both the general wards and the SRU whilst at
Hospitals C & E organised care was limited to the SRUs and, especially at Hospital
E, appeared less specialised. On the other hand, Hospital B was the slowest to admit
patients to a SRU, provided the worst access to brain imaging, was the least likely to
record a swallow assessment and had the least complete medical records in relation
to the RCPSAP. The capacity of the SRU at Hospital B was also much less than that
at Hospitals C & E. Hospital E gave anti-thrombotic drugs to a greater proportion
without a haemorrhagic stroke than Hospital C and parenteral fluids to a greater




8.4.1 The validity ofthe data describing the structure andprocess ofstroke care
Before considering the relationship between our data describing the structure and
process of care and the hospital outcomes it is important to consider the validity of
our data and their suitability to the task of correlating care with its outcome.
Regrettably, the data suffer from a number of shortcomings.
The validity of our data was compromised by our methods of measurement and by
our partial knowledge of what constitutes effective stroke care. Our methods of
measurement are likely to have been affected by two major biases. First, recording
bias, the possibility that the data laid down in the medical record may not properly
reflect the quality of the care that was provided. This bias is likely to be especially
relevant to the RCPSAP criteria, to our identification of MDT meetings and to our
non-evidence based items of care, such as the use of parenteral fluids, urinary
catheters, etc. Fortunately, for the other aspects of care (the type of ward, the
consultant in charge, CT scan date and result, the prescription of an anti-thrombotic
drug) any recording bias is likely to be small because the items represent
fundamental elements that are likely to be recorded in nearly all circumstances. The
potential for recording bias may also have been greater at Hospital A due to its
failure to use a stroke clerking proforma and its lack of a specialist stroke physician,
factors which are known (Davenport et al. 1995b) or seem likely to increase the
recording of key items. In defence of these shortcomings, it is arguable that in the
context of stroke care, the completeness of the medical record is not so much a bias
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but a subtle marker of quality since stroke care is most effective when delivered by
an integrated team within which excellent communication and hence detailed and
complete records are vital. There is also weak evidence from other fields of
medicine that better recording is generally associated with better quality of care
(Lyons and Payne 1974; Starfield et al. 1979; Zuckerman et al. 1975). However,
whilst there is certainly something in these arguments, they are not sufficiently
strong to negate the possibility of recording bias altogether.
The second potential reason for inaccurate measurement is observer error. As with
our casemix data, this may have occurred because our audit assistant was aware of
the hospital to which the patient was admitted and, in many cases, also their outcome
(Caplan et al. 1991b; Gjorup et al. 1986). Again this is most likely to be relevant to
the RCPSAP, MDT and non-evidence based criteria since the other criteria are less
open to interpretation; and also to Hospital A since a greater proportion of its
medical records were jumbled or incomplete (see section 7.4). Observer error, in the
form of biased reporting, may also have affected the collection of data describing the
structure of stroke care by interview, especially the more detailed items such as the
average length of MDT meetings or the attendance of nurses at therapy sessions,
since these are open to interpretation and even manipulation. However, our




Our partial knowledge of what constitutes effective stroke care limited the validity of
our structure and process data in two ways. Our limited ability to specify the
essential elements of organised care (see section 3.6 and (Dennis 2000)) meant that it
was difficult to set anything other than basic standards by which to judge
performance. Thus, our main measurements of organised care were based only upon
the proportions admitted to a SRU, the proportion with a recorded MDT meeting and
the proportion discharged from the care of a specialist stroke physician. Comparison
of these data between hospitals rests on the assumption that all SRUs, MDTs and
stroke physicians are equally effective, and clearly this is unlikely to be the case. In
mitigation, our structural survey and cross-tabulation of items allowed us to flesh out
these measurements and provided some insight into the accessibility and working
practices of each SRU. Nonetheless, our measurements remain somewhat superficial
and certainly do not tell us how well the therapeutic activities of the team members
were performed or how well they were co-ordinated toward appropriately selected
rehabilitation goals. Indeed, this point highlights a wider failing, namely our failure
to measure the very stuff of stroke care (the therapeutic activities of physicians,
nurses and therapists) wherever it was provided, whether on a SRU or an ordinary
ward. This failing was largely unavoidable. In the mid-1990s, there were almost no
evidence or consensus based criteria by which to judge the value of these activities (a
situation that, fortunately, is beginning to improve - see section 2.2) and, even if
there were, many are either not routinely recorded e.g. the amount of time spent with
a therapist; positioning and lifting techniques on the ward; effective early
mobilisation; efforts to maintain morale; etc., or are of uncertain validity when
retrospectively collected e.g. the identification and treatment of complications by
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medical staff (Davenport et al. 1996a). As a result, for the majority of patients at
each hospital (who were not admitted to a SRU) the content validity of our
measurements of the process of care is low.
The other short-comings of our structure and process data relate to their suitability to
the investigation of the relationship between the quality of care and its outcome.
Here, McAuliffe (1978) suggests that the measured items of care should be: evidence
based; emphasise therapeutic aspects (rather than just the recording of baseline data);
influence the outcomes under investigation; make allowance for legitimate variation;
and be combined in such a way that the relationship between the overall quality of
care and its outcome is measured. Our measurements do indeed emphasise the
provision of some items of care that are proven or strongly held to influence the
study outcomes and the items that are not directly therapeutic are important and are
likely to facilitate the provision of items that are. However, to varying degrees, our
data fall short of the remainder ofMcAuliffe's criteria.
The most important of these shortcomings is the already mentioned failure to directly
measure the therapeutic activities of physicians, nurses and therapists in all cases.
These activities are the very ones that have an impact on death and disability, the
outcomes under investigation. Since the majority of patients at each hospital were
not admitted to a SRU, it follows that we have failed to directly measure those
aspects of care which impact the study outcomes in the majority of patients. As a
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result, our ability to consider whether any overall differences in death or dependency
might have been caused by the observed differences in care is limited.
Our data did make allowance for legitimate variation in provision of care using time
limits and extenuating circumstances for the RCPSAP criteria (see 3.6.2) and
stratification by predicted prognosis for the other criteria. Stratification is likely to
have been moderately successful: the cohorts within each stratum had remarkably
similar prognoses and so, in broad terms, similar treatment needs. Also, our
principal criteria are largely applicable irrespective of casemix e.g. it is arguable that
nearly all patients ought to be admitted to a SRU or have a CT scan, etc. However,
neither method, but especially stratification, can have accounted for the many and
subtle factors that influence the provision of care. Furthermore, by shrinking the size
of the cohorts, stratification reduced the power of the comparisons. Hence, it
remains possible that even moderate sized differences in the provision of care
between hospitals may still reflect differences in casemix and/or the play of chance.
Lastly, I did not construct an objective composite measure (a quality index) to
quantify the overall quality of care at each hospital. I considered that the validity of
a quality index would be open to considerable doubt given its need to measure
'apples and oranges' using the same, arbitrary yardstick and its inability to account
for the inter-linked nature of stroke interventions. Instead, I provided a quasi-
objective summary of the overall quality of care, leaving the informed reader to
agree or disagree. The drawbacks to this method are its subjectivity, its imprecision
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(reducing the power to differentiate between hospitals) and the inability to formally
correlate quality of care with outcome.
In summary, our data describing the structure and processes of stroke care are not
ideal. In particular, it is possible that their validity may be lower at Hospital A than
at the other four hospitals. Our limited measurements and the format of the data also
restricts the extent to which any correlation between quality of care and its outcome
can be tested. Nonetheless, it is important to understand that many of these
shortcomings were fundamentally insurmountable because of our basic lack of
knowledge about stroke care (especially as it was in the mid 1990s) and because of
the practical impossibility of prospectively measuring the numerous and on-going
activities of routine care across several hospitals. As such, the quality of our data is,
in all probability, about the best that could have been achieved under the
circumstances of a large, retrospective and simple study and it should be borne in
mind that they still provide a reasonable description of important aspects of stroke
care. Indeed, perhaps the most important observation is that the collection of a
relatively few items describing the structure and process of care appear able to
identify a range of opportunities to improve the quality of stroke care at most if not
all hospitals. It is also notable that many of these structure and process items are
very simple and might lend themselves to routine data collection.
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8.4.2 Relationship between the quality of the structure and processes of stroke
care and its outcome, after adjustingfor casemix
The survey of structure and process of care suggests that, overall, the quality of care
for patients with stroke was lowest at Hospital A, highest at Hospital D and
intermediate at Hospitals B,C & E. It will be recalled that, after adjusting for
casemix, the hospital outcomes data mirrored this result: Hospital A had the worst
outcome (in terms of case fatality), Hospital D had the best outcome (in terms of
death or dependency) and Hospitals B,C & E had intermediate and largely
indistinguishable outcomes. On first inspection, therefore, it would appear that there
is indeed a relationship between routinely collected stroke outcomes (adjusted for
casemix) and the quality of stroke care, in turn raising the possibility that a routine
system ofmeasuring stroke outcomes, based on the methods described in this study,
might well act as a valid and practical indicator of the quality of stroke care.
However, the study findings are more complex than they first appear.
The first considerations are practical. In the real world, it is unlikely that the routine
measurement of dependency at a defined time after discharge will be attempted in the
near future. For the medium term, it is likely that routine systems will have to use
case fatality data alone or, as is currently the case in the UK, a combination of case
fatality and place of residence data (measured as destination at time of discharge) as
the key measures of outcome after stroke. Our findings suggest that, even under the
relatively ideal circumstances of the SOP, these systems are likely to be of only
limited value. Specifically, it appears that the systems might have a role in
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identifying hospitals with marked shortcomings in stroke care. Thus, Hospital A had
the highest adjusted case fatality and, by some margin, the lowest quality of stroke
care. However, the same systems would appear to be insensitive to more moderate
yet clearly important differences in care, such as the two fold variation in the
proportion admitted to a SRU or the two and a half fold variation in the proportion
cared for by a specialist stroke physician noted between Hospitals B to E. Indeed, it
is notable that, on its own, the outcome of alive & at home was insensitive to any of
the variations in the quality of care in the SOP.
These findings are important for two reasons. First, Hospitals B to E are likely to be
representative of many, perhaps even the majority, of hospitals in Scotland which
provide average to good stroke services but which have scope to improve in one or
other aspect of care. A system ofmeasuring the quality of stroke care based upon the
outcomes of case fatality and residence data would clearly fail to identify these
opportunities. Worse, by failing to flag them up, the system would run the risk of
engendering an attitude of complacency rather than one of critical self reflection i.e.
it might actually be detrimental to attempts to improve the quality of stroke care at
many hospitals. Second, our findings raise the possibility that dichotomised
residence data (institutional care vs. other) may be peculiarly unsuited to the task of
measuring the quality of stroke care. Three reasons are likely to underlie this
observation: first, the simple dichotomisation of residence data may obscure real but
subtle differences in residential outcome (see section 7.7); second, because it so often
equates to marked dependency, long term institutional care may be peculiarly
determined by initial stroke severity and relatively little by hospital care; and third,
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long-term institutional care is heavily dependent on local cultural factors (the wishes
and expectations of patient and family) and social resources (whether the patient
lived alone before the stroke, the size and layout of their house, the availability of
community support, etc.) over which the hospital has no control (Brosseau et al.
1996; McKenna et al. 2002). Rudd et al (2001a) noted similar difficulties when
trying to interpret variations between UK regions in the proportions of patients
discharged to institutional care, the considerable differences not being explicable in
terms of pre-stroke accommodation or disability, age, gender, length of stay (a proxy
for stroke severity), the type of unit in which the majority of the stay took place or
disability at discharge. Taken together, these observations underline the need for
great caution when interpreting comparisons of rates of institutionalisation between
hospitals, the need for further study of the reasons for the residual variation and even
the need to reconsider the routine publication of this outcome.
In time, however, it may become possible to routinely measure dependency after
stroke and so to report the combined outcome of 'death or dependency', the most
clinically relevant outcome measured by the SOP. As a more rounded measure of
outcome, one might expect death or dependency to act as a more sensitive indicator
of the quality of stroke care. Somewhat surprisingly, this was not the case in the
SOP. Using it, we were able to identify that Hospital D had the best quality of care
but entirely failed to identify that Hospital A had the worst. The indications of
quality of care based on death or dependency were also quite different to the
indications based on case fatality data. Indeed, the correct identification of the
hospitals with the best, intermediate and worst qualify of quality of care was only
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possible when both case fatality and 'death or dependency' were reported. The
finding of non-uniform performance across different measures of outcome has been
noted previously in other fields of medicine (Hartz.A.J. and Kuhn 1994; Iezzoni et
al. 1994; Silber et al. 1995; Silber and Rosenbaum 1997). The suggested
explanation for the phenomenon is that different outcomes are influenced by
different aspects of care, the quality of which may vary within a given hospital. For
stroke, it is arguable that case fatality is primarily influenced by the quality of
management in the first few weeks (the majority of deaths after stroke occur within
30 days), in particular the prevention and treatment of the complications of
immobility and cardiovascular disease; and that dependency is strongly influenced
by the quality of the rehabilitation services (Stroke Unit Trialists' Collaboration
1997b). Following this logic, it is perhaps not a surprise that the optimum
measurement of the quality of stroke care using outcomes seems to require the
measurement of case fatality and functional dependency.
However, before we adopt adjusted case fatality and death or dependency data as
legitimate indicators of the quality of stroke care, two other aspects of our findings
merit consideration. First, it is important to note that we have studied only a small
number of hospitals and so have provided only one example where each outcome
correctly identified a hospital with better or worse stroke care. Our findings
therefore do not tell us anything about the accuracy (the sensitivity and specificity)
with which the proposed system of outcome measurement would be able to
differentiate hospitals with exceptionally good or bad care from those with
acceptable standards of care. As noted (see section 1.5.4), unless sensitivity and
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specificity are high, the system would be of limited value and would also be harmful
in terms of wasted resources and needlessly dented reputations. Regrettably, because
a proper determination of sensitivity and specificity will require the study of tens of
hospitals, for reasons of cost, it is uncertain that it will ever take place.
Second, it is also important that we reconsider the credibility of our findings; in
particular, to question whether the residual differences in outcome can plausibly have
resulted from the observed differences in care. If this were the case, two hypotheses
follow. At Hospital A one should find deficiencies in the initial management of
stroke relative to Hospitals B to E but rehabilitation of about equal quality to that at
Hospitals B,C & E; and at Hospital D one should find initial management of equal
quality to that at Hospitals B,C & E but rehabilitation of a much higher quality. As
noted, the relative crudeness of our structure and process of care data limits our
ability to explore these hypotheses. Nonetheless, various lines of evidence can be
followed.
First, one may consider whether the differences in outcome might have been caused
by the measured differences in the provision of organised rehabilitation, by far the
most efficacious intervention for stroke that was routinely available in the mid 1990s.
To illustrate this, consider Hospitals A & D. In comparison to conventional care, it
is estimated that 22 patients (95% CI 10 to oo) need to be treated on a SRU to prevent
one death and 16 (95% CI 10 to 25) to prevent one case of death or dependency
(Stroke Unit Trialists' Collaboration. 1997a). Since Hospital D admitted 154 patients
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to a SRU and Hospital A none, it is reasonable to assume that this difference led to
about seven fewer deaths and ten fewer cases of death or dependency at Hospital D,
equating to 1.3 fewer deaths and 1.8 fewer cases of death or dependency per 100
admissions. After adjusting for casemix, there were in fact 5.6 fewer deaths and 11.3
fewer cases of death or dependency per 100 admissions at Hospital D i.e. the
measured difference in SRU care is likely to explain only a fraction of the residual
difference in each outcome between the two hospitals. Even if one assumes that
equally good organised care was extended to all 292 patients with a recorded MDT at
Hospital D, this would still have led to only 2.4 fewer deaths and 3.3 fewer cases of
death or dependency per 100 admissions i.e. it would still explain only about half of
the residual difference in case fatality and about a quarter of the residual difference
in death or dependency. Given that the differences in the provision of organised care
between the remaining hospitals were of a similar size or smaller, it is even less
likely that they can explain their equally large residual differences in case fatality or
death or dependency.
Thus, if they are the result of differences in the quality of care, the majority of the
residual differences in outcome must be due to differences in therapeutic aspects of
care that we did not measure. This possibility can only be examined by inference.
Three observations support the hypothesis at Hospital A i.e. that Hospital A provided
the worst initial management of stroke but rehabilitation of a similar quality to that at
Hospitals B,C & E. First, Hospital A had the worst performance in terms of several
mainly non-therapeutic markers of initial management (the completeness of the
initial history and examination, the recording of a swallow assessment, the recoding
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of a clear diagnostic formulation and the provision of CT head scan); second, the
higher adjusted case fatality at Hospital A was mainly the result of higher case
fatality in patients with severe stroke i.e. just those in whom shortcomings in the
prevention and treatment of complications and cardiovascular disease would be most
likely to lead to death; and third, the split nature of Hospital A provides a plausible
mechanism. All patients at Hospital A were admitted to the main hospital but only
transferred to the affiliated hospitals if they required on-going rehabilitation. It is
possible that the main hospital may have provided poor initial care whilst the
affiliated hospitals, each with a specialist geriatric rehabilitation ward, may have
provided rehabilitation of a similar quality to that at Hospitals B,C & E. There are
some inconsistencies with these lines of reasoning, in particular, Hospital A was not
deficient in some markers of initial management and there was little documented
evidence of co-ordinated team working on the geriatric rehabilitation units.
Nonetheless, a plausible argument can be made that the outcomes at Hospital A
might have been caused its methods of care.
The situation in relation to Hospital D is somewhat different. To explain its
outcomes, it should have provided initial care of equal quality to Hospitals B,C & E
but rehabilitation of a much higher standard. The structure of stroke care at Hospital
D suggests a possible mechanism. Here, the majority of patients were admitted to
the general wards (where initial care may have been of 'average' quality) but about
half subsequently came under the care of the specialist stroke physician (who may
have focused excellent organised rehabilitation services on those most likely to
benefit). However, this argument is difficult to sustain. First, some of our
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measurements of initial management at Hospital D suggest that it was, in fact,
somewhat better than that at Hospitals B,C & E. Thus, Hospital D had the greatest
proportion with a recorded swallow assessment and diagnostic formulation, the
greatest and fastest access to CT head scanning, the least use of indwelling urinary
catheters and the greatest proportion prescribed subcutaneous heparin (reflecting
greatest involvement in the International Stroke Trial (International Stroke Trial
Collaborative Group 1997a)). Second, only a small proportion of the lower adjusted
death or dependency at Hospital D is explicable by its differential provision of
organised stroke care (see above). Thus, the great majority of its lower level of
dependency must have arisen from superior rehabilitation provided to patients who
remained on the general wards, who were not under the care of the stroke physician
and who, in the same setting, apparently received initial care of only average quality.
This is difficult to believe. Third, and most important, the residual differences in
death or dependency between Hospital D and Hospitals B,C & E were very large and
occurred overwhelmingly in patients with the least severe stroke (see section 7.6.6),
which is to say, in patients at relatively low risk of being dead or dependent at six
months regardless of intervention. Hence, it is hard to conceive that any differences
in care can have caused the large differences in dependency that were found. Thus, it
is difficult to argue that that the outcomes at Hospital D are likely to have resulted
from its methods of care.
The final consideration is the quality of the data describing structure, process and
outcome on which all these deliberations are based. As detailed in chapter seven and
here, they clearly suffer from a host of actual and potential shortcomings which,
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together, might plausibly explain much or even all of the observed associations
between better adjusted outcome and better quality of care. In particular, rather than
worse quality of care, a reasonable alternative explanation of the higher adjusted case
fatality at Hospital A may simply be systematic underestimation of baseline risk
together with the play of chance. Similarly, the finding that Hospital A had the
'worst' quality of care may also, in part, reflect biased measurement. Given the
difficulty in ascribing the very much lower level of death or dependency at Hospital
D to better care, a plausible alternative explanation may simply be inadequate
adjustment for the very much more favourable baseline characteristics of its patients.
Thus, the findings of our investigation into the relationship between routinely
collected and adjusted outcomes and the quality of stroke care are complex and
somewhat inconclusive. In many respects, our findings appear to support the use of
case fatality and death or dependency data as valid indicators of the quality of stroke
care. However, this optimistic conclusion should be treated cautiously. The
sensitivity and specificity of the method has obviously not been established and
detailed consideration of our findings casts a degree of doubt on the causal nature of
the observed associations between better adjusted outcome and better quality of care.
Even if our findings are valid, in the absence of dependency data, a routine system of
quality measurement based on case fatality and institutionalisation (i.e. an enhanced
version of systems currently in place in the UK) might only be sensitive to the most
marked deficiencies in care; indeed, it appears that institutionalisation data may be
altogether unsuited to the routine measurement of the quality of stroke care. To all
this can be added the observation that even the most sensitive outcome-based system
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(the combination of case fatality and death or dependency data) failed to identify the
important differences in quality of care between Hospitals B,C & E, the potential
shortcomings at Hospital D (in terms of the prescription of parenteral fluids and the
provision of nursing staff on its geriatric wards) or the apparently excellent aspects of
initial management at Hospital A.
In summary, a key purpose of the SOP was to investigate the utility of an idealised
yet routinely feasible outcomes-based system ofmeasuring the quality of stroke care.
In answer to this question, our findings suggest that, if ever implemented in full, our
methods might indeed be useful in identifying hospitals with outlying standards of
care but that if only partially implemented (i.e. if only case fatality and residence
data are collected) the system might only be useful in identifying hospitals with
marked shortcomings in care. Both systems, but especially the latter, will
undoubtedly fail to identify important opportunities to improve the quality of stroke
care at many, perhaps most, hospitals with seemingly average outcomes. These
uncertain and somewhat disappointing conclusions derive from a method of
measuring and comparing outcomes far superior to that which is currently in use in
the UK. Given this state of affairs, one must ask oneself whether there is not a more
certain and useful way that we can measure the quality of hospital stroke care. This




1. Important aspects of the structure and process of stroke care varied substantially
between the five study hospitals. Overall, the quality of stroke services appeared
highest at Hospital D, intermediate at Hospitals B,C&E and lowest at Hospital A.
2. This ranking matched the ranking based upon the combined outcomes of case
fatality and death or dependency at six months, adjusted for casemix, suggesting
that our system for measuring outcome might provide a valid method by which to
routinely identify hospitals with particularly high or low quality of care.
3. A partial system that reported only case fatality at six months, adjusted for
casemix using our methods, would be less sensitive but might have a limited role
in identifying hospitals with very marked shortcomings in stroke care.
4. Despite its apparent face validity, institutionalisation appears to be an insensitive
indicator of quality of stroke care. Routine comparisons of institutionalisation




5. All these conclusions must remain tentative because of the small number of
hospitals studied and the potential continuing impact of biased measurement,
variation in casemix and the play of chance. The findings of the SOP should be
regarded only as possibilities that merit further investigation.
6. Even our 'ideal' system would fail to identify moderate but potentially important
opportunities to improve the quality of care at many if not most hospitals.
7. Simple structure and process data clearly provide a rich source of information
with which to understand and plan improvements in stroke care. However, their
interpretation is also problematic, in particular because of our still limited library
of robust evidence linking structures and processes to outcome, the difficulty in
generalising the efficacy data that we have, and our reliance on information
































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 8.1 Comparison of the median predicted probability of death by six months
(with inter-quartile range & 2.5th & 97.5 h percentiles) between hospitals per tertile of
predicted risk
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174 263 189 148 134
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In this thesis, I have attempted to address two questions regarding the use of
outcomes data to measure the quality of stroke care. The first question was practical
and asked whether it is feasible to considerably improve the systems currently used
to collect outcome data for stroke in Scotland. The findings of this thesis suggest
that this may indeed be the case, although a number of caveats still apply.
In Chapter Four, I showed that the strategy of selecting subsets of cerebrovascular
disease codes in order to routinely identify cohorts of patients with acute stroke,
whilst reasonably accurate at many hospitals, may result in seriously misleading
comparisons of case fatality (in terms of attempts to measure the quality of care) at
others. To improve the accuracy of routine case identification it is clear that the root
cause of the problem, namely the poor quality of diagnostic information in discharge
documentation, has to be addressed. This will require education of physicians, their
involvement in coding and the provision of adequate time and resources. It might be
argued that the strength of the commitment of the NHS to the collection of high
quality clinical information might be measured by the extent to which these rather
old suggestions are implemented. However, and perhaps fortunately, it is also clear
that an important secondary benefit of a decision to collect our casemix variables is
that they would effectively label the patient as having had an acute stroke. Hence,




In Chapter Five, I showed that our casemix variables were very reliable when
measured prospectively, reasonably reliable and valid when measured
retrospectively, just as accurate as urinary incontinence and conscious level, and that
minor changes in their presentation might lead their collection to be more accurate
still. Thus, it seems our casemix variables may indeed be suited to routine collection.
However, I did not establish this directly (I did not measure the reliability and
validity of the variables under truly routine conditions and in all grades of stroke)
and ideally this should be done. Nonetheless, given their simplicity and the
encouraging findings of the studies that were performed, it seems unlikely that their
collection by junior doctors would be seriously in error.
In order to make the routine reporting of our casemix variables a reality, clinicians
would first have to be persuaded to engage in their systematic collection. To do so,
the task would have to be made simple and appear relevant (Kendrick 2001). The
provision of a means of recording the variables as part of the usual process of care,
for example on a stroke clerking proforma, would ensure that data collection was
straightforward (Kendrick 2001). The relevance of the exercise would hopefully be
obvious. Unlike the current system in Scotland which clinicians view as remote and
of dubious value, our proposed system is grounded in rigorous clinical research and
is capable of delivering credible comparisons of outcome. As such, it is likely that
its very existence would tap into the natural enthusiasm of clinicians to participate in
activities that allow them to better understand and improve their practice (Kendrick
2001). However, for clinicians not won over by this argument, it is also the case that
data collection could be mandated as part of clinical governance.
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In Chapters Four, Six and Seven, I showed that SMR1 data in their current format
can be used to construct a system of postal follow up for survivors of stroke that
would be practically feasible. Although feasible, it was also clear that the overall
level of response would be poor after a single contact, only moderate after a second,
and that the level of response would vary between hospitals. Despite this, and rather
interestingly, bias in the comparison of functional outcome between several hospitals
in the SOP remained small, especially if a second follow up was sent. However,
between other hospitals, perhaps the minority, it is likely that bias would remain
large enough to mislead efforts to measure the quality of stroke care. Fortunately,
should the routine collection of functional outcome ever be attempted, it is likely that
other strategies would reduce the impact of non-response to a more acceptable level:
first, response might be improved by the perhaps obvious expedient of routinely
reporting the full address to which the patient was discharged on the SMR1 and also
by changes in the design of the contact letters and questionnaires; and second,
adjustment for important casemix (using our methods) would itself attenuate the
impact of non-response, although the extent of this 'protection' might vary between
hospitals. This conclusion requires confirmation by further study.
In the SOP, the efficient operation of the system of follow up required only the
services of a small number of part-time staff. One might argue, therefore, that a
relatively small but dedicated unit might be able to do the same for the roughly 7,000
stroke survivors discharged from hospital every year in Scotland (Clinical Outcomes
Working Group 1999b). Indeed, one might envisage an official centre having the
ability to automatically link to other centrally held databases to identify up-dated
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survival, GP and patient address data, which would greatly facilitate the entire
process. Alternatively, modification of the SMR1, now an entirely electronic
document, to report the address to which the patient was discharged should also be
simple. In reality, however, the cost of establishing and running a routine system of
postal follow up at a national level, coupled perhaps with its very novelty, seems
likely to prevent its implementation in the near future.
The second question addressed asked whether our improved system of outcome
measurement would be able to act as a valid indicator of the quality of stroke care.
My findings in Chapters Seven and Eight raised the possibility that should our full
system ever be implemented (one reporting case fatality and death or dependency)
the resulting outcomes data might indeed have a role in identifying hospitals with
moderately large differences in the quality of care and hence the system might have a
role as a useful 'quality safety net'. On the other hand, should only our partial
system be implemented (i.e. one which reported case fatality alone) it appears that it
would have a more limited role, able to identify some hospitals with very marked
shortcomings in care but would be insensitive to quite large differences in care
between others. The additional reporting of institutionalisation after stroke (as a
proxy for functional outcome) would not appear to rectify this situation. The
explanation for this finding is likely to relate to the peculiar sensitivity of
institutionalisation to baseline stroke severity and to social and cultural factors
outside of hospital control, in addition, perhaps, to the crudeness of dichotomised
residence data. Regardless, it is clear that differences between hospitals in rates of
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institutionalisation should be interpreted with particular caution and their routine
publication, at least as a quality indicator, perhaps reconsidered.
However, because of the small number of hospitals studied and the likely continuing
influence of bias, confounding and the play chance, all the foregoing conclusions
must remain tentative. Indeed, it is important to recall that virtually no other studies
which have examined the relationship between outcome and the quality of stroke
care using the hospital as the unit of analysis have reached similarly positive
conclusions (see section 2.4). This observation alone raises the possibility that my
findings may be spurious. On the other hand, it is also the case that the SOP was in
many ways methodologically superior to previous studies: the SOP studied a larger
number of hospitals and patients than the negative studies which also collected
detailed casemix and process of care data; and the SOP made considerably more
detailed measurements of casemix, outcome and the structure and process of care
than the negative studies which included larger numbers of hospitals. On balance,
therefore, it would seem prudent to regard the positive findings of the SOP simply as
interesting possibilities that merit further investigation. To establish the true ability
of our systems to indicate the quality of stroke care will require a much larger study
involving tens of hospitals, able to determine their sensitivity and positive predictive
value. As noted, it seems far from certain that this will ever be carried out.
In the absence of a definitive study, and assuming that my findings are true, it is still
possible to make some predictions as to the likely accuracy and usefulness of our
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improved systems (Davies and Crombie 1997; Mannion and Davies 2002; Palmer
1997). Unfortunately, it seems that their utility would be limited:
. Even if our full system were implemented, it is inevitable that it would
misclassify a proportion of hospitals. If simulation studies are to be believed,
despite making powerful adjustment for casemix, it is likely that the sensitivity
and positive predictive value of the system would actually be quite low. As
noted, even with perfect casemix adjustment and sample sizes as large as 900,
sensitivity might reach only 68% and positive predictive value only 32% (see
section 1.6.3) The very considerable problems associated with false positive and
false negative identification of hospitals as 'quality outliers' have already been
discussed (see section 1.6.4). These problems would be even greater should only
our partial system be implemented.
Because of the need to provide reasonably confident comparisons of outcome,
the system would be able to report on the quality of care only every few years i.e.
the relevance of its findings to current practice would be reduced. The use of a
rolling period of observation (say, the previous three years) might allow the
production of annual reports but clearly this would only be a partial solution.
. Although the system might identify the existence of a quality problem, it would
not identify the remedy i.e. the system would be a prelude to further investigation
rather than to action to improve the quality of care.
. No matter how accurate they eventually turn out to be, our improved systems
would remain limited to the identification of "bad apples". For the great bulk of
hospitals all the effort put in to the collection of data would fail to provide certain
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information with which to act to improve the quality of stroke care. Indeed, as I
showed in Chapter Eight, the systems would undoubtedly obscure moderate but
important opportunities to do so at many (perhaps all) hospitals.
The last point underlines how even our improved systems would be out of step with
emerging practice in quality improvement. The contemporary philosophy is moving
away from the notion of dividing hospitals into those that pass or fail in relation to
some quality standard and then applying remedial action in the group that fails
(Laffel and Blumenthal 1989). Instead, borrowing from industrial quality science, it
is now recognised that improvement is necessary at all hospitals regardless of their
baseline level of performance; that the knowledge for this improvement comes from
a detailed understanding of the complex systems involved in the provision of health
care; and that in overall terms greater benefit results from incremental improvements
in the quality of care at the majority of hospitals rather than revolution at the few i.e.
by moving the mean of the bell curve of the performance distribution rather than by
dealing with the minority in its tails (Berwick et al. 1992a; Davies and Lampel 1998;
Laffel and Blumenthal 1989). Clearly, even perfectly accurate outcomes data cannot
properly address this agenda.
Of course, a range of improvements could be tried in an attempt to make our
proposed systems more accurate still. In particular, drawing from my findings and
the current literature, the following methods should be explored:
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. More refined measures of functional outcome might be used. In Chapter Six I
showed that the MRS should probably be used in preference to the simple
dependency question and suggested that the practicality of using even more
sensitive measures of functional outcome and methods of comparison in the
routine setting should be investigated.
Adjustment for casemix might be improved by the addition of other (routinely
collectable) variables. In particular, the addition of social deprivation to the
model predicting death or dependency should be investigated further (Chapter
Seven). The addition of urinary incontinence also merits further investigation,
although my findings suggest that it is unlikely to be helpful (Chapter Seven).
. More fundamentally, instead of using a traditional method of regression,
adjustment for casemix using a multilevel model (a method which recognises that
elements within a system are often linked in a hierarchical fashion, e.g. patient,
unit, hospital, society, each giving rise to variation that contributes to the whole)
might allow the variation in outcome that is attributable to the hospital to be
better teased out (Anonymous 2000).
By allowing for a prior hypothesis about the performance of hospitals (perhaps
based on their outcomes to date (Langford 1997)) a Bayesian approach to
accounting for the play of chance might allow for more confident comparisons of
outcome (and hence better discrimination between hospitals) than is possible
using a frequentist approach (Bland and Altman 1998). The two methods
certainly lead to quite different impressions of the quality of care, although which
is the more valid remains to be determined (Austin and Naylor 2001).
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• The use of control charts might allow for more easily interpreted comparisons of
adjusted outcome (Mohammed et al. 2001). A control chart plots the mean
number of adjusted outcomes against the number of patients treated (to form an
upward sloping line) and then adds two further lines (control lines) usually three
standard deviations above and below. The hospital outcomes are then marked
and, for hospitals with outcomes outside of a control line a 'special cause' is
suggested and further investigation indicated. The benefit of the method,
therefore, would appear to lie in its ability to dispense with a morass of
confidence intervals and to draw attention to variation that is highly unlikely
(<0.3% likelihood) to be due to chance.
Nonetheless, it cannot be over-emphasised that no matter how well these
improvements might increase the confidence with which differences in outcome can
be attributed to differences in care, they cannot overcome the fundamental
limitations of an outcomes-based system, namely, its failure to inform about quality
of care at the majority of hospitals, its reduced relevance to current practice and its
inability to identify necessary remedial action. Thus, there is good reason to believe
that despite the effort and expenditure, the return in terms of valid identification of
opportunities to improve care may not be worthwhile. Furthermore, it is notable that
a system based on outcomes would also be relatively easy to subvert. For example,
performance might be 'improved' by assigning stroke as a secondary diagnosis on
the SMR1 for patients who die, ensuring that they do not appear in any audit; by
assigning patients with TLA a stroke code, thereby improving the prognosis of the
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measured cohort; and by systematically reporting casemix worse than is truly the
case, improving outcome in relation to that predicted (Dennis 2000).
A system based upon the routine measurement of the structure and process of stroke
care might answer many of the criticisms of an outcomes-based system. Almost by
definition, it would be widely applicable. As I showed in Chapter Eight, each
hospital in the SOP had shortcomings in one or more aspect of care that represented
an opportunity to improve their stroke service. A system that measured structure and
particularly process of care would have a number of other advantages (Crombie and
Davies 1998; Mant 2001;Palmer 1997). In comparison to outcomes data, these data
would be:
. More easily measured. Consider, for example, the difficulty in measuring
functional outcome after stroke in comparison to the ease with which the medical
record or SMR1 can identify whether and for how long a patient was admitted to
a stroke rehabilitation unit.
More easily interpreted. Causal ambiguity permeates the use of outcomes data.
Process data, on the other hand, more directly reflect the care that was provided
and are much less influenced by variation in casemix and hence the question of
attribution is clear. Also, provided the worth of the process has been established,
data can be interpreted in relation to the research evidence, avoiding the need to
make comparisons between hospitals.
More sensitive. Large numbers of observations are needed to overcome the play
of chance in order to reveal differences in outcome that can be confidently
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attributed to differences in care. Much smaller sample sizes are required for
comparisons of the process of care. For example, it has been calculated that to
confidently draw attention to a 31% difference in the use of effective
interventions after myocardial infarction requires the measurement of outcome in
1350 patients at each hospital but the measurement of the process of care in only
27 (Mant and Hicks 1995). Process data therefore provide much more timely
measurements of the quality of care.
An indicator for action. Measurement of process often suggests the actions
needed to improve care. For example, the observation that, say, only 60% of
patients with an ischaemic stroke were discharged on aspirin would immediately
direct attention to an investigation ofwhy this were so.
It is also suggested that process data provide the only means to monitor and prevent
'near misses' (potentially serious deficiencies in care that uncommonly lead to
serious adverse outcomes), to learn from otherwise overlooked outcomes (e.g. the
death of a patient with an elderly patient with a severe stroke may still have been
contributed to by poor quality of care) and to study unnecessary resource use
(Crombie and Davies 1998).
These considerable benefits have not been lost on the stroke community in the UK
who, since the early 1990s, have focused their efforts to measure quality of care on
this approach (see section 2.3). As noted, the RCPSAP represented the first attempt
to develop a comprehensive instrument to measure the quality of stroke care in the
UK (Gompertz et al. 1994a). Its later incarnation, the Intercollegiate Stroke Audit
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Package (ISAP), was developed in tandem with an authoritative set of clinical
guidelines and incorporated sections devoted to the structure of care and the
activities of therapists and nurses (Gompertz et al. 2001; Rudd et al. 2001b).
Similarly sophisticated tools for measuring the structure and process of stroke care
have recently been developed in the USA (Holloway et al. 2001; LaClair et al. 2001)
and a more limited instrument has been tested in Holland (van Straten et al. 1997).
The practicality and power of the approach has been shown by a series of national
audits using the ISAP in England, Wales and Northern Ireland over the period 1998
to 2001 (Rudd et al. 1999; Rudd et al. 2001b; Rudd and Pearson 2002). Despite
participation being voluntary and without administrative support, over 95% of acute
trusts that admitted stroke patients took part in the most recent survey. Data were
collected locally (from the medical records of 40 consecutive patients), collated and
analysed centrally, and the results fed back within three months. The reports were
confidential but allowed for anonymous comparison with other hospitals and were
combined with regional meetings to discuss the findings and promote action. This
relatively simple, timely, inclusive and non-threatening approach coincided with, and
is likely to have been partly responsible for, considerable improvements in the
quality of stroke care. A further national audit is planned for 2004 and it seems that
the method may become the routine tool for quality assessment in England, Wales
and Northern Ireland (Rudd and Pearson 2002).
However, there are important shortcomings to a purely structure and process based
approach to measuring the quality of stroke care which were examined in Chapter
Eight in relation to the quality of our own data. To recap, the difficulties essentially
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stem from our still limited (although undoubtedly expanding) knowledge of what
constitutes effective stroke care and the fact that most interventions that we know or
suspect are effective are not recorded in a manner that describes what was done or
with how much skill, and yet, for practical reasons, the measurement of the process
of care must still be based upon routinely recorded data. As a result, much ofwhat is
measured refers to the completeness of record keeping in relation to non-therapeutic
aspects of care and/or to aspects of care whose link with outcome may not be
grounded in hard evidence; and, even where there is hard evidence of effectiveness
(in particular in relation to the provision of formally organised stroke care) because
of the difficulties of definition and measurement, one cannot be certain that the
measured items are equally effective across different clinical settings and hence the
meaning of comparisons is unclear.
To these fundamental problems can be added the fact that the collection of process
data is time consuming - it is estimated that to audit 40 sets of medical records using
the ISAP takes 20 hours (Rudd et al. 2001b) - and may be prone to observer error.
Indeed, when self assessed, the potential for observer error might relatively easily
translate into fraud, either through the simple expedient of relabelling current
practice (such that an ordinary ward round becomes a MDT meeting and an ordinary
ward becomes a stroke unit) or cheating in the completion of audit forms (Dennis
2000). Structure and process criteria are also prescriptive and so run the risk of
stifling clinical innovation and, by reflecting current practice, have the potential to
become obsolete (Mannion and Davies 2002). With our current knowledge base and
methods, therefore, it would seem prudent to interpret differences in structure and
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process of stroke care with some caution (Davenport and Dennis 1996). Indeed,
given these facts and together with the finding that hospital level analyses have until
now failed to associate better process scores with better outcomes, some observers
have suggested that outcomes should remain the prime measure of quality until we
better understand the process of care (McNaughton et al. 2003), which, of course,
brings us back to where we started from.
Thus, stroke medicine finds itself in the difficult situation that neither a system based
solely upon outcomes nor one based solely upon the structure and process of care can
provide a completely valid and practical way to measure the quality of hospital
stroke services. The practical solution to this dilemma would appear to lie in the
observation that the advantages and drawbacks of each method are, in many respects,
complimentary (Mannion and Davies 2002). The real challenge would therefore
appear to lie in the creation of a system capable of measuring structure, process and
outcome. A system such as this would almost certainly be more effective and
acceptable. Consider, if both sets ofmeasurement were to agree about the quality of
care, it would be more difficult to dispute the findings and any suggested
improvements would be more likely to be pushed through (Donabedian 1988); and, if
the two methods were to disagree, attention would be directed to the possibility of
inadequate or manipulated measurement (Donabedian 1988), helping to guard




Just such a system, known as "Riks-Stroke", has been in operation in Sweden since
1994 (Asplund et al. 2003). Data collection is kept simple to ease participation and
includes clinically important baseline characteristics, key items of care and outcome
at discharge and at three months (survival, functional status and residence).
Hospitals receive confidential annual reports in which their results are compared with
national data and suggestions made as to how to improve their service. The public
are able to access the data but only at a county level i.e. aggregated across two or
more hospitals. Participation is voluntary and the centre is in regular contact with
hospitals, establishing and refining the areas ofmeasurement. A drawback is that not
all patients at each hospital are registered on Riks-Stroke, opening up the possibility
of biased comparisons. Nonetheless, Riks-Stroke has coincided with and is likely to
have contributed to clear improvements in stroke services in Sweden over the last ten
years, particularly in the area of stroke unit provision. A comparable regionally
based system has operated in Germany since 1994 (Heuschmann et al. 2003). More
recently, national stroke registries capable of collecting structure, process and
outcome data have been established in Austria (Steiner et al. 2003) and Poland
(Czlonkowska et al. 2003) and, in the USA, a prototype system, the Paul Coverdell
National Acute Stroke Registry (Wattigney et al. 2003), is under development.
The situation in Scotland has also moved on from that in the early 1990s when the
SOP was first designed. Following the reorganisation of the NHS in 1997 and the
report of the Coronary Heart Disease and Stroke Task Force in 2001 (Anonymous
2001), an integrated approach to tackling Scotland's heavy burden of cardio- and
cerebrovascular disease is being developed (Anonymous 2002). The establishment
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of a credible and effective national system to routinely measure and improve the
quality of stroke care forms a central plank of this strategy. In line with this, the
official emphasis on the value of outcomes data has been replaced with plans to
create a system capable of routinely measuring the structure, process and outcome of
stroke care. It is gratifying that the methods and findings of the SOP have made an
important contribution to the development of this approach.
The foundation of the proposed system is a set of rigorously developed national
standards and review criteria, based on the Cochrane database of systematic reviews
and Scottish Intercollegiate Guidelines Network documents relating to the
management of stroke (Anonymous 2003b). For each patient, hospitals will be
required to collect a data set comprising simple aspects of the process of stroke care
(including: whether the patient was admitted to a stroke unit, was under the care of a
stroke physician, had a CT head scan or was discharged on an anti-thrombotic drug)
and casemix data including the pathological sub-type of the stroke and the six
variables used to adjust comparisons of outcome in the SOP. Appropriate computer
software will be provided but the means of entering the data will remain the
responsibility of each hospital. The data will be reported to the centre periodically,
linked to centrally held death certification data, and comparative data made public. A
study to test the feasibility of routinely collecting the proposed minimum data set is
under way. In addition, selected aspects of the structure and process of care will be
audited periodically in greater detail using a method similar to, but briefer than, the
ISAP. Currently there are no plans to measure functional outcome and residence at a
defined time after admission, although interestingly, the national strategy for stroke
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mandates the follow up of all survivors at 3 months (Anonymous 2003b). This
would appear to be an ideal opportunity to get around the whole issue of postal
follow up and, instead, provide a questionnaire inquiring into functional outcome as
part of the usual process of care, perhaps with arrangements for its return to a central
authority by post to avoid the possibility ofbiased response.
Thus, having begun this thesis as a response to Scotland's brave but in some senses
misguided attempt to routinely measure the quality of stroke care using a crude
system of outcome measurement, I end it with Scotland on the verge of acquiring a
sophisticated system capable ofmeasuring all three elements of the structure, process
and outcome triad. Indeed, by forcing the issue of quality of care to be debated and
researched, this remarkable change may be the greatest legacy of the decision to
publish the CRAG Outcome Indicators (Mannion and Davies 2002). Nonetheless,
the development of a comprehensive and credible system of measurement is only
part of the story. Long experience suggests that the use ofmeasurement data to bring
about real improvements in the quality of care depends also upon the environment
into which those data are released. Their effective use requires both the creation of a
learning culture where failure can be openly discussed and the establishment of
systems within hospitals capable of responding in a constructive manner (Mannion
and Davies 2002; Mannion and Goddard 2003). A key element in establishing a
learning culture is the perception that the system for measuring performance is used
for understanding rather than judging the activities of clinicians (Thomson et al.
1997). For the system proposed in Scotland, the close co-operation of clinicians in
its development and their active involvement in data collection should help ensure a
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feeling of ownership rather than oversight. However, as a centrally orchestrated and
published system, care will have to be taken to prevent it from appearing to 'name
and shame' under-performing units. Indeed, the question of routine publication of its
findings may need to be revisited. Within hospitals, a number of inter-linked
strategies will have to be developed to disseminate results to front line staff and to
support the implementation of change. The latter might involve education of
clinicians and other users, fostering networks of interested professionals to encourage
the exchange of ideas, identification of clinicians to champion the data and to
provide a clear direction for change, the provision of appropriate incentives (in
particular those related to peer status and professional reputation), and perhaps even
assistance in adopting some of the successful techniques of industrial quality science
(Berwick et al. 1992a; Berwick et al. 1992b; Berwick 1996; Davies and Lampel
1998; Laffel and Blumenthal 1989; Mannion and Davies 2002; Mannion and
Goddard 2003). The decision to create a series ofmanaged care networks for stroke
in Scotland and for those networks to talk to one another is a welcome step in this
direction. However, in order to make best use of the information that is about to
become available and to guard against any negative consequences of performance
measurement, it is clear that much work remains to be done. Rather than further
honing the tools of quality measurement, important though this may be, the most
important challenges facing those wishing to actually improve the quality of care for
patients with stroke in Scotland would now appear to lie in this direction.
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Date information collected :
Date sent to punching
Date returned from punching














Is data available for this patient 0
YES 1
so -;
Date of first admission / 1
Date of first clerking / 1
YES - 1
Did this patient have an acute stroke so -:
IfNO what was the diagnosis '
Ifdiagnosis is not stroke.no more data need be collected





IfYES to acute stroke - Date of symptom onset
Date unknown
What category of stroke did patient have 9 (Find from results ofCT scan or autopsy)









































































1. Does the patient have a history ofDiabetes MdJitus ?
2. Does the patient have a history of
(a) Ischaemic heart disease ?
(b) Myocardial infarction ?
3 Is the patient married, not a widow/er and not divorced/separated 9
or Does tne patient have a living partner ?
or Does the patient NOT live alone 9
4. Is the patient known to be in employment ?
Where not known, record as NO
5 Prior to the event, could the patient live independently i e carry
out everyday activities unaided 9 (e g walking, bathing, feeding,
dressing)
6 Is the patient's systolic blood pressure > 160 mmHg '
7 Does the patient open their eyes spontaneously WITHOUT verbal
or painful stimulus 9
8 Does the patient move their UNAFFECTED limbs (if any)
purposefully 9 This does not consider their affected limbs
9 Can the patient tell you their name, the place and time correctly 9
10 Can the patient lift both arms against gravity 9
11 Is the patient unable to walk without the aid of another person 9
They may use any other aid
HLTAUD Issue No I (7 pages)
12 Was a CT scan done ?
Ifyes, date of first scan.
13.Was the patient given subcutaneous heparin 9
Ifyes, date started.
14 Was the patient given parenteral fluids 9
Ifyes, date parenteral fluids started
15 Was an NG rube inserted 9
Ifyes, date first inserted
Was thisfor (circle one code) - fluids only 0
- fluid & food 9
- neither/uncertain 9
16 Has urinary incontinence been recorded since the event 9
(Patient has an indwelling catheter or 2 or more documented
episodes of incontinence within 7 days of the event)
17 Was a unnary catheter inserted 9
Ifyes. date inserted
18 Was a multi-disciplinary case conference held 9
Ifyes. date of first multi-disciplinary case conference
19 Was a PEG tube inserted 9
Ifyes. date first inserted




yes -1 so -:
20 Did the patient have any fractures
Ifyes, site ofmost recent fracture
date most recent fracture was noted










21 Did the patient have any pressure sores 1
Ifyes, date pressure sore first noted
22 Was the patient finally discharged on Aspirin
23 Was ihe patient finally discharged on Warfarin 1
Is there any other relewnt information ahout patient history '
Please state .
Details of time taken hy auditor










Surname First Name Code Number
Please delete or white out the patients name after the audit has been completed.
1: History Yes No
24b rs
No, but...
Is the source of the history documented? □ □ □
[jC~ Answer "no. but..." if it is recorded that patient is alen A oriented
and communication is normal.
Is the rate of onset of symptoms recorded? □ □ □
Any record of drugs on admission? (dose &freq unless prs> □ □ □
DCP" Answer "no. but..." if it is recorded that patient ts unconscious, confused,
aphasic or unaware of the symptoms and there are no possible witnesses.
7 days
2: Risk factors
Is the presence or absence of the following risk factors documented?
("nil relevant", "previously well", "PMH nil" are not acceptable)
Yes No No, but
Previous stroke or transient ischaemic attack □ □ □
History of hypertension □ □ □
History of heart disease (angina. Ml. valws. arrhythmias, failure) I I □ □
Peripheral vascular disease (claudication, arterial surgery) □ □ □
History of diabetes □ □ □
History of hyperlipidaemia □ □ □
Smoking tnon. ex. or current) □ □ □
AlCOhOl (must specify amount in units, pints, bottles etc.) □ □ □
\JB* Answer "no. but..." if it is recorded that patient is unconscious, confused
or aphasic and died within 3 days. Where survivors cannot communicate,






Is ONE of A, B or C recorded?
A. Two or more activities of daily living
ie.g. Ambulation. Bathing.Continence,Dressing, Emotion/cognition)
B. Any more difficult tasks (e.g. shopping, driving, working)
C. That the patient is either 'housebound" or
'Independent" (Tit and well" is not adequate)
OCT Answer "no. but..." if it is noted that information not amilable on admission






Is use of social services recorded? □ □ □
Answer ho, but..." if it is noted that information not available on admission
and patient died within 3 days, or noted to be independent or performing more difficult tasks.
Is employment recorded? □ □ □
DCT Answer "no. but..." if it is noted that information not available on admission
and patient died within 3 days, or is over 65 years old.
4: General examination
24hrs
Have the following been recorded? Yes No
Pulse rate and rhythm □ □
Blood pressure □ □
Heart sounds □ □
Neck bruitS (presence or absence) □ □
Peripheral pulses (presence or absence) □ □





Have the following been specifically recorded? Yes No
Conscious level □ □
(e.g. Glasgow Coma Scale <GCSi. alert, drowsy, unrousablei
Eye movements mi IV VI intact, doll's eye response if unconscious) □ □
Power in the limbs (response to pain if unconscious) □ □ No. but.
Communication (recorded as normal or any abnormality specified) □ □ □
Trunk control or gait □ □ □
Swallowing (gag reflex is not enough) □ □ □
OCT* Answer "no. but..." if it is recorded that patient is unconscious.
Yes No No, but..
Formal mental test score (e.g. Hodkmsorn □ □ □
VlSUOSpatial function (e.g. neglect, mattennon. agnosia etc.) □ □ □
Visual fields □ □ □
Sensory testing (including pmpnoceprion) □ □ □
24hrs
Answer "no. but..." if it is recorded that patient is unconscious, drowsy (GCS < 15).
unable ro communicate, or otherwise unable
6: Clinical diagnosis Yes No
Has a clear diagnostic formulation been made? CD CZH
'including neurological deficit, likely sue of cerebral lesion and relevant risk factors/
24hn
7: Usual baseline investigations
Are these in the notes?
Answer "no. but..." if
patient died within 24 hours,
a decision to withhold active
treatment noted.
or investigation performed within
previous month.
7 davs
Yes No No, but...
FBC □ □ □
ESR/Viscosity LJ □ □
U&E □ □ □
Glucose □ □ □





Have any of the following been carried out?
Yes No No. but...
CT Scan □ □ □
Answer "ho, but..." if it is recorded that:-
a) an accurate diagnosis is not needed to make management decisions
Or.
b) none of the following "cast-iron" indications for CT apply
i) diagnosis is in doubt no clear onset or gradual onset over 48hrs +
- unexpected deterioration after stroke
unexplained unconsciousness
ii) cerebellar symptoms or signs
iii) marked headache, vomiting or meningism
ivj patient on warfarin, or anticoagulation is considered
v) carotid endarterectomy is considered
Yes No No, but...
Investigation for rare causes of stroke CZI EH O
(e.g. lupus anticoagulant. VDRL. ANF, echo, blood cultures, clotting studies)
Answer "no. but..." if patient is over 55 or one or more risk factors are documented
7 days
24hrs
9: Immediate management plan
Are plans for the following recorded? yes No no. but...
Hydration (records must specify oral. IV + Nil By Mouth, or nasogastric) □ □ □
EJB* Answer "no. but..." if swallowing is said to be normal
Urinary incontinence (records must specify pa/Is, sheath or catheter) □ □ □
DB* Answer "no. but..." if it is reconled that patient is continent of urine
10: Management during the first week
7 days
Any record of the following? Yes No No. but...
Consultant review □ □ □
Review of important neurological deficits
(i.e. conscious level, communication, swallowing, hemtparesis)
□ □ □




Any record of the following in the first month?









List Of patient's problems (functional <t social if appropriate) □ □ □
Objectives, or goals of rehabilitation (destination at least) □ □ □
Re-assessment of functional status □ □ □
The results of a multidisciplinary meeting □ □ □
OCT" Answer "no. but..." if patient dies or is discharged within 7 days
Information given to patient and/or relatives □ □ □
Answer "no, but..." if patient unconscious, receptive dysphasia or confused
and there are no relatives.
12: Discharge planning
During admission
Are the following recorded?
(In notes or discharge summary) Yes No No. but...
Ownership of accommodation (Council, owner occupied) □ □ □
Type Of accommodation (e.g. residential, warden-supervised, private) I I □ □
Whether living alone or not □ □ □
Stairs/ground floor/ lift □ □ □
Access to toilet □ □ □
Whether informal support is available □ □ □
(e.g. friends, relatives, neighbours)
Answer "ho, but..." if any of the following apply it is recorded that the information
was not available, and the patient died or was discharged within 7 days; the patient was






Any record of the following?
(in the doctors' notes or summon, not cardex/nursing charts) Yes No No, but...
Blood pressure at least four days after stroke □ □ □
Anti-hypertensive medication □ □ □
DC Answer "ho, but..." if patient dies or is normotensive
(systolic <180 and diastolic <100)
Long-term aspirin □ □ □
QGP" Answer "no, but..." if patient dies, haemorrhage is recorded
or pt unable to take aspirin for any other reason.
Long-term anticoagulation □ □ □
UC Answer "no, but..." if patient dies, is documented not to be in atrial fibrillation
or any contraindication, such as haemorrhage, falls or confusion is recorded.
Advice about smoking CI □ □
EW Answer "no, but..." if patient dies or is recorded to be a non-smoker.
Non-invasive carotid imaging (eg. duplex scan) CC □ □
DC" Answer "no. but..." if residual disability, haemorrhagic stroke
posterior circulation stroke, stroke of uncertain distribution,
patient unwilling to consider surgery, dies or aged >75.
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Appendix 3: Modified Rankin Scale
0 No symptoms
1 Minor symptoms which do not interfere with lifestyle
2 Symptoms which lead to some restriction of lifestyle but do not interfere with
the patient's capacity to look after themselves
3 Symptoms which significantly restrict lifestyle and/or prevent totally
independent existence
4 Symptoms which clearly prevent independent existence though not needing
constant attention
5 Severe handicap, totally dependent, requiring constant attention day and night
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M125MIEH667BE 19 April 19%
Please answer the following questions.
If you are unable to fill in this form yourself, please ask someone who knows
you well to help you.
Please tick EITHER Yes QR No for every question.
I. Wen; you admitted to hospital with
a. A heart attack? Yes No
b. A stroke (including sub-arachnoid Yes No
haemorrhage)?
c. Another problem? Yes No
are you staying now?
a. Same place as before your illness. Yes No
b. In hospital. Yes No
c. With family. Yes No
d. In a nursing or residential home. Yes No
e. Other, please specify Yes No
3. Are you taking regular
a. Aspirin? Yes No
b. Blood pressure lowering tablets? Yes No
c. Warfarin? Yes No




M125M1EH667BE 19 Apnl 199b
4. Do you need help from anybody with everyday Yes
activities?
No
If you had a stroke
5. If you had a stroke (including sub-arachnoid Yes No
haemorrhage), has it left you with any problems?
Now, for each of the following five areas, could you please tick the one
sentence which best describes how you are now.
a. Walking
I have no problems with walking about.
I have some problems with walking about.
I am confined to bed.
b. Self care
I have no problems with self care.
I have some problems with self care.
I am unable to wash and dress myself.
c. Usual activities (for example - work, housework, family or leisure activities).
I have no problems performing my usual activities.
\
I have some problems performing my usual activities,
I





M125M1EH667BE 19 April 1996
d. Pain/discomfort
I have no pain or discomfort.
I have moderate pain or discomfort.
I have extreme pain or discomfort.
e. Anxiety /depression
I am not anxious or depressed.
I am moderately anxious or depressed.
I am extremely anxious or depressed.




(of person completing the form)
Please return the completed questionnaire to us in the enclosed freepost envelope.
THANK YOU FOR YOUR HELP
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Re: Mrs M Jones DOB: 12 December 1935
We understand from Dr McDowall that Mrs Jones was discharged from the Western
General Hospital on the 19 April 1996 having had a stroke.
The physicians at the Western General Hospital are collaborating with us to determine
the feasibility of following up all admitted stroke patients to provide information
which might reflect the quality ofhospital based stroke services.
We would be grateful if you or a member of your staff could check that this
patient is still alive and forward the enclosed stamped envelope to them at their
home address. Could you please complete the address on this envelope as we do
not routinely have access to this information.
The envelope contains an introductory letter, a short questionnaire to determine the
patient's functional status and a ffeepost envelope in which the patient or carer can
return the completed questionnaire to us.
If the patient has died or is no longer on your list, please fill in any available
details on the form attached and return it to us in the other freepost envelope
enclosed. If, however, you are able to forward the enclosed envelope to the
patient, please ignore the attached form.
The information which we are collecting will be kept strictly confidential.
Thank you very much for your help.
Yours sincerely,
Dr Martin Dennis
Consultant in Stroke Medicine
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Please do not send this to the patient
If the patient has died or is no longer on your list, please fill in any
available details on this form and return it to us in the freepost
envelope which is enclosed with the patient's questionnaire.
If you have forwarded the questionnaire to the patient, please ignore
this form.
Re: Mrs M Jones DOB: 12 December 1935




If the patient has moved practice, could you please tell us the name and
address of the new GP.
THANK YOU FOR YOUR HELP
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We understand from Dr McDowall that you were discharged
from the Western General Hospital in April 1996.
We are studying how to use information about recovery to
improve hospital care for stroke patients in the future. I am
writing to ask if you would be kind enough to help in this study
by letting us know about your recovery. Your reply is important
and by contributing to this study, it may help to improve stroke
care.
Could we ask you, or someone who knows you well, to
complete and return the enclosed questionnaire? No stamp is
required on the envelope provided and, of course, all
information received will be kept strictly confidential. Many






Appendix 7: Multiple logistic regression
The standard multiple logistic regression equation is given as:
In [p / 1-p] = a + b}Xi + b2X2 + b^Xj + bXi
where
In is the natural logarithm
p is the probability of an outcome
a is a constant
X, are the predictor variables and
bi are the coefficients of the predictor variables.
It follows that:
p/ 1-p = eY
where
Y = a + bjXj + b2X2 + b3X3 + bXi (= the linear predictor)
and hence that:
p = eY/ (1 + e1)
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Appendix 8: W and Ws scores: calculation of standard error and
confidence interval
Wscore
The standard error of the W score is calculated as:
se(w) = (100/n) VHp, (1-pi)
where
th
Pi is the probability of an outcome for the i individual
and hence the 95% confidence interval is calculated as:
W score +/- 1.96 se
Ws score
The variance ofwj (the W score in each stratum) is calculated as:
var (wj) = (I[Pi (l-pi)])j
(nj /100)2
where
(I[pi(l-Pi)]) j is the sum ofPi(l-pt) in stratumj
The standard error of the Ws score is calculated as:
se (wj) = V21 over strata (var Wj) fj 2
where
fj 2 is the square of the fraction of the reference population in intervalj
and hence the 95% confidence interval is calculated as:
Ws score +/- 1.96 se
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Appendix 9: Method for estimating the error in the measurement of
outcome that results from reduced sensitivity in the identification of
acute strokes (using routine hospital discharge data)
Assumptions
1. Let the true case fatality rate be 30%
2. Let the true predicted case fatality rate be 30%, hence the ratio of observed to
predicted deaths (O/P) = true adjusted case fatality = 1
3. Let the sensitivity of the routine hospital discharge data be: 90, 80 or 70%
4. Let the unreported ('missed') cohort of patients have varying
baseline stroke severity (by predicted risk of death)
examine scenarios where the mean baseline severity in the unreported cohort is
the same (30% predicted risk of death) or worse (40 and 50%) than in the
reported cohort.
• quality of care (by impact on O/P ratio of deaths; worse care gives higher ratio)
examine scenarios where the quality of care in the unreported cohort is the same
(O/P = 1) or worse (resulting in a 10% or 20% higher case fatality rate; O/P 1.10
and 1.20) than in the reported cohort.
Calculations
1. Take a hospital sample with 1000 patients.
2. Calculate the overall observed number of deaths: 1000 x 0.3 = 300
3. Calculate the overall predicted number of deaths: 1000 x 0.3 = 300
4. Calculate the number of patients in the reported and unreported cohort e.g. for
90% sensitivity = 900 and 100 patients, respectively.
5. Calculate the predicted number of deaths in the unreported cohort by applying
the specified level of baseline severity e.g. for 40% predicted risk of death: 100 x
0.4 = 40.
6. Calculate the observed number of deaths in the unreported cohort by applying the
specified O/P death ratio to the predicted number of deaths e.g. for 10% higher
case fatality 40 x 1.10 = 44.
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7. Calculate the predicted number of deaths in the reported cohort by subtracting the
number of deaths predicted in the unreported cohort from the overall number
predicted e.g. 300 - 44 = 256 deaths.
8. Calculate the observed number of deaths in the reported cohort by subtracting the
number of deaths observed in the unreported fraction from the overall number of
deaths observed e.g. 300 - 40 = 260.
9. Use the resulting data to calculate the crude and adjusted (O/P) case fatality rate
in the reported cohort. Continuing the example:
crude case fatality = 260/900 = 28.9%
adjusted case fatality (O/P) = 260/256 = 1.02
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Appendix 10a: Follow up letters sent to the GP and patient in the
DIRECT arm of the follow up trial
Letter sent to GP to ensure passive consent to contact patient
i. First letter sent to all patients










Re: Mrs M Jones DOB: 12 December 1935
We understand from Dr McDowall that Mrs Jones was discharged from the Western
General Hospital on the 19 April 1996 having had a stroke.
The physicians at the Western General Hospital are collaborating with us to determine
the feasibility of following up all admitted stroke patients to provide information
which might reflect the quality ofhospital based stroke services.
We intend to send a short questionnaire, designed to determine functional status,
directly to Mrs Jones using the address in her hospital record. To avoid distressing
bereaved relatives, we will only mail questionnaires to patients who do not appear on
monthly mortality records for your area. The information we are collecting will be
kept strictly confidential.
If there is any reason why we should not send Mrs Jones a questionnaire or you wish
to know more about the study, please phone us (and ask for Dr Nicolas Weir orMr
Mike McDowall) or return the enclosed form (ffeepost) within one week of the
postmark on this letter. Please could you let us know the reason ifwe should not
make contact - this information should prove helpful in future planning.
Thank you for your help.
Yours sincerely,
DrMartin Dennis
Consultant in Stroke Medicine
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Follow Up Refusal Form




(ifdead, please state date, place and cause ifpossible)









We understand from Dr McDowall that you were discharged
from the Western General Hospital in April 1996.
We are studying how to use information about recovery to
improve hospital care for stroke patients in the future. I am
writing to ask if you would be kind enough to help in this study
by letting us know about your recovery. Your reply is important
and by contributing to this study, it may help to improve stroke
care.
Could we ask you, or someone who knows you well, to
complete and return the enclosed questionnaire? No stamp is
required on the envelope provided and, of course, all
information received will be kept strictly confidential. Many













About a month ago, I wrote to ask how you had recovered
following your discharge from the Western General Hospital in
April 1996. As we've not heard from you so far, I thought I
would write again.
We are studying how to use information about recovery to
improve hospital care for stroke patients in the future. We are
very keen to learn about your recovery and I hope you can help
us in our study. Your reply will certainly make our study more
accurate and increase the chance that our findings will influence
future stroke care.
Could we ask you, or someone who knows you well, to
complete and return the enclosed questionnaire? No stamp is
required on the envelope provided and, of course, all
information received will be kept strictly confidential. Many






Appendix 10b: Follow up letters sent to GP and patient in the INDIRECT
arm of the follow up trial
i. Letter sent to GP to request that they forward our questionnaire to the patient
ii. First letter to patient
iii. Second letter sent to GP to request that they forward our questionnaire to non-
responders to first follow up










Re: Mrs M Jones DOB: 12 December 1935
We understand from Dr McDowall that Mrs Jones was discharged from the Western
General Hospital on the 19 April 1996 having had a stroke.
The physicians at the Western General Hospital are collaborating with us to determine
the feasibility of following up all admitted stroke patients to provide information
which might reflect the quality of hospital based stroke services.
We would be grateful if you or a member of your staff could check that this
patient is still alive and forward the enclosed stamped envelope to them at their
home address. Could you please complete the address on this envelope as we do
not routinely have access to this information.
The envelope contains an introductory letter, a short questionnaire to determine the
patient's functional status and a ffeepost envelope in which the patient or carer can
return the completed questionnaire to us.
If the patient has died or is no longer on your list, please fill in any available
details on the form attached and return it to us in the other freepost envelope
enclosed. If, however, you are able to forward the enclosed envelope to the
patient, please ignore the attached form.
The information which we are collecting will be kept strictly confidential.
Thank you very much for your help.
Yours sincerely,
Dr Martin Dennis
Consultant in Stroke Medicine
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Please do not send this to the patient
If the patient has died or is no longer on your list, please fill in any
available details on this form and return it to us in the freepost
envelope which is enclosed with the patient's questionnaire.
If you have forwarded the questionnaire to the patient, please ignore
this form.
Re: Mrs M Jones DOB: 12 December 1935




If the patient has moved practice, could you please tell us the name and
address of the new GP.





We understand from Dr McDowall that you were discharged
from the Western General Hospital in April 1996.
We are studying how to use information about recovery to
improve hospital care for stroke patients in the future. I am
writing to ask if you would be kind enough to help in this study
by letting us know about your recovery. Your reply is important
and by contributing to this study, it may help to improve stroke
care.
Could we ask you, or someone who knows you well, to
complete and return the enclosed questionnaire? No stamp is
required on the envelope provided and, of course, all
information received will be kept strictly confidential. Many













Re: Mrs M Jones DOB: 12 December 1935
A month ago I wrote to asking ifMrs Jones was still alive following a stroke in April
1996. We have not had a reply from Mrs Jones and I hope you don't mind us chasing
things up.
In collaboration with the physicians at the Western General Hospital we are studying
the feasibility of following up stroke patients to provide information which might
reflect the quality of hospital stroke services. The questionnaire has been sent to a
relatively small number of patients so it is crucial that we achieve a high response
rate to prevent potentially biased and misleading results.
In case you did not receive the previous letter or it got mislaid, I am enclosing a
further copy. Even if you did pass on the previous letter, please could you do so
again as similar problems may have prevented Mrs Jones replying. The enclosed
envelope contains an introductory letter, a short questionnaire and a freepost
envelope in which the patient or carer can return the completed questionnaire.
We would be grateful if you or a member of your staff could check that this
patient is still alive and forward the enclosed stamped envelope to them at their
home address. Could you please complete the address on this envelope as we do
not routinely have access to this information. If the patient has died or is no
longer on your list, please fill in any available details on the form attached and
return it to us in the freepost envelope enclosed.
The information we are collecting will be kept strictly confidential.
Thank you again for your co-operation
Yours sincerely,
Dr Martin Dennis
Consultant in Stroke Medicine
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Please do not send this to the patient
If the patient has died or is no longer on your list, please fill in any
available details on this form and return it to us in the freepost
envelope which is enclosed with the patient's questionnaire.
If you have forwarded the questionnaire to the patient, please ignore
this form.
Re: Mrs M Jones DOB: 12 December 1935




If the patient has moved practice, could you please tell us the name and
address of the new GP.





About a month ago, I wrote to ask how you had recovered
following your discharge from the Western General Hospital in
April 1996. As we've not heard from you so far, I thought I
would write again.
We are studying how to use information about recovery to
improve hospital care for stroke patients in the future. We are
very keen to learn about your recovery and I hope you can help
us in our study. Your reply will certainly make our study more
accurate and increase the chance that our findings will influence
future stroke care.
Could we ask you, or someone who knows you well, to
complete and return the enclosed questionnaire? No stamp is
required on the envelope provided and, of course, all
information received will be kept strictly confidential. Many






Appendix 11: Ethical approval for the follow up trial
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LOTHIAN RESEARCH ETHICS COMMITTEE
/
CERTIFICATE OF ETHICAL OPINION
LREC Reference Number: LREC/1997/4/52
Title: Improving response rates and estimating the non-response bias of a postal questionnaire
used to follow up stroke patients admitted to hospital six months previously and discharged
alive
Researcher: Dr N Weir
The Medicine/Clinical Oncology Research Ethics Committee of the Lothian Research Ethics
Committee (the Committee) reviewed this proposed research and is of the opinion that it is
ethical and appropriate to be carried out in the Lothian Area. This opinion encompasses all
aspects of the application including the Patient/Subject Information Sheet and ail other
accompanying documentation provided.
The LREC application form, protocol, subject information sheet, information on compensation
arrangements, payments to researchers and the provision of expenses to subjects (where
appropriate) were reviewed and approved and the members of the Committee present at the
meeting are shown on the attached Membership List.
This opinion is issued subject to the following conditions and is invalid if they are not followed:
■ You must obtain appropriate management approval from the relevant NHS Trust(s)
before starting the proposed research. It is the NHS Trust(s) that ultimately decide
whether or not this research should go ahead taking account of the advice of the Local
Research Ethics Committee.
• You must notify the Sub-Committee and the relevant NHS Trust(s), in advance, of any
significant proposed deviation from the original protocol or application form and obtain
approval for any such amendments using the Amendment Approval Request Form.
• You must submit reports to the Sub-Committee and the NHS Trust(s) once the study is
underway if there are any unusual or unexpected results which raise questions about
the safety of the research.
• You must report annually on successes, or difficulties, in recruiting subjects in order to
provide useful feedback on perceptions of the study among patients and volunteers
using the Progress Report Form.
• Where the study is terminated prematurely you must report within fifteen days indicating
the reasons for early termination.
You must submit a final report within three monfttsjjf thec»mpletion_Qfthe studyjasing
the Progress Report Form.
• This opinion does not cover the inclusions of adults with incapacity in any study. Such
opinion can only be given by the Multi-Centre Research Ethics Committee for Scotland.
Peter Reith Dale Kelr
Secretary Administrator





Appendix 12: Statement of contribution
The collection of data for the SOP was carried out between August 1995 and March
1999 under the auspices of the Department of Clinical Neurosciences in the
University of Edinburgh. I was a clinical research fellow employed in this
department between September 1996 and March 2000 under the supervision of Dr.
Martin Dennis; subsequently I have been employed as a Specialist Registrar in
Neurology at the Royal Hallamshire Hospital, Sheffield. I performed all analyses
between summer 1999 and winter 2002.
My contribution to the thesis was as follows:
I designed the sub-studies pertaining to:
the accuracy of routine cerebrovascular disease discharge data;
the validity and reliability of the collection of predictive data
. the methods of delivering the outcome questionnaire
the ascertainment of outcome in non-responders to follow up
the second survey of the structure of stroke care
I collected predictive data prospectively in 92 patients and retrospectively (from the
medical records) in 200 patients with acute stroke.
I obtained ethical approval for the study investigating the response to different
methods of postal follow up, supervised its running, and traced and obtained
outcome data for the 66 non-responders.
I was responsible for dealing with day to day problems related to the running of the
SOP proper.
1 lead the task of cleaning, organising and checking the SOP data-set once data
collection was complete.




Appendix 13: Publications arising from this thesis
Publications
The reliability of the variables in a new set ofmodels that predict outcome after stroke
NU Weir, C Counsell, M McDowall, A Gunkel, M Dennis
J.Neurol.Neurosurg.Psychiatry 2003;74: 447-451
Towards a national system for monitoring the quality of hospital based stroke services
N Weir and M Dennis for the Scottish Stroke Outcomes Study Group
Stroke 2001;32:1415-1421
Presentations to learned societies
Stroke outcomes: useful indicators of the quality of stroke care? (platform)
NU Weir on behalf of the Scottish Stroke Outcomes Group
Association ofBritish Neurologists 1999, London
Stroke outcomes: useful indicators of the quality of stroke care? (platform)
NU Weir on behalfof the Scottish Stroke Outcomes Group
British Association of Stroke Physicians 1999, Nottingham
Are stroke outcomes useful indicators of the quality of stroke care? (platform)
NU Weir on behalf of the Scottish Stroke Outcomes Group
National Casemix Conference 1999, Keele University
The Five Hospitals Study (platform)
NU Weir on behalf of the Scottish Stroke Outcomes Group
The Royal College of Physicians of Edinburgh, 1999
Which diagnostic codes are important for large scale and routine stroke studies? (poster)
NU Weir, MA McDowell, AJ Gunkel, MS Dennis
European Stroke Conference 1997, Amsterdam, Holland
Abstract in Cerebrovascular Diseases 1997; 7 (suppl 4): 71 A
Stroke League Tables: are they likely to reflect differences in quality? (poster)
N Weir on behalf of the Scottish Stroke Outcomes Group
European Stroke Conference 1999, Venice, Italy




Aboderin, I. and Venables, G. (1996). Stroke management in Europe. Pan European
consensus meeting on stroke management. Journal ofInternal Medicine 249, 173-
180.
Altman, D. G. (1999). Practical statistics for medical research. Chapman &
Hall/CRC: London.
Altman, D. G. and Royston, P. (2000). What do we mean by validating a prognostic
model? Stat.Med. 19,453-473.
Anderson, C. S., Jamrozik, K. D., Burvill, P. W., Chakera, T. M. H., Johnson, G. A.,
and Stewart-Wynne, E. G. (1993). Ascertaining the true incidence of stroke:
experience from the Perth Community Stroke Study, 1989-90. MedJAust 158, 80-
84.
Anderson, P. (1999). Popularising hospital performance data. BMJ 31$, 1772.
Anonymous. (1989). Stroke. Towards better management. The Royal College of
Physicians of London: London.
Anonymous. (1990). Precise clinical summaries: the source of high quality SMR
data. Guidelines for clinicians. Summary of recommendations. Edinburgh,
Information & Statistics Division, Common Services Agency for the Scottish Health
Service.
Anonymous (1993). Dicing with death rates. Lancet 341, 1183-1184.
Anonymous (1994). Royal College ofPhysicians Stroke Audit Package Introductory
Booklet. Royal College ofPhysicians of London: London.
Anonymous (1995). Core Patient Profile Information in Scottish Hospitals
(COPPISH) Scottish Morbidity Record Data Manual. ISD, NHS in Scotland:
Edinburgh.
Anonymous (1996). Significance tests. In An introduction to medical statistics'. (Ed.
M. Bland.) pp. 133-151. Oxford University Press: Oxford,UK.
Anonymous (1997). Patterns and trends in male mortality. In 'Health Inequalities'. (F.
Drever and M. WhiteheadEds.) pp. 95-107. Office ofNational Statistics, The
Stationary Office: London.
Anonymous (1998a). Fifty years ago. The new NHS: message to the medical
profession from the Minister of Health. BMJ3Y1, 56.




Anonymous (1999). Comparing groups - continuous data. In 'Practical statistics for
medical research'. (Ed. D. G. Altman.) pp. 179-228. Chapman & Hall/CRC: Boca
Raton.
Anonymous. (2000). Clinical indicators (league tables) - a discussion paper, pi7.
London, British Medical Association.
Anonymous. (2001). Coronary Heart Disease/Stroke Task Force Report. The
Scottish Executive, Edinburgh
Anonymous. (2002). Coronary Heart Disease and Stroke. Strategy for Scotland. The
Scottish Executive, Edinburgh.
Anonymous. (2003a) Scottish Stroke Services Audit: report of an audit on the
organisation of services for stroke patients 1997-1998. Glasgow, Royal College of
Physicians & Surgeons of Glasgow.
Anonymous. (2003b) Draft clinical standards for stroke services.
http://www.clinicalstandards.org/pdf/draftstand/Draft%20stroke.pdf. NHS Quality
Improvement Scotland, Edinburgh.
Antiplatelet Trialists' Collaboration. (1988). Secondary prevention of vascular
disease by prolonged antiplatelet treatment. BMJ 296, 320-321.
Antiplatelet Trialists' Collaboration. (1994). Collaborative overview of randomised
trials of antiplatelet therapy -1: Prevention of death, myocardial infarction, and
stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308,
81-106.
Antithrombotic Trialists' Collaboration (2002). Collaborative meta-analysis of
randomised trials of antiplatelet therapy for prevention of death, myocardial
infarction, and stroke in high risk patients. BMJ 324, 71-86.
Aron, D. C., Harper, D. L., Shepardson, L. B., and Rosenthal, G. E. (1998). Impact
of risk-adjusting cesarean delivery rates when reporting hospital performance. JAMA
279, 1968-1972.
Asplund, K., Hulter-Asberg, K., Norrving, B., Stegmayr, B., Terent, A., Wester, P.
O., Riks-Stroke Collaboration (2003). Riks-stroke - a Swedish national quality
register for stroke care. Cerebrovasc.Dis. 15 Suppl 1, 5-7.
Asplund, K., Tuomilehto, J., Stegmayr, B., Wester, P. O., and Tunstall-Pedoe, H.
(1988). Diagnostic Criteria and Quality Control of the Registration of Stroke Events
in the MONICA Project. Acta Med Scand 26-39.
Atrial Fibrillation Investigators. (1994). Risk factors for stroke and efficacy of
antithrombotic therapy in atrial fibrillation, analysis of pooled data from five
randomised controlled trials. Archives ofInternalMedicine 154, 1449-1457.
403
References
Austin, P. C. and Naylor, C. D. (2001). A comparison of a Bayesian vs. a frequentist
method for profiling hospital performance. Journal ofEvaluation in Clinical
Practice 7, 35-45.
Baird, A. E., Dashe, J., Connor, A., Burzynski, C., Schlaug, G., and Warach, S.
(2000). Comparison ofRetrospective and Prospective Measurements of the National
Institutes ofHealth Stroke Scale. Cerebrovasc.Dis. 10, 80-81.
Baker, R. and Fraser, R. C. (1995). Development of review criteria: linking
guidelines and assessment of quality. BMJ311, 370-373.
Bamford, J., Sandercock, P., Dennis, M., Burn, J., and Warlow, C. (1990a). A
prospective study of acute cerebrovascular disease in the community: the
Oxfordshire Community Stroke Project 1981-86. 2. Incidence, case fatality rates and
overall outcome at one year of cerebral infarction, primary intracerebral and
subarachnoid haemorrhage. J.Neurol.Neurosurg.Psychiatry 53, 16-22.
Bamford, J., Dennis, M., Sandercock, P., Burn, J., and Warlow, C. (1990b). The
frequency, causes and timing of death within 30 days of a first stroke: the
Oxfordshire Community Stroke Project. J.Neurol.Neurosurg.Psychiatry 53, 824-829.
Bamford, J., Sandercock, P., Dennis, M., Warlow, C., Jones, L., McPherson, K.,
Vessey, M., Fowler, G., Molyneux, A., and Hughes, T. (1988). A prospective study
of acute cerebrovascular disease in the community: the Oxfordshire Community
Stroke Project 1981-86. 1. Methodology, demography and incident cases of first-ever
stroke. J.Neurol.Neurosurg.Psychiatry 51, 1373-1380.
Bamford, J. M., Sandercock, P. A., Warlow, C. P., and Slattery, J. (1989).
Interobserver agreement for the assessment of handicap in stroke patients. Stroke 20,
828.
Barclay, S., Todd, C., Finlay, I., Grande, G., and Wyatt, P. (2002). Not another
questionnaire! Maximising the response rate, predicting non-response and assessing
non-response bias in postal questionnaire studies ofGPs. Family Practice 19, 105-
111.
Barer, D., Ellul, J., and Watkins, C. (1996). Correcting outcome data for casemix in
stroke medicine. Structures and processes should be audited, rather than outcomes.
BMJ 313, 1005-1006.
Barer, D. H. (1989). The natural history and functional consequences of dysphagia
after hemispheric stroke. J.Neurol.Neurosurg.Psychiatry 52, 236-241.
Barer, D. H. and Mitchell, J. R. (1989). Predicting the outcome of acute stroke: do
multivariate models help? Q.J.Med. 70, 27-39.




Berwick, D. M., Enthoven, A., and Bunker, J. P. (1992a). Quality management in the
NHS: the doctor's role I. BMJ304, 235-239.
Berwick, D. M., Enthoven, A., and Bunker, J. P. (1992b). Quality management in the
NHS: the doctor's role II. BMJ304, 304-308.
Berwick, D. M. and Wald, D. L. (1990). Hospital leaders' opinions of the HCFA
mortality data. JAMA 263, 247-249.
Bilsker, D. and Goldner, E. M. (2002). Routine outcome measurement by mental
health-care providers: is it worth doing? Lancet 360, 1689-1690.
Bindman, A. B. (1999). Can physician profiles be trusted? JAMA 281,2142-2143.
Black, N. (1996). Why we need observational studies to evaluate the effectiveness of
healthcare. BMJMl, 1215-1218.
Bland, J. M. and Altman, D. G. (1998). Bayesians and ffequentists. BMJMl, 1151.
Blumberg, M. S. (1991). Biased estimates of expected acute myocardial infarction
mortality using MedisGroups Admission Severity Groups. JAMA 265, 2965-2970.
Blumenthal, D. (1994). The variation phenomenon in 1994. N.Engl.JMed. 331,
1017-1018.
Blumenthal, D. (1996a). Quality ofHealth Care. Part 1: Quality ofCare - What is it?
N.Engl.JMed. 335, 891-894.
Blumenthal, D. (1996b). Quality ofHealth Care. Part 4: The origins of the quality of
care debate. N.Engl.J.Med. 335, 1146-1149.
Bobrow, R. S. (2000). The unintended consequences ofmeasuring quality on the
quality of care. N.Engl.J.Med. 342, 519.
Bogousslavsky, J., Regli, F., Uske, A., and Maeder, P. (1991). Early spontaneous
hematoma in cerebral infarct: is primary cerebral haemorrhage overdiagnosed?
Neurology 41, 837-840.
Bonita, R. (2002). Epidemiology of stroke. Lancet 339, 342-344.
Braitman, L. E. and Davidoff, F. (1996). Predicting clinical states in individual
patients. Annals ofInternal Medicine 125, 406-412.
Brazier, J. E., Walters, S. J., Nicholl, J. P., and Kohler, B. (1996). Using the SF-36
and Euroquol on an elderly population. Quality ofLife Research 5, 195-204.
Brennan, P. and Silman, A. (1992). Statistical methods for assessing observer
variability in clinical measures. BMJ 304, 1491-1494.
405
References
Brennan, T. A., Leape, L. L., Laird, N. M., Hebert, L., Localio, A. R., Lawthers, A.
G., Newhouse, J. P., Weiler, P. C., and Hiatt, H. H. (1991). Incidence of adverse
events and negligence in hospitalized patients. Results of the Harvard Medical
Practice Study I. N.Engl.J.Med. 324, 370-376.
Britton, M., Hindmarsh, T., Murray, V., and Tyden, S. A. (1984). Diagnostic errors
discovered by CT in patients with suspected stroke. Neurology 34, 1504-1507.
Brook, R. H., McGlynn, E. A., and Cleary, P. D. (1996). Quality in Health Care. Part
2: Measuring quality of care. N.Engl.J.Med. 335, 966-970.
Brosseau, L., Potvin, L., Philippe, P., and Boulanger, Y-L. (1996). Post-stroke
inpatient rehabilitation. II. Predicting discharge disposition. American Journal of
Physical Medicine & Rehabilitation 75, 431-436.
Brown, M. M. (2003). Carotid angioplasty and stenting: are they therapeutic
alternatives? Cerebrovasc.Dis. 11 Supple 1, 112-118.
Burn, J. P. (1992). Reliability of the modified Rankin Scale. Stroke 23, 438.
Burns, F. (1998). Information for Health. An information strategy for the modern
NHS 1998-2005. A national strategy for local implementation. Leeds, NHS
Executive.
Bushnell, C. D., Johnston, D. C. C., and Goldstein, L. B. (2001). Retrospective
assessment of initial stroke severity. Comparison of the NIH Stroke Scale and the
Canadian Neurological Scale. Stroke 32, 656-660.
Campion, F. X. and Rosenblatt, M. S. (1996). Quality assurance and medical
outcomes in the era of cost containment. Surgical Clinics ofNorth America 76, 139-
159.
Candelise, L., Pinardi, G., and Aritzu, E. (1990). Stroke disability assessed by
telephone interivew: reliability and reproducibility. Journal ofNeurology 237, 143.
Caplan, R. A., Posner, K. L., and Cheney, F. W. (1991). Effect of outcome on
physician judgements of appropriateness of care. JAMA 265, 1957-1960.
Cargill, V., Cohen, D., Kroenke, K., and Neuhauser, D. (1986). Ongoing patient
randomization: an innovation in medical care research. Health Serv.Res. 21, 663-678.
Chassin, M. R., Hannan, E. L., and DeBuono, B. A. (1996). Benefits and hazards of
reporting medical outcomes publicly. N.Engl.J.Med. 334, 394-398.
Clarke, A and McKee, M. (1992). The consultant episode: an unhelpful measure.
BMJ 305, 1307-1308.
Clinical Outcome Working Group. (1993). Clinical Outcome Measures Report. The
Scottish Office Clinical Resource and Audit Group, Edinburgh.
406
References
Clinical Outcome Working Group. (1994). Clinical Outcome Indicators. The Scottish
Office Clinical Resource and Audit Group, Edinburgh.
Clinical Outcome Working Group. (1998). Clinical Outcome Indicators. The Scottish
Office Clinical Resource and Audit Group, Edinburgh.
Clinical Outcome Working Group. (1999). Clinical Outcome Indicators. The Scottish
Office Clinical Resource and Audit Group, Edinburgh.
Clinical Standards Advisory Group. (1995) Urgent and emergency admissions to
hospital. HMSO, London.
Collins, R., Peto, R., MacMahon, S., Hebert, P., Fiebach, N. H., Eberlein, K. A.,
Godwin, J., Qizilbash, N., Taylor, J. O., and Hennekens, C. H. (1990). Blood
pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood
pressure: overview of randomised drug trials in their epidemiological context. Lancet
335, 827-838.
Counsell, C. and Dennis, M. (2001). Systematic review of prognostic models in
patients with acute stroke. Cerebrovasc.Dis. 12, 159-170.
Counsell, C., Dennis, M., McDowall, M., and Warlow, C. (2002). Predicting
outcome after acute and subacute stroke. Development and validation of new
prognostic models. Stroke 33, 1041-1047.
Counsell, C. E. (1998) The prediction of outcome in patients with acute stroke.
Univeristy of Cambridge,UK. [Thesis]
Crombie, I. K. and Davies, H. T. O. (1998). Beyond health outcomes: the advantages
ofmeasuring process. J.Eval.Clin.Pract. 4, 31-38.
Czlonkowska, A., Milewska, D., and Ryglewicz, D. (2003). The Polish experience in
early stroke care. Cerebrovasc.Dis. 15 Suppl 1, 14-15.
D'Olhaberriague, L., Litvan, I., Mitsias, P., and Mansbach, H. H. (1996). A
reappraisal of reliability and validity studies in stroke. Stroke 27, 2331-2336.
Dans, P. E., Weiner, J. P., and Otter, S. E. (1985). Peer Review Organisations.
Promises and potential pitfalls. N.EnglJ.Med. 313,1131-1137.
Davenport, R. J. and Dennis, M. S. (1996). Measuring the process of care is not
always straightforward. BKfJ 312, 185.
Davenport, R. J., Dennis, M. S., and Warlow, C. P. (1995). Improving the recording
of the clinical assessment of stroke patients using a clerking proforma. Age and
Aging 24, 43-48.
Davenport, R. J., Dennis, M. S., Wellwood, I., and Warlow, C. P. (1996a).
Complications after acute stroke. Stroke 27, 415-420.
407
References
Davenport, R. J., Dennis, M. S., and Warlow, C. P. (1996b). Effect of correcting
outcome data for case mix: an example from stroke medicine. BMJ 312, 1503-1505.
Davenport, R. J., Dennis, M. S., and Warlow, C. P. (1996c). The accuracy of Scottish
Morbidity Record (SMR1) data for identifying hospitalised stroke patients. Health
Bulletin 54 ,402-405.
Davies, H. T. and Shields, A. V. (1999). Public trust and accountability for clinical
performance: lessons from the national press reportage of the Bristol hearing.
J.Eval.Clin.Pract. 5, 335-342.
Davies, H. T. O. and Crombie, I. K. (1997). Interpreting health outcomes.
J.Eval. CIin.Pract. 3, 187-199.
Davies, H. T. O. and Lampel, J. (1998). Trust in performance indicators? Quality in
Health Care 7, 159-162.
De Haan, R., Horn, J. S., Limburg, M., Van Der Meulen, J., and Bossuyt, P. (1993).
A comparison of five stroke scales with measures of disability, handicap, and quality
of life. Stroke 24, 1178-1181.
Demlo, L. K. and Campbell, P. M. (1981). Improving hospital discharge data:
lessons from the National Hospital Discharge Survey. Medical Care 19,1030-1040.
Dennis, M. (2000). Stroke services: the good, the bad and the ... Journal ofthe Royal
College ofPhysicians ofLondon 34, 92-96.
Dennis, M. (2001). FOOD (Feed Or Ordinary Diet): A family of randomized trials
evaluating feeding policies for patients admitted to hospital with recent stroke.
Cerebrovasc. Dis. 11, 32.
Dennis, M. and Warlow, C. (1991). Strategy for stroke. BMJ 636-638.
Dennis, M., Wellwood, I., and Warlow, C. (1997a). Are simple questions a valid
measure of outcome after stroke? Cerebrovasc. Dis. 7, 22-27.
Dennis, M., Wellwood, I., O'Rourke, S., MacHale, S, and Warlow, C. (1997b). How
reliable are simple questions in assessing outcome after stroke? Cerebrovasc. Dis. 7,
19-21.
Dennis, M. S., Bamford, J. M., Molyneux, A. J., and Warlow, C. P. (1987). Rapid
resolution of signs of primary intracerebral haemorrhage in computed tomograms of
the brain. BMJ (Clin Res Ed) 295, 379-381.
Department ofHealth (2000). An organisation with memory: report of an expert
group on learning from adverse events in the NHS. The Stationary Office: London.
Department ofHealth Expert Advisory Group on Cancer. (1995) A policy
framework for commissioning cancer services. DOH, London
408
References
Dewey, H. M., Donnan, G. A., Freeman, E. J., Sharpies, C. M, Macdonell, R. A.,
McNeil, J. J., and Thrift, A. G. (1999). Interrater reliability of the National Institutes
ofHealth Stroke Scale: rating by neurologists and nurses in a community-based
stroke incidence study. Cerebrovasc.Dis. 9, 323-327.
Dillman, D. A. (1978). Mail and telephone surveys - the total design method.
J. Wiley & Sons: New York.
Doll, H., McPherson, K., Davies, J., Flood, A., Smith, J., Williams, G., Ginzler, M.,
Petticrew, M., and Black, N. (1991). Reliability of questionnaire responses as
compared with interview in the elderly: views of the outcome of transurethral
resection of the prostate. Social Science andMedicine 33, 1303-1308.
Dombovy, M. L., Basford, J. R., Whisnant, J. P., and Bergstralh, E. J. (1987).
Disability and use of rehabilitation services following stroke in Rochester, Minnesota
1975-1979. Stroke 18, 830-836.
Donabedian, A. (1988). The quality of care. How can it be assessed? JAMA 260,
1743-1748.
Donnan, G. A. (1992). Investigation of patients with stroke and transient ischaemic
attack. Lancet 339, 879-880.
Dorman, P. J., Slattery, J., Farrell, B., Dennis, M. S., Sandercock, P. A. G., and the
United Kingdom collaborators in the International Stroke Trial (1997a). A
randomised comparison of the Euroquol and Short Form-36 after stroke. BMJ 315,
461.
Dorman, P. J., Waddell, F., Slattery, J., Dennis, M., and Sandercock, P. (1997b). Is
the EuroQol a valid measure of health-related quality of life after stroke? Stroke 28,
1876-1882.
Dubois, R. W., Rogers, W. H., Moxley, J. H., Draper, D., and Brook, R. H. (1987).
Hospital inpatient mortality. Is it a predictor of quality? N.Engl.J.Med. 317, 1674-
1680.
Duncan, G., Ritchie, L.C., Jamieson, D.M., and McLean, M.A. (1995). Acute stroke
in South Ayrshire: comparative study ofpre and post stroke units. Health Bulletin
(Edinb). 53, 159-166
Duncan, P. W., Horner, R. D., Reker, D. M., Samsa, G. P., Hoening, H., Hamilton,
B., LaClair, B. J., and Dudley, T. K. (2002a). Adherence to postacute rehabilitation
guidelines is associated with functional recovery in stroke. Stroke 33, 167-178.
Duncan, P. W., Reker, D. M., Horner, R. D., Samsa, G. P., Hoening, H., LaClair, B.
J., and Dudley, T. K. (2002b). Performance of a mail-administered version of a




Duncan, P. W., Lai, S. M., Tyler, D., Perera, S., Reker, D. M., and Studenski, S.
(2002c). Evaluation of proxy responses to the Stroke Impact Scale. Stroke 33, 2593-
2599.
Duncan, P. W., Jorgensen, H. S., and Wade, D. T. (2000). Outcome measures in
acute stroke trials. A systematic review and some recommendations to improve
practice. Stroke 31, 1429-1438.
Duncan, P. W., Lai, S. M., Bode, R. K., Perera, S., and DeRosa, J. (2003). Stroke
Impact Scale-16: A brief assessment of physical function. Neurology 60, 291-296.
Ebrahim, S. and Redfem, J. (1999) Stroke care - a matter of chance: a national
survey of stroke services. The Stroke Association.
Ellekjaer, H., Holmen, J., Kruger, O., and Terent, A. (1999). Identification of
incident stroke in Norway. Hospital discharge data compared with a population-
based stroke register. Stroke 30, 56-60.
Ellwood, P. M. (1988). Shattuck lecture-outcomes management. A technology of
patient experience. N.Engl.J.Med. 318, 1549-1556.
English, T. A., Bailey, A. R., Dark, J., and Williams, W. G. (1984). The UK Cardiac
Surgical Register 1977-82. BMJ 289, 1205-1208.
Epstein, A. M. (1998). Rolling down the runway. The challenges ahead for quality
report cards. JAMA 279, 1691-1696.
European Carotid Surgery Trialists' Collaborative Group. (1991). MRC European
Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%)
or with mild (0-29%) carotid stenosis. Lancet 337, 1235-1243.
Evans, A., Perez, I., Harraf, F., Melbourn, A., Steadman, J., Donaldson, N., and
Kalra, L. (2001). Can differences in management processes explain different
outcomes between stroke unit and stroke-team care? Lancet 358, 1586-1592.
Ferro, J. M., Falcao, I., Rodrigues, G., Canhao, P., Melo, T. P., Oliveira, V., Pinto, A.
N., Crespo, M., and Salgado, A. V. (1996). Diagnosis of transient ischaemic attack
by the nonneurologist. Stroke 27, 2225-2229.
Ferro, J. M., Pinto, A. N., Falcao, I., Rodrigues, G., Ferreira, J., Falcao, F., Azevedo,
E., Canhao, P., Melo, T. P., Rosas, M. J., Oliveira, V., and Salgado, A. V. (1998).
Diagnosis of stroke by the nonneurologist. A validation study. Stroke 29, 1106-1109.
Fine, L. G., Keogh, B. E., Cretin, S., Orlando, M., Gould, M. M., and for the
NufTield-Rand Cardiac Surgery Demonstration Project Group (2003). How to
evaluate and improve the quality and credibility of an outcomes database: validation
and feedback study on the UK Cardiac Surgery Experience. BMJ 326, 25-28.
Fleiss, J. L., Cohen, J., and Everitt, B. S. (1969). Large sample standard errors of
kappa and weighted kappa. Psych Bull 72, 323-327.
410
References
Frain, J. P., Frain, A. E., and Carr, P. H. (1996). Experience ofmedical senior house
officers in preparing discharge summaries. BMJ 312, 350.
Frater, A. and Costain, D. (1992). Any better? Outcome measures in medical audit.
BMJ 304, 519-520.
Fullerton, K. J., Mackenzie, G., and Stout, R. W. (1988). Prognostic indices in
stroke. Q.J.Med. 66, 147-162.
Gautam, P., Macduff, C., Brown, I., and Squair, J. (1996). Unplanned readmissions
of elderly patients. Health Bulletin 54, 449-457.
Gillum, L. A. and Johnston, S. C. (2001). Characteristics of academic medical
centers and ischemic stroke outcomes. Stroke 32, 2137-2142.
Giuffrida, A., Gravelle, H., and Roland, M. (1999). Measuring quality of care with
routine data: avoiding confusion between performance indicators and health
outcomes. BMJ3>\9, 94-98.
Gjorup, T., Kelbaek, H., Stenbygard, L., and Sorensen, F. (1986). Effect of
knowledge of serum enzyme concentrations on doctors' interpretation of
electrocardiographic manifestations in suspected acute myocardial infarction. BMJ
292, 27.
Glader, E. L., Stegmayr, B., Johansson, L., Hulter-Asberg, K., and Wester, P. O.
(2001). Differences in long-term outcome between patients treated in stroke units
and in general wards: a 2-year follow-up of stroke patients in Sweden. Stroke 32,
2124-2130.
Gladman, J. R., Harwood, D. M., and Barer, D. H. (1992). Predicting the outcome of
acute stroke: prospective evaluation of five multivariate models and comparison with
simple methods. J.Neurol.Neurosurg.Psychiatry 55, 347-351.
Glance, L. G., Osier, T., and Shinozaki, T. (2000). Effect of varying the casemix on
the standardised mortality ratio and W statistic. A simulation study. Chest 117, 1112-
1117.
Goldstein, H. and Myers, K. (1996). Freedom of information: towards a code of
ethics for performance indicators. Research Intelligence 57, 12-16.
Goldstein, H. and Spiegelhalter, D. J. (1996). League tables and their limitations:
statistical issues in comparisons of instiutional performance. Journal ofthe Royal
Statistical Society 159, 385-443.
Goldstein, L. B. (1998). Accuracy of ICD-9-CM coding for the identification of
patients with acute ischaemic stroke. Effect of modifier codes. Stroke 29, 1602-
1604.
Goldstein, L. B. and Chilukuri, V. (1997). Retrospective assessment of initial stroke
severity with the Canadian Neurological Scale. Stroke 28, 1181-1184.
411
References
Gompertz, P., Dennis, M., Hopkins, A., and Ebrahim, S. (1994). Development and
reliability of the Royal College ofPhysicians Stroke Audit Form. Age andAging 23,
378-383.
Gompertz, P., Pound, P., Briffa, J., and Ebrahim, S. (1995). How useful are non-
random comparisons of outcomes and quality of care in purchasing hospital stroke
services? Age andAging 24, 137-141.
Gompertz, P. H., Irwin, P., Morris, R., Lowe, D., Rutledge, Z., Rudd, A. G., and
Pearson, M. G. (2001). Reliability and validity of the Intercollegiate Stroke Audit
Package. J.Eval.Clin.Pract. 7, 1-11.
Green, J., Passman, L. J., and Wintfeld, N. (1991). Analyzing hospital mortality. The
consequences of diversity in patient mix. JAMA 265, 1849-1853.
Green, J. and Wintfeld, N. (1993). How accurate are hospital discharge data for
evaluating effectiveness of care? Medical Care 31, 719-731.
Green, J. and Wintfeld, N. (1995). Report cards on cardiac surgeons. Assessing New
York State's approach. N.Engl.J.Med. 332, 1229-1232.
Green, J., Wintfeld, N., Krasner, M., and Wells, C. (1997). In search ofAmerica's
best hospitals. The promise and reality of quality assessment. JAMA 277, 1152-1155.
Green, J., Wintfeld, N., Sharkey, P., and Passman, L. J. (1990). The importance of
severity of illness in assessing hospital mortality. JAMA 263, 241-246.
Green, S. B. and Byar, D. P. (1984). Using observational data from registries to
compare treatments: the fallacy of omnimetrics. Stat.Med. 3, 361-370.
Greenfield, S., Cretin, S., Worthman, L. G., Dorey, F. J., Solomon, N. E., and
Goldberg, G. A. (1981). Comparison of a criteria map to a criteria list in quality-of-
care assessment for patients with chest pain: the relation of each to outcome. Medical
Care 19, 255-272.
Grimshaw, J. and Russell, I. (1993). Achieving health gain through clinical
guidelines. 1 developing scientifically valid guidelines. Quality in Health Care 2,
243-248.
Gulliford, M. C., Petruckevitch, A., and Burney, P. G. J. (1991). Hospital case notes
and medical audit: evaluation of non-response. BMJ 302, 1128-1129.
Hancock, R. J., Oddy, M., Saweirs, W. M., and Court, B. (1997). The RCP stroke
audit package in practice. J.R.Coll.Physicians Lond 31, 74-78.
Hannan, E. L., Racz, M. J., Jollis, J. G., and Peterson, E. D. (1997). Using medicare
claims data to assess provider quality for CABG surgery: does it work well enough?
Health Serv.Res. 31, 659-678.
412
References
Harley, K. and Jones, C. (1996). Quality of Scottish Morbidity Record (SMR) data.
Health Bulletin 54,410-417.
Harrell, F. E., Jr., Lee, K. L., and Mark, D. B. (1996). Multivariate prognostic
models: issues in developing models, evaluating assumptions and adequacy, and
measuring and reducing errors. Stat.Med. 15, 361-387.
Hartz.A.J. and Kuhn, E. M. (1994). Comparing hospitals that perfrom coronary
artery bypass surgery: the effect of outcome measures and data sources. Am.J.Public
Health 84, 1609-1614.
Hartz.A.J., Kuhn, E. M., and Krakauer, H. (1997). The relationship of the value of
outcome comparisons to the number of patients per provider. International Journal
for Quality in Health Care 9, 247-254.
Hasan, M., Meara, R. J., and Bhowmick, B. K. (1995). The quality of diagnostic
coding in cerebrovascular disease. International Journalfor Quality in Health Care
7,407-410.
Heart Protection Study Collaborative Group (2002). MRC/BHF Heart Protection
Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a
randomised placebo-controlled trial. Lancet 360, 7-22.
Hennekens, C. H. and Buring, J. E. (1987). Cohort Stuides. In "Epidemiology in
Medicine", pp. 153-177. (Little, Brown and Company: Boston/Toronto.)
Henon, H., Godefroy, O., Leys, D., Mounier-Vehier, F., Lucas, C., Rondepierre, P.,
Duhamel, A., and Pruvo, J. P. (1995). Early predictors of death and disability after
acute cerebral ishemic event. Stroke 26, 392-398.
Heuschmann, P. U., Berger, K., Misselwitz, B., Hermanek, P., Leflfnann, C.,
Adelmann, M., Buecker-Nott, H-J., Rother, J., Neundoerfer, B., Kolominsky-Rabas,
P. L., for the German Stroke Registers Study Group and for the Competence Net
Stroke (2003). Frequency of thrombolytic therapy in patients with acute ischemic
stroke and the risk of in-hospital mortality. The German Stroke Registers Study
Group. Stroke 34, 1106-1113.
Hoening, H., Duncan, P. W., Horner, R. D., Reker, D. M., Samsa, G. P., Dudley, T.
K., and Hamilton, B. B. (2002). Structure, process and outcomes in stroke
rehabilitation. Medical Care 40, 1036-1047.
Hoening, H., Sloane, R., Horner, R. D., Zolkewitz, M., and Reker, D. (2001).
Differences in rehabilitation services and outcomes among stroke patients cared for
in veterans hospitals. Health Serv.Res. 35, 1293-1318.
Hoeymans, N., Feskens, E. J., Van Den Bos, G. A., and Kromhout, D. (1998). Non-
response bias in a study of cardiovascular diseases, functional status and self-rated
health among elderly men. Age Ageing 27, 35-40.
413
References
Hofer, T. P. and Hayward, R. A. (1996). Identifying poor-quality hospitals. Can
hospital mortality rates detect quality problems for medical diagnoses? Medical Care
34, 737-753.
Hollis, S., Yates, D. W., Woodford, M., and Foster, P. (1995). Standardised
comparison of performance indicators in trauma: a new approach to case-mix
correction. The Journal ofTrauma: Injury, Infection and Critical Care 38, 763-766.
Holloway, R. G., Vickrey, B. G., Benesch, C., Hinchey, J. A., and Bieber, J. (2001).
Development of performance measures for acute ischaemic stroke. Stroke 32, 2058-
2074.
Hopkins, A. (1996). Clinical audit: time for a reappraisal? Journal ofthe Royal
College ofPhysicians ofLondon 30, 415-425.
Hosmer, D. W. and Lemeshow, S. (1995). Confidence interval estimates of an index
of quality performance based on logistic regression models. Stat.Med. 14, 2161-
2172.
Hsia, D. C., Krushat, W. M., Fagan, A. B., Tebbutt, J. A., and Kusserow, R. P.
(1988). Accuracy of diagnostic coding for Medicare patients under the Prospective-
Payment System. N.Engl.J.Med. 318, 352-355.
Hulka, B. S. and Romm, F. J. (1979). Peer review in ambulatory care: use of explicit
criteria and implicit judgements. Medical Care 17, 1-73.
Iezzoni, L. (1990). Using administrative diagnostic data to assess the quality of
hospital care. The pitfalls and potential uses of ICD-9-CM. International Journal of
Technology Assessment in Health Care 6, 272-281.
Iezzoni, L. (1997a). Risk adjustment for measuring health care outcomes. (Health
Administration Press: Chicago, Illinois.)
Iezzoni, L., Daley, J., Heeren, T., Foley, S. M., Hughes, J. S., Fisher, E. S., Duncan,
C. C., and Coffman, G. A. (1994). Using administrative data to screen hospitals for
high complication rates. Inquiry 31, 40-55.
Iezzoni, L. I. (1994). Using risk-adjusted outcomes to assess clinical practice: an
overview of issues pertaining to risk adjustment. Annals ofThoracic Surgery 58,
1822-1826.
Iezzoni, L. I. (1996). 100 apples divided by 15 red herrings: cautionary tale from the
mid-19th century on comparing hospital mortality rates. Annals ofInternal Medicine
124, 1079-1085.
Iezzoni, L. I. (1997b). The risks of risk adjustment. JAMA 278, 1600-1607.
Iezzoni, L. I., Foley, S. M., Daley, J., Hughes, J., Fisher, E. S., and Heeren, T.
(1992). Comorbidities, complicatoins and coding bias. JAMA 267, 2197-2203.
414
References
Indredavik, B, Bakke, F., Slordahl, S. A., Rokseth, R., and Haheim, L. L. (1999).
Treatment in a combined acute and rehabilitation stroke unit. Which aspects are
most important? Stroke 30, 917-923.
International Stroke Trial Collaborative Group. (1997). The International Stroke
Trial (1ST); a randomised trial of aspirin, subcutaneous heparin, both or neither
among 19435 patients with acute ischaemic stroke. Lancet 349, 1569-1581.
Irwin, P. and Rudd, A. (1998). Casemix and process indicators of outcome in stroke.
The Royal College of Physicians minimum data set for stroke. J.R.Coll.Physicians
Lond 32, 442-444.
Jakovljevic, D, Sarti, C., Sivenius, J., Torppa, J., Mahonen, M., Immonen-Raiha, P.,
Kaarsalo, E., Alhainen, K., Kuulasmaa, K., Tuomilehto, J., Puska, P., and Salomaa,
V. (2001). Socioeconomic status and ischaemic stroke. Stroke 32, 1492-1498.
Jencks, S. F., Cuerdon, T., Burwen, D. R., Fleming, B., Houck, P. M., Kussmaul, A.
E., Nilasena, D. S., Ordin, D. L., and Arday, D. R. (2000). Quality ofmedical care
delivered to medicare beneficiaries. A profile at state and national levels. JAMA 284,
1670-1676.
Jencks, S. F., Williams, D. K., and Kay, T. L. (1988a). Assessing hospital-associated
deaths from discharge data. The role of length of stay and comorbidities. JAMA 260,
2240-2246.
Jencks, S. F., Daley, J., Draper, D., Thomas, N., Lenhart, G., and Walker, J. (1988b).
Interpreting hospital mortality data. The role of clinical risk adjustment. JAMA 260,
3611-3616.
Jencks, S. F., Huff, E. D., and Cuerdon, T. (2003). Changes in the quality of care
delivered to Medicare beneficiaries, 1998-1999 to 2000-2001. JAMA 289, 305-312.
Jessee, W. F. and Schranz, C. M. (1990). Medicare mortality rates and hospital
quality: are they related? Qual.Assur.Health Care 2, 137-144.
Jollis, J. G. and Romano, P. S. (1998). Pennsylvania's focus on heart attack - grading
the scorecard. JAMA 338, 983-987.
Jorgensen, H. S., Nakayama, H., Raaschou, H. O., Vive-Larsen, J., Stoier, M., and
Olsen, T. S. (1995). Outcome and time course of recovery in stroke. Part II: time
course of recovery. The Copenhagen Study Group. Arch.Phys.Med.Rehabil. 76, 406-
411.
Justice, A. C., Covinsky, K. E., and Berlin, J. A. (1999). Assessing the
generalisability of prognostic information. Annals ofInternal Medicine 130, 515-
524.
Kahn, K. L., Rogers, W. H., Rubenstein, L. V., Sherwood, M. J., Reinisch, E. J.,
Keeler, E. B., Draper, D., Kosecoff, J., and Brook, R. H. (1990). Measuring quality
415
References
of care with explicit process criteria before and after implementation of the DRG-
based prospective payment system. JAMA 264, 1969-1973.
Kasner, S. E., Chalela, J. A., Luciano, J. M., Cucchiara, B. L., Raps, E. C.,
McGarvey, M. L., Conroy, M. B., and Localio, A. R. (1999). Reliability and validity
of estimating the NIH Stroke Scale score from medical records. Stroke 30,1534-
1537.
Kay, R., Wong, K. S., Perez, G., and Woo, J. (1997). Dichotomizing stroke outcomes
based on self-reported dependency. Neurology 49, 1694-1696.
Kendrick, S. (2001). Using all the evidence: towards a truly intelligent National
Health Service. Health Bull.(Edinb.) 59, 71-76.
Kendrick, S. and Clarke, J. (1993). The Scottish record linkage system. Health
Bulletin 51, 72-79.
King's Fund Consensus Conference. (1988). Treatment of stroke. BMJ 297, 126-128.
Knaus, W. A., Draper, E. A., Wagner, D. P., and Zimmerman, J. E. (1986). An
evaluation of outcome from intensive care in major medical centers. Annals of
Internal Medicine 104 , 410-418.
Kohli, H. S. and Knill-Jones, R. P. (1992). How accurate are SMR1 (Scottish
Morbidity Record 1) data? Health Bull. (Edinb.) 50, 14-23.
Kothari, R. U., Brott, T., Broderick, J. P., and Hamilton, C. A. (1995). Emergency
physicians. Accuracy in the diagnosis of stroke. Stroke 26, 2238-2241.
Kramer, A. M., Kowalsky, J. C., Lin, M., Grigsby, J., Hughes, R., and Steiner, J. F.
(2000). Outcome and utilisation differences for older persons with stroke in HMO
and fee-for-service systems. Journal ofthe American Geriatric Society 48, 726-734.
Kunst, A. E., del Rios, M., Groenhof, F., Mackenbach, J. P., and for the European
Union Working Group on Socioeconmic Inequalities in Health (1998).
Socioeconomic inequalities in stroke mortality among middle-aged men. An
international overview. Stroke 29, 2285-2291.
LaClair, B. J., Reker, D. M., Duncan, P. W., Horner, R. D., and Hoening, H. (2001).
Stroke care:a method for measuring compliance with AHCPR guidelines. American
Journal ofPhysical Medicine & Rehabilitation 80, 235-242.
Laffel, G. and Blumenthal, D. (1989). The case for using industrial quality
management science in health care organisations. JAMA 262, 2869-2873.
Langford, I. H. (1997). Bayesian analysis should be used instead of league tables of
performance. BMJ 314, 73-74.
Langhorne, P. (1995). Developing comprehensive stroke services: an evidence-based
approach. Postgraduate Medical Journal 71, 733-737.
416
References
Langhorne, P. and Dennis, M. (1998). Stroke units: an evidence based approach.
BMJ Books: London.
Langhorne, P., Li Pak Tong, B., and Stott, D. J. (1999). Association between
physiological homeostasis and early recovery after stroke. Stroke 30, 2526-2527.
Langhorne, P. and Pollock, A (2002). What are the components of effective stroke
unit care? Age Ageing 31, 365-371.
Langhorne, P., Wagenaar, R., and Partridge, C. (1996). Physiotherapy after stroke:
more is better? Physiotherapy Research International 1, 75-88.
Langhorne, P., Williams, B. O., Gilchrist, W., and Howie, K. (1993). Do stroke units
save lives? Lancet 342, 395-398.
Laupacis, A., Sekar, N., and Stiell, I. G. (1997). Clinical prediction rules. A review
and suggested modifications ofmethodological standards. JAMA 277, 488-494.
Leatherman, S. and McCarthy, D. (1999). Public disclosure of health care
performance reports: experience, evidence and issues for policy. International
Journalfor Quality in Health Care 11, 93-105.
Leibson, C. L., Naessens, J. M., Brown, R. D., and Whisnant, J. P. (1994). Accuracy
of hospital discharge abstracts for identifying stroke. Stroke 25, 2348-2355.
Lembcke, P. A. (1967). Medical auditing by scientific methods illustrated by major
female pelvic surgery. JAMA 162, 646-655.
Libman, R. B., Wirkowski, E., Alvir, J., and Rao, T. H. (1995). Conditions that
mimic stroke in the emergency department. Implications for acute stroke trials.
Ach.Neurol. 52, 1119-1122.
Lindley, R. I., Amayo, E. O., Marshall, J., Sandercock, P. A., Dennis, M., and
Warlow, C. P. (1995). Hospital services for patients with acute stroke in the United
Kingdom: the Stroke Association survey of consultant opinion. Age Ageing 24, 525-
532.
Lindley, R. I., Waddell, F., Livingstone, M., Sandercock, P., Dennis, M. S., Slattery,
J., Smith, B., and Warlow, C. (1994). Can simple questions assess outcome after
stroke? Cerebrovasc. Dis. 4, 314-324.
Liu, L., Reeder, B., Shuaib, A., and Mazagri, R. (1999). Validity of stroke diagnosis
on hospital discharge records in Saskatchewan, Canada: implications for stroke
surveillance. Cerebrovasc.Dis. 9, 224-230.
Long, A. F. (1997b). Measuring health outcomes - requirements for routine practice.
In 'Health outcomes and evaluations: context, concepts and successful applications'.
(A. F. Long and E. Bitzer Eds. ) pp. 47-57. Universtiy of Leeds: Leeds.
417
References
Long, A. F. (1997a). The role of health outcomes in health care evaluation. In 'Health
outcomes and evaluation: context, concepts and successful applications'. (A. F. Long
and E. Bitzer Eds.) pp. 33-43. University of Leeds: Leeds.
Luft, H. S. and Hunt, S. S. (1986). Evaluating individual hospital quality through
outcome statistics. JAMA 255,2780-2784.
Lyons, T. F. and Payne, B. C. (1974). The relationship of physicians' medical
recording performance to their medical care performance. Medical Care 12, 714-720.
Mallinson, S. (1998). The Short-Form 36 and older people: some problems
encountered when using postal administration. J.Epidemiol.CommunityHealth 52,
324-328.
Malmgren, R., Bamford, J., Warlow, C., Sandercock, P., and Slattery, J. (1989).
Projecting the number of patients with first ever stroke and patients newly
handicapped by stroke in England and Wales. BMJ 29%, 656-660.
Mannion, R. and Davies, H. T. O. (2002). Reporting health care performance:
learning from the past, prospects for the future. J.Eval.Clin.Pract. 8, 215-228.
Mannion, R. and Goddard, M. (2003). Public disclosure of comparative clinical
performance data: lessons from the Scottish experience. J.Eval.Clin.Pract. 9, 277-
286.
Mant, J. (2001). Process versus outcome indicators in the assessment of quality of
health care. International Journalfor Quality in Health Care 13, 475-480.
Mant, J. and Hicks, N. (1995). Detecting differences in quality of care: the sensitivity
ofmeasures of process and outcome in treating acute myocardial infarction. BMJ
311,793-796.
Mant, J. and Hicks, N. R. (1996). Assessing quality of care: what are the implications
of the potential lack of sensitivity of outcome measures to differences in quality?
J.Eval.Clin.Pract. 2, 243-248.
Mant, J., Mant, F., and Winner, S. (1997). How good is routine information?
Validation of coding for acute stroke in Oxford hospitals. Health Trends 29, 96-99.
Marshall, E. C. and Spiegelhalter, D. J. (1998). Reliability of league tables of in vitro
fertilisation clinics: retrospective analysis of live birth rates. BMJ316, 1701-1705.
Marshall, M. N., Shekelle, P. G., Leatherman, S., and Brook, R. H. (2000). The
public release of performance data. What do we expect to gain? A review of the
evidence. JAMA 283, 1866-1874.
Martin, J., Meltzer, H., and Elliot, D. (1988). OPCS surveys of disability in Great
Britain. The prevalence of disability amongst adults. HMSO: London.
Maxwell, R. J. (1984). Quality assessment in health. BMJ 288, 1470-1472.
418
References
Maxwell, R. J. (1992). Dimensions of quality revisited: from thought to action.
Qual.Health Care 1 , 171-177.
McAuliffe, W. E. (1978). Studies ofProcess-Outcome correlations in medical care
evaluations: a critique. Medical Care 16, 907-930.
McCloone, P. (1994) Carstairs scores for Scottish postcode sectors from the 1991
Census. Public Health Research Unit, University of Glasgow, Glasgow.
McDowell, I. and Newell, C. (1996). Measuring Health. A guide to rating scales and
questionnaires.
McKee, M. and Hunter, D. (1995). Mortality league tables: do they inform or
mislead? Quality in Health Care 4, 5-12.
McKee, M. and James, P. (1997). Using routine data to evaluate quality of care in
British hospitals. Medical Care 35, OS102-OS111.
McKee, M., Rafferty, A-M., and Aiken, L. (1997). Measuring hospital performance:
are we asking the right questions? Journal ofthe Royal Society ofMedicine 90, 187-
191.
McKenna, K., Tooth, L., Strong, J., Ottenbacher, K., Connell, J., and Clearly, M.
(2002). Predicting discharge outcomes for stroke patients in Australia. American
Journal ofPhysical Medicine & Rehabilitation 81, 47-56.
McNaughton, H. (1996). Stroke audit in a New Zealand hospital. N.ZMed.J. 109,
257-260.
McNaughton, H., McPherson, K., Taylor, W., and Weatherall, M. (2003).
Relationship between process and outcome in stroke care. Stroke 34, 713-717.
McPherson, K., Wennberg, J. E., Hovind, O. B., and Clifford, P. (1982). Small area
variations in the use of common surgical procedures: an international comparison of
New England, England and Norway. N.Engl.J.Med. 307, 1310-1314.
Miles, A., Bentley, P., Grey, J., and Polychronis, A. (1995). Purchasing quality in
clinical practice; what on Earth do we mean? J.Eval.Clin.Pract. 1, 87-95.
Milne, R. and Clarke, A (1990). Can readmission rates be used as an outcome
indicator? BM/301, 1139-1140.
Mitchell, J. B., Ballard, D. J., Whisnant, J. P., Ammering, C. J., Samsa, G. P., and
Matchar, D. B. (1996). What role do neurologists play in determining the costs and
outcomes of stroke patients? Stroke 27, 1937-1943.
Modan, B. and Wagener, D. K. (1992). Some epidemiological aspects of stroke:




Mohammed, M. A., Cheng, K. K., Rouse, A., and Marshall, T. (2001). Bristol,
Shipman, and clinical governance: Shewart's forgotten lessons. Lancet 357, 463-467.
Moreno, R. and Apolone, G. (1997). Impact of different customisation strategies in
the performance of a general severity score. Critical Care Medicine 25, 2001-2008.
Murray, C. J. L. and Lopez, A. D. (1997a). Mortality by cause for eight regions of
the world: Global Burden ofDisease Study. Lancet 349,1269-1276.
Murray, C. J. L. and Lopez, A. D. (1997b). Global mortality, disability, and the
contribution of risk factors: Global Burden of Disease Study. Lancet 349, 1436-1442.
Naylor, C. D. (1995). Grey zones of clinical practice:some limits to evidence-based
medicine. Lancet 345, 840-842.
Neuhauser, D. (1990). Ernest Amory Codman,M.D., and end results ofmedical care.
International Journal ofTechnology Assessment in Health Care 6, 307-325.
News at Ten and Independent Television News. 9-12-1994. London, UK.
NHS Executive. (1999) Quality and performance in the NHS:clinical indicators.
BMA Books, London.
Normand, S-L. T., Glickman, M. E., Sharma, R. G. V. R. K., and McNeil, B. J.
(1996). Using admission characteristics to predict short-term mortality from
myocardial infarction in elderly patients. Results from the Cooperative
Cardiovascular Project. JAMA 275 , 1322-1328.
Norris, J. W. and Hachinski, V. C. (1982). Misdiagnosis of stroke. Lancet 1, 328-
331.
North American Symptomatic Carotid Endarterectomy Trial Collaborators. (1991).
Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade
carotid stenosis. N.Engl.J.Med. 325, 445-453.
Noseworthy, J. H., Ebers, G. C., Vandervoort, M. K., Farquhar, R. E., Yetisir, E., and
Roberts, R. (1994). The impact of blinding on the results of a randomized, placebo-
controlled multiple sclerosis clinical trial. Neurology 44, 16-20.
O'Connor, G. T., Quinton, H. B., Traven, N. D., Ramunno, L. D., Dodds, T. A.,
Marciniak, T. A., and Wennberg, J. E. (1999). Geographic variation in the treatment
of acute myocardial infarction: the Cooperative Cardiovascular Project. JAMA 17,
627-633.
OMahoney, P. G., Rodgers, H., Thomson, R. G., Dobson, R., and James, O. F. W.




Omoigui, N. A., Miller, D. P., Brown, K. J., Annan, K., Cosgrove, D 3rd., Lytle, P.,
Loop, F., and Topol, E. J. (1996). Outmigration for coronary bypass surgery in an era
of public dissemination of clinical outcomes. Circulation 93, 27-33.
Orchard, C. (1994). Comparing health outcomes. BMJ 308, 1493-1496.
Palmer, R. H. (1997). Process-based measures of quality: the need for detailed
clinical data in large health care databases. Annals ofInternal Medicine 127, 733-
738.
Panayiotou, B. N., Fotherby, M. D., Potter, J. F., and Castleden, C. M. (1993). The
accuracy fo diagnostic coding of cerebrovascular disease. Medical Audit News 3,
153-155.
Parker, C. J., Dewey, M. E., and on behalf of the TOTAL Study Group (2000).
Assessing research outcomes by postal questionnaire with telephone follow-up.
Int.J.Epidemiol. 29, 1065-1069.
Parry, G. J., Gould, C. R., McCabe, C. J., and Tarnow-Mordi, W. O. (1998). Annual
league tables ofmortality in neonatal intensive care units: longitudinal study.
International Neonatal Network and the Scottish Neonatal Consultants and Nurses
Collaborative Study Group. BMJ 316, 1931-1935.
Patel, A. R., Gray, G., Lang, G. D., Baillie, F. G. H., Fleming, L., and Wilson, G. M.
(1976a). Scottish Hospital Morbidity Data. 1. Errors in diagnostic returns. Health
Bull. (Edinb.) 34, 215-220.
Patel, A. R., Hutcheon, A. W., and Wilson, G. M. (1976b). Scottish Hospital
Morbidity Data. 3. Some suggestions for improvement of the accuracy. Health
Bull. (Edinb.) 34,227-228.
Peterson, E. D., DeLong, E. R., Jollis, J. G., Muhlbaier, L. H., and Mark, D. B.
(1998). The effects ofNew York's bypass surgery provider profiling on access to
care and patient outcomes in the elderly. Journal of the American College of
Cardiology 32, 993-999.
Picavet, H. S. (2001). National health surveys by mail or home interview: effects on
response. J.Epidemiol.Community Health 55, 408-413.
Pound, P., Sabin, C., and Ebrahim, S. (1999). Observing the process of care: a stroke
unit, elderly care unit and general medical ward compared. Age Ageing 28,433-440.
PROGRESS Collaborative Group (2001). Randomised trial of a perindopril-based
blood-pressure-lowering regimen among 6105 individuals with previous stroke or
transient ischaemic attack. Lancet 358, 1033-1041.
Radical Statistics Health Group (1995). NHS "indicators of success": what do they
tell us? BMJ 310 , 1045-1050.
421
References
Relman, A. S. (1988). Assessment and accountability. The third revolution in
medical care. N.Engl.J.Med. 319, 1220-1222.
Retchin, S. M., Brown, R. S., Yeh, S. C., Chu, D., and Moreno, L. (1997). Outcomes
of stroke patients in Medicare fee for service and managed care. JAMA 278, 119-124.
Ricci, S., Celani, M. G., La Rosa, F., Vitali, R., Duca, E., Ferraguzzi, R., Paolotti,
M., Seppoloni, D., Caputo, N., and Chiurulla, C. (1991). SEPIVAC: a community-
based study of stroke incidence in Umbria, Italy. J.Neurol.Neurosurg.Psychiatry 54,
695-698.
Roberts, L. and Counsell, C. (1998). Assessment of clinical outcomes in acute stroke
trials. Stroke 29, 986-991.
Rockall, T. A., Logan, R. F. A., Devlin, H. B., Northfield, T. C., for the National
Audit ofAcute Upper Gastrointestinal Haemorrhage (1995). Variation in outcome
after acute upper gastrointestinal haemorrhage. Lancet 346, 346-350.
Rodgers, H., Dennis, M., Cohen, D., Rudd, A., on behalf of the British Association
of Stroke Physicians (2003). British Association of Stroke Physicians: benchmarking
survey of stroke services. Age Ageing 32,211-217.
Romano, P. S. and Mark, D. H. (1994). Bias in the coding of hospital discharge data
and its implications for quality assessment. Medical Care 32, 81-90.
Rosenthal, G. E., Shah, A., Way, L. E., and Harper, D. L. (1998). Variations in
standardized hospital mortality rates for six common medical diagnoses. Implications
for profiling hospital quality. Medical Care 36, 955-964.
Rothwell, P. M. (2000). Interpretation of variations in outcome in audit of clinical
interventions. Lancet 355, 4-5.
Rothwell, P. M., Eliasziw, M., Gutnikov, S. A., Fox, A. J., Taylor, D. W., Mayberg,
M. R., Warlow, C. P., Barnett, H. J., for the Carotid Trialists' Collaboration (2003).
Analysis of pooled data from the randomised controlled trials of endarterectomy for
symptomatic carotid stenosis. Lancet 361, 107-116.
Rothwell, PM. and Warlow, C. (1995). Is self-audit reliable? Lancet 346, 1623.
Rowley, G. and Fielding, K. (1991). Reliability and accuracy of the Glasgow Coma
Scale with experienced and inexperienced users. Lancet 337, 535-538.
Rudd, A. G., Irwin, P., Rutledge, Z., Lowe, D., Wade, D., Morris, R., and Pearson,
M. G. (1999). The national sentinel audit for stroke: a tool for raising standards of
care. J.R.Coll.Physicians Lond 33, 460-464.
Rudd, A. G., Irwin, P., Rutledge, Z., Lowe, D., Wade, D. T., and Pearson, M.
(2001a). Regional variations in stroke care in England, Wales and Northern Ireland:




Rudd, A. G., Lowe, D., Irwin, P., Rutledge, Z., Pearson, M., on behalf of the
Intercollegiate Stroke Working Party (2001b). National stroke audit: a tool for
change? Quality in Health Care 10, 141-151.
Rudd, A. G. and Pearson, M. (2002). National stroke audit. ClinicalMedicine 2, 496-
498.
Ryan, M. P. and Dodd, W. (1993). The measurement of process and the role of
information technology. Proceedings ofthe Royal Society ofEdinburgh 101B, 31-53.
Sackett, D. L., Haynes, R. B., and Tugwell, P. (1985). Clinical Epidemiology A
basic science for clinical medicine. Little, Brown and Company: Boston/Toronto.
Schmulling, S., Grond, M., and Rudolf, J. (1998). Training as a prerequisite for
reliable use ofNIH Stroke Scale. Stroke 29, 1258-1259.
Schwartz, J. S. and Lurie, N. (1990). Assessment ofmedical outcomes. New
opportunities for achieving a long sought-after objective. International Journal of
Technology Assessment in Health Care 6, 333-339.
Scott, C. (1961). Research on mail surveys. Journal ofthe Royal Statistical Society
124, 143-195.
Scottish Intercollegiate Guidelines Network (SIGN). (1997a). Management of
patients with stroke I. Assessment, investigation, immediate management and
secondary prevention. SIGN: Edinburgh.
Scottish Intercollegiate Guidelines Network (SIGN). (1997b). Management of
patients with stroke: II. Management of carotid stenosis and carotid endarterectomy.
SIGN: Edinburgh.
Scottish Intercollegiate Guidelines Network (SIGN) (1997c). Management of
patients with stroke: III. Identification and management of dysphagia. SIGN:
Edinburgh.
Scottish Intercollegiate Guidelines Network (SIGN) (1998). Management of patients
with stroke: IV. Rehabilitation, prevention and management of complications, and
discharge planning. SIGN: Edinburgh.
Secretary of State for Health, Wales Northern Ireland and Scotland. (1989) Working
for Patients. HMSO, London.
Secretary of State for Scotland. (1997) Designed to Care. The Stationery Office,
Edinburgh.
Shapiro, M. F, Park, R. E., Keesey, J., and Brook, R. H. (1994). The effect of
alternative case-mix adjustments on mortality differences between municipal and
voluntary hospitals in New York City. Health Serv.Res. 29, 95-112.
423
References
Sheikh, K. and Mattingly, S. (1981). Investigating non-response bias in mail surveys.
Journal ofEpidemiology and Community Health 35, 293-296.
Shinar, D., Gross, C. R., Mohr, J. P., Caplan, L. R., Price, T. R., Wolf, P. A., Hier, D.
B., Kase, C. S., Fishman, I. G., and Wolf, C. L. (1985). Interobserver variability in
the assessment of neurologic history and examination in the Stroke Data Bank.
Arch.Neurol. 42, 557-565.
Shu, B-P., Lemeshow, S., Hosmer, D. W., Klar, J., Avrunin, J., and Teres, D. (1996).
Factors affecting the performance of the models in the Mortality Probability Model II
system and strategies of customisation: a simulation study. Critical Care Medicine
24, 57-63.
Siemiatycki, J. (1979). A comparison ofmail, telephone, and home interview
strategies for household health surveys. Am.J.Public Health 69, 238-245.
Signorini, D. F. and Weir, N. U. (1999). Any variability in outcome comparisons
adjusted for casemix must be accounted for. BMJ 318, 128.
Silber, J. H. and Rosenbaum, P. R. (1997). A spurious correlation between hospital
mortality and complication rates. Medical Care 35, OS77-OS92.
Silber, J. H., Rosenbaum, P. R., Schwartz, J. S., Ross, R. N., and Williams, S. V.
(1995). Evaluation of the complication rate as a measure of quality of care in
coronary artery bypass graft surgery. JAMA 21A, 317-323.
Skilbeck, C. E., Wade, D. T., Hewer, R. L., and Wood, V. A. (1983). Recovery after
stroke. J.Neurol.Neurosurg.Psychiatry 46, 5-8.
Sloan, M., Kreiger, N., and James, B. (1997). Improving response rates among
doctors: randomised trial. BMJ 315, 1136.
Smeeth, L., Fletcher, A. E., Stirling, S., Nunes, M., Breeze, E., Ng, E., Bulpitt, C. J.,
and Jones, D. (2001). Randomised comparison of three methods of administering a
screening questionnaire to elderly people: findings from the MRC trial of the
assessment and management of older people in the community. BMJ 323,1-7.
Smith, E. J., Ward, A. J., and Smith, D. (1990). Trauma scoring methods.
Br.J.Hosp.Med. 44, 114-118.
Smith, P. (1990). The use of performance indicators in the public sector. Journal of
the Royal Statistical Society 153, 53-72.
Smith, P. (1995). On the unintended consequences ofpublishing performance data in
the public sector. International Journal ofPublic Administration 18, 277-310.
Smith, R. (1998). All changed, changed utterly. British medicine will be transformed
by the Bristol case. BMJ 316, 1917-1918.
424
References
Smith, T. (1994). Clinical outcome measures: medical emergency readmissions.
Health Bulletin 52, 333-341.
Smith, W. C., Crombie, I. K., Campion, P. D., and Knox, J. D. (1985). Comparison
of response rates to a postal questionnaire from a general practice and a research unit.
BMJ(CI in.Res.Ed) 291, 1483-1485.
Smithard, D. G., O'Neill, P. A., Park, C., Morris, J., Wyatt, R., England, R., and
Martin, D. F. (1996). Complications and outcome after acute stroke. Does dysphagia
matter? Stroke 27, 1200-1204.
Spiegelhalter, D. J. (1999). Surgical audit: statistical lessons from Nightingale and
Codman. Journal ofthe Royal Statistical Society 162, 45-58.
Sprague, L. (2002). Contracting for quality; Medicare's quality improvement
organisations. NHPFIssue Brief 1-15.
Starfield, B., Steinwachs, D., Morris, I., Bause, G., Siebert, B. A., and Westin, C.
(1979). Concordance between medical records and observations regarding
information on coordination of care. Medical Care 17, 758-766.
Stegmayr, B. and Asplund, K. (1992). Measuring stroke in the population: quality of
routine statistics in comparison with a population-based stroke registry.
Neuroepidemiology 11 ,204-213.
Stegmayr, B., Asplund, K., Hulter-Asberg, K., Norrving, B., Peltonen, M., Terent,
A., and Wester, P. O. (1999). Stroke units in their natural habitat: can the results of
randomised trials be reproduced in routine clinical practice? Stroke 30, 709-714.
Steiner, M. M., Brainin, M., the participants in the Austrian Stroke Registry for
Acute Stroke Units (2003). The quality of acute stroke units on a nation-wide level:
the Austrian Stroke Registry for acute stroke units. European Journal ofNeurology
10, 353-360.
Sterne, J. A. C. and Davey Smith, G. (2001). Sifting the evidence - what's wrong
with significance tests? BMJ 322,226-231.
Stingele, R., Bluhmki, E., Hacke, W. (2001) Bootstrap statistics ofECASS 2 data:
just another post hoc analysis of a negative stroke trial? Cerebrovasc. Dis. 11, 30-33.
Streiner, D. L. and Norman, G. R. (1989). Health measurement scales. A practical
guide to their development and use. Oxford University Press: Oxford.
Stroke Unit Trialists' Collaboration. (1997a). Collaborative systematic review of the
randomised trials of organised (stroke unit) care after stroke. 5M/314, 1151-1158.
Stroke Unit Trialists' Collaboration. (1997b). How do stroke units improve patient




Taub, N. A., Wolfe, C. D., Richardson, E., and Burney, P. G. (1994). Predicting the
disability of first-time stroke sufferers at 1 year. 12-month follow-up of a
population-based cohort in southeast England. Stroke 25, 352-357.
The Heart Outcome Prevention Evaluation Study Investigators (2000). Effects of an
angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high
risk patients. N.Engl.J.Med. 342, 145-153.
The Intercollegiate Working Party for Stroke (2000). National Clinical Guidelines
for Stroke. Royal College ofPhysicians of London: London.
The Intercollegiate Working Party for Stroke (2002). National Clinical Guidelines
for Stroke: a concise update. Clinical Medicine 2, 231-233.
The National Institute for Neurological Disorders and Stroke rt-PA Stroke Study
Group (1995). Tissue plasminogen activator for acute ischaemic stroke.
N.Engl.J.Med. 333, 1581-1587.
The Secretary of State for Health. (1997) The new NHS modern and dependable.
DOH, London.
Thomas, J. W. and Hofer, T. P. (1998). Research evidence on the validity of risk-
adjusted mortality rate as a measure of hospital quality of care. Medical Care
Research and Review 55, 371-404.
Thomas, J. W. and Hofer, T. P. (1999). Accuracy of risk-adjusted mortality rate as a
measure of hospital quality of care. Medical Care 37, 83-92.
Thomas, J. W. and Holloway, J. J. (1991). Investigating early readmission as an
indicator for quality of care studies. Medical Care 29, 377-394.
Thomas, J. W., Holloway, J. J., and Guire, K. E. (1993). Validating risk-adjusted
mortality as an indicator for quality of care. Inquiry 30, 6-22.
Thomson, R. G., McElroy, H., and Kazandjian, V. A. (1997). Maryland Hospital
Quality Indicator Project in the United Kingdom: an approach for promoting
continuous quality improvement. Quality in Health Care 6, 1-7.
Thorvaldsen, P., Asplund, K., Kuulasmaa, K., Rajakangas, A., Schroll, M., for the
WHO MONICA Project (1995). Stroke incidence, case fatality, and mortality in the
WHO MONICA Project. Stroke 26, 361 -367.
Treurniet, H. F., Essink-Bot, M-L., Mackenbach, J. P., and van der Maas, P. J.
(1997). Health-related quality of life: an indicator of quality of care? Quality ofLife
Research 6 , 363-369.
Tymms, P. and Wiggins, A. (2000). Schools' experience of league tables should
make doctors think again. BMJ 321, 1467.
426
References
van den Bos, G. A. M., Smits, J. P. J. M., Westert, G. P., and van Straten, A. (2002).
Socioeconomic variations in the course of stroke: unequal health outcomes, equal
care? Journal ofEpidemiology and Community Health 56, 943-948.
van Gijn, J. (1992). Measurement of outcome in stroke prevention trials.
Cerebrovasc. Dis. 2, 23-34.
van Straten, A., van der Meulen, J. H. P., van Crevel, H., Habbema, J. D. F., and
Limburg, M. (1997). Quality of hospital care for stroke patients in the Netherlands.
Cerebrovasc. Dis. 7, 251-257.
von Arbin, M., Britton, M., de Faire, U., Helmers, C., Miah, K., and Murray, V.
(1981). Accuracy of bedside diagnosis in stroke. Stroke 12, 288-293.
Wade, D. T. (1995a). Personal physical disability. In 'Measurement in neurological
rehabilitation'. (Ed. Anonymous.) pp. 70-82. Oxford University Press: Oxford.
Wade, D. T. (1995b). Activities ofdaily living (ADL) and extended ADL tests. In
'Measurement in neurological rehabilitation'. (Ed. Anonymous.) pp. 175-194. Oxford
University Press: Oxford.
Wade, D. T. and Hewer, R. L. (1985). Outlook after an acute stroke: urinary
incontinence and loss of consciousness compared in 532 patients. Q.J.Med. 56, 601-
608.
Wade, D. T. and Hewer, R. L. (1987). Functional abilities after stroke: measurement,
natural history and prognosis. J.Neurol.Neurosurg.Psychiatry 50, 177-182.
Walshe, K. and Higgins, J. (2002). The use and impact of inquiries in the NHS. BMJ
325, 895-900.
Wardlaw, J. M. (1994). Controversies in management: computed tomography
provides accurate diagnosis. BMJ 309, 1498-1499.
Wardlaw, J. M., del Zoppo, G., and Yamaguchi, T. (2003). Thrombolysis for acute
ischaemic stroke (Cochrane Review). In 'The Cochrane Library'. Update Software:
Oxford.
Warlow, C. P., Dennis, M. S., Hankey, G. J., Sandercock, P. A. G., Bamford, J. M.,
and Wardlaw, J. (1996). Reducing the burden of stroke and improving public health.
In 'Stroke: a practical guide to management', pp. 632-649. Blackwell Science:
Oxford,UK.
Wasson, J. H., Sox, H. C., Neff, R. K., and Goldman, L. (1985). Clinical prediction
rules. Applications and methodological standards. N.Engl.J.Med. 313, 793-798.
Wattigney, W. A., Croft, J. B., Mensah, G. A., Alberts, M. J., Shephard, T. J.,
Gorelick, P. B., Nilasena, D. S., Hess, D. C., Walker, M. D., Hanley, D. F.,
Shwayder, P., Girgus, M., Neff, L. J., Williams, J. E., LaBarthe, D. R., and Collins, J.
427
References
L. (2003). Establishing data elements for the Paul Coverdell National Acute Stroke
Registry. Stroke 34, 151-156.
Ween, J. E., Alexander, M. P., DEsposito, M., and Roberts, M. (1996). Incontinence
after stroke in a rehabilitation setting: outcome associations and predictive factors.
Neurology 47, 659-663.
Weir, N. U., Sandercock, P. A. G., Lewis, S. C., Signorini, D. F., Warlow, C. P., on
behalf of the 1ST Collaborative Group (2001). Variations between countries in
outcome after stroke in the International Stroke Trial (1ST). Stroke 32, 1370-1377.
Wen, S. W., Hernandez, R., andNaylor, C. D. (1995). Pitfalls in nonrandomized
outcomes studies. The case of incidental appendectomy with open cholecystectomy.
JAMA 274, 1687-1691.
Wennberg, J. E. (2002). Unwarranted variations in healthcare delivery: implications
for academic medical centres. BMJ 325, 961-964.
Wennberg, J. E., Freeman, J. L., and Culp, W. J. (1987). Are hospital services
rationed in New Haven or over-utilised in Boston? Lancet 1, 1185-1189.
Westgren, M., Divon, M., Greenspoon, J., and Paul, R. (1986). Missing hospital
records: a confounding variable in retrospective studies. American Journal of
Obstetrics and Gynaecology 155, 269-271.
Wilkin, A. andMcColl, I. (1987). Surgical audit: the clinician's view. Theoretical
Surgery 1, 195-206.
Wilkin, D. (1987). Conceptual problems in dependency research. Social Science and
Medicine 24, 867-873.
Williams, J. G. and Mann, R. Y. (2002). Hospital episode statistics: time for
clinicians to get involved? Clinical Medicine 2, 34-37.
Williams, L. S., Yilmaz, E. Y., and Lopez-Yunez, A. M. (2000). Retrospective
assessment of initial stroke severity with the N1H stroke scale. Stroke 31, 858-862.
Wilson, K. and Roe, B. (1998). Interviewing older people by telephone following
initial contact by postal survey. J.Adv.Nurs. 27, 575-581.
Wolfe, C. D., Tilling, K., Beech, R., Rudd, A. G., for the European BIOMED Study
of Stroke Care Group (1999). Variations in case fatality and dependency from stroke
in western and central Europe. Stroke 30, 350-356.
Wolfe, C. D. A. (2000). The impact of stroke. British Medical Bulletin 56, 275-286.
World Health Organisation (1980). The International Classification of Impairments,
Disabilities and Handicaps. World Health Organisation: Geneva.
428
References
World Health Organisation (2001). The International Classification ofFunction,
Disability and Health. World Health Organisation: Geneva.
Wyatt, J. C. (1995). Hospital information management: the need for clinical
leadership. BMJ 311, 175-180.
Wyatt, J. C. and Altman, D. G. (1995). Commentary: Prognostic models: clinically
useful or quickly forgotten? BMJ 311, 1539-1541.
Yammarino, F. J., Skinner, S. J., and Childers, T. L. (1991). Understanding mail
survey response behaviour. Public Opinion Quarterly 55, 613-639.
Yao, P., Wiggs, B. R., Gregor, C., Sigurnjak, R., and Dodek, P. (1999). Discordance
between physicians and coders in assignment of diagnoses. InternationalJournalfor
Quality in Health Care 11, 147-153.
Yates, D. W., Woodford, M., and Hollis, S. (1992). Preliminary analysis of the care
of injured patients in 33 British hospitals: first report of the United Kingdom major
trauma outcome study. BMJ 305, 737-740.
Yates, J. M. and Davidge, M. G. (1984). Can you measure performance? BMJ 288,
1935-1936.
Yeoh, C. and Davies, H. (1993). Clinical coding: completeness and accuracy when
doctors take it on. BMJ 306, 972.
Younge, P. A., Coats, T. J., Gurney, D., and Kirk, C. J. C. (1997). Interpretation of
the Ws statistic: application to an integrated trauma system. The Journal ofTrauma:
Injury, Infection and Critical Care 43, 511-515.
Zalkind, D. L. and Eastaugh, S. R. (1997). Mortality rates as an indicator of hospital
quality. Hosp.Health Serv.Adm 42, 3-15.
Zuckerman, A. E., Starfield, B., Hochreiter, C., and Kovasznay, B. (1975).
Validating the content of pediatric outpatient medical records by means of tape-
recording doctor-patient encounters. Paediatrics 56, 407-411.
429
